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Abstract 
 Therapeutic monoclonal antibodies (MAb) are produced as secreted complex glycoproteins from 
mammalian cell systems and represent one of the most important classes of therapeutic medicines for the 
treatment of a variety of human diseases. Their benefit in health care and high economic impact provide 
the driving force for the development of improved production levels with the focus of optimizing clinical 
efficacy. One important issue is the optimization of monoclonal antibody production. A frequent 
approach used to address this challenge is the engineering of mammalian cell lines to increase antibody 
production levels through genetic manipulation. Valuable information can then be obtained by monitoring 
the effects of genetic changes on the biochemistry of the cell associated with MAb production. Global 
protein expression profiling of mammalian cells used for the production of biopharmaceuticals may 
reveal key biochemical characteristics associated with MAb-producing cell lines. A better understanding 
of these characteristics can in turn lead to more rational strategies for cell line and process development. 
   
 The proposed research relates to a larger NSERC Strategic Network (MAbNet) Grant to develop 
and establish a novel platform for the large-scale manufacture of specific glycoforms of therapeutic 
monoclonal antibodies. The efficacy of these recombinant MAbs will be enhanced by the control of their 
glycosylation profiles. The work presented in this thesis will assist MAbNet in meeting their objectives. 
Specifically, we use 2D-Differential In-Gel Electrophoresis (2D-DIGE) to quantify protein expression 
differences between EG2-hFc1-producing Chinese Hamster Ovary cells (CHO-1A7) with its parental cell 
line (CHO-BRI). Here, we identified 34 unique differentially expressed proteins associated with EG2-
hFc1 production that relate to various biological processes including protein processing, carbohydrate 
metabolism, amino acid metabolism, energy metabolism, apoptosis, and cell proliferation pathways. 
 
 The majority of identified significant protein expression changes and their associated metabolic 
processes seem to prioritize energy production in CHO-1A7 cells. Due to the metabolic load of 
recombinant antibody production, the CHO-1A7 cell line attempts to meet the energy requirements 
needed for recombinant protein biosynthesis while maintaining cell viability and efficient protein folding 
mechanisms. 
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A 2-D proteome reference map was also constructed for the CHO-BRI host cell line containing 
131 identified protein spots. The map provides information that will further expand our understanding of 
this particular cell line. It will be a useful tool for studies investigating physiological responses and 
protein expression patterns of CHO-BRI to genetic and environmental perturbations.  
 
The set of identified differentially expressed proteins provides data on the downstream changes in 
protein expression due to genetic manipulation, and furthermore can provide targets for cell-line specific 
optimization of antibody production. The work described in this thesis furthers our understanding of 
antibody production in a specific CHO cell line. 
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Chapter 1 
Introduction 
 The following sections (1.2.1, 1.2.2, 1.2.3 are based on a published review by Raymond Ho and 
Brendan J. McConkey (2011), Modulating glycosylation of recombinant monoclonal antibodies for 
therapeutic applications, Current Topics in Biotechnology, Vol. 6, pages 57-69. [1] 
 
 The concept of a cell can be seen as analogous to a manufacturing plant: an intricate network of 
blueprints and protocols, which are mediated by a number of personnel working in a concerted fashion to 
produce high-value products. As with the manufacture of any goods, it is essential to optimize the 
production process by regulating and fine-tuning the various steps within the production pipeline. This is 
possible by improving our understanding of the complex biological processes - including gene and 
protein expression, metabolism, host cell engineering, and post-translational modifications - that govern 
these biological manufacturing platforms. As a result, not only do commercial industries benefit from 
such research, but groups involved in health care are also impacted due to the availability of these 
products targeted towards therapeutic and diagnostic applications.  
  
 Mammalian cell expression systems are the most widely used manufacturing platform for the 
production of recombinant proteins. A variety of alternative expression systems exist, such as transgenic 
yeasts, fungi, plants, and insect cell lines, that offer some advantages over mammalian systems, such as 
high titers of protein expression and relatively inexpensive growth media [2-14]. However, the 
optimization of cost, productivity, efficacy, and potential for immunogenicity remains a challenging task 
for the biopharmaceutical industry for both mammalian and non-mammalian systems. With the 
advancements in recombinant DNA technology, media design, bioprocessing development, and metabolic 
engineering techniques, Chinese hamster ovary (CHO) cells have become the mammalian cell line of 
choice, and has become the industry's workhorses for nearly 70% of all recombinant therapeutic proteins 
produced today [15]. Significant improvements in protein production in CHO cells have lead to titers up 
to 10 g/L in order to satisfy the growing market demands for recombinant therapeutics [16].  
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1.1 Chinese Hamster Ovary Cells (CHO Cells) 
 CHO cells are a cell line derived from the ovary of the Chinese hamster (Cricetulus griseus), and 
although they are often used in biological and medical research, they are most commonly known for use 
in biopharmaceutical production. The first immortalized chinese hamster ovary cell line was isolated from 
a primary tissue culture by Dr. Theodore T. Puck in 1957 [17]. Since then, several cell lines have been 
derived from the original, including the CHO-K1 cell line, which is a widely used proline-auxotrophic 
strain. The CHO-K1 strain was mutagenized to derive the CHO-DUKX, a cell line with a deletion of one 
dhfr allele, resulting in a deficiency in dihydrofolate reductase (DHFR) activity [18]. Similarly, a deletion 
in both dhfr alleles from the CHO-pro3- strain, another derivative of the original CHO cell line that 
requires proline, yielded the CHO-DG44 cell line resulting in a more stable DHFR-minus cell line [19].  
  
 To develop CHO cell line with the ability to produce a protein of interest, clonal selection is 
performed by co-transfection of the gene of interest with a functional copy of the DHFR gene, followed 
by growth in media devoid of glycine, hypoxanthine, and thymidine. To enhance chances of securing a 
high producing strain, the transgene can be efficiently amplified by culturing transfected CHO cells in 
high levels of methotrexate (MTX), which decreases DHFR activity. The mere presence of an exogenous 
DHFR gene is insufficient for survival; rather, by applying this selection pressure, the transfected CHO 
cells adapt by amplifying the copy number of the DHFR locus, which in turn co-amplifies the transgene 
[15]. 
 
 Several reasons can be attributed to the popularity of CHO cells as a recombinant protein 
manufacturing platform. Firstly, since CHO cells have been developed under Good Manufacturing 
Practice conditions [20], it may be easier to obtain market approval of therapeutic proteins from 
regulatory agencies such as the FDA. Secondly, powerful gene amplification systems allow for increased 
specific productivity in a mammalian system such as CHO cells. Thirdly, CHO cells have greater capacity 
for proper protein folding and appropriate post-translational modifications, producing recombinant 
proteins with glycosylation patterns that are compatible with and similar to those produced in human 
glycoproteins. Finally, CHO cultures can be adapted to and grown in serum-free suspension conditions, 
which can facilitate large-scale batch cultures in bioreactors. The use of serum-free cell culture media 
provides several beneficial reasons over the use of serum-based media including the cost of the serum, the 
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undefined nature of the serum, and the batch-to-batch variability in composition of the serum. 
Additionally, it is less difficult to purify recombinant proteins produced by a cell line from a serum-free 
supernatant [21]. 
1.2 Monoclonal Antibodies   
 CHO cells continue to be the dominant eukaryotic expression system for the production of 
complex recombinant proteins due to a number of reasons including the ability to perform post-
translational modifications and ensure proper folding of the final protein product. As a result, CHO cells 
have become the predominant expression vehicle for the production of recombinant monoclonal 
antibodies (MAbs). 
 
  For therapeutic applications, MAbs represent one of the most important classes of therapeutic 
medicines for the treatment of a variety of human diseases. Their benefit in health care and high economic 
impact provides the driving force for the development of improved production levels with the focus of 
optimizing clinical efficacy. Presently, there are 20 rMAbs licensed and marketed, six of which are 
known as blockbuster therapeutic monoclonal antibody products (i.e. Avastin, Herceptin, Remicade, 
Rituxan, Humira and Erbitux) with more than $25 billion in annual sales [22]. Thus, large-scale processes 
must be established, with respect to bioreactor designs and culture parameters associated with high 
productivity levels, that meet market demands while at the same time reducing costs [23; 24].  
 
 The clinical success of therapeutic antibodies continues to drive development, with a focus on 
optimizing clinical efficacy which may potentially lead to a lowered cost of treatment by reducing the 
dose and duration of treatment. However, optimization of antibodies for production of next-generation 
therapeutics is still a nascent field. 
1.2.1 Structure and Function of MAbs 
Structure 
 Currently licensed MAbs are derived from the immunoglobulin G (IgG) class [22]. In the 
simplest case, the structure of an IgG molecule consists of two identical heavy chains and two identical 
light chains that associate with each other through hydrogen bonding, van der Waals interactions and 
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disulfide linkages (Figure 1-1). Each individual light chain consists of a variable domain (VL) and a 
constant domain (CL), whereas each individual heavy chain consists of a variable domain (VH) and three 
constant domains (CH1, CH2, and CH3). The discrete domains within antibody molecules have various 
functions and may be specifically targeted for genetic manipulation. Two identical Fab fragments, each of 
which contains a light chain and the VH and CH1 domains of the heavy chain, confer antigen specificity. 
Here, the Fv fragment (consisting of the VH and VL regions as depicted in Figure 1-1) houses 
complementarity-determining regions (CDRs) that are highly variable in their amino acid sequences. This 
hypervariable region results in an antibody’s specificity for a single epitope (i.e. the part on an antigen 
recognized by an antibody). The Fc fragment consists of two heavy chain fragments, each containing CH2 
and CH3 domains interlinked through disulfide bonds. The Fc fragment has been shown to confer effector 
function through interactions with lymphocyte receptors (FcγRs) and can subsequently trigger antibody-
dependent cell-mediated cytotoxicity (ADCC), a mechanism by which a cell-mediated immune response 
is activated against target cells [25]. The overall mass of a typical IgG molecule is approximately 150 
kDa. 
 
 
Figure 1-1. Structure of an IgG antibody molecule.  Conventional IgG shown on the left with two 
symmetric Fab (antigen-binding) fragments and one Fc (constant) fragment. Heavy chains (shown in 
blue) and light chains (shown in green) are interlinked by disulfide bonds. Conserved sites of N-
glycosylation occur on Asn297 residues of the heavy chain CH2 domains. Antigen-binding fragments 
shown on the right represent different types of antibodies variants under research and development for 
various therapeutic applications. Fc = crystallisable fragment, Fab = Fragment antigen-binding, Fv = 
Fragment variable, scFv = single-chain fragment variable, VH = Heavy chain [26]. 
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 All human-derived IgG molecules contain a single conserved N-glycosylation site (Asn297) 
within the Fc fragment at each CH2 domain of both heavy chains (Figure 1-1). The presence or absence 
of oligosaccharides at this constant Fc region of an IgG monoclonal antibody has been observed to have a 
profound impact on the antibody’s effector functions and efficacy [27-29]. Oligosaccharides attached in 
the Fab region where antigen binding occurs may also affect antigen specificity [30-32]. Electrospray 
ionization mass spectrometry coupled with endoglycosidases have been used for glycan analysis of both 
Fab and Fc, which may contribute to the development of therapeutic IgG with customized glycan profiles 
[32]. Therefore, it is important to develop methods that allow the production of recombinant MAbs, 
particularly for therapeutics, with specific and consistent glycosylation profiles. 
 
Function  
 Antibodies are a crucial part of the immune system, in which they identify and neutralize foreign 
objects. An antibody is a protein produced by B-cells that recognizes an antigen, a unique part that is 
displayed on the surfaces of foreign and/or potentially harmful invaders such as bacteria and viruses. The 
therapeutic potential of monoclonal antibodies lies in their high specificity to their target antigen. The 
therapeutic antibody initially forms an antigen-antibody immune complex that can directly neutralize its 
target, for example, by blocking a part of the microbe that is essential for its invasion and survival. 
Alternatively, an antibody can tag a microbe for attack by subsequent activation of a series of downstream 
biological cascades, such as antibody-dependent cell-mediated cytotoxicity (ADCC) and complement-
dependent cell cytotoxicity (CDC) that result in the elimination of the target [25].  
  
 In ADCC, surface antigens are bound by antibodies, which then recruit effector cells (e.g. natural 
killer cells, macrophages, neutrophils, and eosinophils) of the immune system that actively lyses the 
target cell. In CDC, the binding of antibodies to surface antigens of a bacteria, for example, initiates 
activation of the complement system, which can eliminate the microbe in one of two ways. First, the 
binding of the antibody marks the microbe for ingestion by phagocytes in a process called opsonization. 
Secondly, components of the complement system forms the membrane attack complex, which are 
transmembrane channels that disrupt the phospholipid bilayer of target cells, resulting in cell lysis and 
death. 
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1.2.2 Glycosylation and its Importance in Protein Therapeutics 
 Glycosylation of proteins is a fundamental biological process, and its impact on mechanisms of 
action, treatment costs, and clinical efficacy in recombinant antibody-based therapeutics research is of 
ongoing interest [25; 33-35]. Glycosylation is a post-translational modification process where varying 
glycan structures are attached to a number of glycosylation sites on a protein. There are two forms of 
glycosylation that can occur on a given protein: N-glycosylation and O-glycosylation. O-linked glycans, 
commonly of the mucin-type, are initially catalyzed by an N-acetylgalactosamine transferase enzyme, 
which transfers an N-acetylgalactosamine to a serine or threonine residue on the fully folded protein and 
confers protein stability [36]. Protein N-glycosylation initially occurs in the endoplasmic reticulum (ER) 
through various sequential oligosaccharide additions or removal before transported to the Golgi apparatus 
for further processing. 
 
 The Golgi N-glycan processing pathways are not always pursued to completion in a reaction 
pathway, resulting in a heterogeneous mixture of glycoprotein products. Many secreted glycoproteins are 
glycosylation pathway intermediates, producing a pool of different glycoforms. For a given glycoprotein, 
the distribution of glycans is collectively referred to as the glycoform profile. Macroheterogeneity refers 
to the variation in the site-occupancy of N-glycans at N-glycosylation sites on a protein. In other words, a 
protein may have multiple N-glycosylation sites, but a particular site may or may not be occupied by an 
N-glycan. A number of aspects can influence macroheterogeneity. For example, a study demonstrated that 
the extent of core N-glycosylation of tissue plasminogen activator is dependent on disulfide bond 
formation. Covalent bonds occur co-translationally in the ER and may hinder the ability of glycosylating 
enzymes to access the particular glycosylation site, leading to macroheterogeneity [37]. By contrast, the 
varying glycan structure within the same glycosylation site of glycoprotein molecules is referred to as 
microheterogeneity and has been broadly investigated in mammalian cell systems used to produce 
recombinant proteins [38]. 
 
 Depending on the types and number of glycan structures attached to a MAb, it has been shown to 
impact its biological properties, including potency [25; 33; 39-42], clearance rate [43-46], solubility [47; 
48], secretion [43], and immunogenicity [43; 49; 50]. For example, a reduction of fucosylation by genetic 
engineering methods have been attributed to enhanced levels of ADCC [25; 33; 51-55]. Similarly, the 
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presence of terminal sialic acid residues on glycan branches extends a glycoprotein’s in vivo circulatory 
half-life [45; 46; 56]. 
 
 For any given glycoprotein, the glycan profile depends on a number of factors including: (i) the 
particular host cell line used and its corresponding complement of glycosylation enzymes [10; 13; 43; 57; 
58]; (ii) medium composition [43; 59]; (iii) culture conditions [60]; and (iv) method of downstream 
processing. In addition, the protein primary structure, such as the number and location of glycosylation 
sites, will directly influence the glycosylation profile [33].  
 
 Thus, numerous strategies have attempted to control and enhance the resulting glycosylation 
patterns of glycoproteins by implementing metabolic control strategies (ie: media supplementation and 
nucleotide sugar precursor feeding) [61-68], employing cell-engineering methods to reduce fucosylation 
[28; 41; 69; 70] in addition to increasing sialylation [45; 46], as well as monitoring cell culture conditions 
[60; 71-75]. 
 
 Due to the impact of varying glycosylation patterns on the pharmacokinetics and efficacy of 
therapeutic recombinant MAbs, a thorough understanding of the glycosylation pathways and the enzymes 
involved is vital for the production of glycoprotein drugs with consistent glycoform profiles. 
1.2.3  Mechanism of Glycosylation 
 During the protein elongation phase of protein translation in the ER, N-glycosylation can occur 
by the transfer of a dolichol-linked oligosaccharide precursor, Glucose3Mannose9N-acetylglucosamine2 
(Glc3Man9GlcNAc2) by oligosaccharyl transferase (OST) to an available consensus sequence Asn-X-
Ser/Thr, where X can be any amino acid except proline (Figure 1-2). In IgG, this consensus sequence is 
conserved at Asn297 within the CH2 domain of the Fc fragment. The oligosaccharides attached are 
composed of a core pentasaccharide with added variable units of fucose, galactose, N-acetylglucosamine 
(GlcNAc) and sialic acid.  
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Figure 1-2. N-glycan Precursor. Glc3Man9GlcNAc2 attached to Asn-X-Ser/Thr consensus sequence. The 
box indicates the core pentasaccharide. 
 
 After attachment of the initial Glc3Man9GlcNAc2 oligosaccharide, this precursor is further 
processed by α-1,2 glucosidase I (Gluc I), which removes the terminal glucose, followed by α-1,3 
glucosidase II  (Gluc II), which sequentially removes the next two glucose monosaccharide subunits. 
Following glycoprotein folding, ER resident mannosidase I (Man I) removes at least one mannose 
monosaccharide from the attached glycans, forming the core structure, before the glycoprotein is actively 
transported to the Golgi apparatus [43; 76] (Figure 1-3). 
 
 The Golgi itself contains several enzyme groups that are involved in the N-glycosylation pathway 
that catalyzes the addition of various sugars to the existing attached glycan structure thereby forming 
high-mannose, hybrid, or complex-type glycans (Figure 1-3). High-mannose structures consist of 
multiple mannose residues attached to the common tri-mannosyl core structure. Complex-type glycans 
have two or more GlcNAc residues as well as variable numbers of galactose and sialic acid residues 
attached to the nonreducing end of the tri-mannosyl core. Finally, the hybrid type has branches of both the 
high-mannose and complex type glycans [8]. The number of branches determines the antennarity of the 
glycan structure. N-acetylglucosaminyltransferase catalyzes the addition of GlcNAc to the mannose 
sugars of the glycan core structure. The terminal ends of the glycan structure can be extended through 
addition of galactose and sialic acid by galactosyltransferase and sialyltransferase respectively. 
Fucosyltransferase catalyzes the addition of fucose to GlcNAc proximal to the protein, or attached to the 
outer arm GlcNAc further down the glycan branch.
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Figure 1-3.Processing of N-Glycans in the Glycosylation Pathway. Enzymes: (a) α-1,2 glucosidase I, (b) α-1,3 glucosidase II, (c) mannosidase 
I, (d) N-acetylglucosaminyltransferase I, (e) mannosidase II, (f) N-acetylglucosaminyltransferase II, (g) β-1,4-galactosyltransferase, (h) α-1,6-
fucosyltransferase, (i) α-2,3-sialyltransferase. Incomplete Golgi transferase reactions often lead to the export of N-glycan intermediates from the 
Golgi resulting in a heterogeneous mixture of glycoforms. Adapted from [43].
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1.3 Proteomics 
 As genomics is associated with the study of genes, proteomics is the large-scale study of proteins. 
In general, proteomics involves the qualitative and quantitative comparative analysis of an organism’s 
complete complement of proteins (i.e. the proteome) to promote our understanding of various biological 
processes. In other words, proteomics involves the analysis of changes in an organism's protein 
expression profile when subjected to various biological perturbations. The utility of proteomic studies is 
realized when, for example, global expression profiling of mammalian cells give insights for genetic 
intervention to possibly create better host cell lines, or even provide rational strategies for cell line and 
process development. 
 
 Coupling large-scale proteomics with mass spectrometry, thousands of proteins can be identified 
from a complex protein extract. For this to be successful, however, sufficient protein separation is 
required for unambiguous identifications. One major approach to protein separation widely used in 
proteomics is the gel-based method known as two-dimensional gel electrophoresis (2D-GE). 
1.3.1 2D-GE 
 Two-dimensional gel electrophoresis (2D-GE) has been a traditional workhorse of proteomics for 
analyzing whole cell proteomes. In this method the proteins are separated on a polyacrylamide gel in two 
separate steps. The first dimension step, isoelectric focusing, separates the proteins horizontally across a 
gel strip according to their isoelectric points (pI). In other words, the proteins are subjected to electric 
currents that cause them to migrate along the pH gradient of the gel strip, and stops at the point where the 
protein has an overall net charge of zero. The second dimension step follows a standard sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) procedure that separates proteins vertically down 
a polyacrylamide gel from the gel strip according to their molecular weight. Following separation, 
proteins are visualized by either Coomassie or silver staining and relevant spots can be subsequently 
identified by mass spectrometry. Ideally, each spot on the resulting gel corresponds to one protein in the 
original proteome. However, this is not always the case due to proteins of similar size, pI, and/or 
fragments that may resolve to the same location on the 2D array. Though 2D-GE is a relatively simple 
visual method for mapping differences in protein expression, this approach is limited due to its low 
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detection sensitivity, poor solubility of membrane proteins, relatively low throughput, and low 
reproducibility of gels [77]. Two-dimension differential in-gel electrophoresis (2D-DIGE) circumvents 
many of the issues associated with traditional 2D-GE, such as reproducibility and limited dynamic range, 
and allows for more accurate and sensitive quantitative proteomic studies.  
1.3.2 2D-DIGE 
 2D-DIGE is an important proteomics technique that allows relative quantitation of each protein 
spot after the simultaneous separation of thousands of proteins within a protein extract. The technique 
relies on the labeling of samples, prior to separation, with one of three spectrally resolvable fluorescent 
CyDyes (Cy2, Cy3, and Cy5), allowing multiplexing of samples into the same gel. Protein spots are 
detected and quantitated based on the intensity of the fluorescent emission when they are scanned with a 
specific wavelength corresponding to each CyDye. The scanned gel images and the corresponding 
intensity values of each protein spot can be analyzed using DeCyder (GE Healthcare, Uppsala, Sweden) 
and subjected to statistical analysis to generate a list of differentially expressed protein spots.  
 
 This system enables the expression levels of two or more different complex protein samples to be 
directly compared on the same 2D gel, which substantially reduces gel-to-gel variability as experienced in 
the traditional method. In addition, the sensitivity of fluorescent labeling is superior compared to 
colorimetric methods. The detection limit is in the order of 150 – 500 pg for a single protein, with a linear 
dynamic range of five orders of magnitude. In comparison, silver-staining has a detection limit of 1 ng of 
protein and  Coomassie Brilliant Blue G250 staining with sensitivity around 10 ng, with linear dynamic 
ranges of one- or two- orders of magnitude [78]. 
 
 Each CyDye DIGE fluor contains an N-hydroxy succinimidyl ester reactive group, which can 
covalently bond with the terminal amino group of lysine side chains forming an amide linkage. A 
minimal labeling method was employed in the present work to ensure that visualized proteins are labeled 
with a single dye molecule only.  The three fluors are mass matched and add approximately 500 Da to the 
labeled protein, and therefore the increase in molecular weight between protein samples remains 
consistent. Additionally, the pI of the protein is maintained upon labeling as all three fluors contain an 
intrinsic charge of +1. In order to maximize the amount of protein available for MS, coomassie-stained 
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preparative gels are generated, and selected protein spots are excised and subjected to protein 
identification via MS. 
1.3.3 Protein Identification via Mass Spectrometry 
 To determine the identity of a protein, the excised gel spot is first subjected to the method of in-
gel digestion, where the protein spot of interest is digested proteolytically. The resulting peptide mixtures 
are then further resolved and enriched by liquid chromatography (LC) or directly analyzed by MS. A 
mass spectrometer consists of three main parts: an ion source for sample ionization to generate gas phase 
ions; a mass analyzer for separation of ions according to their mass to charge (m/z) ratios; and a detector, 
which measures the intensity of the ions [79]. 
 
 Two common ionization methods employed are electrospray ionization (ESI) and matrix-assisted 
laser desorption ionization (MALDI), which produce ions in the gas phase from macromolecules such as 
proteins and peptides. The list of the experimentally measured masses of the resulting proteolytic 
peptides, referred to as a peptide mass fingerprint (PMF), are used as input to search against a protein 
database of predicted masses that would arise from digestion of known proteins. Identification is achieved 
when there is a match between the PMF of the target protein and a specific protein candidate in the 
database. However, very little structural information can be gained from the simple mass spectrum 
obtained from one round of MS [80].  
 
 In tandem MS, the ionized peptides (parent ions) from the first round of MS are selected and 
fragmented via bombardment with an inert gas, resulting in fragmented ions (daughter ions), generating 
MS/MS spectra that reveals structural information that is related to the sequence of the peptide [79]. This 
MS/MS data can be used by algorithms such as PEAKS [81] to sequence the target peptides by method of 
de novo sequencing.  
 
 Due to the lack of available genomic information, previous CHO proteomic studies were 
performed by searching against protein databases of related species including Mus musculus (mouse), 
Rattus norvegicus (rat) and Homo sapiens, though this leads to a reduction in stringency for the protein 
identifications. In 2011, the first draft genomic sequence of the CHO-K1 cell line was published [82], 
simplifying CHO proteomic analyses. The 2.45 gigabase long genome features 24,383 predicted genes on 
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21 chromosomes. The availability of the CHO genomic sequence facilitated a complementary large-scale 
proteomic study in which 6164 proteins were identified [83]. Additionally, another study showed a 
considerable improvement in both the number of proteins identified and the confidence of those 
identifications by searching against a CHO-specific protein database [84]. The new sequence information 
thus paves the way for improved interpretation of proteomic results from CHO cells. 
1.3.4 Data Analysis Using PEAKS Studio 5.3 Proteomic Mass Spectrometry Software 
 PEAKS Studio 5.3 is a complete software package that is commercially available from 
Bioinformatics Solutions Inc (ON, Canada) for proteomics mass spectrometry data analysis. It can 
incorporate raw mass spectrometry data from all major mass spectrometry vendors, and analysis is 
performed in a user-friendly easy-to-use graphical interface. PEAKS is an effective tool for peptide and 
protein identification by employing multiple analytical algorithms such as the combination of auto de 
novo sequencing with database searching. The inChorus tool, which combines the search results of 
multiple search engines, can help improve the overall protein coverage as well as the confidence of 
protein identification. The software can also characterize PTMs and potential mutations. For a target 
organism that does not have a protein database, the SPIDER tool performs homology searches on a 
database of a closely related species. Additionally, data resulting from a variety of quantitative proteomic 
techniques (ICAT, iTRAQ, SILAC, LFQ, and user defined labels) can also be analyzed. Finally, PEAKS 
can handle large datasets by utilizing high-throughput workflows (Figure 1-4) whereby multiple tasks 
can be set to run automatically upon the completion of a previously assigned task. Results can then be 
visualized, validated, and reported. 
 
 Peptide de novo sequencing is PEAKS' best-known function, whereby a peptide sequence is 
derived directly from tandem mass spectra, without the use of a protein database. The de novo sequencing 
algorithm of PEAKS was evaluated and compared with four other commonly used algorithms, and was 
found to perform best with the greatest sensitivity in analyzing QSTAR and LCQ mass spectrometer data 
[85]. For each amino acid in the de novo sequence, a local confidence score that ranges from 0% to 99% 
is assigned, indicating how confident the algorithm is with a particular amino acid at a particular position. 
The ALC score is the average of all the local confidence scores of each individual amino acid within a 
peptide sequence, and this reflects the average correct ratio of amino acids in the sequence. The TLC 
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score reflects the expected total number of correct amino acids in a particular sequence. The two 
aforementioned measurements can be used to evaluate the correctness of the de novo peptide sequence. 
 
Figure 1-4. PEAKS General MS Data Analysis Workflow. Filtered raw MS scans undergo de novo 
sequencing followed by database searching for peptide and protein identifications. Further searches and 
refinement can also be performed with the SPIDER and PTM identification tools. 
(http://www.bioinfor.com/peaks/features/overview.html) 
  
 By incorporating PEAKS' de novo sequencing results into the PEAKS DB search tool, the 
accuracy and sensitivity of the peptide identification is significantly improved [86]. PEAKS DB functions 
by the conventional database search approach where a corresponding spectrum is searched against a 
database of known spectra. The accuracy is measured by the false discovery rate (FDR), which reports the 
expected percentage of false positives in all identifications above the score threshold within a given 
dataset. Typically, PEAKS DB is run in conjunction with a target-decoy database to estimate the FDR. 
This method combines a target database with a decoy database of the same size. The search is then 
conducted on the two combined databases and the number of false positives can be estimated by the 
search engine's outcome. The user can define the FDR score threshold such that increasing the score 
would increase accuracy. However, this will at the same time reduce sensitivity. Therefore, the setting for 
the FDR score threshold needs to be considered with respect to an acceptable expected number of false 
positives. 
 
 15 
 
 The inChorus function is another useful tool that combines the database search results of PEAKS 
DB with other search engines (Mascot, X!Tandem, Omssa, and Proteome Discoverer (Sequest)) as shown 
in Figure 1-5. Since the search engines use independent algorithms, they can be used to confirm each 
other's results. As a consequence, the confidence of the identification as well as the overall coverage is 
enhanced. Result validation by employing the FDR is also applied to determine each engine's contribution 
to the final result. PEAKS offers a summary view that provides a comprehensive visual examination of 
the analysis results with subsequent result statistics. Score thresholds can also be specified in the 
summary view to quickly and efficiently filter results. Final filtered results can be exported for 
publication or result sharing with non-PEAK users. 
 
 
Figure 1-5. PEAKS inChorus Multi-Engine ID Tool. A built-in tool that combines the results from 
different database search engines to enhance the accuracy and sensitivity of peptide identifications. 
(http://www.bioinfor.com/peaks/features/inchorus.html) 
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Chapter 2 
Comparative Proteomic Analysis of Antibody-Producing CHO Cells 
2.1 Introduction 
 The present work provides a better understanding of the in vivo biochemical changes within CHO 
cells that are involved in recombinant protein production via a proteomics approach. The parental non-
producing strain, termed CHO-BRI developed at the Biotechnology Research Institute (Montreal, 
Canada), was derived from the CHO-DXB11 subtype, a cell line lacking dihydrofolate reductase activity. 
Transfection of CHO-BRI resulted in a cell line that expresses a chimeric heavy chain camelid MAb 
known as EG2-hFc1. This recombinant cell line was termed CHO-1A7. The objective of performing a 
comparative proteomic analysis is to study systemic changes at the protein level between CHO-BRI and 
CHO-1A7 and to identify important mechanisms related to these changes that are associated with EG2-
hFc1 production. Differentially expressed proteins will be examined and identified. These may include 
proteins that are related to protein translation and protein folding machinery as a response to the 
production of a recombinant product.  
 
 EG2-hFc1, as described previously by Zhang et al. (2009), is a chimeric heavy chain antibody 
constructed by fusing a single domain portion named EG2 to the fragment crystallizable region of human 
IgG1 (hFc1), resulting in a bivalent 84 kDa construct [87]. The EG2 domain originates from a heavy 
chain antibody collection that is produced in Camelidae (llamas, camels, alpacas) immunized with a 
variant of EGFR, a protein that is widely known as a tumor marker [88]. Features of camelid single 
domain antibodies include high thermostability [89], relatively high proteolytic resistance [90], high 
expression yields in various expression systems[87], and relatively small size, making them ideal 
candidates as therapeutic agents. Although this kind of antibody lacks a light chain and is composed of a 
heavy chain dimer only, it is fully functional in antigen recognition.  
 
 EG2-hFc1 targets cells that express a receptor tyrosine kinase known as epidermal growth factor 
receptor (EGFR). EGFR plays a fundamental role in the control of certain cellular processes including 
growth, proliferation, and angiogenesis; and mutations in the EGFR gene are associated with a variety of 
human cancers [91-93]. A recent in vivo study tested the tumour-targeting properties of EG2-hFc to 
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glioblastoma tumours. The study demonstrated high apparent affinity of EG2-hFc1 to EGFR (sub-nM 
range), long plasma half-life and slow clearance rate (12 hours), and enhanced tumour penetration [93]. 
These results suggest that EG2-hFc1 may be an excellent therapeutic candidate for targeting EGFR-
overexpressed cells in various tumours. As such, it is important to implement strategies to enhance both 
the specific productivity and quality of EG2-hFc1 in CHO cells, particularly if it is to be used as a 
therapeutic agent. 
 
 By performing a comparative proteome analysis between CHO-BRI (non-producer) and CHO-
1A7 (EG2-hFc1-producer), the cellular proteins identified associated with EG2-hFc1 production may 
provide potential cell-engineering targets in an attempt to develop more efficient CHO cell expression 
systems. Additionally, the protein expression patterns can be correlated with particular glycoform profiles 
associated with the CHO-1A7 strain. 
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2.2 Materials and Methods 
2.2.1 Cell Lines 
 Cell lines were kindly provided by Dr. Yves Durocher at the Biotechnology Research Institute 
(BRI) (Montréal, Canada). The CHO-1A7 cell line was engineered for the stable expression of the 
chimeric heavy chain antibody EG2-hFc1. It originates from CHO-BRI cells that are a suspension-
adapted and serum-free subtype of DXB11-CHO cells, a cell line lacking dihydrofolate reductase activity 
[18; 94].  
 
 The development of the cell lines, cell culture and transfection was contributed by Mr. Igor Slivac 
from Dr. Yves Durocher's lab at the BRI. The cell line was cultured in suspension culture conditions 
inside a humidified incubator at 37
o
C and 5% of CO2. The EG2-hFc1 cDNA was cloned into the pTT44 
vector,  which is a modified pTT5 vector [95] containing a puromycin expression cassette. The sequence 
expressing EG2-hFc1 is under the control of a cytomegalovirus (CMV) promoter. The parental strain of 
CHO-BRI cells (at density 2.0 x 10
6 
cells/ml and 99% viability) were transfected with the linearized 
construct pTT44-EG2hFc1 using PEImax as a transfection reagent in 2 ml of CD DG44 media 
(Invitrogen, ON, Canada). The following day, the cells were put under puromycin selection (10 g/ml) 
until the pool of resistant transfectants finally reached 80-90% viability. Single cell dilution in 96-well 
plates was applied to isolate the best-producing clone. After routine microscopic investigation of the 
colony development and a dot blot analysis, the clone named CHO-1A7 was chosen and expanded for 
cryopreservation. The clone was found to have a specific growth rate of about 0.03 h
-1 
and a doubling 
time of around 24 hours.
 
Clone stability was subsequently assessed by continuous maintenance of 25 ml 
cell culture for 64 days in PowerCHO-2CD media (Lonza, ON, Canada) supplemented with glutamine (8 
mM). During 8 days batch cultivation, the volumetric productivity was 50-60 mg/l of EG2-hFc1. 
 
 Culture media samples from parental CHO-BRI cells and the newly established CHO-1A7 cell 
line that constitutively produces EG2-hFc1 were harvested after 8 days of batch cultivation. Six parallel 
cultivations were carried out in 250 mL shaker flasks (Corning) for both cell lines. PowerCHO-2CD 
culture medium was inoculated at 0.25 x 10
6
 cells/mL with highly viable cells (99%) in exponential 
growth phase for both cell lines. The shaker flasks, each containing 60 mL of cell culture, were kept in 
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suspension culture (120 rpm) in a humidified incubator at 37°C with 5% CO2 for eight days. Both cell 
lines and their replicates were grown under the same culture conditions. Cell density and viability were 
routinely checked every other day. On day 8, culture media samples were harvested (at density 6.75 x 10
6
 
cells/mL for CHO-BRI, and 7.50 x 10
6
 cells/mL for CHO-1A7), clarified by centrifugation and filtered 
through a 0.45 m membrane. Cell pellets were collected and kept frozen until analysis. 
2.2.2 Cell Lysis and Protein Extraction 
 Frozen cell pellets from each cell line were obtained from the BRI (Montréal, Canada). 
Approximately 2 x 10
7
 cells were pelleted at 1000 rpm for 5 minutes, followed by aspiration and removal 
of the growth media. The resulting cell pellet was washed three times with sterile ice cold 1X phosphate-
buffered saline (PBS) solution (137mM sodium chloride (NaCl) (Merck, Darmstadt, Germany), 2.7mM 
potassium chloride (KCl) (VWR, Mississauga, Canada), 10mM sodium phosphate dibasic (Na2HPO4) 
(Merck, Darmstadt, Germany), 17.6mM potassium phosphate monobasic (KH2PO4) (BioShop Canada 
Inc., Burlington, Canada). During each wash, the PBS-cell mixture was centrifuged at 1000 rpm for 5 
minutes followed by the removal of the PBS wash buffer. After the third wash, cell pellets were stored at 
-80
o
C or immediately lysed as described below.  
  
 For whole cell protein extraction, the cell pellets were re-suspended in 500 μL lysis buffer 
containing 7M urea (Fisher, ON, Canada), 2M thiourea (Fisher, ON, Canada), 50mM Tris pH 8.0 (Fisher, 
ON, Canada), 4% CHAPS (3-[(3-Cholamidopropyl) dimethylammonio]-1-propanesulphonate) (Fisher, 
ON, Canada), and 15µL protease inhibitor cocktail (Sigma, ON, Canada). Cell suspensions were then 
vortexed and homogenized by sonication (Microson Ultrasonic Cell Disrupter, Misonix, NY, USA) two 
times for 30 seconds each at a power level of 4 at 4
o
C. Following sonication, the cell homogenates were 
incubated on a rotator at 4
o
C for 3.5 hours to ensure complete cell lysis. The samples were clarified by 
centrifugation for 30 minutes at 14,000 rpm at 4
o
C to remove insoluble cell debris. The protein-containing 
supernatants were transferred into new microcentrifuge tubes and stored at -20
o
C until protein 
concentration determination.  
  
Bio-Rad Protein Assay  
 The protein concentrations were measured using the Bio-Rad protein assay (Bio-Rad 
Laboratories LTD, ON, Canada), which is based on the Bradford method [96]. For each Bio-Rad protein 
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assay run, a linear standard curve was constructed using bovine serum albumin (BSA) (Sigma, ON, 
Canada) as a standard at concentrations of 2, 4, 6, 8, and 10μg/mL. The protein samples and BSA 
standards were measured in triplicates to ensure accuracy of the assay. The absorbances were measured at 
595nm (Varian Cary 50 Bio UV-Visible Spectrophotometer), and the protein concentrations were 
calculated. 
2.2.3 Protein Sample Clean-Up  
 To remove interfering substances such as detergents, salts, lipids, phenolics and nucleic acids, the 
protein sample was subjected to the Amersham 2-D Clean-Up Kit (GE Healthcare, Uppsala, Sweden). A 
volume of 200μL containing approximately 400μg of protein was added to 450µL of precipitant, 
vortexed, and incubated on ice for 15 minutes. Following incubation, 450µL of co-precipitant was added 
to the sample mixture and briefly vortexed. The sample was then centrifuged at 14,000 rpm for 5 minutes 
at 4
o
C and the supernatant was removed. 40µL of co-precipitant was then added to the pellet, incubated 
on ice for 5 minutes, followed by centrifugation at 14,000 rpm for 5 minutes at 4
o
C. The supernatant was 
removed and the resulting pellet was re-suspended in 40µL of MilliQ water, 1mL of wash buffer, and 
5µL of wash additive. The sample was then vortexed and incubated for 40 minutes at -20
o
C, vortexing 
every 10 minutes. After incubation, the sample was centrifuged for 5 minutes at 14,000 rpm and the 
supernatant was removed. The pellet was then re-suspended in 100µL lysis buffer and incubated at room 
temperature for 1 hour to ensure complete re-suspension.  
  
 The protein concentration of the above samples, which were subjected to the protein sample 
clean-up procedure, were determined by the Bio-Rad protein assay as per the protocol outlined in Section 
2.2.1. Hence, the protein concentration of the samples were determined before and after sample clean-up. 
2.2.4 Two-Dimension Differential In-Gel Electrophoresis 
2.2.4.1 Protein Sample Labeling  
 Two-Dimension Differential In-Gel Electrophoresis (2D-DIGE) was employed to detect 
differentially expressed proteins. Six biological replicate gels were prepared for comparative proteomic 
analysis between CHO-1A7 and CHO-BRI cell lines. Table 2-1 shows the labeling strategy adopted in 
the present work. For each gel, 2 protein samples and an internal standard were each labeled with a 
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different CyDye DIGE Fluor minimal dye (GE Healthcare, Uppsala, Sweden). The internal standard was 
generated by pooling an equal amount of all protein samples and was used to aid in spot-matching in a 2-
D image analysis software. Potential dye bias was taken into account by employing a dye swap procedure 
during the labeling of protein replicates (Table 2-1). 
 
Table 2-1. 2D-DIGE Experimental Design. 
Gel # Cy3 Cy5 Cy2 
1 CHO-1A7-1 CHO-BRI-1 Internal Std 
2 CHO-1A7-2 CHO-BRI-2 Internal Std 
3 CHO-1A7-3 CHO-BRI-3 Internal Std 
4 CHO-BRI-4 CHO-1A7-4 Internal Std 
5 CHO-BRI-5 CHO-1A7-5 Internal Std 
6 CHO-BRI-6 CHO-1A7-6 Internal Std 
 
 Fifty μg of each protein sample was labeled with 1µL of 200pmol/µL CyDye DIGE Fluor 
minimal dye according to Table 2-1. Following labeling, the samples were incubated on ice in the dark 
for 30 minutes. To stop further labeling, 1µL of 10mM lysine was added, vortexed, and incubated on ice 
in the dark for 10 minutes. The three protein sample tubes were then combined for a total of 150µg 
protein mixture loaded per gel. Finally, sufficient rehydration buffer (7M urea (Fisher, ON, Canada), 2M 
thiourea (Fisher, ON, Canada), 4% CHAPS (Fisher, ON, Canada), 20 mM dithiothreitol (DTT) (Fisher, 
ON, Canada), 0.5% pH 3-10 IPG buffer ampholytes (GE Healthcare, Uppsala, Sweden)) was added to the 
combined protein mixture for a total sample volume of 450µL per gel. 
2.2.4.2 First Dimension Separation 
Gel Strip Rehydration 
 The combined protein samples containing rehydration buffer were each pipetted onto individual 
lanes on the Immobiline Drystrip Reswelling Tray (GE Healthcare, Uppsala, Sweden). Immobiline 
DryStrip, pH 3-10NL, 24cm immobilized pH gradient (IPG) gel strips (GE Healthcare, Uppsala, Sweden) 
were warmed at room temperature for 5 minutes and then applied to a lane of the reswelling tray, gel side 
down. The strips were placed on the surface of the sample solution and adjusted so that any air bubbles 
were removed and the gel was fully coated with sample. Approximately 2.5mL of PlusOne DryStrip 
Cover Fluid (GE Healthcare, Uppsala, Sweden) was added to each lane to prevent gel drying and urea 
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crystallization. The reswelling tray was verified to be level with the surface and then wrapped with 
aluminum foil. The strips were allowed to rehydrate in the dark overnight, from 12 to 20 hours maximum. 
 
Isoelectric Focusing 
 First-dimensional isoelectric focusing (IEF) was performed using the Ettan IPGphor II system 
(GE Healthcare, Uppsala, Sweden) at 20
o
C. First, a ceramic manifold tray (GE Healthcare, Uppsala 
Sweden) was placed atop the Ettan IPGphor II apparatus, which was then overlaid with 130mL of 
PlusOne DryStrip Cover Fluid (mineral oil) (GE Healthcare, Uppsala, Sweden). The strips were removed 
from the reswelling tray and transferred to the ceramic manifold tray with the gel side facing up. The 
strips were aligned so that the black lines at the top of the gel were just below the top dot of the ceramic 
manifold. Two paper wicks, each wetted with 150µL MilliQ water, were partially placed over the + and – 
ends of the strip. Once all the strips were positioned, electrodes were placed on top of the tray so that they 
were in contact with the paper wicks and the top surface of the IEF apparatus. IEF was carried out using 
the following protocol: 
 Step 1. 100V (1 hr) 
 Step 2. 500V (2 hr) 
 Step 3. Gradient to 1000V (2 hrs) 
 Step 4. Gradient to 3000V (3 hrs) 
 Step 5. 3000V (2 hrs) 
 Step 6. Gradient to 8000V (3 hrs) 
 Step 7. 8000V (10:00 hrs) 
 Step 8. 500V (24 hrs) 
 IEF was completed at Step 7 and the strips were maintained at 500V until second dimension 
separation. 
2.2.4.3 Second Dimension Separation 
Gel Casting 
 All DIGE non-fluorescent clear glass plates, plastic spacers (sheets and blocks), and gel caster 
were washed thoroughly using MilliQ water with Sparkleen detergent (Fisher, ON, Canada) and 
deionized (DI) water. They were further rinsed with 70% ethanol then methanol and wiped dry with 
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KimWipes. For each gel, a plate sandwich was made by aligning and pressing a large and a short plate 
together firmly while ensuring the edges were straight. The plate sandwiches and plastic spacers were 
added alternatively into the DALTsix gel caster (GE Healthcare, Uppsala, Sweden). Plastic spacers were 
added to ensure the plates sit flush with the height of the edge of the gel caster. Spacer blocks were used 
when there were less than 6 plate sandwiches. To complete assembly, the faceplate was added and 
tightened with screws. On both sides of the faceplate, six spring clamps were used to completely seal the 
gel caster. 
  
 Fresh 12% polyacrylamide gel solution (30% acrylamide mix (BioShop Canada Inc., Burlington, 
Canada), 1.5M Tris pH 8.8 (Fisher, ON, Canada), 10% sodium dodecyl sulfate (SDS) (BioShop Canada 
Inc., Burlington, Canada), 10% ammonium persulfate (Fisher, ON, Canada), tetramethylethylenediamine 
(TEMED) (Sigma, ON, Canada)) was made after the gel caster had been assembled and immediately 
poured into the gel caster, ensuring air bubbles were removed and the gel solution was level within the 
caster. More gel solution was added until the gel level was 0.5cm below the lower edge of the short plate. 
To prevent the gel from drying, 2mL of MilliQ water was layered ontop of the gel between the plate 
sandwiches. Once the gels solidified, the gel caster was disassembled and the plate sandwiches were 
removed and rinsed with DI water to eliminate any gel residues. The top surfaces of the gels were layered 
again with DI water and the outer surfaces dried until ready for use in second dimension separation. 
 
Equilibration 
 Following completion of IEF, the strips were removed and placed in an equilibration tube with 
the plastic side in contact with the tube. Each strip was reduced in 10mL equilibration buffer (6M urea 
(Fisher, ON, Canada), 30% glycerol (Fisher, ON, Canada), 50 mM Tris, pH 8.8 (Fisher, ON, Canada), 2% 
SDS (BioShop Canada Inc., ON, Canada)) with 1% w/v DTT (Fisher, ON, Canada) for 15 minutes, 
followed by alkylation in 10mL equilibration buffer with 2.5% w/v iodoacetamide (IAA) (Sigma, ON, 
Canada) for 15 minutes.  
 
Electrophoresis 
 Following the equilibration step, each immobilized pH gradient (IPG) strip was inserted into a 
plate sandwich and aligned with the top edge of the gel. Bubbles between the strip and the gel were 
removed. The water layer on top of the gel was then decanted and replaced with an agarose sealing 
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solution (25mM Tris base (Fisher, ON, Canada), 192mM glycine (Fisher, ON, Canada), 0.1% SDS 
(BioShop Canada Inc., Burlington, Canada), 0.5% agarose (BioShop Canada Inc., Burlington, Canada), 
0.002% bromophenol blue (Fisher, ON, Canada)). A maximum of 6 gel plate sandwiches were placed 
into the cassette carrier, and any unused slots were filled with spacer blocks. The upper buffer chamber 
was fitted firmly onto the carrier. Prior to inserting the cassette carrier assembly, the lower buffer 
chamber of the DALTsix Electrophoresis unit (GE Healthcare, Uppsala Sweden) was filled with 4.5L of 
1X running buffer (25mM Tris base (Fisher, ON, Canada), 192mM glycine (Fisher, ON, Canada), 0.1% 
SDS (BioShop Canada Inc., Burlington, Canada)) and cooled to 10
o
C using the MultiTemp III 
Thermostatic Circulator (GE Healthcare, Uppsala, Sweden). Once the 1X running buffer was cooled to 
the desired temperature, the cassette carrier assembly was then positioned in the electrophoresis unit. The 
upper buffer chamber was filled with 2X running buffer (50 mM Tris base (Fisher, ON, Canada), 384mM 
glycine (Fisher, ON, Canada), 0.2% SDS (BioShop Canada Inc., Burlington, Canada)) above the "MIN" 
line indicator. The gel apparatus lid was added and electrophoresis began at 1 watt/gel for 30 minutes. 
After half an hour, the settings were increased to 17.5 watts/gel and electrophoresis continued until the 
blue dye front was about 0.5cm away from the bottom of the gel. The 2D-DIGE gel plate sandwiches 
were removed from the cassette carrier, rinsed with DI water and wiped dry prior to gel scanning. 
2.2.4.4 Gel Scanning and Analysis  
 The plate sandwiches containing 2D-DIGE gels were scanned under fluorescence acquisition 
mode using the Typhoon 9400 scanner (GE Healthcare, Uppsala Sweden). The PMT was set to 575V and 
the scanning resolution was set to 200µm with a focal plane of +3mm. The filters used for each channel 
were: 580 BP30 Cy3 and 670 BP30 Cy5.  
   
 All the resulting gel images were cropped to the same size using PDQuest Advanced 2-D 
Analysis Software v8.0.1 (Bio-Rad Laboratories LTD, ON, Canada) and then uploaded into DeCyder 
v7.0 software (GE Healthcare, Uppsala, Sweden). The gel images were first processed in the DeCyder 
Differential In Gel Analysis (DIA) module by detecting the number of spots per gel image. The spot 
detection procedure uses an arbitrary number inputted by the user to guide the detection. The estimate 
number was set to 2500 to detect as many spots as possible on a gel image. Gel-to-gel matching was then 
performed by matching detected spots across all gel images using the DeCyder Biological Variation 
Analysis (BVA) module. Only spots that matched across all six replicate gels were considered and these 
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were assigned master spot numbers that could be shared between gels. Their relative spot intensity levels 
were extracted from DeCyder v7.0 and imported into the statistical package R v2.12.0 [97] for statistical 
analysis. 
 
Statistical Analysis using R 
 Differences in protein abundance were assessed based on the intensity ratios of the paired 
samples. However, dye bias may arise due to differences between the labeling efficiencies or scanning 
properties of the fluors. As such, the spot intensity levels must first be normalized to adjust for effects 
arising from variation in the experimental system rather than from biological differences between protein 
samples. R was used for normalization as well as to generate a spot-picking list composed of proteins that 
showed a statistically significant change in relative protein abundance (paired t-test; FDR corrected p < 
0.05). 
 
 Intra-gel normalization was first performed on the relative spot intensity levels of all spots within 
a particular gel image to account for dye bias. The underlying assumption is that the bulk of the signals 
between two treatments to be compared should have signal intensities that are closely matched, and that 
biological differences should only be seen in a small proportion of proteins. The method of normalization 
was based on LOESS normalization [98]. To achieve this, an MvA plot was generated by plotting the log-
transformed sum intensity of the two signals in each channel (Cy3, Cy5) against the log-transformed 
difference between those signals (x-axis: log2 (Cy5) + log2 (Cy3); y-axis: log2 (Cy3) - log2 (Cy5)). The 
smoothing function LOESS, which uses a locally weighted least squares estimate of a regression fit, was 
used to fit a regression line to this data plot. The function operates by taking small sections of the data at a 
time and fitting a linear regression line to that area of data. This function is then applied using a moving 
window strategy across the whole intensity range. By performing the smoothing function, each window 
undergoes local fitting that is adjusted by its relevant scaling factor. The result is a smoothed curvilinear 
regression line that represents the deviation of the data away from the zero axis. With the above 
assumption in mind, this deviation is due to experimental artefact rather than biological differences. As 
such, a correction was applied to align the data back to the zero axis by adjusting the log difference 
values. 
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  Inter-gel normalization was then performed on the LOESS normalized data by method of quantile 
normalization [99], to account for bias in terms of gel-specific effects. The expected distribution of 
intensity levels should be similar between gels, or in other words, the distribution of effect sizes should be 
more or less consistent across samples. Quantile normalization adjusts intensities on each gel so that all 
gels have similar distributions of intensity levels. 
 
 Once adjusted and log-transformed, the relative spot intensity levels were subjected to a paired t-
test and an initial list of p-values was produced. This list was subjected to the False Discovery Rate 
(FDR) procedure of Benjamini and Hochberg [100]. Proteins were considered differentially expressed if 
they had a calculated FDR below 10%. 
2.2.5 Protein Identification via Mass Spectrometry 
 Protein spots that showed statistically significant differential expression between CHO-BRI and 
CHO-1A7 were excised from coomassie-stained preparative gels. These spots were subjected to in-gel 
tryptic digestion followed by LC-MS/MS analysis. The resulting mass spectrometry data was analyzed 
using PEAKS Studio v5.3 (Bioinformatics Solutions Inc., ON, Canada) for protein identification. 
2.2.5.1 Colloidal Coomassie Stained Preparative Gels 
 To visualize protein spots, coomassie-stained gels were prepared for spot excision and 
identification. A total of 800µg containing a pool of all 12 protein samples were loaded onto 24cm pH 3-
10NL IPG strips. The procedure for first and second dimension separation using 12% polyacrylamide gels 
was similar to that of 2D-DIGE (see section 2.2.4.2 and section 2.2.4.3) with a few modifications. CyDye 
labeling of protein samples was not used for running preparative gels. 
 
 After second dimension separation was completed, the cassette carrier assembly was removed 
from the DALTsix Electrophoresis unit and the gel plate sandwich was removed. A slanted ruler edge was 
used to carefully open the gel plate sandwich without breaking the gel piece. Using the ruler to help free 
the edges, the gel piece was then transferred into a container with MilliQ water and placed on a rocking 
platform for 5 minutes. After rinsing, the water was removed and proteins were fixed with 10% acetic 
acid/50% methanol for 10 minutes. The gels were further rinsed with MilliQ water and stained overnight 
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with GelCode® Blue Stain Reagent (Thermo Scientific, ON, Canada) at room temperature followed by 
destaining for 5 hours in MilliQ water on a rocking platform. The resulting stained gel was scanned using 
the EXQuest Spot Cutter (Bio-Rad Laboratories LTD, ON, Canada). Spot matching between 2D-DIGE 
and preparative gels was performed using PDQuest Advanced 2-D Analysis Software v8.0.1 (Bio-Rad 
Laboratories LTD, ON, Canada) prior to protein spot excision. 
2.2.5.2 Multiwell In-Gel Trypsin Digestion 
 To minimize keratin contamination, all equipment used was cleaned thoroughly and all 
procedures were followed carefully. The flow hood was sprayed and wiped down with 70% ethanol, and 
the UV light was activated for 30 minutes prior to digesting samples. All pipette tips and 96-well plates 
were rinsed twice with MilliQ water, methanol, and 100% acetonitrile (ACN) and let dry overnight in a 
flow hood. 
  
 This method is based on a multiwell in-gel protein digestion protocol developed by Pluskal et al., 
2002 [101] with some modifications. Briefly, this protocol takes advantage of 96-well plates that allows 
up to 96 protein gel spots to be processed simultaneously. A 96-well perforated filter plate (Cat# CB080, 
Thermo Scientific, ON, Canada) was stacked atop a 96-well collecting plate (Cat# AB-1058, Thermo 
Scientific, ON, Canada) such that the protein gel spots were processed in the first plate and the washes 
were collected in the second plate. Note that during the destaining, reduction, and alkylation steps, washes 
were collected in the second plate, by centrifugation, and discarded. Once proteins were fully digested, 
centrifugation was applied to draw the extracted digests into a new clean collection plate.    
 
Protein Spot Excision 
 Spots of interest were excised from the preparative gel using a 1.5mm cutter tip size in the 
EXQuest Spot Cutter (Bio-Rad Laboratories LTD, ON, Canada). The gel pieces were transferred to a 96-
well perforated filter plate. A volume of MilliQ water covered the gel pieces to prevent from drying, and 
the plate was stored at 4
o
C until ready for protein digestion. 
 
Destaining 
 To remove coomassie blue stains, the gel pieces were washed with 30µL of 50 mM ammonium 
bicarbonate (NH4HCO3) (Fisher, ON, Canada) and mixed on a rocking platform for 5 minutes. The waste 
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was removed and discarded by centrifugation. The above wash and removal steps were repeated another 
two times.   
 
 The gel pieces were then shrunk with 30µL of 50% ACN/25mM NH4HCO3, and mixed on a 
rocking platform for 10 minutes. The waste was removed and discarded by centrifugation. The 
dehydration and removal steps were repeated another two times. 
 
Reduction and Alkylation 
 After destaining, the gel pieces were reduced with 30µL of 10 mM DTT in 50 mM NH4HCO3 for 
30 minutes at 37
o
C. The supernatant liquid was then removed by centrifugation and discarded. Following 
reduction, the gel pieces were alkylated with 30µL of 100mM IAA in 50 mM NH4HCO3 for 15 minutes in 
the dark at room temperature. The supernatant liquid was then removed by centrifugation and discarded. 
Next, the gel pieces were dehydrated with 50µL of 50% ACN/25mM NH4HCO3, and mixed on a rocking 
platform for 15 minutes. All liquid was removed via centrifugation. 
 
Trypsin Digestion 
 A 0.2µg/µL trypsin stock solution was freshly prepared by adding 100µL of Promega 
resuspension buffer to 20µg of lyophilized Promega Modified Sequencing Grade Trypsin (Promega 
Corporation, Madison, USA). From this trypsin stock solution, a 13ng/µL trypsin working solution was 
prepared in 50mM NH4HCO3. The gel pieces were covered with 40µL of the 13ng/µL trypsin working 
solution and incubated overnight at 37
o
C. 
 
Peptide Extraction  
 A new clean 96-well collection plate was used to collect the supernatant. The 96-well perforated 
filter plate containing the protein digest was removed from incubation and the liquid was transferred to 
the receiving wells of the 96-well collection plate by centrifugation. The gel pieces were then washed 
with 20µL of 25mM NH4HCO3, mixed on a rocking platform for 10 minutes, and collected using the 
same collection plate. Next, the gel pieces were alternatively reswollen and dehydrated twice with 20µL 
of 5% formic acid (Fisher, ON, Canada) and 20µL of 100% acetonitrile (ACN), while mixing and 
collecting the supernatants in between steps. The extracted peptides were subsequently stored at -20
o
C 
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until ready to evaporate down. When ready for LC-MS/MS analysis, the protein digests were evaporated 
down to dryness and reconstituted in 5µL of 0.1% formic acid in water. 
2.2.5.3 Mass Spectrometry (LC-MS/MS) 
 The digested peptides were sent to the Hospital for Sick Children Mass Spectrometry Facility 
(ON, Canada) for mass spectrometry (MS) analysis. The procedure is outlined below. 
 
 The samples were loaded onto a 150µm ID pre-column (Magic C18, Michrom Biosciences, 
Auburn, CA) at 4µl/min and separated over a 75µm ID analytical column. Using an EASY n-LC nano-
chromatography pump (Proxeon Biosystems, Odense Denmark), the peptides were eluted over 60 minutes 
at 300nL/min in a 0 to 40% ACN gradient in 0.1% formic acid. The peptides were eluted into a LTQ 
linear ion trap mass spectrometer (Thermo-Fisher, San Jose, CA) operated in a data dependent mode. Six 
MS/MS scans were obtained per MS cycle. 
2.2.5.4 Database Searching and Protein Identification 
 Protein identification was performed using PEAKS Studio v5.3 (Bioinformatics Solutions Inc., 
ON, Canada) which combines auto de novo sequencing with database searching. A draft version of the 
genome sequence of the CHO-K1 cell line was recently established, hence all mass spectra were searched 
against the corresponding CHO protein database [82]. A study recently showed a considerable 
improvement in both the number of proteins identified and the confidence of those identifications (as 
determined by searching against a CHO-specific protein database) [84]. 
  
 Instrument parameters and settings selected in PEAKS Studio v5.3 are found in Table 2-2. A 
refining filter was initially applied to the raw MS data to filter scans with a PEAKS quality value of 0.65 
or greater. Auto de novo sequencing was then performed on filtered scans using the parameters from 
Table 2-3. The de novo sequencing results were searched against the CHO protein database using the 
inChorus function within PEAKS, which combines the results of two search engines, namely: PEAKS 
DB and X!Tandem. The use of two unique search engines helps in increasing overall coverage and 
confidence of the protein identifications by utilizing different search algorithms. The database search 
parameters for each search engine are listed in Table 2-4 and Table 2-5, respectively. 
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Table 2-2. PEAKS Instrument Parameter Settings. 
Parameter Setting 
Manufacturer Thermo Scientific 
Ion source ESI (nano-spray) 
Fragmentation type CID, CAD, IRMPD (y and b ions) 
MS precursor scan Linear ion trap 
MS/MS product scan Linear ion trap 
 
Table 2-3. PEAKS Auto de novo Sequencing Parameter Settings. 
Parameter Setting 
Parent ion error tolerance 2.0 Da 
Fragment ion error tolerance 0.5 Da 
Enzyme Trypsin 
Fixed PTM Carbamidomethylation (57.02 Da) 
Variable PTM Oxidation (M) (15.99 Da) 
Maximum allowed variable PTM per peptide 3 
# of candidates reported per spectrum Up to 5 
 
Table 2-4. PEAKS DB Search Engine Parameter Settings. 
Parameter Setting 
Parent mass error tolerance 2.0 Da 
Fragment mass error tolerance 0.5 Da 
Enzyme Trypsin 
Max missed cleavages 1 
Fixed modifications Carbamidomethylation (57.02 Da) 
Variable modifications Oxidation (M) (15.99 Da) 
Max variable PTM per peptide 3 
Decoy performed True (FDR decoy set) 
 
Table 2-5. X!Tandem Search Engine Parameter Settings. 
Parameter Setting 
Fragment mass error tolerance 0.5 Da 
Residue, modification mass 57.02@C 
User defined potential modification 15.99@M 
Protein cleavage sites [RK]|{P} 
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 For PEAKS DB, the results were evaluated based on a percentage system. The higher the 
percentage score, the more reliable and accurate the identification. The FDR was also applied and 
estimated with decoy sequences. A protein identification was considered successful when the protein 
score was ≥ 90% with ≥ 2 unique peptides and an FDR below 1%. Additionally, at least 2 unique peptides 
must also be identified in the X!Tandem search engine. For some samples, there was more than one 
confident protein ID. The molecular weight (MW) and isoelectric points (pI) of these protein IDs were 
compared with their relative spot locations on the gel to confirm and/or reject an identification. 
2.2.5.5 Functional Annotation Analysis Using DAVID  
 The resulting list of differentially expressed proteins (gene list) was compiled and uploaded onto 
the DAVID (the database for annotation, visualization, and integrated discovery) bioinformatics resources 
for functional and pathway analysis. DAVID is a publicly available web-based tool 
(http://david.abcc.ncifcrf.gov/) that is able to extract meaningful biological information associated with 
large gene lists that is important to a particular biological study [102; 103]. It operates by mapping 
systematically a large number of interesting genes in a given list to their associated biological annotation 
(e.g., gene ontology terms), and statistically highlight those that are overrepresented. Due to many 
redundant biological annotation terms, the Functional Annotation Clustering tool found within DAVID 
was used to cluster enriched related terms into a single group. DAVID calculates a p-value to determine 
the significance of each gene-term enrichment by using a modified Fisher’s exact test (EASE score). This 
way, DAVID only looks for the most overrepresented terms and more attention can be given to groups 
with enrichment scores greater than or equal to 1.3 (enrichment score of 1.3 is equivalent to non-log scale 
0.05) [103]. 
 
 Due to the fairly recent publication of the CHO-K1 genome sequence, the DAVID 
knowledgebase has not yet integrated the gene/protein identifiers and their corresponding biological 
annotations for CHO cells. As an alternative, the gene list was compiled using gene accession numbers of 
mouse homologs. As such, the gene population background that was used was the whole mouse genome 
for gene-term enrichment analysis.  
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2.3 Results 
 A comparative proteomic analysis was conducted between the antibody producing CHO-1A7 
strain with its corresponding non-producing parental strain CHO-BRI. In the present study, six biological 
replicate cell cultures from each strain were collected and subjected to cell lysis and protein extraction. 
The differences in expression at the protein level were examined with 2D-DIGE by detecting and 
quantifying the relative abundance of the protein spots resolved on a gel. Mass spectrometry was 
performed to identify proteins that showed statistically significant differential expression.  
2.3.1 Cell Growth and Viability 
 The CHO-1A7 line, which expresses and secretes EG2-hFc1 under the control of a CMV 
promoter, was created through the transfection of CHO-BRI cells with the pTT44-EG2-hFc1 construct. In 
the present work, the clone was found to have a specific growth rate of about 0.03 h
-1
 and a doubling time 
of around 24 hours. 
 
 The newly designed clone, after being checked for its stability, was used for batch production of 
EG2-hFc1. In order to collect an adequate amount of cell biomass as well as to avoid accumulation of 
cellular debris in media, the process was finished after 8 days when the cell growth reached stationary 
phase and the viability decreased to approximately 90% (Figure 2-1). On day 8, harvested culture media 
samples achieved a density of 6.75 x 10
6
 cells/mL for CHO-BRI, and 7.50 x 10
6
 cells/mL for CHO-1A7. 
2.3.2 Cell Lysis and Protein Extraction 
 Whole cell protein extracts were obtained from CHO samples after cell lysis by sonication. Cell 
lysates were subjected to a clean-up procedure to remove interfering substances. For protein concentration 
determination, BSA was used to generate the standard curve depicted in Figure A 1 via the Bio-Rad 
protein assay. 
 
 The protein concentration (as shown in Table A 1) was used to determine the amount that was 
required for sample labeling (50 µg per sample) as shown in section 2.2.4.1.  
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Figure 2-1. Growth and viability curve during 8 days batch cultivation in (A) CHO-1A7 and for the 
production of EG2-hFc1 in (B) CHO-BRI. Solid lines represent cell densities whereas dashed lines 
represent cell viabilities for each biological replicate. (Igor Slivac, BRI, Montréal, Canada). 
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2.3.3 Gel Scanning and Analysis  
 2D-DIGE gels were scanned and the relative quantities of proteins were measured by 
fluorescence. The gels were scanned at 580nm and 670nm, which corresponded to Cy3 and Cy5 channels 
respectively. Due to technical difficulties, scanning the gel at 488nm, which corresponded to the internal 
standard labeled with Cy2, was not possible. However, this did not pose a problem as the internal 
standard was only meant to aid spot-matching in DeCyder.  
 
 Protein spots labeled with Cy3 appear green, whereas protein spots labeled with Cy5 appear red. 
Figure 2-2 shows a representative 2D-DIGE protein expression map generated from one of the six 
biological replicates. All 6 gels showed fairly uniform spot separation, suggesting the electrophoresis 
process was reproducible and that the resulting spot maps were comparable. Spots that appear yellow 
indicates that the two protein samples have roughly equal amounts of the corresponding protein. With 
most proteomic studies, the relative abundance of the majority of proteins within the same cell line do not 
differ significantly. As expected, the majority of spots in all 6 gels were yellow, indicating no significant 
differences in abundance. Spots that appear more red or green indicates greater abundance of that 
particular protein in a sample depending on the labeling design. These differences are difficult to visualize 
by the naked eye; therefore, the images were processed using the gel analysis software DeCyder v7.0. 
 
 After cropping all the gel images to the same size, they were then processed in DeCyder. Firstly, 
the DIA module was applied to detect and identify protein spots in conjunction with the first-level-of-
matching (within gel). Next, the images were processed in the BVA module to match spots between gels. 
The number of spots detected per gel as well as the number of spots matched across all 6 gels are shown 
in Table 2-6. 
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Figure 2-2. Sample Image of 2D-DIGE Gel 1. CHO-BRI-1 was labeled with Cy5 and CHO-1A7-1 was 
labeled with Cy3. Arrows indicate the direction of protein separation. Proteins were separated initially in 
the first dimension on a non-linear gradient pH 3 -10, and subsequently separated in the second dimension 
on a 12% polyacrylamide gel. Green and red fluorescence were measured independently (532 nm for Cy3 
and 635 nm for Cy5), and protein spots with equal abundance between samples appear yellowish in the 
combined image above. 
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Table 2-6. Spot Detection in 2D-DIGE Gel Images. 
Gel Number Samples (Fluorescent Label) # of Spots Detected 
# of Spots Matched 
Across All Gels 
1 
CHO-BRI-1 (Cy5) 
1844 
912 
CHO-1A7-1 (Cy3) 
2 
CHO-BRI-2 (Cy5) 
1824 
CHO-1A7-2 (Cy3) 
3 
CHO-BRI-3 (Cy5) 
1871 
CHO-1A7-3 (Cy3) 
4 
CHO-BRI-4 (Cy3) 
1826 
CHO-1A7-4 (Cy5) 
5 
CHO-BRI-5 (Cy3) 
1885 
CHO-1A7-5 (Cy5) 
6 
CHO-BRI-6 (Cy3) 
1789 
CHO-1A7-6 (Cy5) 
 
2.3.4 Statistical Analysis in the Generation of a Spot-Picklist  
 A compilation of a list of differentially expressed protein spots was generated as a subset from the 
912 spots that were present in all 6 gels. This list was known as the spot-picklist.  
 
 Differences in fold change are generally difficult to interpret. Subtle fold changes may reflect 
proteins that were regulated slightly in response to changes occurring in cell cultures. Therefore, using a 
fold change threshold may not be a good indicator of differentially expressed proteins as biologically 
relevant proteins that undergo small fold changes would be filtered out. To establish the spot-picklist, a 
statistical threshold and a fixed FDR threshold must both be passed in order for a spot to be considered 
differentially expressed. A paired t-test was used, in assessing differences in protein abundance between 
CHO-BRI and CHO-1A7, to generate an initial list of spots with p < 0.05. The complete p-value list was 
subjected to the FDR procedure, generating a list of significant spots for which the expected FDR is at 
most 10% as shown in Table 2-7. 
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Table 2-7. Differentially Expressed Protein Spots. Raw fold change was calculated as the average 
intensity ratios between paired samples. A green label indicates spots that were selected for LC-MS/MS. 
Spot 
ID 
Raw Fold 
Change 
p-Value FDR (< 0.1) 
Spot 
ID 
Raw Fold 
Change 
p-Value FDR (< 0.1) 
679 1.99 2.70E-05 1.84E-02 929 -1.38 3.84E-03 6.64E-02 
1210 -1.39 4.04E-05 1.84E-02 1804 1.14 3.87E-03 6.64E-02 
663 1.55 6.85E-05 2.08E-02 705 1.21 3.92E-03 6.64E-02 
1779 -1.25 1.35E-04 2.59E-02 1089 -1.08 3.94E-03 6.64E-02 
1215 -1.31 1.42E-04 2.59E-02 1622 -1.31 4.06E-03 6.64E-02 
918 1.05 1.77E-04 2.69E-02 1473 1.26 4.11E-03 6.64E-02 
1815 1.09 2.75E-04 2.82E-02 651 1.21 4.19E-03 6.64E-02 
1299 -1.20 3.17E-04 2.82E-02 1027 1.09 4.20E-03 6.64E-02 
681 -1.17 3.22E-04 2.82E-02 1274 1.22 4.21E-03 6.64E-02 
511 1.18 3.41E-04 2.82E-02 635 -1.14 4.22E-03 6.64E-02 
841 -1.57 3.41E-04 2.82E-02 577 -1.25 4.31E-03 6.65E-02 
575 -1.12 4.63E-04 3.52E-02 1607 -1.07 4.44E-03 6.65E-02 
854 -1.07 5.86E-04 4.01E-02 549 1.10 4.45E-03 6.65E-02 
524 1.07 6.31E-04 4.01E-02 566 1.12 4.61E-03 6.77E-02 
1572 -1.26 6.60E-04 4.01E-02 1251 -1.14 5.09E-03 7.37E-02 
187 -1.28 7.71E-04 4.40E-02 1336 -1.13 5.39E-03 7.61E-02 
359 1.08 9.76E-04 5.23E-02 1095 -1.09 5.62E-03 7.61E-02 
1505 1.44 1.10E-03 5.28E-02 379 -1.07 5.64E-03 7.61E-02 
1184 1.15 1.13E-03 5.28E-02 980 1.09 5.64E-03 7.61E-02 
372 1.11 1.32E-03 5.28E-02 1234 1.11 5.68E-03 7.61E-02 
909 1.11 1.43E-03 5.28E-02 545 1.14 5.96E-03 7.69E-02 
1026 -1.22 1.47E-03 5.28E-02 1194 1.11 5.96E-03 7.69E-02 
153 1.16 1.48E-03 5.28E-02 959 -1.20 6.00E-03 7.69E-02 
1494 1.44 1.49E-03 5.28E-02 313 -1.12 6.07E-03 7.69E-02 
835 1.10 1.52E-03 5.28E-02 893 1.20 6.40E-03 7.84E-02 
231 1.25 1.56E-03 5.28E-02 881 -1.09 6.41E-03 7.84E-02 
1202 -1.31 1.56E-03 5.28E-02 832 1.16 6.47E-03 7.84E-02 
1683 -1.15 1.68E-03 5.48E-02 1791 1.14 6.56E-03 7.84E-02 
1159 1.17 1.86E-03 5.56E-02 1306 -1.26 6.62E-03 7.84E-02 
529 1.06 2.00E-03 5.56E-02 1228 -1.25 6.74E-03 7.88E-02 
364 1.05 2.08E-03 5.56E-02 410 1.08 6.97E-03 8.05E-02 
423 -1.10 2.09E-03 5.56E-02 234 1.09 7.31E-03 8.33E-02 
428 1.11 2.13E-03 5.56E-02 807 -1.06 7.40E-03 8.33E-02 
726 -1.16 2.15E-03 5.56E-02 465 -1.06 7.70E-03 8.56E-02 
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Spot 
ID 
Raw Fold 
Change 
p-Value FDR (< 0.1) 
Spot 
ID 
Raw Fold 
Change 
p-Value FDR (< 0.1) 
1301 -1.32 2.35E-03 5.56E-02 1098 -1.26 7.90E-03 8.68E-02 
1437 1.17 2.36E-03 5.56E-02 1304 -1.18 8.49E-03 9.22E-02 
1211 -1.17 2.41E-03 5.56E-02 1711 1.16 8.63E-03 9.26E-02 
245 1.12 2.44E-03 5.56E-02 1540 -1.12 8.74E-03 9.27E-02 
1522 -1.46 2.46E-03 5.56E-02 487 -1.16 8.93E-03 9.36E-02 
543 1.11 2.49E-03 5.56E-02 240 1.05 9.16E-03 9.50E-02 
1321 -1.28 2.50E-03 5.56E-02 727 -1.12 9.39E-03 9.62E-02 
660 1.32 2.79E-03 6.06E-02 369 1.05 9.66E-03 9.63E-02 
1526 -1.19 3.18E-03 6.64E-02 837 -1.08 9.79E-03 9.63E-02 
1493 -1.10 3.24E-03 6.64E-02 1028 -1.14 9.82E-03 9.63E-02 
1208 -1.41 3.34E-03 6.64E-02 1691 -1.15 9.88E-03 9.63E-02 
1519 -1.49 3.43E-03 6.64E-02 316 -1.06 9.92E-03 9.63E-02 
1570 1.38 3.58E-03 6.64E-02 544 -1.12 1.02E-02 9.70E-02 
1543 -1.33 3.72E-03 6.64E-02 181 -1.20 1.02E-02 9.70E-02 
    
1138 1.03 1.03E-02 9.70E-02 
 
 From Table 2-7, 97 protein spots passed both the statistical and FDR thresholds. This initial spot-
pick list was further manually screened and visually inspected to filter out artifactual spots due to errors in 
spot detecting, splitting, or matching. Consequently, a total of 86 spots that exhibited changes in 
abundance were excised and identified by LC-MS/MS. 
2.3.5 Colloidal Coomassie Stained Preparative Gels 
 After the analysis of the 2D-DIGE gel images and the generation of a spot-picklist consisting of 
spots of interests, coomassie stained gels were prepared for spot excision and subsequent MS analysis. All 
12 CHO protein samples were pooled together to ensure all proteins were represented on the preparative 
gel. The protein concentration of the pooled sample was first determined via the protein standard curve in 
Figure A 2. 
 
 The protein concentration was determined to be 4.64 ± 0.83 µg/µL for the CHO-Pooled protein 
sample. Approximately 800 µg of the CHO-Pooled protein sample was loaded onto IPG strips to develop 
preparative gels for protein identification. 
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2.3.6 Protein Identification 
 Several preparative gels of the CHO-Pooled protein sample were run for spot excision and protein 
identification. The assigned spot IDs from the spot picklist generated from the analysis of 2D-DIGE gels 
were matched to their corresponding spots on the preparative gels using PDQuest Advanced 2-D Analysis 
Software v8.0.1.  
  
 Out of the 86 selected spots, a total of 52 protein spots were successfully identified by LC-
MS/MS (Table 2-8). Their relative locations on a gel are shown in Figure 2-3. Of these, 26 protein spots 
were down-regulated, and 26 were up-regulated, resulting in 34 unique protein identifications. The unique 
protein identifications stem from the observation where multiple spots that were identified were matched 
to the same protein. This reflects the fact that certain proteins have many isoforms within the cell, which 
can be observed as a "train" of spots on a 2D gel (Figure 2-3). These isoforms have similar molecular 
weight but varying pI due to PTMs such as phosphorylation. A proportion of spots were not identified 
(orange dots with no annotations in Figure 2-3), however, this generally occurs with many other 2D-
DIGE studies. Another preparative gel could be run in an attempt to identify them. However, a first pass 
with 60% of the selected spots identified was sufficient for an initial analysis of the global expression 
changes in CHO-1A7. 
  
 Of the 34 unique protein IDs, 15 protein spots were consistently down-regulated, and 18 were 
consistently up-regulated, and 1 showed mixed behaviour. The identified proteins were classified into five 
broad categories according to their biological function in Table 2-8.  
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Table 2-8. List of Identified Differentially Expressed Proteins Associated with EG2-hFc1-Producing CHO Strain. The relative abundance 
ratios subjected to a paired t-test that pass a p-value of 0.05 and an FDR cutoff of 0.10 were considered to be statistically significant. Multiple 
spots representing different protein isoforms were identified and matched to the same protein. Fold Change < 1, is shown as -1/FC in table. A fold 
change of 1 corresponds to no change. 
Protein Name 
Short 
Name 
Spot 
ID 
Accession 
no. 
PEAKS 
Score 
p-value 
MW 
(kDa)* 
pI* 
% 
Coverage 
# of 
Peptides 
Matched 
Fold 
change 
Biological process 
            
Protein processing            
Heat shock 75 kDa protein Trap1 364 EGV93626 99.2 2.08E-03 80.3 6.64 43 22 1.05 Chaperone - Protein 
folding 
Heat shock 70 kDa protein 9 Grp75 372 EGW06687 99.2 1.32E-03 65.8 5.83 57 29 1.11 Chaperone - Protein 
folding 
359 98.2 9.76E-04 7 3 1.08 
369 99.2 9.66E-03 59 31 1.05 
Serpin H1 Serpinh1 635 EGW02226 99.2 4.22E-03 46.6 8.74 38 12 -1.14 Chaperone - Protein 
folding for collagen 
60 kDa Heat shock protein Hspd1 465 EGW00783 99.2 7.70E-03 56.5 6.90 52 19 -1.06 Chaperone - Protein 
folding 
Heat shock protein HSP 90-alpha Hsp90aa1 929 EGV94858 98.9 3.84E-03 38.1 4.58 22 5 -1.38 Chaperone - Protein 
folding 
Endoplasmin GRP94 841 EGW09701 99.1 3.41E-04 92.6 4.74 15 8 -1.57 Chaperone - Protein 
processing and transport 
60S Acidic ribosomal protein P0 Rplp0 893 EGV93157 99.2 6.40E-03 29.9 8.68 38 7 1.20 Protein biosynthesis 
Protein disulfide-isomerase A6 Pdia6 1026 EGW08481 99.0 1.47E-03 28.4 4.80 27 5 -1.22 Chaperone - Protein 
folding 
            
Structural proteins            
Beta-actin Actb 726 EGW06240 99.1 2.15E-03 41.7 5.29 29 7 -1.16 Cytoskeletal component 
1028 99.1 9.82E-03 27 5 -1.14 
1228 98.9 6.74E-03 26 5 -1.25 
837 99.1 9.79E-03 25 7 -1.08 
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Protein Name 
Short 
Name 
Spot 
ID 
Accession 
no. 
PEAKS 
Score 
p-value 
MW 
(kDa)* 
pI* 
% 
Coverage 
# of 
Peptides 
Matched 
Fold 
change 
Biological process 
Vimentin Vim 1202 EGW02055 99.2 1.56E-03 53.7 5.05 38 9 -1.31 Intermediate filaments for 
maintaining cell integrity 
1208 99.2 3.34E-03 30 12 -1.41 
1210 99.2 4.04E-05 41 12 -1.39 
1215 99.2 1.42E-04 34 7 -1.31 
1301 98.6 2.35E-03 8 4 -1.32 
1522 98.2 2.46E-03 17 5 -1.46 
544 99.2 1.02E-02 62 25 -1.12 
Lamin B1 Lmnb1 379 EGV92912 99.1 5.64E-03 55.0 4.99 33 11 -1.07 Provides framework for 
nuclear envelope 
Lamin A Lmna 410 EGW07066 99.2 6.97E-03 64.0 7.75 60 33 1.08 Provides framework for 
nuclear envelope 
428 99.2 2.13E-03 64 39 1.10 
Calcium-binding protein p22 Chp 1304 EGV97270 98.7 8.49E-03 22.5 4.97 25 4 -1.18 RegulatesNa+/H+ 
exchangers which regulate 
intracellular pH and 
cytoskeletal organization 
            
Metabolic enzymes            
Aconitate hydratase Aco2 313 EGW13953 98.8 6.07E-03 85.4 8.07 10 4 -1.12 TCA cycle 
Aldehyde dehydrogenase Aldh 543 EGW07431 99.2 2.49E-03 45.9 5.55 44 15 1.11 Oxidation of aldehydes to 
carboxylic acids 
545 99.2 5.96E-03 59 20 1.14 
549 99.2 4.45E-03 44 16 1.10 
Acyl-coenzyme A thioesterase 2 Acot2 651 EGW01631 99.1 4.19E-03 49.8 8.27 25 9 1.21 Lipid metabolism 
Citrate synthase Cs 679 EGW12503 99.1 2.70E-05 51.7 8.70 32 5 1.99 Carbohydrate 
metabolism/TCA cycle 
663 99.0 6.85E-05 22 5 1.55 
Aspartate aminotransferase Ast 705 EGW01755 99.1 3.92E-03 47.4 9.13 23 7 1.21 Amino acid metabolism 
3-hydroxyacyl-CoA dehydrogenase type-
2 
Hsd17b10 1234 EGW02330 99.2 5.68E-03 27.2 7.70 72 12 1.11 Oxidation of fatty acids, 
alcohols, and steroids 
Methylenetetrahydrofolate dehydrogenase Mthfd1l 234 EGV95936 99.1 7.31E-03 105.4 7.02 23 15 1.09 Folate metabolism 
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Protein Name 
Short 
Name 
Spot 
ID 
Accession 
no. 
PEAKS 
Score 
p-value 
MW 
(kDa)* 
pI* 
% 
Coverage 
# of 
Peptides 
Matched 
Fold 
change 
Biological process 
187 99.1 7.71E-04 13 8 -1.28 
181 99.2 1.02E-02 19 9 -1.20 
Procollagen-lysine, 2-oxoglutarate 5-
dioxygenase 3 
Plod3 316 EGW01863 98.9 9.92E-03 37.7 5.88 20 4 -1.06 Hydroxylation of lysyl 
residues in collagen-like 
peptides 
Dihydrolipoyl dehydrogenase Dld 524 EGV93120 99.2 6.31E-04 54.1 7.96 30 12 1.07 Catabolism of branched-
chain amino acids 
529 99.2 2.00E-03 44 14 1.06 
3-hydroxyisobutyrate dehydrogenase Hibadh 1027 EGW08863 99.1 4.20E-03 31.7 5.17 33 6 1.09 Amino acid catabolism 
Glycerol-3-phosphate dehydrogenase Gpd2 660 EGW05701 99.2 2.79E-03 80.7 5.92 34 17 1.32 Carbohydrate/Lipid 
metabolism 
            
Apoptosis/Cell Proliferation           
Proliferating cell nuclear antigen Pcna 959 EGV92404 99.1 6.00E-03 28.8 4.57 41 9 -1.20 Acts as a processivity 
factor DNA polymerase in 
eukaryotic DNA 
replication 
Histone H2A type 1 Hist1h2ab 1779 EGV96120 98.9 1.35E-04 28.5 11.04 24 4 -1.25 Regulate transcription, 
DNA repair, DNA 
replication, and 
chromosomal stability 
DNA-directed RNA polymerase I, II, and 
III subunit RPABC1 
Polr2e 1159 EGV99483 98.3 1.86E-03 25.4 5.52 27 3 1.17 Catalyze transcription of 
DNA 
Prohibitin Phb 245 EGW01773 98.9 2.44E-03 29.8 5.57 21 4 1.12 Role in regulating 
proliferation, inhibits DNA 
synthesis 
Programmed cell death 6 Pdcd6 1505 EGW09040 99.0 1.10E-03 25.5 5.56 27 5 1.44 Induction of apoptosis by 
extracellular signals 
            
Energy Metabolism            
SPRY domain-containing protein 4 Spryd4 1299 EGW12495 98.9 3.17E-04 23.1 8.85 30 5 -1.20 Uncharacterized 
ATP-binding cassette sub-family G 
member 3 
Abcd3 918 EGV92982 99.1 1.77E-04 69.6 5.43 13 6 1.05 Peptide-transporter across 
extra- and intra-cellular 
membranes 
NADH dehydrogenase Ndufv1 566 EGW12368 99.1 4.61E-03 50.6 7.53 21 8 1.12 Oxidative phosphorylation 
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Protein Name 
Short 
Name 
Spot 
ID 
Accession 
no. 
PEAKS 
Score 
p-value 
MW 
(kDa)* 
pI* 
% 
Coverage 
# of 
Peptides 
Matched 
Fold 
change 
Biological process 
NADH dehydrogenase Ndufs3 1138 EGW03953 99.1 1.03E-02 30.1 7.78 34 7 1.03 Oxidative phosphorylation 
ATP synthase subunit beta Atp5b 575 EGW12490 99.2 4.63E-04 56.4 5.18 45 17 -1.12 ATP synthesis 
* MW and pI were calculated from the amino acid sequence, derived from the accession no., using the ExPASy Compute pI/MW tool [104] and 
compared with gel location. 
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Figure 2-3. Preparative 2-D Gel of Whole Protein Extract from CHO-Pooled Protein Samples. Successfully identified protein spots are 
labeled and annotated according to their short name format from Table 2-9. Orange dots with no annotations were unsuccessful in protein 
identification. The relative estimates of the molecular weight and pI were obtained based on the protein identifications. There is no significant 
meaning regarding the selected blue spot; DeCyder functions by having a spot selected at all times. 
45 
2.3.7 Functional Annotation Analysis Using DAVID 
 The compiled gene list was subjected to DAVID’s various analytical modules to explore 
enriched functionally related gene groups and their relationship to antibody production. Given an 
abnormal biological process in a given study, genes that are related to the abnormality should have a 
higher potential (enriched) to be selected as a relevant group by high-throughput screening 
technologies. The degree of enrichment is decided by performing a comparison against a set gene 
population background. Thus, the enrichment can be quantitatively measured by statistical methods 
such as Fisher's exact test. An enrichment score (for each group) is determined by a geometric mean 
of all the enrichment p-values of each annotation term in the group followed by a minus log 
transformation that is applied on the averaged p-values. The enrichment score is a relative score used 
to rank overall importance of annotation term groups. DAVID only looks for the most 
overrepresented terms and more attention can be given to groups with enrichment scores greater than 
or equal to 1.3 [103]. Application of the aforementioned tool revealed a total of 3 clusters with 
enriched gene ontology (GO) terms that are involved in a number of biological processes, as 
represented in Table 2-9. 
Table 2-9. Enriched Functional Annotation Clusters Observed from the Corresponding Gene 
List. 
Annotation 
Cluster # 
Enrichment 
Score 
Enriched Terms 
# of Genes 
Involved 
p-value 
1 3.08 
Nad 6 1.40E-05 
Generation of precursor metabolites and 
energy 
6 
2.40E-04 
Oxidoreductase activity, acting on NADH or 
NADPH 
3 
5.90E-03 
Electron transport chain 3 2.50E-02 
2 2.98 
Chaperone 6 7.70E-06 
Unfolded protein binding 5 1.70E-05 
Stress response 4 7.70E-05 
Protein folding 5 1.70E-04 
3 2.39 
Generation of precursor metabolites and 
energy 
6 
2.40E-04 
Cellular respiration 3 7.50E-03 
Citrate cycle (TCA cycle) 3 7.80E-03 
Energy derivation by oxidation of organic 
compounds 
3 
2.00E-02 
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 Analysis of the proteomic data by Functional Annotation Clustering revealed the enrichment 
of a number of GO terms including protein folding and processing, oxidative phosphorylation, and 
carbohydrate metabolism. Additionally, based on the uploaded gene list, DAVID identified a number 
of genes that play an important role in two related metabolic network pathways as represented in 
Table 2-10.  
Table 2-10. Genes Associated with Two Metabolic Pathways. 
KEGG Pathway p-value Genes Involved 
Valine, leucine and isoleucine degradation 9.80E-04 Aldehyde dehydrogenase 
  
Dihydrolipoamide dehydrogenase 
  
3-hydroxyacyl-CoA dehydrogenase type-2 
  
3-hydroxyisobutyrate dehydrogenase 
Citrate cycle (TCA cycle) 7.80E-03 Aconitase 2 
  
Citrate synthase 
  
Dihydrolipoamide dehydrogenase 
  
 The proteins identified reflect observations of metabolic changes within the proteome of 
CHO-1A7 as compared with that of CHO-BRI. Certain heat shock proteins (Trap1, Grp75) were up-
regulated whereas others (Hspd1, Hsp90aa1) were down-regulated. Molecular ER chaperones 
(Serpinh1, Grp94, Pdia6) were differentially down-regulated in EG2-hFc1-producing cells. The up-
regulation of Rplp0, a component involved in protein biosynthesis, was also observed while the 
majority of proteins (Actb, Vim, Lmnb1, Chp) related to the structural integrity of the cell showed 
down-regulation. Enzymes involved in various metabolic processes including carbohydrate (Aco2, 
Aldh, Cs, Gpd2), amino acid (Ast, Plod3, Dld, Hibadh), and lipid (Acot2) metabolism were generally 
up-regulated. Proteins involved in DNA repair, DNA replication and transcription, apoptosis, and 
cellular respiration were also found to be differentially expressed. Two examples of spots that were 
observed to be differentially regulated are shown in Figure 2-4. 
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Figure 2-4. Sample Differentially Regulated Protein Spots. A visual observation of spots that 
showed up-regulation (top left, Pdcd6, Spot ID 1505) and down-regulation (top-right, Vim, Spot IDs 
1208, 1210, 1215). (bottom) The "3-D volume view" from the DeCyder analysis showing the same 
spots that were up- and down-regulated based on spot volume. 
 
 A few of the identified proteins (Grp75, Actb, Vim, Lmna, Aldh, Cs, Mthfd1l, Dld) were 
observed to appear in multiple spot locations on the resulting 2-D gel (Figure 2-3). There was no 
indication of the appearance of the protein spot unique to EG2-hFc1 at the approximate location of 84 
kDa (dimer form) and theoretical pI of 7.73. Additionally, EG2-hFc1 was not among the list of 
differentially expressed proteins detected by 2D-DIGE. This is likely due to secretion of EG2-hFc1 
into the media following protein biosynthesis, which was confirmed by SDS-PAGE (Figure 2-5). 
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Figure 2-5. Coomassie Stained SDS-PAGE Gel of EG2-hFc1 Purified from an 8 Day Batch 
Cultivation of CHO-1A7 Media Samples. Std represents the protein standard ladder. Ctrl represents 
the control sample with 100 mg/L of purified EG2-hFc1. Biological replicates are numbered 1 to 6. 
The stained bands represent the monomer form of EG2-hFc1 (42 kDa) (Igor Slivac, BRI, Montréal, 
Canada). 
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2.4 Discussion 
 In this study, a derivative CHO-BRI cell line was engineered to produce the EG2-hFc1 
chimeric heavy chain monoclonal antibody, producing a recombinant cell line denoted CHO-1A7. 
The cell lines were cultured and provided by Dr. Yves Durocher's group at the Biotechnology 
Research Institute (Montreal, Canada). The method of 2D-DIGE was employed to examine the effects 
of EG2-hFc1 expression on the proteome profiles between the producing (derivative) and non-
producing (parental) strains. These two cell types were each partitioned and cultured in separate 
replicate batch processes, and sampled near early stationary phase (Day 8) for pairwise proteomic 
analysis. A cell density of approximately 6.75 x 10
6
 cells/mL for CHO-BRI, and 7.50 x 10
6
 cells/mL 
for CHO-1A7 resulted at harvest. 
 
 It is often difficult to infer changes in expression levels of any one particular individual 
protein and its effect on the biological state of the cell including recombinant protein production. This 
becomes increasingly difficult when the results of expression levels for individual proteins are subtle. 
We attempt to gain a systems-level understanding by grouping identified proteins based on their 
functional biological processes which provide a greater insight on the major cellular processes that 
can be affected as a result of recombinant EG2-hFc1 expression. 
 
Apoptosis/Cell-Proliferation  
 A cellular response that involved proteins in the apoptotic and cell proliferation pathways was 
observed. The production of EG2-hFc1 may potentially be a stress factor for the cell, as some of its 
energy is directed towards recombinant protein biosynthesis as a result of using a strong promoter. 
Hsp60 and Hsp90, which are protein chaperones that exhibit anti-apoptotic activity [105; 106], were 
down-regulated in CHO-1A7. In contrast, mitochondrial heat shock proteins, Trap1 and Grp75, were 
observed to be up-regulated in the same cell line. Trap1 has been shown to be linked to various 
biological pathways and its up-regulation promotes cell proliferation [107]. Grp75 is predominantly 
localized in the mitochondria, suggesting that it does not play a direct role in protein folding during 
the expression of EG2-hFc1. Also known as mortalin, Grp75 is an inducible chaperone that is 
responsive to stress, and is also believed to influence cell proliferation and ageing [108; 109]. As a 
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result, the up-regulation of Trap1 and Grp75 may be indicative of CHO-1A7 changes consistent with 
prolonging or maintaining cellular life span.  
  
 Other apoptotic/cell proliferation-related proteins, including prohibitin (Phb), proliferating 
cell nuclear antigen (Pcna), aldehyde dehydrogenase (Aldh), NADH dehydrogenase [ubiquinone] 
iron-sulfur protein 3 (Ndufs3), and programmed cell death 6 protein (Pdcd6), were found to be 
differentially regulated in this study. Phb over-expression has been shown to increase cell survival by 
arresting cells in the G0/G1 phase, which leads to the inhibition of cell proliferation [110]. Pcna 
enhances the processivity of DNA polymerases in replication-linked processes by recruiting crucial 
players to the replication fork [111]. Aldh is an enzyme responsible for the oxidation of a wide 
variety of aldehydes to their corresponding carboxylic acids using NAD or NADP as a coenzyme. A 
number of studies have observed a decrease in cell proliferation as a consequence of Aldh inhibition 
[112-114]. Both Pdcd6 and Ndufs3 are positive regulators of apoptosis, the latter also being a subunit 
of mitochondrial complex I. Inhibition of Ndufs3 has been shown to provide resistance to IFN-
β/Retinoic acid-induced apoptosis [115; 116]. Phb was up-regulated in this study while Pcna was 
down-regulated, both of which coincide with the increased viability observed at 8 day cultivation in 
CHO-1A7 in comparison to CHO-BRI cells. A number of studies have shown an increase in 
recombinant protein production in growth-arrested CHO cells [117-119], and this suggests a shift 
away from cell proliferation processes due to EG2-hFc1 production. The up-regulation of Ndufs3 and 
Pdcd6 may suggest the initiation of apoptosis in a portion of cells by the end of the batch cultivation 
process. The expression of many anti- and pro-apoptotic proteins may reflect changes in cell 
signalling influencing apoptosis and viability, and may therefore reflect an increase of the population 
of dying cells. 
 
Molecular Chaperones 
 Intracellular perturbations caused by a variety of stressors, including oxidative stress, glucose 
and amino acid deprivation, protein over-expression, and inhibition of glycosylating enzymes, can 
lead to protein misfolding and aggregation within the ER [120]. If aberrant protein folding becomes 
overwhelming, the unfolded protein response (UPR) can be activated in eukaryotes, which attempts to 
restore protein folding as well as proper post-translational modifications. UPR proteins were observed 
to be differentially regulated in a recent proteomic study that investigated apoptosis in a MAb-
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producing CHO cell line during prolonged cultivation [121]. However, in this study, the key 
molecular chaperones of the UPR pathway (Erp29, Erp72, Hsp70, Calnexin, Calreticulin, Grp78/Bip, 
Xbp1) [122] did not show any significant differential expression. The discrepancy could in part be 
due to the investigation of differentially expressed proteins associated with apoptosis in the former 
study rather than MAb production in our study. Similarly, there was a lack of apparent changes in 
these proteins in earlier studies on recombinant CHO cells producing high and low levels of dhfr-GFP 
fusion protein [123] as well as with CHO cells producing human growth hormone [124]. This might 
indicate that the stress on the protein folding machinery is insufficient to invoke the UPR response 
and any differences may be cell-line specific or may be associated with levels of proteins produced.  
 
 Two ER-resident proteins, protein disulfide-isomerase (PDI) and GRP94 showed down-
regulation in the EG2-hFc1-producing CHO-1A7 strain. PDI is a thiol oxidoreductase involved in the 
formation, isomerization, and reduction of disulfide bonds [125]. PDI also exhibits chaperone 
activity, where it aids wrongly folded proteins to reach a correctly folded state. GRP94, also known as 
endoplasmin, is implicated to be involved with chaperoning secretory proteins [126]. GRP94 was also 
shown to associate with unassembled immunoglobulin chains exerting chaperone activity [127]. 
Down-regulation of PDI and GRP94 in this present work could suggest more efficient protein folding 
in CHO-1A7 cells. It is possible that the endogenous levels of PDI and GRP94 are adequate for the 
post-translational processing requirements of EG2-hFc1. Additionally, the reduced expression of 
Hspd1 and Hsp90aa1 further support this hypothesis. Both Hspd1 and Hsp90aa1 are heat shock 
proteins that exhibit chaperone activity essential for proper protein folding within the mitochondria 
and cytosol, respectively [127; 128]. Hsp90aa1 is a member of the Hsp90 family of proteins known 
for their key roles in signal transduction, protein folding, and protein degradation. They participate in 
the regulation of stress response and, in association with co-chaperones, function to stabilize and 
refold denatured or misfolded proteins after stress[129]. Hspd1 and Hsp90aa1 are located in different 
cellular compartments and are not directly involved with MAb production. As the cell’s energy is 
partly redirected towards MAb production, this may result in a reduced demand for certain 
chaperones, with a resultant drop in expression level. Although other studies noted an increased 
expression of Hspd1 in high-producing GS-NS0 cell lines [127; 130], this contrasting result may be 
due to the differences in the cell lines used and suggest that CHO cells may have a greater efficiency 
in sustaining protein synthesis and folding. 
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Structural Proteins  
 Cytoskeletal proteins that are related to the structural integrity of the cell, including vimentin 
(Vim) and β-actin (Actb), generally showed reduced expression in CHO-1A7 cells. Vimentin was 
recently hypothesized to contribute to mitochondrial morphology and organization by interacting with 
the mitochondria and its associated microtubules [131]. Knockdown of vimentin resulted in 
mitochondrial fragmentation and reorganization that might ultimately disturb ATP generation [131]. 
Down-regulation of vimentin in CHO-1A7 cells could be related to the down-regulation of proteins 
involved in ATP synthesis (ie: Atp5b) and thus EG2-hFc1-producing cells harvested after 8 day batch 
cultivation could have expended most of their energy towards protein biosynthesis compared to the 
control. However, further investigation into the role and interaction of this protein with the 
mitochondria are warranted.  
  
 Several studies have accumulated evidence of a close association between the cellular 
microfilament network and the structure and organization of the cellular protein translation apparatus 
[132-137]. Perturbations of actin filaments have been shown to affect the protein synthesis machinery 
in CHO cells, with disruption of the actin filament network resulting in a reduction in protein 
translation [138]. In addition, a subsequent study observed that eukaryotic translation elongation 
factor 1A (eEF1A) acts as a regulator that affects translation initiation through the actin cytoskeleton 
[137]. Although antibody titers were not measured throughout the batch cultivation process, the 
down-regulation of actin may reflect a reduction in protein biosynthesis owing to the cells having 
been harvested at stationary phase. 
 
Metabolic Enzymes  
 Various metabolic enzymes are differentially regulated in association with EG2-hFc1 
expression, including proteins related to carbohydrate, amino acid, and lipid metabolism. Citrate 
synthase (Cs) catalyzes the condensation of acetyl-CoA and oxaloacetate to form citrate. It is a key 
enzyme in the citric acid cycle that provides energy for cellular functions including protein 
biosynthesis. During the process of catalyzing the irreversible conversion of glycerol-3-phosphate to 
dihydroxyacetone phosphate, the enzyme glycerol-3-phosphate dehydrogenase (Gpd2) concurrently 
transfers electrons from flavin adenine dinucleotide (FAD) to the electron transport chain [139]. 
Aconitate hydratase (Aco2) is sensitive to the accumulation of reactive oxygen species (ROS) 
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resulting from increased electron flow through the respiratory chain [140], and thus regulates citrate 
accumulation by reversible isomerisation of citrate to isocitrate. The decreased levels of Aco2 
observed in this present work may reflect increased expression of Cs and Gpd2, and possibly 
correspond to higher levels of citrate and subsequent levels of electron flux towards ATP synthesis. 
Similarly, the up-regulation of dihydrolipoyl dehydrogenase (Dld), a component of various multi-
enzyme systems, suggests a shift in metabolic flux towards energy generation via the pyruvate 
dehydrogenase complex (PDC), the α-ketoglutarate dehydrogenase complex (KGDC), and the 
branched-chain α-keto acid dehydrogenase complex (BCKDC). The PDC plays a key role in linking 
the glycolysis pathway to the citric acid cycle by converting pyruvate into acetyl-CoA and 
concurrently yielding NADH for cellular respiration [141]. The KGDC catalyzes the decarboxylation 
of α-ketoglutarate into succinyl-CoA in the citric acid cycle [142]. Finally, the BCKDC is responsible 
for regulating homeostatic levels of branched chain amino acids (BCAA) – isoleucine, leucine, and 
valine - through catabolic activities that yield end-products that eventually lead to the citric acid cycle 
for energy metabolism [143]. For example, BCKDC catalyzes the irreversible degradation of valine 
via a two-step mechanism to initially yield 3-hydroxyisobutyrate (HIB). Next, 3-hydroxyisobutyrate 
dehydrogenase (Hibadh), also observed to be up-regulated in this study, enzymatically converts HIB 
to succinyl-CoA [143].  
  
 Aspartate aminotransferase (Ast) is involved in an anapleurotic reaction that replenishes TCA 
intermediates via a reversible reaction forming oxaloacetate (OAA), and thus is important in both the 
TCA cycle and amino acid metabolism. Many of the differentially regulated metabolic enzymes 
discussed above can be associated with the TCA cycle. The TCA cycle is the central hub of 
metabolism and is crucial for energy production and subsequent biosynthesis. The metabolic load, 
which is the amount of energy required to express a particular gene within a cell, may have increased 
as a response to recombinant antibody production. The differential expression of enzymes noted in 
this study seem to generally point towards an increase in energy generation as a means to meet the 
energy demands of increased recombinant protein biosynthesis. 
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2.5 Conclusion 
 The present study monitored global changes in the protein expression profiles between CHO 
cells engineered to produce a chimeric heavy chain monoclonal antibody EG2-hFc1 and the 
corresponding non-producer parental cell line. A total of 86 protein spots were selected for 
subsequent MS sequencing, which yielded 34 unique protein identifications. Through functional 
analyses, the production of EG2-hFc1 has shown evidence of pathway changes associated with 
chaperone activity, cytoskeletal elements involved in protein translation machinery, carbohydrate and 
amino acid metabolism. Additionally, the major cellular processes affected include the regulation of 
the apoptotic and cell proliferation pathways as well as energy derivation. The upregulation of 
metabolic enzymes suggests increased energy production in CHO-1A7 cells. This is thought to be a 
direct response of the CHO-1A7 cell line to meet the energy requirements needed for recombinant 
protein biosynthesis while maintaining cell viability.  
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Chapter 3 
Development of a 2-D CHO Protein Reference Map via Multiplexing 
3.1 Introduction 
 Presently, the costs of mass spectrometry analysis of protein samples are fairly affordable if 
there are a low number of samples to be analyzed. The costs range from $85 to $150 per sample at 
various facilities in Ontario, Canada that offer MS/MS services. The price can be reduced to as low as 
$60 per sample if all the sample handling and data analysis is performed by the investigators who use 
those services. To develop comprehensive 2-D proteome reference maps, however, the identification 
of hundreds of protein spots would become costly, time-consuming, and laborious. This would 
discourage researchers from expanding the 2-D gel database, which would otherwise provide 
beneficial tools for proteomic studies. Hence, in the following studies, we developed a multiplexing 
scheme that would facilitate the development of 2-D protein reference maps at a significantly reduced 
cost, while identifying a large number of protein spots. This method would allow up to 528 protein 
spots to be identified at a cost of approximately $34 per sample. 
 
 CHO proteome reference maps have been established as efforts to better understand CHO cell 
physiology and protein expression changes caused by genetic or culture environmental perturbations.  
In 1999, the first comprehensive 2-D CHO proteome reference map was published by Champion and 
colleagues [144]. Whole cell protein extracts from a CHO-DUKX host cell line were silver-stained 
and the investigators identified 25 cellular proteins by MS and MS/MS. Using fluorescence staining, 
Hayduk et al (2004) significantly improved the number of protein identifications to 224 
identifications in a CHO-K1 host cell line [145]. The most recently published protein reference map, 
in 2010, belongs to the dihydrofolate reductase-deficient CHO-DG44 host cell line [146]. Composing 
of over 1400 silver-stained protein spots, a total of 179 spots, which represented 106 unique proteins, 
were identified [146]. 
  
 Though several 2-D proteome reference maps have been published for CHO cells, the studies 
mentioned were performed at a time when the proteome database of CHO cells was rather limited. As 
a result, the researchers performed protein database searching from related species including Mus 
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musculus (mouse), Rattus norvegicus (rat) and Homo Sapiens leading to a loss of stringency in the 
identifications. Secondly, an attempt to comprehensively identify over 1000 gel spots from a given 
whole cell protein extract, by mass spectrometry, would be relatively costly. Finally, the CHO 2-D 
protein reference maps published to date contain annotation data within the articles themselves, 
thereby limiting its usefulness when one relies on visual comparison of one's gels to the images 
displayed in the manuscript.  
 
 The present study addresses these issues. A 2-D proteome reference map was generated for 
the CHO-BRI host cell line to further expand our understanding of this particular cell line. It will be a 
useful tool for studies investigating physiological responses and protein expression patterns of CHO-
BRI to genetic and environmental modifications. Mass spectral data analysis was performed against a 
CHO-specific protein database to enhance the confidence of protein identifications. A multiplexed 
design was developed to maximize the number of protein identifications while minimizing the cost 
from gel-based maps. The proof of principle of this unique experimental design was tested with 
CHO-BRI cells and further developed using Escherichia coli (strain MG1655) cells. Finally, the 
resulting CHO-BRI 2-D proteome reference map and its corresponding proteomic data can be 
deposited into the World-2DPAGE Repository (a public database for gel-based proteomics data 
linked to protein identifications published in literature). These mapping efforts would contribute to 
optimizing the growth of CHO cells and efficient cell line engineering initiatives which could lead to 
enhanced recombinant protein production. 
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3.2 Materials and Methods 
3.2.1 Multiplex Experimental Design 
 A paired gel design was devised in a multiplexed fashion that allows up to 528 spots to be 
identified by mass spectrometry as seen in Figure 3-1. The design incorporated two preparative gels 
that were produced from a single whole cell protein extract sample. Spots were matched between the 
two gels and assigned spot IDs using PDQuest Advanced 2-D Analysis Software v8.0.1. Spots were 
then excised into the wells of a 96-well perforated filter plate, with increasing abundant spots going 
down the rows of the plate, such that two of the same spot ID (1 from each gel) appears in two 
different wells of a given row. For example, according to Figure 3-2, spot #1 was excised into wells 
H1 and H2. Spot #30 was excised into wells H6 and H9. Similarly, spot #55 was excised into wells 
H7 and H12. Each unique spot ID appears in a unique pair of wells that only correspond to that 
specific spot ID. After mass spectrometry analysis, the proteins within each well were identified. By 
observing for pairs of protein IDs within each row and the combination of wells they are found in, 
this was mapped back to their corresponding spot ID, which subsequently mapped back to the 
corresponding protein spot on the preparative gel.   
  
 In this multiplex design, 11 spots are placed into each well, which corresponds to 66 unique 
protein spots per row. With 8 rows per 96-well perforated filter plate, this would correspond to a total 
of 528 protein spots that could potentially be identified from a preparative gel of a target organism. 
The proof of concept was initially confirmed using the CHO-BRI cell line to develop a 2-D CHO 
protein reference map. The method was further developed using the Escherichia coli (E. coli) strain 
MG1655 as a model organism. For the E. coli samples, a control plate was also run that contained 96 
single protein spots excised into each well from a third preparative gel to facilitate comparison. 
Specifically, 12 protein spots for each row (1 per well) of the singlet plate were randomly selected 
from the list of 66 unique protein spots in the multiplex design to keep in accordance with the 
increasing abundant levels down the plate (Figure 3-3). This also facilitates comparison to see if the 
proteins identified in the singlet plate would also be identified in the multiplex plate on a per row 
basis. 
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Figure 3-1. Multiplex Paired Gel Design (A). Two preparative gels were run from a single protein 
sample. Protein spots were excised into the wells of a 96-well perforated filter plate. Each well 
consists of 11 protein spots. Each row contains 66 unique spots that result in 528 unique spots across 
the entire plate. 
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Figure 3-2. Multiplex Paired Gel Design (B). A schematic example: each unique spot ID appears in 
a pair of unique wells that only corresponds to that spot ID. Pairs of protein IDs can then be mapped 
back to the corresponding pair of wells which maps back to the location of the protein spot on the 
preparative gel. This schematic is applied to rows A through H. 
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Figure 3-3. Singlet Gel Design (Control). A schematic example: For a given row, 12 spots were 
randomly selected from the list of 66 unique protein spots generated in the multiplex design. This 
second plate was denoted the 'singlet plate' and consisted of a total of 96 protein spots.  
 
3.2.2 Cell Lysis and Protein Extraction 
CHO-BRI 
 CHO-BRI protein samples from the comparative proteomic study described in Chapter 2 
were used, with cell lysis and protein extraction as previously described. The six CHO-BRI biological 
replicate protein samples were pooled together (total volume: ~700µL) and subjected to the Bio-Rad 
protein assay prior to protein sample clean-up. 
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MG1655 
 E. coli strain MG1655 was kindly provided by Dr. Matthew Scott from the University of 
Waterloo. The cells were grown in minimal M63 media with 20mM NH4
+
 as the nitrogen source and 
0.2% glucose for the carbon source. The doubling time was roughly 1 hour. 
 
 The method for cell lysis and protein extraction was similar to that of section 2.2.2 with 
minor changes. After washing with PBS, MG1655 was re-suspended in 1000µL lysis buffer and 
24µL protease inhibitor. Nucleic acids were removed from the extract by addition of 1% protamine 
sulfate (Calbiochem, Billerica, USA). Due to high cell density, the extracted protein samples 
underwent 20x dilution prior to protein concentration determination by the Bio-Rad protein assay. 
3.2.3 Protein Sample Clean-Up 
 The protein sample clean-up procedure was similar to that of section 2.2.3 with a few 
modifications. 
 
CHO-BRI  
 The pooled protein sample with a volume of approximately 700µL was split into 150µL 
aliquots for protein sample clean-up. After clean-up, the aliquots were pooled back together and re-
suspended in 600µL lysis buffer. The protein concentration was determined once more by the Bio-
Rad protein assay (see section 2.2.2).  
 
MG1655 
 A volume of 25µL from the MG1655 protein extract was aliquoted into 10 microcentrifuge 
tubes for sample clean-up. After clean-up, the aliquots were pooled together and re-suspended in 1mL 
lysis buffer. The protein concentration was determined once more by the Bio-Rad protein assay (see 
section 2.2.2). 
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3.2.4 2-D SDS-PAGE 
CHO-BRI 
 Due to a limited amount of sample, three colloidal coomassie stained preparative gels were 
initially prepared as per the protocol in section 2.2.5.1. 
 
MG1655 
 Six colloidal coomassie stained preparative gels were initially prepared as per the protocol in 
section 2.2.5.1. 
3.2.5 Gel Scanning and Analysis  
  The resulting stained gels were scanned using the EXQuest Spot Cutter camera. All the gel 
images were cropped to the same size and the spot detection wizard within PDQuest Advanced 2-D 
Analysis Software v8.0.1 was used to facilitate spot matching. A maximum value was chosen for 
each spot detection parameter resulting in an increase in the sensitivity of the spot detection wizard 
while minimizing the detection of image noise. Additionally, optional settings to remove horizontal 
and vertical streaks, speck removal, and background subtraction were selected.  
 
 The number of matched spots was then determined between each pair of gel images (Gel 1 vs 
2, Gel 1 vs 3, Gel 2 vs 3 etc). The pair of gels that resulted in the greatest number of matched spots 
were selected for the multiplex experiment due to increased coverage of the entire proteome. In the 
MG1655 experiment, a third gel that had the most number of spots detected was used as the single gel 
control. Next, the list of spot IDs for the matched spots between paired gels, including their relative x- 
and y- coordinates on the gel as well as their spot intensity levels, were exported into MATLAB 
v7.5.0 (The MathWorks, Inc) to generate spot-picking lists totaling 528 unique protein spots. The 
algorithm generated 13 pick lists (6 for each gel in the paired design and 1 for the singlet control). 
The pick lists were generated in such a way that row A of the plate contained the least abundant 
protein spots (as determined by their intensity levels), with increasing abundance towards row H in 
order to ensure consistency in abundance levels between each row. This is to minimize masking of 
low abundant spots by high abundant spots which may not be seen during protein identification steps. 
 
 63 
 
 Subsequently, the spot-picking lists were imported into PDQuest as several .txt files and the 
manual excision function was used to excise spots of interest. Due to the differences in the 
positioning of the gel inside the EXQuest Spot Cutter, the x- and y-coordinates of each spot of 
interest must be manually screened and corrected to ensure the correct spot of interest was excised. 
Spot excision was carried out as per section 2.2.5.2 under 'Protein Spot Excision'. 
3.2.6 Multiwell In-Gel Trypsin Digestion 
 The multiwell in-gel trypsin digestion was performed according to section 2.2.5.2 following 
protein spot excision. 
3.2.7 Mass Spectrometry (LC-MS/MS) 
 The digested peptides were sent to the Hospital for Sick Children Mass Spectrometry Facility 
(ON, Canada) for mass spectrometry (MS) analysis. The CHO-BRI samples were analyzed according 
to section 2.2.5.3. 
 
 To improve accuracy, the MG1655 samples were run on an LTQ Orbitrap instrument with a 
UPLC system, which has ± 10ppm accuracy on the parent ions. This speeds up database searches and 
end up with a lower false positive rate. The procedure was performed by Mr. Paul Taylor for the 
MG1655 samples and is outlined below: 
  
 The digested peptides were loaded onto a 75μm x 2cm C18 (3μm particle size) pre-column 
(Thermo-Fisher Scientific, ON, Canada) at 4μl/min and separated over a 75μm ID x 15cm analytical 
column packed with C18 (2μm) beads (Thermo-Fisher Scientific, ON, Canada) fitted with an emitter 
tip. The peptides were eluted over 120 minutes at 250 nL/min using a 0 to 35% ACN gradient in 0.1% 
formic acid using an EASY n-LC 1000 nano-chromatography pump (Proxeon Biosystems, Odense 
Denmark). The peptides were eluted into a LTQ-Orbitrap hybrid mass spectrometer (Thermo-Fisher, 
Bremen, Germany) operated in a data dependant mode. MS/MS was carried out in the linear ion trap. 
Six MS/MS scans were obtained per MS cycle.  
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3.2.8 Database Searching and Protein Identification 
 The raw data files were searched using PEAKS Studio v5.3. Protein identification was 
performed similarly to section 2.2.5.4 with a minor change to the instrument parameters, de novo 
parameters, and PEAKS DB search parameters for MG1655.  
 
CHO-BRI 
 The instrument parameters, de novo parameters, and PEAKS DB search parameters were the 
same as section 2.2.5.4. 
 
MG1655 
 The MS precursor scan was set to FT-ICR/Orbitrap and the parent ion/mass error tolerance 
was set to 20 ppm in the de novo and PEAKS DB search parameters because the data was obtained 
from analyzing on a more sensitive instrument. The de novo sequencing results were searched against 
the UniProt database under the E. coli taxa. 
3.2.9 Cross-matching Between Protein IDs and Spot IDs 
 In PEAKS DB, proteins identified by a shared subset of peptides are characterized into the 
same group. Occasionally, one or more peptides will map back to several protein identifiers all of 
which correspond to the same actual protein sequence (eg: homologs in different strains). This poses 
a problem as the matching algorithm relies on this for identifying pairs of the exact same protein 
identifiers. To circumvent this issue, all protein identifiers were queried in UniRef (UniProt 
Reference Clusters) to identify a unique and universal UniRef ID that represents a given protein. In 
other words, all identical sequences and subfragments with 11 or more residues are placed into a 
single record, which would facilitate proper matching. 
 
 R was used to perform the cross-matching for each multiplexed experiment. We looked for 
successful intersections where a particular UniRefID appears in 2 and only 2 of the 12 wells for a 
given row.     
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3.3 Results 
3.3.1 Cell Lysis and Protein Extraction 
 Following cell lysis and protein sample clean-up, the protein concentrations of CHO-BRI and 
MG1655 samples were determined by the Bio-Rad protein assay. BSA was used as a protein standard 
to generate the standard curves depicted in Error! Reference source not found.. 
 
 The protein concentrations were calculated for CHO-BRI and MG1655 samples as shown in 
Table B 1. The protein concentration was used to determine the volume of sample required to load 
approximately 800µg of protein per preparative gel. 
3.3.2 Gel Scanning and Analysis  
 Coomassie stained preparative gels were scanned and the number of spots were detected for 
each gel. Combinations of pairs of gels were then analyzed to determine the pair that gave the highest 
number of spots matched. As indicated in Table 3-1, Gel 1 vs 3 was chosen for the CHO-BRI 
sample, and Gel 3 vs 4 was chosen for the MG1655 sample. The initial multiplex run was performed 
on CHO-BRI samples (Gel 1 and Gel 3) to confirm the proof-of-principle. The E.coli MG1655 data 
was performed as a comprehensive follow-up with modifications to the protocol, such as an inclusion 
of a single gel control plate and use of a more sensitive mass spectrometer to facilitate comparison. 
Gel 5 contained the highest number of detected spots, as shown in Table 3-2, and was chosen to be 
the singlet control plate for MG1655. Once the third gel was chosen, it was matched with the 
previously selected gel pair (Gel 3 vs 4) to assign the same spot IDs for all 3 gels. 
 
 
 
 
 
 
 
 66 
 
Table 3-1. Spot Matching Comparison Between Each Combination of Gel Pairs. Highlighted 
rows with the highest number of spots matched indicate pairs of gels that were chosen for the paired 
gel multiplex experiment. A third gel that has the next most number of spots detected was chosen as 
the single control plate for MG1655, and was matched with the previously selected gel pair to assign 
the same spot IDs for all 3 gels, as highlighted in blue.  
 Gel Comparison # of Spots Matched 
CHO-BRI Gel 1 vs 2 673 
Gel 1 vs 3 685 
Gel 2 vs 3 600 
MG1655 Gel 1 vs 2 895 
Gel 1 vs 3 884 
Gel 1 vs 4 946 
Gel 1 vs 5 927 
Gel 1 vs 6 782 
Gel 2 vs 3 862 
Gel 2 vs 4 907 
Gel 2 vs 5 860 
Gel 2 vs 6 738 
Gel 3 vs 4 981 
Gel 3 vs 5 924 
Gel 3 vs 6 863 
Gel 4 vs 5 977 
Gel 4 vs 6 888 
Gel 5 vs 6 853 
Gel 3 vs 4 vs 5 782 
 
Table 3-2. Spot Detection in MG1655 Gels for Multiplex. The highlighted row indicates the third 
gel that was chosen for the single control plate. 
 Gel # # of Spots Detected 
MG1655 1 1370 
2 1342 
3 1356 
4 1481 
5 1497 
6 1311 
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3.3.3 Database Searching and Protein Identification 
 After spots from each gel were excised according to the spot-picking lists generated through 
MATLAB v7.5.0, they were identified using PEAKS Studio 5.3. Table B 2, Table B 3, and Table B 
4 in Appendix B shows these identifications for both CHO-BRI and MG1655 multiplexed 
experiments as well as the MG1655 singlet control, respectively.  
3.3.4 Cross-matching Between Protein IDs and Spot IDs 
 Protein IDs were cross-matched to look for successful intersections where a particular 
UniRefID appears in 2 and only 2 of the 12 wells for a given row. The following tables (Table 3-3 
and Table 3-4) display these results for CHO-BRI and MG1655 samples, respectively. 
 
CHO-BRI 
Table 3-3. Successful Protein ID Cross-Matches for CHO-BRI. 
Wells 
Spot 
ID 
Cluster ID 
MW 
(kDa)/pI* 
MW 
(kDa)/pI^ 
Protein ID 
A01 A08 3217 UniRef90_P31937 29.0/5.7 31.7/5.2 3-hydroxyisobutyrate dehydrogenase, mitochondrial 
A01 A09 4606 UniRef90_Q12874 70.4/5.8 58.8/5.2 Splicing factor 3A subunit 3 
   
UniRef90_G3IAS8 70.4/5.8 185.7/6.1 Kinesin-like protein KIF27 
A01 A10 2201 UniRef90_P63101 26.7/4.8 27.8/4.7 14-3-3 protein zeta/delta 
   
UniRef90_P31946 26.7/4.8 28.1/4.8 14-3-3 protein beta/alpha 
A01 A11 1504 UniRef90_Q16576 51.6/4.6 47.7/4.9 Histone-binding protein RBBP7 
A02 A06 5101 UniRef90_G3HZ25 23.7/6.3 25.5/5.0 
NADH dehydrogenase [ubiquinone] flavoprotein 2, 
mitochondrial 
A02 A11 4306 UniRef90_G3IND2 42.5/5.7 30.9/5.4 26S proteasome non-ATPase regulatory subunit 13 
A02 A12 6601 UniRef90_P31040 72.1/6.9 68.0/6.3 
Succinate dehydrogenase [ubiquinone] flavoprotein subunit, 
mitochondrial 
A04 A06 5504 UniRef90_G3HR08 55.5/6.3 50.3/6.4 Cytosol aminopeptidase 
A05 A07 4709 UniRef90_G3HEZ0 73.0/5.8 65.8/5.8 Stress-70 protein, mitochondrial 
A05 A09 2207 UniRef90_P08758 32.2/5.4 35.8/4.9 Annexin A5 
A05 A11 6212 UniRef90_G3HNV4 25.1/8.5 16.4/8.5 Triosephosphate isomerase 
   
UniRef90_G3I216 25.1/8.5 20.4/8.9 Triosephosphate isomerase 
A06 A07 7101 UniRef90_Q99N15 24.1/8.6 27.3/8.9 
17beta-hydroxysteroid dehydrogenase type 10/short chain L-
3-hydroxyacyl-CoA dehydrogenase 
A06 A12 6304 UniRef90_Q15365 42.3/7.7 37.5/6.7 Poly(rC)-binding protein 1 
   
UniRef90_Q9CXW2 42.3/7.7 41.2/8.6 28S ribosomal protein S22, mitochondrial 
A07 A08 1112 UniRef90_G3I6E6 18.7/4.7 32.0/5.2 Actin, cytoplasmic 2 
   
UniRef90_P60709 18.7/4.7 41.7/5.3 Actin, cytoplasmic 1 
A07 A10 4406 UniRef90_G3HE28 50.7/5.8 40.1/5.4 Mitochondrial-processing peptidase subunit beta 
A07 A11 4010 UniRef90_P35232 15.5/5.9 29.8/5.6 Prohibitin 
A07 A12 1206 UniRef90_P12004 33.0/4.6 28.8/4.6 Proliferating cell nuclear antigen 
A08 A11 603 UniRef90_G3H0U6 71.3/3.8 50.1/5.5 Protein disulfide-isomerase A3 
B02 B05 4011 UniRef90_G3IBF1 14.6/6.2 31.1/4.5 Nucleophosmin 
B02 B06 6603 UniRef90_P31040 72.1/7.0 68.0/6.3 
Succinate dehydrogenase [ubiquinone] flavoprotein subunit, 
mitochondrial 
B02 B10 1205 UniRef90_G3HC01 30.2/4.5 35.4/4.7 Tropomyosin alpha-3 chain 
B03 B04 3710 UniRef90_P46061 72.9/5.6 63.4/4.6 Ran GTPase-activating protein 1 
   
UniRef90_P21981 72.9/5.6 76.9/5.0 Protein-glutamine gamma-glutamyltransferase 2 
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B03 B06 6407 UniRef90_G3HNG2 47.3/7.0 49.8/8.3 Acyl-coenzyme A thioesterase 2, mitochondrial 
B03 B09 6303 UniRef90_G3HHK0 39.5/7.1 35.4/7.1 28S ribosomal protein S31, mitochondrial 
B03 B11 7102 UniRef90_Q99N15 24.2/8.6 27.3/8.9 
17beta-hydroxysteroid dehydrogenase type 10/short chain L-
3-hydroxyacyl-CoA dehydrogenase 
B03 B12 4105 UniRef90_G3GTF9 22.1/5.7 18.9/5.5 ATP synthase subunit d, mitochondrial 
B04 B08 2104 UniRef90_Q99653 22.7/4.9 22.5/5.0 Calcineurin B homologous protein 1 
B04 B10 4404 UniRef90_G3HE28 50.5/5.7 40.1/5.4 Mitochondrial-processing peptidase subunit beta 
B04 B11 1507 UniRef90_Q16576 53.2/4.6 47.7/4.9 Histone-binding protein RBBP7 
B04 B12 6202 UniRef90_G3I2M0 31.9/6.9 25.5/8.6 Sulfatase-modifying factor 2 
B05 B07 4119 UniRef90_P02794 20.4/6.2 21.2/5.3 Ferritin heavy chain 
B06 B07 613 UniRef90_Q14697 71.8/3.9 104.0/5.6 Neutral alpha-glucosidase AB 
B06 B10 1320 UniRef90_P07910 40.9/4.7 33.5/5.0 Heterogeneous nuclear ribonucleoproteins C1/C2 
B07 B10 6204 UniRef90_P35232 28.2/7 29.8/5.6 Prohibitin 
B07 B11 4706 UniRef90_Q9CQN1 78.7/5.7 73.8/5.7 Heat shock protein 75 kDa, mitochondrial 
B07 B12 402 UniRef90_Q9DB77 45.7/3.8 46.6/9.0 Cytochrome b-c1 complex subunit 2, mitochondrial 
   
UniRef90_G3HQI8 45.7/3.8 229.3/8.1 Myosin-Vb 
B08 B10 4612 UniRef90_P17987 71.5/6.2 60.3/5.8 T-complex protein 1 subunit alpha 
B09 B11 3717 UniRef90_A4FUY3 75.6/5.6 83.2/5.1 Prolyl 3-hydroxylase 1 
C01 C09 2202 UniRef90_G3HEQ3 25.1/5.1 25.2/5.1 Ran-specific GTPase-activating protein 
C01 C10 2705 UniRef90_Q14568 76.4/5.2 39.4/4.6 Putative heat shock protein HSP 90-alpha A2 
C02 C03 4210 UniRef90_P35232 28.3/5.7 29.8/5.6 Prohibitin 
C02 C10 1101 UniRef90_P56537 24.8/4.5 26.6/4.6 Eukaryotic translation initiation factor 6 
C04 C06 2608 UniRef90_P30153 71.5/5.1 65.3/5.0 
Serine/threonine-protein phosphatase 2A 65 kDa regulatory 
subunit A alpha isoform 
   
UniRef90_P30154 71.5/5.1 66.2/4.8 
Serine/threonine-protein phosphatase 2A 65 kDa regulatory 
subunit A beta isoform 
C04 C07 6104 UniRef90_G3HNV4 24.7/7.1 16.4/8.5 Triosephosphate isomerase 
   
UniRef90_G3I216 24.7/7.1 20.4/8.9 Triosephosphate isomerase 
C05 C12 5705 UniRef90_O00571 72.7/6.5 73.1/6.7 ATP-dependent RNA helicase DDX3X 
C06 C08 1207 UniRef90_G3HC01 29.3/4.6 35.4/4.7 Tropomyosin alpha-3 chain 
C06 C11 2612 UniRef90_Q9R0A0 71.1/5.3 41.1/5.0 Peroxisomal membrane protein PEX14 
C07 C10 4913 UniRef90_Q8CGK3 98.8/6.1 98.9/5.7 Lon protease homolog, mitochondrial 
C08 C10 6302 UniRef90_P11021 36.2/7.0 70.5/5.0 78 kDa glucose-regulated protein 
C08 C11 1211 UniRef90_B9A067 29.3/4.6 79.0/6.6 Mitochondrial inner membrane protein 
D01 D03 5701 UniRef90_Q8BMF4 72.7/6.3 58.8/5.7 
Dihydrolipoyllysine-residue acetyltransferase component of 
pyruvate dehydrogenase complex, mitochondrial 
D01 D07 4509 UniRef90_Q02790 69.0/6.0 51.8/5.4 Peptidyl-prolyl cis-trans isomerase FKBP4 
   
UniRef90_G3IAS8 69.0/6.0 185.7/6.1 Kinesin-like protein KIF27 
D02 D07 5901 UniRef90_P05091 92.8/6.3 54.4/5.7 Aldehyde dehydrogenase, mitochondrial 
D02 D12 6507 UniRef90_P09622 56.1/7.2 50.2/6.5 Dihydrolipoyl dehydrogenase, mitochondrial 
D03 D05 3718 UniRef90_O95302 72.5/5.6 60.4/4.8 Peptidyl-prolyl cis-trans isomerase FKBP9 
D03 D06 6505 UniRef90_G3IE04 65.2/7.2 53.4/6.1 Pre-mRNA-processing factor 19 
D03 D11 1204 UniRef90_P56537 24.9/4.5 26.6/4.6 Eukaryotic translation initiation factor 6 
D05 D07 4407 UniRef90_O96019 49.3/5.8 47.3/5.4 Actin-like protein 6A 
D06 D12 4412 UniRef90_G3HE28 50.8/6.1 40.1/5.4 Mitochondrial-processing peptidase subunit beta 
   
UniRef90_G3HKP3 50.8/6.1 40.6/5.6 Cytochrome b-c1 complex subunit 1, mitochondrial 
D07 D08 408 UniRef90_Q8CGK3 50.4/3.9 98.9/5.7 Lon protease homolog, mitochondrial 
D07 D10 6412 UniRef90_G3HNG2 47.7/7.2 49.8/8.3 Acyl-coenzyme A thioesterase 2, mitochondrial 
D07 D12 207 UniRef90_Q3V3R1 29.6/4.4 102.2/6.2 Monofunctional C1-tetrahydrofolate synthase, mitochondrial 
E01 E03 5209 UniRef90_O88696 26.3/6.6 24.1/5.6 
Putative ATP-dependent Clp protease proteolytic subunit, 
mitochondrial 
E01 E04 5614 UniRef90_Q9CQN1 72.3/6.7 73.8/5.7 Heat shock protein 75 kDa, mitochondrial 
E01 E09 3101 UniRef90_Q3V3R1 21.1/5.5 102.2/6.2 Monofunctional C1-tetrahydrofolate synthase, mitochondrial 
E01 E12 3410 UniRef90_Q7TP98 45.8/5.6 51.4/5.4 Interleukin enhancer-binding factor 2 
E02 E04 5006 UniRef90_G3HDS1 14.6/6.7 14.9/11.0 Histone H4 
   
UniRef90_B9W7J9 14.6/6.7 11.6/11.4 Histone H4 
   
UniRef90_P62805 14.6/6.7 11.2/11.4 Histone H4 
   
UniRef90_G3HPV6 14.6/6.7 28.5/11.0 Histone H2A type 1 
E02 E05 503 UniRef90_P34897 53.9/3.9 52.6/8.1 Serine hydroxymethyltransferase, mitochondrial 
E02 E08 6406 UniRef90_G3HKP3 51.4/7.0 40.6/5.6 Cytochrome b-c1 complex subunit 1, mitochondrial 
E02 E09 407 UniRef90_Q9DB77 46.1/3.9 46.6/9.0 Cytochrome b-c1 complex subunit 2, mitochondrial 
   
UniRef90_P00505 46.1/3.9 44.7/9.0 Aspartate aminotransferase, mitochondrial 
   
UniRef90_G3HQI8 46.1/3.9 229.3/8.1 Myosin-Vb 
E03 E04 2315 UniRef90_P07910 40.0/5.2 33.5/5.0 Heterogeneous nuclear ribonucleoproteins C1/C2 
 69 
 
E03 E10 5703 UniRef90_B9A067 73.0/6.5 79.0/6.6 Mitochondrial inner membrane protein 
E04 E05 6503 UniRef90_Q9Y265 53.1/7.0 50.2/6.0 RuvB-like 1 
E04 E06 4710 UniRef90_P28331 72.6/5.9 77.0/5.4 
NADH-ubiquinone oxidoreductase 75 kDa subunit, 
mitochondrial 
E04 E09 4508 UniRef90_Q9GZL7 53.0/6.0 47.7/5.6 Ribosome biogenesis protein WDR12 
   
UniRef90_P51855 53.0/6.0 52.2/5.6 Glutathione synthetase 
E04 E11 4111 UniRef90_P20108 23.3/5.9 21.6/5.7 Thioredoxin-dependent peroxide reductase, mitochondrial 
   
UniRef90_Q8K3J1 23.3/5.9 20.4/5.1 
NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, 
mitochondrial 
E04 E12 6403 UniRef90_Q9UQ80 48.5/6.9 43.7/6.1 Proliferation-associated protein 2G4 
E05 E07 6004 UniRef90_P09622 12.1/7.1 50.2/6.5 Dihydrolipoyl dehydrogenase, mitochondrial 
E05 E08 609 UniRef90_Q71U36 71.3/3.8 50.1/4.9 Tubulin alpha-1A chain 
   
UniRef90_G3IAS8 71.3/3.8 185.7/6.1 Kinesin-like protein KIF27 
E05 E09 4501 UniRef90_G3HZY1 52.2/5.7 57.2/5.4 RuvB-like 2 
   
UniRef90_Q9Z1N5 52.2/5.7 49.0/5.4 Spliceosome RNA helicase Ddx39b 
E06 E07 6611 UniRef90_Q16822 71.7/7.4 67.1/6.6 Phosphoenolpyruvate carboxykinase [GTP], mitochondrial 
   
UniRef90_P49368 71.7/7.4 60.5/6.1 T-complex protein 1 subunit gamma 
E07 E10 1410 UniRef90_G3ILN5 44.4/4.6 34.4/4.7 Reticulocalbin-3 
   
UniRef90_G3H584 44.4/4.6 28.2/4.8 SPARC 
E07 E12 2708 UniRef90_Q9Z0X1 75.7/5.3 55.5/7.3 Apoptosis-inducing factor 1, mitochondrial 
E08 E10 2302 UniRef90_G3HNJ3 35.7/4.8 51.8/5.5 Clusterin 
E09 E11 1110 UniRef90_G3GVX1 24.8/4.7 21.7/8.7 Ribosome-binding protein 1 
      UniRef90_G3HN14 24.8/4.7 23.8/5.7 Transitional endoplasmic reticulum ATPase 
F01 F03 204 UniRef90_G3HNG5 25.2/4.2 50.4/6.4 Acyl-coenzyme A thioesterase 1 
F01 F06 3915 UniRef90_G3I6E6 138.4/5.6 32.0/5.2 Actin, cytoplasmic 2 
F01 F11 6420 UniRef90_P49411 49.9/7.9 45.0/6.3 Elongation factor Tu, mitochondrial 
F02 F03 7002 UniRef90_G3I129 12.2/8.8 48.7/8.8 Ubiquitin 
   
UniRef90_P0CG83 12.2/8.8 19.2/6.6 Polyubiquitin (Fragment) 
F02 F06 3901 UniRef90_Q16822 103.5/5.4 70.7/6.6 Phosphoenolpyruvate carboxykinase [GTP], mitochondrial 
F03 F04 1416 UniRef90_G3HNJ3 51.0/4.7 51.8/5.5 Clusterin 
F03 F05 4609 UniRef90_G3IAS8 71.2/6.0 185.7/6.1 Kinesin-like protein KIF27 
F03 F06 5514 UniRef90_G3HR08 57.8/6.7 50.3/6.4 Cytosol aminopeptidase 
F03 F09 3507 UniRef90_G3HZY1 52.0/5.6 57.2/5.4 RuvB-like 2 
F03 F10 5114 UniRef90_P20108 23.5/6.8 21.6/5.7 Thioredoxin-dependent peroxide reductase, mitochondrial 
F03 F11 4207 UniRef90_P62873 34.0/5.7 37.2/5.6 
Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit 
beta-1 
F04 F05 2502 UniRef90_P27797 52.9/4.8 48.1/4.3 Calreticulin 
F04 F07 4502 UniRef90_Q71U36 53.3/5.7 50.1/4.9 Tubulin alpha-1A chain 
F05 F10 5112 UniRef90_P00505 22.4/6.7 44.7/9.0 Aspartate aminotransferase, mitochondrial 
F05 F11 4117 UniRef90_P32119 22.3/6.1 21.8/5.7 Peroxiredoxin-2 
F06 F08 5309 UniRef90_G3HHK0 38.9/6.7 35.4/7.1 28S ribosomal protein S31, mitochondrial 
F07 F09 5501 UniRef90_Q8BKZ9 53.2/6.2 48.0/5.8 
Pyruvate dehydrogenase protein X component, 
mitochondrial 
F07 F10 5207 UniRef90_H0X554 25.6/6.5 30.8/6.3 
NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, 
mitochondrial 
F07 F11 7201 UniRef90_Q8K0D5 25.5/8.5 79.4/5.9 Elongation factor G, mitochondrial 
F10 F12 4405 UniRef90_Q91W90 48.7/5.7 43.0/5.2 Thioredoxin domain-containing protein 5 
G01 G02 2407 UniRef90_P81117 50.4/5.1 47.4/5.0 Nucleobindin-2 
G02 G04 5515 UniRef90_G3H0U6 68.1/6.7 50.1/5.5 Protein disulfide-isomerase A3 
G02 G10 4503 UniRef90_Q9Z1N5 51.7/5.7 49.0/5.4 Spliceosome RNA helicase Ddx39b 
G02 G12 6414 UniRef90_P49411 49.5/7.3 49.6/7.7 Elongation factor Tu, mitochondrial 
G03 G12 4216 UniRef90_P62873 34.5/6.0 37.4/5.6 
Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit 
beta-1 
G04 G05 3715 UniRef90_P28331 72.4/5.6 79.8/5.9 
NADH-ubiquinone oxidoreductase 75 kDa subunit, 
mitochondrial 
G04 G06 6508 UniRef90_P09622 53.4/7.2 54.1/8.0 Dihydrolipoyl dehydrogenase, mitochondrial 
   
UniRef90_P34897 53.4/7.2 55.9/8.7 Serine hydroxymethyltransferase, mitochondrial 
G04 G08 4108 UniRef90_P02794 21.5/5.7 21.2/5.3 Ferritin heavy chain 
G05 G06 5401 UniRef90_G3GS40 44.4/6.3 38.8/4.9 
Succinyl-CoA ligase [GDP-forming] subunit beta, 
mitochondrial 
G06 G07 1310 UniRef90_G3ILN5 41.0/4.6 34.4/4.7 Reticulocalbin-3 
G07 G12 3007 UniRef90_P09382 15.0/5.7 14.8/5.5 Galectin-1 
G08 G10 6415 UniRef90_P00505 44.9/7.3 47.4/9.1 Aspartate aminotransferase, mitochondrial 
G09 G10 5102 UniRef90_G3I6E6 23.4/6.3 32.0/5.2 Actin, cytoplasmic 2 
 70 
 
G11 G12 6701 UniRef90_B9A067 73.1/6.9 79.3/6.4 Mitochondrial inner membrane protein 
H01 H09 2602 UniRef90_P81117 70.4/4.9 50.3/5.1 Nucleobindin-2 
H01 H12 3704 UniRef90_G3HSM8 72.4/5.5 67.7/5.2 Lamin-B2 
H02 H04 5301 UniRef90_P50213 39.6/6.3 39.6/6.5 
Isocitrate dehydrogenase [NAD] subunit alpha, 
mitochondrial 
H03 H04 717 UniRef90_G3H697 73.2/4.4 62.4/4.4 Glucosidase 2 subunit beta 
H03 H08 4601 UniRef90_G3IGQ3 70.9/5.7 23.1/8.9 Heat shock cognate 71 kDa protein 
H04 H07 3409 UniRef90_G3GS40 50.0/5.6 38.8/4.9 
Succinyl-CoA ligase [GDP-forming] subunit beta, 
mitochondrial 
H04 H10 3501 UniRef90_G3I2N0 42.5/5.2 42.5/5.2 Inhibitor of nuclear factor kappa-B kinase-interacting protein 
H05 H06 6510 UniRef90_P09622 54.1/8.0 54.1/8.0 Dihydrolipoyl dehydrogenase, mitochondrial 
   
UniRef90_P05091 56.5/7.5 56.5/7.5 Aldehyde dehydrogenase, mitochondrial 
H06 H07 3610 UniRef90_P48643 71.0/5.6 59.5/5.3 T-complex protein 1 subunit epsilon 
H06 H08 3001 UniRef90_P09382 14.8/5.5 14.8/5.5 Galectin-1 
H06 H10 1314 UniRef90_G3IBF1 31.0/4.5 31.0/4.5 Nucleophosmin 
H08 H11 3611 UniRef90_P08003 72.0/5.6 72.0/5.6 Protein disulfide-isomerase A4 
*MW and pI of the identified proteins were estimated from their gel locations and compared to 
^calculated values using ExPASy Compute pI/MW tool [104]. Spot pattern and location were further 
cross-referenced with available CHO 2D reference maps [124; 145]. 
 
 According to Table 3-3,  a total of 131 spots were successfully identified. The relative 
locations of the identified spots for the CHO-BRI multiplexed sample are shown below (Figure 3-4). 
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Figure 3-4. (CHO-BRI Multiplex) Identified Spots and Their Relative Locations According to 
Table 3-3. 
 
MG1655 
Table 3-4. Successful Protein ID Cross-Matches for MG1655. Highlighted in green are protein IDs 
that were also identified in the singlet control plate, refer to Table A-3 in Appendix A. 
Wells 
Spot 
ID 
Cluster ID 
MW 
(kDa)/pI* 
MW 
(kDa)/pI^ 
Protein ID 
A01 A06 4001 UniRef90_A7ZPW1 14.2/5.9 15.5/5.5 Nucleoside diphosphate kinase 
A01 A11 2605 UniRef90_B5F6U1 50.5/5.3 49.8/5.3 Argininosuccinate synthase 
A02 A04 3706 UniRef90_A8ACN8 55.9/5.7 55.3/5.8 ATP synthase subunit alpha 
   
UniRef90_P23847 55.9/5.7 57.4/5.7 Periplasmic dipeptide transport protein 
A02 A09 2516 UniRef90_A7ZHR7 35.1/5.3 88.4/4.9 Outer membrane protein assembly factor BamA 
A02 A10 2220 UniRef90_A7ZPU1 22.5/5.3 22.5/5.3 Uracil phosphoribosyltransferase 
A03 A04 2406 UniRef90_P0A797 35.0/5.3 34.8/5.5 6-phosphofructokinase isozyme 1 
A03 A06 3209 UniRef90_P22731 26.3/5.6 26.3/5.6 
High-affinity branched-chain amino acid transport 
ATP-binding protein LivF 
A04 A06 4810 UniRef90_P33363 78.8/6.0 81.4/5.8 Periplasmic beta-glucosidase 
A04 A09 14 UniRef90_P0A6G4 16.4/5.1 17.6/5.1 Protein YgaD 
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A05 A06 4211 UniRef90_P38489 26.7/6.0 23.9/5.8 Oxygen-insensitive NAD(P)H nitroreductase 
A05 A09 2714 UniRef90_A7ZPV7 53.7/5.3 47.0/5.7 Histidine--tRNA ligase 
A05 A10 1606 UniRef90_B7UMJ8 44.3/5.2 31.6/8.8 ATP synthase gamma chain 
A05 A11 2206 UniRef90_P0AEN3 27.3/5.3 26.1/5.3 NAD(P)H-flavin reductase 
A06 A07 3304 UniRef90_B5FTC5 29.7/5.5 27.7/5.9 Deoxyribose-phosphate aldolase 
A06 A11 4301 UniRef90_P0A9L8 30.3/5.9 28.1/5.6 Pyrroline-5-carboxylate reductase 
B01 B02 2403 UniRef90_A7ZHR7 35.0/5.3 88.4/4.9 Outer membrane protein assembly factor BamA 
B01 B03 1611 UniRef90_P02930 51.7/5.2 51.5/5.2 Outer membrane protein tolC 
B01 B06 4405 UniRef90_P33030 34.7/6.0 36.1/6.0 Uncharacterized protein YeiR 
B01 B10 3512 UniRef90_Q8X4S6 43.6/5.7 43.6/5.7 
Acetylornithine/succinyldiaminopimelate 
aminotransferase 
B02 B07 1803 UniRef90_P06971 78.7/5.2 78.7/5.1 Ferrichrome-iron receptor 
B02 B12 3303 UniRef90_A7ZH92 34.4/5.5 33.6/5.5 Homoserine kinase 
B04 B07 1109 UniRef90_P0A9W9 20.7/5.2 20.2/5.3 Protein YrdA 
B05 B06 215 UniRef90_Q32EF3 24.1/5.1 26.1/5.1 
1-(5-phosphoribosyl)-5-[(5-
phosphoribosylamino)methylideneamino] imidazole-
4-carboxamide isomerase 
B05 B10 2302 UniRef90_P23917 34.4/5.3 32.5/5.5 Fructokinase 
B06 B07 1302 UniRef90_B5F769 34.3/5.2 31.4/4.8 Bis(5'-nucleosyl)-tetraphosphatase, symmetrical 
B09 B10 2312 UniRef90_P58603 31.2/5.3 33.5/5.3 Protease 7 
C02 C04 2311 UniRef90_P0ADS7 34.5/5.3 26.6/6.1 Uncharacterized protein yggE 
C02 C05 610 UniRef90_P02930 51.1/5.4 51.5/5.2 Outer membrane protein tolC 
C02 C09 2306 UniRef90_A8ALS4 29.1/5.3 28.7/5.7 Dihydrodipicolinate reductase 
C02 C12 3505 UniRef90_A8AKV5 39.4/5.5 42.1/5.8 tRNA (uracil(54)-C(5))-methyltransferase 
   
UniRef90_P00509 39.4/5.5 43.6/5.5 Aspartate aminotransferase 
   
UniRef90_Q0T204 39.4/5.5 41.0/6.3 
4-hydroxy-3-methylbut-2-en-1-yl diphosphate 
synthase 
C03 C08 3517 UniRef90_A7ZSR4 35.6/5.8 38.9/5.7 3-dehydroquinate synthase 
C04 C10 4804 UniRef90_P0A928 85.1/6.0 31.4/4.9 Nucleoside-specific channel-forming protein tsx 
C04 C11 2518 UniRef90_B7MI93 43.0/5.3 42.3/5.5 Acetylornithine deacetylase 
C05 C10 2513 UniRef90_Q8X732 35.1/5.3 35.9/5.6 N-acetyl-gamma-glutamyl-phosphate reductase 
C06 C08 1309 UniRef90_P25906 31.7/5.2 30.7/5.3 Putative oxidoreductase YdbC 
C06 C11 4203 UniRef90_P75736 26.7/5.9 28.4/5.9 Esterase ybfF 
C07 C10 4513 UniRef90_A8ACN8 39.6/6.1 55.3/5.8 ATP synthase subunit alpha 
C07 C12 3113 UniRef90_Q3Z3B7 21.8/5.8 21.2/5.9 Flavoprotein WrbA 
C08 C11 4112 UniRef90_B7UN33 20.0/6.0 19.0/6.1 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase 
C09 C10 15 UniRef90_P0AEB8 10.3/5.1 12.5/5.0 RutC family protein yoaB 
C09 C11 2802 UniRef90_P08331 64.4/5.3 68.9/5.4 
2',3'-cyclic-nucleotide 2'-phosphodiesterase/3'-
nucleotidase 
C10 C11 1016 UniRef90_P12994 15.5/5.2 17.1/5.3 UPF0098 protein ybhB 
C10 C12 2314 UniRef90_P58603 31.0/5.3 33.5/5.3 Protease 7 
C11 C12 4206 UniRef90_P09126 27.8/6.0 27.8/6.0 Uroporphyrinogen-III synthase 
   
UniRef90_P76034 27.8/6.0 27.6/6.0 
Uncharacterized HTH-type transcriptional regulator 
YciT 
D01 D06 2511 UniRef90_P00888 36.8/5.3 38.8/5.4 
Phospho-2-dehydro-3-deoxyheptonate aldolase, Tyr-
sensitive 
D01 D09 3307 UniRef90_A8ALC4 34.5/5.6 29.9/5.5 
2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-
succinyltransferase 
   
UniRef90_A7ZN88 34.5/5.6 31.1/5.6 Molecular chaperone Hsp31 and glyoxalase 3 
D01 D10 408 UniRef90_P0AFK9 34.9/5.1 36.5/4.9 Spermidine/putrescine-binding periplasmic protein 
D01 D11 1408 UniRef90_P66794 35.0/5.2 36.7/5.3 Selenide, water dikinase 
D02 D04 3705 UniRef90_Q3Z3B7 52.4/5.6 21.2/5.9 Flavoprotein WrbA 
D02 D05 2101 UniRef90_Q57M35 21.3/5.2 20.5/5.4 NADH-quinone oxidoreductase subunit I 
D02 D07 2309 UniRef90_B5FTC5 29.0/5.3 27.7/5.9 Deoxyribose-phosphate aldolase 
D02 D09 3407 UniRef90_P31550 34.9/5.8 34.2/5.9 Thiamine-binding periplasmic protein 
D03 D06 1603 UniRef90_P02930 51.4/5.2 51.5/5.2 Outer membrane protein tolC 
D03 D07 3518 UniRef90_B7MG93 38.3/5.8 39.2/6.0 Chorismate synthase 
D03 D08 4510 UniRef90_P0A9K5 40.7/6.0 39.0/5.7 PhoH-like protein 
D03 D10 611 UniRef90_A7ZVS5 47.3/5.1 47.2/5.2 Thymidine phosphorylase 
D04 D09 4215 UniRef90_P0A9D3 22.4/6.0 22.9/5.9 Glutathione S-transferase GstA 
D05 D06 2515 UniRef90_P0A9R0 37.0/5.3 40.0/5.4 Aspartate-semialdehyde dehydrogenase 
D05 D08 3310 UniRef90_P0ADS7 34.5/5.7 26.6/6.1 Uncharacterized protein yggE 
   
UniRef90_Q8X4S5 34.5/5.7 34.0/5.9 Arabinose 5-phosphate isomerase GutQ 
D05 D10 2703 UniRef90_Q8X9Z2 54.3/5.3 53.3/5.4 UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-
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diaminopimelate ligase 
D05 D12 2507 UniRef90_P0AEJ3 41.6/5.3 42.9/5.5 Isochorismate synthase entC 
D06 D09 505 UniRef90_B5Y275 43.7/5.1 44.3/5.1 Phosphopentomutase 
D06 D11 2603 UniRef90_B7N5L4 44.4/5.2 44.4/5.6 CinA-like protein 
D07 D08 3220 UniRef90_A7FGQ6 27.0/5.9 25.8/5.8 NADH-quinone oxidoreductase subunit B 
D07 D10 1209 UniRef90_P09551 27.2/5.2 25.8/5.2 Lysine-arginine-ornithine-binding periplasmic protein 
D08 D10 1802 UniRef90_P06971 78.1/5.2 78.7/5.1 Ferrichrome-iron receptor 
D08 D11 3522 UniRef90_Q9S5G5 41.9/5.8 40.3/5.9 Histidine biosynthesis bifunctional protein HisB 
D10 D12 4507 UniRef90_Q0T204 39.6/6.0 41.0/6.3 
4-hydroxy-3-methylbut-2-en-1-yl diphosphate 
synthase 
D11 D12 603 UniRef90_A8ACN6 51.6/5.0 50.3/4.9 ATP synthase subunit beta 
E02 E03 1801 UniRef90_P06971 77.6/5.1 78.7/5.1 Ferrichrome-iron receptor 
E02 E05 1306 UniRef90_A7ZHM4 29.3/5.2 28.2/5.2 3-methyl-2-oxobutanoate hydroxymethyltransferase 
E02 E06 3 UniRef90_A9MHF3 10.8/4.6 12.4/4.6 50S ribosomal protein L7/L12 
E02 E09 2201 UniRef90_P21367 22.5/5.2 23.1/5.2 Uncharacterized protein ycaC 
E03 E04 109 UniRef90_P76576 20.5/5.1 22.2/5.1 UPF0070 protein yfgM 
E03 E05 213 UniRef90_A4WC74 26.9/5.1 28.4/5.0 Imidazole glycerol phosphate synthase subunit HisF 
E03 E06 2210 UniRef90_A7FGQ6 26.6/5.3 25.8/5.8 NADH-quinone oxidoreductase subunit B 
E03 E08 4410 UniRef90_B5F446 34.7/6.0 34.4/5.9 Aspartate carbamoyltransferase 
E03 E11 4306 UniRef90_P0AAY0 34.4/6.0 30.9/5.6 Probable L,D-transpeptidase YbiS 
E03 E12 2505 UniRef90_A1AC10 43.5/5.3 42.4/5.5 Phosphoribosylglycinamide formyltransferase 2 
E04 E07 4309 UniRef90_P0AEZ1 34.3/6.0 33.1/6.0 5,10-methylenetetrahydrofolate reductase 
E04 E08 4110 UniRef90_B7UN33 19.9/6.0 19.0/6.1 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase 
E04 E10 4209 UniRef90_P12758 27.3/6.0 27.0/5.8 Uridine phosphorylase 
E04 E12 3504 UniRef90_A7ZSR4 35.1/5.4 38.9/5.7 3-dehydroquinate synthase 
E05 E06 3513 UniRef90_Q46856 36.3/5.7 42.1/5.7 Alcohol dehydrogenase YqhD 
E05 E08 1310 UniRef90_P16703 34.4/5.2 32.7/5.4 Cysteine synthase B 
E05 E09 310 UniRef90_P23905 34.4/5.1 33.4/5.3 D-galactose-binding periplasmic protein 
E05 E10 4119 UniRef90_A7ZKL2 20.0/6.1 21.2/6.1 UPF0227 protein ycfP 
E05 E11 2415 UniRef90_P26646 34.6/5.3 34.7/5.6 Putative quinone oxidoreductase YhdH 
E06 E09 2308 UniRef90_P33362 34.1/5.3 30.2/5.6 
Putative osmoprotectant uptake system substrate-
binding protein osmF 
E07 E08 2512 UniRef90_Q8X732 35.1/5.3 35.9/5.6 N-acetyl-gamma-glutamyl-phosphate reductase 
E07 E09 2209 UniRef90_A8ANW8 27.5/5.3 28.0/5.5 Phosphoadenosine phosphosulfate reductase 
E08 E11 2707 UniRef90_P25526 53.2/5.3 51.7/5.4 
Succinate-semialdehyde dehydrogenase [NADP(+)] 
GabD 
E09 E11 2713 UniRef90_P23847 54.6/5.3 57.4/5.7 Periplasmic dipeptide transport protein 
   
UniRef90_A8ALC4 54.6/5.3 29.9/5.5 
2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-
succinyltransferase 
E09 E12 217 UniRef90_P67271 24.4/5.1 26.9/5.4 UPF0135 protein ybgI 
E10 E11 705 UniRef90_P77804 54.3/5.1 52.8/5.0 Protein ydgA 
E10 E12 210 UniRef90_Q32EF3 23.2/5.1 26.1/5.1 
1-(5-phosphoribosyl)-5-[(5-
phosphoribosylamino)methylideneamino] imidazole-
4-carboxamide isomerase 
F01 F03 3204 UniRef90_P0AFU8 22.4/5.4 23.4/5.6 Riboflavin synthase alpha chain 
F01 F04 1212 UniRef90_P0AET9 25.3/5.2 26.8/5.2 7-alpha-hydroxysteroid dehydrogenase 
   
UniRef90_B7MIX6 25.3/5.2 27.0/5.6 Thiazole synthase 
F01 F05 2408 UniRef90_Q3Z3B7 35.0/5.3 21.2/5.9 Flavoprotein WrbA 
F01 F06 219 UniRef90_A8ALC9 25.9/5.1 24.3/5.1 
5'-methylthioadenosine/S-adenosylhomocysteine 
nucleosidase 
F01 F08 4412 UniRef90_P0AB92 35.0/6.0 38.0/6.1 
Phospho-2-dehydro-3-deoxyheptonate aldolase, Phe-
sensitive 
F02 F04 1410 UniRef90_P0A9P5 34.6/5.2 34.5/5.3 Thioredoxin reductase 
F02 F05 2208 UniRef90_A7ZUD3 26.8/5.3 27.0/5.6 Triosephosphate isomerase 
F02 F06 4004 UniRef90_A8API1 11.0/5.9 11.0/5.9 Probable Fe(2+)-trafficking protein 
F02 F07 2606 UniRef90_A8AIH5 44.4/5.3 46.0/5.3 3-phosphoshikimate 1-carboxyvinyltransferase 
F02 F08 2808 UniRef90_P00904 66.4/5.3 56.7/6.1 Anthranilate synthase component II 
F02 F11 3701 UniRef90_P19480 57.3/5.4 55.9/5.6 Alkyl hydroperoxide reductase subunit F 
F03 F04 704 UniRef90_P77804 54.0/5.1 52.8/5.0 Protein ydgA 
F03 F05 3210 UniRef90_A7ZIN4 27.8/5.7 23.6/5.6 Adenylate kinase 
   
UniRef90_Q57RI5 27.8/5.7 28.5/5.8 
2,3-bisphosphoglycerate-dependent phosphoglycerate 
mutase 
F03 F06 3604 UniRef90_A7FDW9 46.0/5.6 44.8/5.7 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 
F03 F08 3110 UniRef90_P0ACS1 20.4/5.8 20.6/5.8 Transcriptional repressor mprA 
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F03 F09 4217 UniRef90_P67082 26.8/6.1 25.8/6.1 UPF0001 protein yggS 
   
UniRef90_P10346 26.8/6.1 26.7/6.1 Glutamine transport ATP-binding protein GlnQ 
F04 F05 3410 UniRef90_P16657 34.6/5.8 27.6/5.6 Enoyl-[acyl-carrier-protein] reductase [NADH] FabI 
   
UniRef90_P0AE20 34.6/5.8 29.3/5.6 Methionine aminopeptidase 
   
UniRef90_P0ADS7 34.6/5.8 26.6/6.1 Uncharacterized protein yggE 
F04 F06 1417 UniRef90_A7ZNJ1 34.6/5.2 33.4/5.5 ATP phosphoribosyltransferase 
F04 F07 4009 UniRef90_P0ADN4 16.1/6.1 13.0/6.1 UPF0438 protein yifE 
F04 F08 4713 UniRef90_B7UPI6 59.6/6.0 61.5/5.9 Glucose-6-phosphate isomerase 
F04 F11 406 UniRef90_Q3Z606 34.9/5.0 35.2/5.1 Transaldolase 1 
F05 F09 3218 UniRef90_P38489 25.7/5.8 23.9/5.8 Oxygen-insensitive NAD(P)H nitroreductase 
F05 F10 1608 UniRef90_P39099 49.8/5.2 44.4/5.4 Periplasmic pH-dependent serine endoprotease DegQ 
F05 F11 3404 UniRef90_P0A797 35.0/5.6 34.8/5.5 6-phosphofructokinase isozyme 1 
F06 F09 3711 UniRef90_P07003 62.0/5.9 62.0/5.9 Pyruvate dehydrogenase [ubiquinone] 
F07 F10 607 UniRef90_A8ACN6 49.7/5.1 50.3/4.9 ATP synthase subunit beta 
   
UniRef90_Q8FG52 49.7/5.1 46.1/5.1 Histidinol dehydrogenase 
F08 F10 2701 UniRef90_P25526 52.9/5.2 51.7/5.4 
Succinate-semialdehyde dehydrogenase [NADP(+)] 
GabD 
F09 F10 3312 UniRef90_P09030 34.4/5.8 31.0/5.8 Exodeoxyribonuclease III 
   
UniRef90_P33362 34.4/5.8 30.2/5.6 
Putative osmoprotectant uptake system substrate-
binding protein osmF 
F09 F11 3301 UniRef90_P0A9L8 29.1/5.4 28.1/5.6 Pyrroline-5-carboxylate reductase 
F10 F11 3521 UniRef90_P0A9K5 40.1/5.8 39.0/5.7 PhoH-like protein 
G01 G02 4708 UniRef90_P0ADG8 59.4/6.0 52.0/6.0 Inosine-5'-monophosphate dehydrogenase 
G01 G08 1203 UniRef90_A1AFA2 22.4/5.2 24.3/5.5 Ribose-5-phosphate isomerase A 
G01 G09 3214 UniRef90_P0A957 22.3/5.8 22.3/5.6 KHG/KDPG aldolase 
   
UniRef90_P0A9D3 22.3/5.8 22.9/5.9 Glutathione S-transferase GstA 
G01 G11 4006 UniRef90_B5FI12 14.3/6.0 15.2/5.9 Ribosome-binding factor A 
   
UniRef90_Q8FK07 14.3/6.0 16.0/6.0 Universal stress protein G 
G02 G03 1202 UniRef90_A7ZHM4 28.7/5.2 28.2/5.2 3-methyl-2-oxobutanoate hydroxymethyltransferase 
G02 G04 3609 UniRef90_A7FDW9 46.1/5.8 44.8/5.7 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 
G02 G05 2804 UniRef90_Q8XEG2 66.0/5.3 66.8/5.6 
Glucosamine--fructose-6-phosphate aminotransferase 
[isomerizing] 
G02 G09 1125 UniRef90_P0A4L6 21.7/5.2 21.1/5.4 Thiol:disulfide interchange protein DsbA 
G03 G04 4305 UniRef90_Q8XBT6 30.1/6.0 31.1/5.9 2,5-diketo-D-gluconic acid reductase A 
G03 G07 4311 UniRef90_A7ZPS4 34.5/6.1 31.3/6.0 Dihydrodipicolinate synthase 
G03 G09 4113 UniRef90_B7UN33 19.8/6.0 19.0/6.1 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase 
G03 G11 3516 UniRef90_Q9S5G5 42.8/5.8 40.3/5.9 Histidine biosynthesis bifunctional protein HisB 
   
UniRef90_A7MH28 42.8/5.8 43.2/5.9 Acetate kinase 
G04 G05 116 UniRef90_P0A252 21.2/5.1 20.6/5.0 Alkyl hydroperoxide reductase subunit C 
G04 G06 4303 UniRef90_P02925 29.0/5.9 28.5/6.0 D-ribose-binding periplasmic protein 
G04 G07 4611 UniRef90_P78067 46.3/6.1 45.8/6.0 Thiosulfate sulfurtransferase YnjE 
G04 G09 1011 UniRef90_P0AEN0 16.4/5.2 26.1/5.3 Cystine-binding periplasmic protein 
   
UniRef90_P0A919 16.4/5.2 16.4/5.3 Outer membrane protein X 
G04 G11 3104 UniRef90_P0AGD5 21.6/5.5 21.1/5.6 Superoxide dismutase [Fe] 
G04 G12 4512 UniRef90_P33570 35.0/6.0 73.0/5.9 Transketolase 2 
G05 G08 111 UniRef90_P0AG09 22.2/5.1 24.6/5.1 Ribulose-phosphate 3-epimerase 
   
UniRef90_P0ADK2 22.2/5.1 25.7/6.1 Uncharacterized protein yiaF 
G05 G09 2204 UniRef90_A7ZPU1 22.4/5.3 22.5/5.3 Uracil phosphoribosyltransferase 
G05 G10 2414 UniRef90_P0A797 35.0/5.3 34.8/5.5 6-phosphofructokinase isozyme 1 
G05 G11 3217 UniRef90_Q3Z3B7 22.4/5.8 21.2/5.9 Flavoprotein WrbA 
G06 G08 3703 UniRef90_P09832 55.3/5.5 51.9/5.5 Glutamate synthase [NADPH] small chain 
   
UniRef90_P23847 55.3/5.5 57.4/5.7 Periplasmic dipeptide transport protein 
G06 G09 1206 UniRef90_P0ACA5 26.6/5.2 24.2/5.2 Stringent starvation protein A 
G06 G12 2315 UniRef90_A7ZN88 34.5/5.3 31.1/5.6 Molecular chaperone Hsp31 and glyoxalase 3 
G07 G08 3509 UniRef90_P0A9K5 39.1/5.6 39.0/5.7 PhoH-like protein 
G07 G09 1312 UniRef90_P58603 30.6/5.2 33.5/5.3 Protease 7 
G07 G11 405 UniRef90_P0AFK9 34.9/5.0 36.5/4.9 Spermidine/putrescine-binding periplasmic protein 
G08 G09 1610 UniRef90_A8AIH5 44.0/5.2 46.0/5.3 3-phosphoshikimate 1-carboxyvinyltransferase 
G08 G11 1201 UniRef90_P0AET9 24.6/5.2 26.8/5.2 7-alpha-hydroxysteroid dehydrogenase 
G08 G12 4111 UniRef90_A7ZHY1 21.8/6.0 20.8/6.0 Phosphoheptose isomerase 
G09 G12 4118 UniRef90_B5XNU6 19.4/6.1 19.4/6.1 UPF0304 protein KPK_1463 
G10 G11 3216 UniRef90_B7MUC3 25.2/5.8 26.2/5.8 Orotidine 5'-phosphate decarboxylase 
G11 G12 1208 UniRef90_Q9S5G3 22.5/5.2 22.8/5.1 Histidine biosynthesis bifunctional protein HisIE 
H01 H02 2405 UniRef90_P0A797 34.9/5.3 34.8/5.5 6-phosphofructokinase isozyme 1 
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H01 H03 2115 UniRef90_P0A4L6 21.7/5.3 21.1/5.4 Thiol:disulfide interchange protein DsbA 
H01 H07 1507 UniRef90_P18815 37.6/5.2 40.5/7.0 Maltose-binding periplasmic protein 
   
UniRef90_Q57RI5 37.6/5.2 28.5/5.8 
2,3-bisphosphoglycerate-dependent phosphoglycerate 
mutase 
H01 H09 107 UniRef90_P0A252 21.6/5.1 20.6/5.0 Alkyl hydroperoxide reductase subunit C 
H01 H10 3215 UniRef90_P12758 27.2/5.8 27.0/5.8 Uridine phosphorylase 
H02 H03 4506 UniRef90_Q9S5G5 42.3/6.0 40.3/5.9 Histidine biosynthesis bifunctional protein HisB 
H02 H07 1213 UniRef90_P0AFM7 26.5/5.2 25.4/5.4 Phage shock protein A 
H02 H08 1121 UniRef90_P0AFH9 20.2/5.2 18.2/5.4 Osmotically-inducible protein Y 
H03 H04 4104 UniRef90_A7ZII0 19.9/5.9 18.3/5.9 UPF0234 protein yajQ 
H03 H07 4502 UniRef90_A7MH28 43.4/5.9 43.2/5.9 Acetate kinase 
   
UniRef90_P0A6F2 43.4/5.9 41.4/5.9 Carbamoyl-phosphate synthase small chain 
H03 H09 2413 UniRef90_A7ZSD0 34.7/5.3 32.3/5.6 Malate dehydrogenase 
   
UniRef90_P00805 34.7/5.3 34.6/5.7 L-asparaginase 2 
H04 H05 605 UniRef90_Q8FG52 49.2/5.1 46.1/5.1 Histidinol dehydrogenase 
H04 H07 4605 UniRef90_A7FDW9 45.9/6.0 44.8/5.7 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 
   
UniRef90_P00370 45.9/6.0 48.6/6.0 NADP-specific glutamate dehydrogenase 
H04 H09 2107 UniRef90_P0AGD5 21.5/5.3 21.1/5.6 Superoxide dismutase [Fe] 
H04 H11 2007 UniRef90_P0C0L2 14.4/5.3 15.0/5.6 Peroxiredoxin osmC 
H05 H07 221 UniRef90_P09551 27.0/5.4 25.8/5.2 Lysine-arginine-ornithine-binding periplasmic protein 
H05 H11 1402 UniRef90_Q57T38 34.6/5.2 30.4/5.1 Elongation factor Ts 
H07 H08 1217 UniRef90_A8ALS4 28.2/5.2 28.7/5.7 Dihydrodipicolinate reductase 
H07 H11 1115 UniRef90_A7ZPU1 22.2/5.2 22.5/5.3 Uracil phosphoribosyltransferase 
H08 H09 2301 UniRef90_A7ZH92 34.4/5.2 33.6/5.5 Homoserine kinase 
H08 H10 1405 UniRef90_Q7N590 34.6/5.2 34.2/5.4 Ribose-phosphate pyrophosphokinase 
H09 H10 309 UniRef90_P0AEU2 29.4/5.1 26.2/5.2 Histidine-binding periplasmic protein 
H09 H11 216 UniRef90_B7UH18 27.0/5.1 14.3/5.1 Autonomous glycyl radical cofactor 
H10 H11 3411 UniRef90_P33570 35.0/5.9 73.0/5.9 Transketolase 2 
*MW and pI of the identified proteins were estimated from their gel locations and compared to 
^calculated values using ExPASy Compute pI/MW tool [104]. 
 
 In Table 3-4, the protein IDs highlighted in green were also matched to the spot and protein 
IDs selected in the singlet plate (Table B 4 in Appendix B). A total of 69 out of 96 spots were 
successfully identified within the MG1655 singlet plate. In contrast, 184 spots were successfully 
identified in the MG1655 multiplexed plate (Table 3-4), indicating approximately a 2.7 fold increase 
in the number of identifications. Some spot IDs have more than 1 corresponding protein ID as a result 
of having more than 1 protein that is common between the same pair of wells. This is likely due to 
proteins or protein fragments of similar MW and pI that co-migrate to the same location on the 2-D 
gel. 
 
 The relative locations of the identified MG1655 spots for both the multiplexed experiment 
and the singlet control are shown in Figure 3-5 and Figure 3-6. 
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Figure 3-5. (MG1655 Multiplex) Identified Spots and Their Relative Locations According to 
Table 3-4. 
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Figure 3-6. (MG1655 Singlet) Identified Spots and Their Relative Locations According to Table 
B 4 in Appendix B. 
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3.4 Discussion 
 Two similar experiments were performed and analyzed within this Chapter. The first 
corresponds to the development of a proteome reference map from CHO-BRI protein extracts. 
Further method development was conducted in the second experiment using E. coli strain MG1655 
protein extracts. 
3.4.1 2-D CHO-BRI Proteome Reference Map 
 A CHO-BRI proteome reference map, which contains 131 identified protein spots, 
representing 90 different proteins was constructed using a multiplexed experimental design. The 
proteins identified in this map represent several cellular compartments, including the cytosol, 
mitochondria, and endoplasmic reticulum, which indicates that the methodology is able to provide a 
degree of representation of all cellular compartments. The identified proteins were categorized based 
on their functional annotation as described from the UniProtKB database. Identified proteins were 
distributed within the following categories: oxidoreductase activity (7%), transcription (10%), amino 
acid metabolism (9%), cell proliferation and apoptosis (11%), translation (9%), lipid metabolism 
(2%), energy metabolism (4%), protein processing/folding/degradation (20%), carbohydrate 
metabolism (9%), cytoskeleton organization (7%), transport (2%), metabolism of cofactors and 
vitamins (1%), signal transduction (1%), calcium ion homeostasis (1%), nuclear envelope (1%), and 
unknown (6%) (Figure 3-7). 
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Figure 3-7. Distribution of CHO-BRI Proteins Identified by MS/MS and Organized into 
Functional Categories. 
 
 The developed 2D CHO-BRI protein reference map was related back to those differentially 
regulated proteins identified from the previous proteomic analysis study (Chapter 2) to look for 
common spots with respect to their identifications and relative spot locations. Nine spots (Trap1 
(364), Actb (1228), Aldh (549), Acot2 (651), Dld (524 and 529), Hibadh (1027), Pcna (959), Ndufs3 
(1138)) from the proteomic study match well with the relative spot locations identified in the CHO 
protein reference map. The low number of matches could be due to several reasons. One reason could 
be the simple fact that those spots were not selected for excision and identification (of the 528 unique 
spots), and was therefore omitted. A more likely reason is that the relative spots may not have been 
identified in the reference map, and therefore comparison is not possible. The fact that certain spots 
were not identified could be due to 'spot trains' on the gel. The appearance of 'spot trains' (several 
spots aligned horizontally one after another indicating similar molecular weight with different pI) on 
the gel for a single gene product is due to post-translational modifications that may arise from 
different extents of protein phosphorylation widespread on mammalian proteins or the presence of 
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multiple protein subunits. This is an issue during cross-matching: if a particular protein ID appears in 
multiple wells of a given row, it would result in several combinations of matched pairs of protein IDs. 
If this happens, then it would not be possible to accurately map the protein IDs back to their 
corresponding spot location on the gel. We decided to select for pairs of protein IDs that appear in '2 
and only 2' of the 12 wells, for a given row, to simplify the cross-matching process as well as to 
determine a baseline of the number of spots that could be accurately identified using this 
methodology. It was unlikely that spots that were part of a particular 'spot train' would pass this 
selection criteria, and would, therefore, be omitted. As some of the proteins identified in the 
proteomic study are observed to be part of a spot train (e.g. Grp75, Vim), it was therefore unlikely 
that these would also be identified in the CHO 2D protein reference map.  
 
 Following the cross-matching procedure, the identified proteins match well according to their 
estimated MW and pI with respect to their locations on the 2D gel (Table 3-3). Spot pattern and 
location were further cross-referenced with available CHO 2D reference maps [124; 145]. 
 
 By multiplexing gel samples in a 96-well plate, we have developed a method for accurately 
identifying a large number of protein samples derived from a coomassie stained 2-D gel. Using this 
method, we have constructed a proteome 2-D reference map of the CHO-BRI cell line, which will 
enable investigation of systematic responses of this cell line to various environmental signals. A 
CHO-specific protein database was used for database searching and protein identification, which 
further improves the confidence of the spots identified compared to CHO protein reference maps 
published to date that use homologous protein sequence databases. The proteome reference map 
developed in this study will be an informative addition to the current CHO 2-D gel database. 
Furthermore, the resulting CHO-BRI 2-D proteome reference map developed in the present work can 
be deposited into the World-2DPAGE Repository to further facilitate its utility in complementing 
other CHO genomic and proteomic studies. 
3.4.2 Using MG1655 for Development of 2-D Gel Multiplexing Design 
 To improve on the 2-D gel multiplexing design, Escherichia coli strain MG1655 was used as 
the test model organism. This cell line was provided by Dr. Matthew Scott from the University of 
Waterloo. MG1655 is a descendent from the original E. coli K-12 wild-type laboratory strain. 
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Originally isolated in 1922, the K-12 strain has become the primary model organism for basic 
biology, molecular genetics and physiology of bacteria, as well as a prominent platform for 
applications in the biotechnology industry. The accuracy and completeness of information regarding 
E. coli has provided inferences of gene functions to other prokaryotic and eukaryotic genomes 
through analogy based on genomic and protein sequence similarities. The entire genome of MG1655 
has been sequenced and is well-characterized [147]. The wealth of information and the availability of 
MG1655 aided in the development of this protein identification technique from 2-D gels. In addition, 
as a prokaryote, it does not possess post-translational modifications that lead to 'spot trains' on a 2-D 
gel. This further simplifies the cross-matching procedure. 
 
 A total of six 2-D gels were prepared to ensure that we had adequate protein samples for MS 
analysis. They were also used for 'back-up' in the event that a gel was ripped during handling, and 
therefore unusable. With a higher number of 2-D gels prepared, a singlet control containing 96 
protein gel pieces was also analyzed in conjunction with the multiplexed plate to facilitate 
comparison. To improve the accuracy of MS analysis and subsequent protein identifications, the 
MG1655 samples were run on an LTQ Orbitrap instrument with a UPLC system, which gives ± 
20ppm accuracy on parent ions. This speeds up database searches and ends up with a lower false 
positive rate.  
 
 With the changes mentioned above, 184 protein spots were successfully identified in the 
multiplexed plate. The estimated MW and pI of these spots match well with calculated values as 
shown in Table 3-4. In comparison to the singlet plate, of which 69 out of 96 protein spots were 
successfully identified, this corresponds to an approximate 2.7 fold increase in the number of protein 
identifications in a single run for the cost of a single 96-well plate. In other words,by utilizing the 
multiplexing approach, we were able to identify almost 3 times as many protein spots as compared to 
a single gel approach using a 96-well plate format. Furthermore, according to Table 3-4, 31 of the 
proteins identified in the multiplexed plate, including their relative spot locations as denoted by their 
spot IDs, matches with the ones identified in the singlet control plate (highlighted in green). This 
match represents approximately 50% of the number of proteins identified in the singlet control. This 
value is acceptable considering the present work was performed as a first pass through to test the 
proof-of-principle resulting in preliminary results. The loss of the other half of matches could 
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partially be attributed to some of the wells that returned pure noise (i.e. no protein identifications 
were obtained) due to problems with sample handling. It could also be due to highly abundant 
proteins that may have appeared in more than 2 wells of a given row, and was therefore not taken into 
account during the matching process. However, the results still suggests that the principle works and 
requires further refinement in combination with the changes already made. Thus the results provide 
groundwork for further research and development to improve the multiplex strategy for developing 2-
D protein reference maps.  
 
 The samples were analyzed by mass spectrometry at the Hospital for Sick Children MS 
facility. In terms of costs, the facility charges approximately $85 per sample for an MS/MS run, 
which would amount to $8160 per 96 samples. In contrast, analysis of a 96-well plate costs $3264, 
which corresponds to $34 per sample when the investigators perform their own data analysis. The 
combination of the multiplexing method developed here using 96-well plates significantly reduces the 
cost of analysis on a per sample basis allowing up to 528 protein spots to be identified for the cost of 
a single 96-well plate. This results in a cost savings percentage of approximately 82%. In the present 
study, 184 protein spots were identified via multiplexing while 69 protein spots were identified in the 
single gel control plate. This results in a cost savings percentage of approximately 62% per 
identification.  
 
 Additionally, in-gel digestion is performed on all samples simultaneously using a multi-
channel pipette, which saves a considerable amount of benchwork time. However, a bottleneck with 
this method comes from mass spectrometry data analysis, which generates a large amount of data that 
is time-consuming to analyze. Protein identification must be performed for each well, which takes up 
computing time and is dependent on the specifications of the computer used. However, the multiplex 
method described in this chapter significantly reduces the labour time in comparison with the 
traditional method of performing in-gel digestion on each individual gel piece per sample tube 
followed by MS analysis. Another advantage is that contaminants are virtually screened and filtered 
during the cross-matching procedure. For example, keratin is a contaminant that poses a problem for 
MS analyses as it is highly abundant and is almost certain to appear during the protein identification 
step. With the multiplex method, it is likely that keratin will be identified in several sample wells for 
each row. However, since the cross-matching step looks for protein IDs that only appear in a pair of 
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unique wells (i.e. appear in 2 and only 2 of the 12 wells per row), contaminants such as keratin will be 
screened out. 
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3.5 Conclusion 
 The present work describes a novel method developed for identifying a large number of 
protein spots from a representative 2D gel. Using this method, a protein reference map, consisting of 
131 identified protein spots, was generated for the CHO-BRI strain. Similarly, a protein reference 
map consisting of 184 identified protein spots was generated for E. coli strain MG1655. 
 
 Some refinement could further improve the number of successful identifications and reduce 
analysis time. If PDQuest incorporated a function that generates the picklists in accordance to the 
specifications of the script developed in MATLAB, this would further reduce the time of the gel 
excision runs as it eliminates the differences in the x- and y- coordinates of each spot of interest due 
to the repositioning of the gel inside the EXQuest Spot Cutter following gel scanning. This would 
also prevent the gel from drying out due to prolonged exposure to air. A method for distinguishing the 
spots within spot trains as a result of post-translational modifications would aid in identification: 
possibly by separating each spot into different rows of the 96-well plate. Automating the in-gel 
digestion procedure would improve the robustness of this method while reducing the loss of sample 
due to sample handling. 
 
 The multiplexing scheme described in this chapter allows for the identification of a large 
number of protein spots from a preparative 2-D gel at a significantly reduced cost and time-
consumption. The method illustrated herein would therefore make the expansion of the current 2-D 
gel database more feasible and applicable to a number of organisms that have a limited number of, or 
non-existent, 2-D protein reference maps.  
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Chapter 4  
Conclusions and Future Directions 
4.1 Proteomic Changes in EG2-hFc1-Producing CHO Cells 
 A comparative proteomic analysis between an EG2-hFc1-producing CHO strain (CHO-1A7) 
and its parental cell line (CHO-BRI) was carried out where 86 protein spots were selected for 
subsequent MS analysis. The successful MS analyses of 52 protein spots yielded 34 unique protein 
identifications. These include proteins involved in apoptosis/cell proliferation regulation, protein 
processing, cell structural integrity, and enzymes related to various metabolic pathways. Functional 
annotation analyses revealed enriched metabolic pathways that are important for the generation of 
precursor metabolites and energy in CHO-1A7. 
  
 A number of differentially regulated proteins were found to be related to the apoptotic and 
cell proliferation processes. Hsp60 and Hsp90 were observed to be down-regulated in CHO-1A7. 
These heat shock proteins are primarily responsible for maintaining the conformation of the cell's 
proteins, particularly in response to environmental stress. Their down-regulation may lead to 
apoptotic processes that result in cell death. Further supporting this hypothesis, Nudfs3 and Pdcd6 
showed an increase in abundance. Ndufs3 and Pdcd6 are positive regulators of apoptosis and their up-
regulation suggests an initiation of apoptosis in a portion of cells by the end of the batch cultivation 
process. In contrast, Grp75 and Trap1 which were observed to be up-regulated in CHO-1A7, are 
known to influence cell proliferation processes, while the over-expression of Phb and under-
expression of Pcna in CHO-1A7 suggests an inhibition of cell proliferation by arresting CHO cells in 
the G0/G1 phase [110]. Growth-arrested CHO cells have been observed to influence increased 
recombinant protein production [117; 119]. The trends of the differentially regulated proteins related 
to apoptosis and cell proliferation seems to have conflicting influences on the fate of CHO cells. 
Whether this is due to harvesting the cells at the end of the batch cultivation process or an effect as a 
result of recombinant protein production is unclear. Nonetheless, the differential expression of anti- 
and pro-apoptotic proteins provides an indication of pathway changes related to cell growth and 
viability in CHO-1A7 that may play a role in recombinant protein production. Further studies are 
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warranted to investigate the connection between apoptotic/cell proliferation proteins with respect to 
antibody production. 
 
 Various molecular chaperones were also observed to be differentially regulated in CHO-1A7. 
PDI, GRP94, Hspd1, and Hsp90aa1 showed down-regulation in CHO-1A7. Both PDI and GRP94 are 
ER-resident chaperones involved in protein processing. PDI catalyzes the formation and breakage of 
cysteine residues within proteins, thus aids in finding the correct arrangement of disulfide bonds 
during protein folding. GRP94 plays a role in the processing and transport of secreted proteins, and it 
has also been implicated to assert chaperoning activity on unassembled immunoglobulin chains. 
Hspd1 is essential for the folding and assembly of newly imported proteins in the mitochondria, while 
Hsp90aa1 functions in the cytosol in the maintenance of properly folded proteins upon stress. The 
drop in expression levels of a number of molecular chaperones may indicate an adequate level of 
efficiency and capacity in sustaining protein translation and folding within the CHO-1A7 cell line. 
Though recombinant protein production is a stressor upon the cell, it may not be at a level high 
enough that would warrant the induction of chaperones.  
 
 Cytoskeletal proteins, including vimentin and β-actin showed reduced expression in CHO-
1A7. They are more commonly known for their involvement with maintaining the integrity of the 
cell, and their down-regulation may indirectly affect ATP generation and protein biosynthesis. 
Vimentin may play a role in maintaining mitochondrial morphology and organization, and its down-
regulation was shown to contribute to mitochondrial fragmentation that may affect energy derivation 
[131]. β-actin was also shown in studies to be related to the protein translation machinery. The 
disruption of the actin filament network in CHO cells resulted in a reduction in protein translation 
[138]. Although antibody titers were not measured throughout the batch cultivation process, the 
down-regulation of β-actin and vimentin may reflect a reduction in protein biosynthesis owing to the 
cells having been harvested at stationary phase. 
  
 Metabolic enzymes related to carbohydrate, amino acid, and lipid metabolism were also 
observed to be differentially expressed in EG2-hFc1-producing CHO cells. The enzymes involved 
relate to the cell's capacity for deriving energy and metabolites from organic compounds in order to 
sustain the production of EG2-hFc1. This was evident in the up-regulation of a number of enzymes 
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(Cs, Gpd2, Dld, Aldh, Ast, Hibadh, Ndufs3, Ndufv1) that are involved in energy generating metabolic 
pathways. These metabolic pathways were also found to be enriched following functional annotation 
analysis using DAVID which is a tool that looks for overrepresented terms from an input gene list. 
The observations noted in the present work suggests a shift in metabolic flux towards energy 
production to meet the energy demands of EG2-hFc1 production.  
 
 From a systems-level perspective, taking into account all the cellular processes involved, it 
appears that CHO-1A7 attempts to increase energy production in order to sustain EG2-hFc1 
productivity while maintaining cell viability. Subsequently, protein processing and protein folding are 
operating at a sufficient level that does not warrant the induction of enzymes involved in those 
biological functions in the production of EG2-hFc1. 
 
 For future studies, a few technical modifications could be employed to increase the number of 
protein identifications. A smaller pI range (ie: pH 4 – 7) could be used to better separate overlapping 
proteins with similar pIs, thereby increasing the resolution of the resulting gels. Further resolution can 
be obtained by separating proteins in a gradient gel, rather than a homogenous 12% SDS-PAGE gel 
during second dimension separation. Automated in-gel trypsin digestion would reduce labour time, 
minimize exposure of gel pieces to air, as well as minimize human errors (e.g. pipetting) due to 
sample handling. 
 
 The present work discusses changes in protein expression levels in CHO-1A7 associated with 
EG2-hFc1 production. It serves as a reference for future studies performed using this particular cell 
line. Based on this study, targeted over-expression of enzymes involved in the generation of energy in 
CHO-1A7 may improve EG2-hFc1 productivity. A comparative proteomic analysis of EG2-hFc1-
producing CHO-BRI derived cell lines with differing productivities would also provide insights into 
cellular changes and biomarkers that correlate with productivity levels. Finally a time-lapse study of 
CHO-1A7 will provide information in regards to the metabolic changes associated with growth via a 
batch process.  
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4.2 Development of 2-D CHO Proteome Reference Map 
 A multiplexing scheme was developed to generate proteome reference maps using 2-D gel-
based methods. The proof of concept was tested using both CHO-BRI and E.coli MG1655 as the 
model cell line and organism respectively. Under this scheme, 131 protein spots were identified in 
CHO-BRI, while 184 protein spots were identified in MG1655. These maps can serve as reference 
markers for cell-line specific 2-D gel studies.  
 
 To date, CHO protein reference maps found in literature were generated without CHO 
genomic sequence. Thus, protein identifications were searched against protein databases of related 
species including Mus musculus (mouse), Rattus norvegicus (rat) and Homo Sapiens, with a resultant 
loss of stringency in the identifications. In the present work, database searching and protein 
identifications were performed against a CHO-specific sequence database corresponding to the recent 
publication of the CHO-K1 genome. A total of 131 protein spots were successfully identified, 
consisting of 90 different proteins distributed over several cellular compartments. The resulting CHO-
BRI 2-D proteome reference map, with its corresponding proteomic data will be deposited into the 
World-2DPAGE Repository to complement future CHO genomic and proteomic studies. 
 
 Following the mapping efforts of the CHO-BRI cell line, the multiplexing method was 
further tweaked using MG1655 as the model organism. MG1655 is a well-characterized bacterial 
strain that contains a wealth of information in literature. In addition, due to the lack of post-
translational modifications of its proteins which would otherwise lead to 'spot trains' on a 2-D gel, the 
cross-matching procedure of the multiplex design is further simplified. A control plate consisting of 1 
gel spot per well of a 96 well-plate allowed the successful identification of 69 protein spots. In 
comparison, 184 protein spots were succesfully identified under the multiplexing methodology, which 
represents a 2.7-fold increase in the number of protein identifications in a single run. Approximately 
50% of the number of proteins identified in the control plate were also identified in the multiplex 
plate and matched well according to their relative locations on the 2-D gels. 
 
 Though the multiplex design could facilitate the identification of a large number of protein 
spots at a reduced cost and time-consumption compared to traditional methods, it could still use 
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further refinement. A method is needed to distinguish between post-translationally modified spots of 
the same protein, possibly by separating each spot within a spot train into different rows of the 96-
well plate. Automating the in-gel trypsin digestion protocol would improve the robustness of this 
method and reduce errors resulting from sample handling. Incorporating a function within PDQuest to 
generate the picklists according to the specifications of the multiplex design would facilitate faster 
excision times, and minimize the amount of time the 2-D gels are exposed to the open environment 
potentially leading to contamination. The analyses of the MS data presents a major bottleneck of this 
method. A single MS run on a 96-well plate generates a large amount of data to analyze. Nonetheless, 
automating gel spot-excision and using a 96-well plate format with multiple gel pieces per well 
significantly reduces the time spent on wet-lab work, as compared to traditional methods, while 
having the capacity to identify a large number of spots. Additionally, the costs of MS analysis is 
reduced, therefore making the expansion of 2-D gel database more feasible and applicable to a 
number of organisms that have a limited number of, or non-existent, 2-D protein reference maps. 
4.3 Contribution to MAbNet 
 This work is a component of a larger project that seeks to establish a novel platform for the 
large-scale manufacture of specific glycoforms of therapeutic monoclonal antibodies. EG2-hFc1 
represents one candidate that is under investigation. The ability to control the glycosylation profiles of 
recombinant MAbs could lead to enhanced therapeutic efficacy. It would also allow the generation of 
recombinant MAbs with various desired properties for other types of studies. The work presented in 
this thesis will assist MAbNet in meeting their objectives, by providing the proteome profile of CHO-
1A7 that corresponds to its glycosylation profile. Although proteins that directly modulate 
glycosylation were not apparent and could not be identified as differentially expressed from the 
proteomic analyses, this is not surprising given the non-specific nature of whole cell proteome 
analysis. In other words, the set up of this experiment was not to specifically look for changes in 
expression of glycosylating enzymes, but to identify systematic changes between an EG2-hFc1 
producing CHO strain and its parental non-producing counterpart as a whole. Thus, the DIGE results 
provides a baseline of the proteome profile of CHO-1A7, where the set of differentially regulated 
proteins associated with the various biological processes and metabolic pathways should be 
considered in the optimization of EG2-hFc1 production. For example, targeted overexpression of 
proteins involved in the TCA cycle may lead to an increase in the production of precursor metabolites 
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and energy required for increased MAb production while ensuring maintenance of cell survival. This 
work can, therefore, serve as a reference check for future proteomic studies on this particular cell line. 
For example, cell-engineering strategies can be employed to reduce core fucosylation of EG2-hFc1 in 
CHO-1A7 and its corresponding proteome profile can then be compared with the results of the 
present study. Additionally, studying the changes to the subcellular proteomes, such as the proteome 
within the ER, may provide information in regards to glycosylation enzymes. The development of a 
2-D gel protein reference map, specifically from the CHO-BRI cell line, contributes to future 
proteomic studies of this particular cell line, including the investigation of physiological responses 
and protein expression patterns as a result of genetic and environmental modifications. 
  
 The enhanced tumour-targeting properties associated with EG2-hFc1 suggest it to be a viable 
therapeutic candidate for the treatment of various cancers. Thus, it is important to optimize the 
production of EG2-hFc1 from its host cell line. The list of differentially expressed proteins identified 
in this study provides possible candidates for targeted metabolic engineering to improve EG2-hFc1 
production in CHO-1A7 cells. Overall, the present work shows the potential of utilizing a proteomics 
approach in understanding the intracellular changes occuring in MAb-producing CHO cells. This will 
provide a key step towards building a fundamental framework for optimizing MAb production. 
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Appendix A  
Proteomic Raw Data and Analysis 
 The following Figures and Tables represent standard curves for the determination of protein 
concentration in the CHO 2D-DIGE experiment. 
 
 
Figure A 1. Standard Curve for CHO 2D-DIGE Experiment. Data points represent the average 
absorbances from triplicate samples with their corresponding standard deviations, using BSA as a 
standard. The equation for the linear regression line (y = 0.0225x) was used to calculate the protein 
concentrations of the CHO-BRI and CHO-1A7 samples.  
 
 By utilizing the standard curve, the following protein concentrations were determined for 
each protein sample (Table A 1) prior to sample labeling. 
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Table A 1. Protein Concentration and Cell Density of CHO Samples for 2D-DIGE. Calculated 
protein concentrations that represent the average and standard deviation of three replicates post 
sample clean-up. 
Sample Protein Concentration (µg/µL) Cell Density (10
6
 cells/mL) 
on day 8 harvest 
CHO-BRI-1 1.66 ± 0.25 7.029 
CHO-BRI-2 1.69 ± 0.10 7.753 
CHO-BRI-3 1.55 ± 0.11 7.166 
CHO-BRI-4 2.07 ± 0.15 6.899 
CHO-BRI-5 1.69 ± 0.13 6.403 
CHO-BRI-6 2.21 ± 0.06 5.243 
CHO-1A7-1 1.63 ± 0.02 7.257 
CHO-1A7-2 1.52 ± 0.21 7.613 
CHO-1A7-3 2.53 ± 0.13 7.377 
CHO-1A7-4 2.24 ± 0.10 7.235 
CHO-1A7-5 1.72 ± 0.07 7.576 
CHO-1A7-6 1.45 ± 0.25 7.970 
 
 
 
Figure A 2. Standard Curve for CHO Preparative Gel. Data points represent the average 
absorbances from triplicate samples with their corresponding standard deviations, using BSA as a 
standard. The equation for the linear regression line (y = 0.0229x) was used to calculate the protein 
concentration of the pooled CHO protein sample.  
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Appendix B 
Multiplex Raw Data and Analysis  
 The following Figure and Table represent standard curves for the determination of protein 
concentration for CHO-BRI and MG1655 in the multiplex experiment. 
 
 
Figure B 1. Standard Curves for CHO-BRI and MG1655 Multiplex Experiments. Data points 
represent the average absorbances from triplicate samples with their corresponding standard 
deviations, using BSA as a standard. The equation for the linear regression line (CHO-BRI: y = 
0.0241x; MG1655: y = 0.03x) was used to calculate the protein concentrations of the CHO-BRI and 
MG1655 samples respectively. 
 
 By utilizing the standard curve, the following protein concentrations were determined for 
each protein sample (Table B 1). 
 
Table B 1. Protein Concentration of CHO-BRI and MG1655 for Multiplex. Calculated protein 
concentrations that represent the average and standard deviation of three replicates post sample clean-
up. 
Sample Protein Concentration (µg/µL) 
CHO-BRI 2.49 ± 0.31 
MG1655 3.17 ± 0.85 
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 The following tables show identified proteins based on PEAKS analyses for both CHO-BRI 
and MG1655 samples. The identifications in each well are organized on a per row basis from a 96-
well plate. 
 
Table B 2. Identified CHO Proteins (Multiplex). Each table denotes a specific row of a 96-well 
plate with identifications shown in each well. 
Row A Cluster ID 
MW 
(kDa)* 
Score 
% 
Sequence 
Coverage 
(%) 
# of 
Unique 
Peptides 
Protein Name 
A01 UniRef90_P11021 72.4 99.2 19 10 78 kDa glucose-regulated protein 
 UniRef90_P08670 53.7 99.1 25 8 Vimentin 
 UniRef90_Q3V3R1 105.4 99.1 18 13 Monofunctional C1-tetrahydrofolate synthase, 
mitochondrial 
 UniRef90_G3IAS8  18.6 99.0 5 5 Kinesin-like protein KIF27 
 UniRef90_Q16576 47.0 98.9 11 4 Histone-binding protein RBBP7 
 UniRef90_P31946 27.9 98.9 23 3 14-3-3 protein beta/alpha 
 UniRef90_P63101 27.7 98.8 22 2 14-3-3 protein zeta/delta 
 UniRef90_P78371 57.5 98.8 11 4 T-complex protein 1 subunit beta 
 UniRef90_P31937 31.7 98.8 21 4 3-hydroxyisobutyrate dehydrogenase, 
mitochondrial 
 UniRef90_Q12874 58.8 98.5 12 3 Splicing factor 3A subunit 3 
A02 UniRef90_P14625 92.6 99.2 20 10 Endoplasmin 
 UniRef90_P08670 53.7 99.1 31 8 Vimentin 
 UniRef90_P02545-2 64.0 99.1 25 6 Isoform C of Prelamin-A/C 
 UniRef90_G3HZ25 25.5 98.5 21 3 NADH dehydrogenase [ubiquinone] flavoprotein 
2, mitochondrial 
 UniRef90_G3IND2  30.9 98.4 14 3 26S proteasome non-ATPase regulatory subunit 
13 
 UniRef90_P31040 71.7 91.1 5 2 Succinate dehydrogenase [ubiquinone] 
flavoprotein subunit, mitochondrial 
A03 UniRef90_P14625 92.6 99.2 27 20 Endoplasmin 
 UniRef90_P08670 53.7 99.1 31 9 Vimentin 
 UniRef90_G3GVX1  21.7 99.1 9 6 Ribosome-binding protein 1 
 UniRef90_Q96J01 41.9 99.0 17 6 THO complex subunit 3 
 UniRef90_G3HN14 237.6 99.0 4 4 Transitional endoplasmic reticulum ATPase 
 UniRef90_G3I220 36.4 98.9 21 5 Cytoskeleton-associated protein 4 
 UniRef90_G3I2Q7  58.0 98.2 6 3 Transcription intermediary factor 1-beta 
 UniRef90_G3HJE0 36.9 97.8 13 3 Mitochondrial import inner membrane translocase 
subunit TIM50 (Fragment) 
A04 UniRef90_P14625 92.6 99.2 25 13 Endoplasmin 
 UniRef90_G1SLD5  111.5 99.2 20 12 Hypoxia up-regulated protein 1 
 UniRef90_P08670 53.7 99.2 44 13 Vimentin 
 UniRef90_P78371 57.5 99.2 36 14 T-complex protein 1 subunit beta 
 UniRef90_G3HR08 50.3 98.8 11 4 Cytosol aminopeptidase 
 UniRef90_G3I2M0 25.5 98.8 20 4 Sulfatase-modifying factor 2 
 UniRef90_P62814 49.9 98.4 14 3 V-type proton ATPase subunit B, brain isoform 
 UniRef90_A4FUY3  73.1 98.3 5 3 Prolyl 3-hydroxylase 1 
A05 UniRef90_P08670 53.7 99.1 34 7 Vimentin 
 UniRef90_P14625 92.6 99.1 16 8 Endoplasmin 
 UniRef90_P08758 36.1 99.0 26 5 Annexin A5 
 UniRef90_G3I2M0 25.5 98.8 24 4 Sulfatase-modifying factor 2 
 UniRef90_P56537 26.6 98.8 29 4 Eukaryotic translation initiation factor 6 
 UniRef90_P02545-2 64.0 98.8 9 3 Isoform C of Prelamin-A/C 
 UniRef90_G3HNV4  16.4 98.8 35 3 Triosephosphate isomerase 
 UniRef90_G3I216 20.4 98.7 21 3 Triosephosphate isomerase 
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 UniRef90_Q8BMF4 68.0 98.5 12 3 Dihydrolipoyllysine-residue acetyltransferase 
component of pyruvate dehydrogenase complex, 
mitochondrial 
 UniRef90_P30153 59.0 98.5 17 3 Serine/threonine-protein phosphatase 2A 65 kDa 
regulatory subunit A alpha isoform 
 UniRef90_Q9Z0X1 66.8 98.4 10 3 Apoptosis-inducing factor 1, mitochondrial 
 UniRef90_G3H8Y5 89.0 98.3 9 3 Collagen alpha-1(VI) chain 
 UniRef90_Q9WTX8  83.2 98.1 9 3 Mitotic spindle assembly checkpoint protein 
MAD1 
 UniRef90_G3HEZ0  65.8 98.1 7 3 Stress-70 protein, mitochondrial 
 UniRef90_P07910 33.7 98.0 23 3 Heterogeneous nuclear ribonucleoproteins C1/C2 
 UniRef90_G3HFL6  69.6 91.8 5 2 ATP-binding cassette sub-family G member 3 
A06 UniRef90_G3HFL6 69.6 98.8 13 4 ATP-binding cassette sub-family G member 3 
 UniRef90_G3HR08 50.3 99.1 27 7 Cytosol aminopeptidase 
 UniRef90_G3HTU8 42.8 99.1 19 6 Galactokinase 
 UniRef90_G3HZ25 25.5 99.1 37 6 NADH dehydrogenase [ubiquinone] flavoprotein 
2, mitochondrial 
 UniRef90_G3I220 36.4 99.0 24 6 Cytoskeleton-associated protein 4 
 UniRef90_P14625 92.6 98.3 8 3 Endoplasmin 
 UniRef90_P30153 59.0 98.3 8 3 Serine/threonine-protein phosphatase 2A 65 kDa 
regulatory subunit A alpha isoform 
 UniRef90_P78371 57.5 97.9 9 3 T-complex protein 1 subunit beta 
 UniRef90_Q15365 37.5 98.8 18 4 Poly(rC)-binding protein 1 
 UniRef90_Q3V3R1 105.4 99.2 18 15 Monofunctional C1-tetrahydrofolate synthase, 
mitochondrial 
 UniRef90_Q99N15 27.2 98.3 20 3 17beta-hydroxysteroid dehydrogenase type 
10/short chain L-3-hydroxyacyl-CoA 
dehydrogenase 
 UniRef90_Q9CXW2 41.2 97.7 8 3 28S ribosomal protein S22, mitochondrial 
A07 UniRef90_G1SLD5 111.5 99.1 18 6 Hypoxia up-regulated protein 1 
 UniRef90_G3HE28 40.1 98.9 14 4 Mitochondrial-processing peptidase subunit beta 
 UniRef90_G3HEZ0 65.8 99.1 22 8 Stress-70 protein, mitochondrial 
 UniRef90_G3I6E6 32.0 98.3 13 3 Actin, cytoplasmic 2 
 UniRef90_P08670 53.7 99.0 20 4 Vimentin 
 UniRef90_P11021 72.4 99.2 24 10 78 kDa glucose-regulated protein 
 UniRef90_P12004 28.8 99.1 40 6 Proliferating cell nuclear antigen 
 UniRef90_P14625 92.6 99.2 19 10 Endoplasmin 
 UniRef90_P35232 29.8 98.2 15 3 Prohibitin 
 UniRef90_P60709 41.7 98.3 10 3 Actin, cytoplasmic 1 
 UniRef90_Q14697 107.0 99.1 19 16 Neutral alpha-glucosidase AB 
 UniRef90_Q61576 64.7 98.8 14 4 Peptidyl-prolyl cis-trans isomerase FKBP10 
 UniRef90_Q99N15 27.2 99.2 60 10 17beta-hydroxysteroid dehydrogenase type 
10/short chain L-3-hydroxyacyl-CoA 
dehydrogenase 
A08 UniRef90_G3H0U6 50.1 98.9 25 4 Protein disulfide-isomerase A3 
 UniRef90_G3HRM9 25.2 99.0 26 5 Prostaglandin E synthase 3 (Fragment) 
 UniRef90_G3I220 36.4 98.2 10 3 Cytoskeleton-associated protein 4 
 UniRef90_G3I2L9 7.8 98.3 59 4 Sulfatase-modifying factor 2 
 UniRef90_G3I2M0 25.5 98.8 19 4 Sulfatase-modifying factor 2 
 UniRef90_G3I6E6 32.0 98.4 20 3 Actin, cytoplasmic 2 
 UniRef90_P08670 53.7 99.2 42 13 Vimentin 
 UniRef90_P10809 56.5 99.1 15 7 60 kDa heat shock protein, mitochondrial 
 UniRef90_P14625 92.6 99.1 20 12 Endoplasmin 
 UniRef90_P31937 31.7 99.0 23 5 3-hydroxyisobutyrate dehydrogenase, 
mitochondrial 
 UniRef90_P60709 41.7 98.4 18 3 Actin, cytoplasmic 1 
A09 UniRef90_G3H0L9 37.5 98.8 15 4 Cathepsin B 
 UniRef90_G3HNJ3 51.8 98.5 13 3 Clusterin 
 UniRef90_G3I1Y9 27.4 99.1 39 7 Sulfated glycoprotein 1 
 UniRef90_G3I220 36.4 99.1 29 6 Cytoskeleton-associated protein 4 
 UniRef90_G3IAS8 185.7 99.0 6 5 Kinesin-like protein KIF27 
 UniRef90_P02545-2 64.0 99.0 24 5 Isoform C of Prelamin-A/C 
 UniRef90_P08670 53.7 99.2 44 16 Vimentin 
 UniRef90_P08758 36.1 99.2 36 10 Annexin A5 
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 UniRef90_P10809 56.5 96.6 9 2 60 kDa heat shock protein, mitochondrial 
 UniRef90_P11021 72.4 99.0 11 5 78 kDa glucose-regulated protein 
 UniRef90_P14625 92.6 99.1 20 13 Endoplasmin 
 UniRef90_P27797 48.2 99.0 19 5 Calreticulin 
 UniRef90_P30153 59.0 99.1 20 7 Serine/threonine-protein phosphatase 2A 65 kDa 
regulatory subunit A alpha isoform 
 UniRef90_Q12874 58.8 91.0 14 2 Splicing factor 3A subunit 3 
 UniRef90_Q9JLH7 51.4 92.2 11 2 CDK5 regulatory subunit-associated protein 3 
A10 UniRef90_G1SLD5 111.5 99.2 19 14 Hypoxia up-regulated protein 1 
 UniRef90_G3HC84 47.8 98.7 14 4 Heat shock protein HSP 90-beta 
 UniRef90_G3HE28 40.1 99.1 21 5 Mitochondrial-processing peptidase subunit beta 
 UniRef90_G3HFL6 69.6 98.7 7 4 ATP-binding cassette sub-family G member 3 
 UniRef90_P02545-2 64.0 99.1 23 8 Isoform C of Prelamin-A/C 
 UniRef90_P14625 92.6 99.1 20 12 Endoplasmin 
 UniRef90_P31946 27.9 98.2 16 2 14-3-3 protein beta/alpha 
 UniRef90_P50213 39.7 98.7 13 4 Isocitrate dehydrogenase [NAD] subunit alpha, 
mitochondrial 
 UniRef90_P62873 37.4 91.6 9 2 Guanine nucleotide-binding protein 
G(I)/G(S)/G(T) subunit beta-1 
 UniRef90_P63101 27.7 98.9 26 3 14-3-3 protein zeta/delta 
 UniRef90_Q14568 38.1 98.4 12 3 Putative heat shock protein HSP 90-alpha A2 
 UniRef90_Q14697 107.0 99.1 15 9 Neutral alpha-glucosidase AB 
A11 UniRef90_G3H0U6 50.1 98.1 11 2 Protein disulfide-isomerase A3 
 UniRef90_G3HNV4 16.4 91.6 29 2 Triosephosphate isomerase 
 UniRef90_G3I216 20.4 91.9 28 2 Triosephosphate isomerase 
 UniRef90_G3IND2 30.9 98.4 14 3 26S proteasome non-ATPase regulatory subunit 
13 
 UniRef90_P08670 53.7 97.9 10 2 Vimentin 
 UniRef90_P10809 56.5 99.1 12 6 60 kDa heat shock protein, mitochondrial 
 UniRef90_P14625 92.6 99.1 19 11 Endoplasmin 
 UniRef90_P35232 29.8 98.3 11 3 Prohibitin 
 UniRef90_Q16576 47.0 98.3 8 3 Histone-binding protein RBBP7 
A12 UniRef90_G3HFP0 15.5 98.2 18 3 Adrenodoxin, mitochondrial 
 UniRef90_G3I220 36.4 98.8 23 4 Cytoskeleton-associated protein 4 
 UniRef90_P08670 53.7 98.4 10 3 Vimentin 
 UniRef90_P10809 56.5 98.3 9 3 60 kDa heat shock protein, mitochondrial 
 UniRef90_P12004 28.8 99.1 40 7 Proliferating cell nuclear antigen 
 UniRef90_P14625 92.6 99.2 24 17 Endoplasmin 
 UniRef90_P30153 59.0 98.9 21 4 Serine/threonine-protein phosphatase 2A 65 kDa 
regulatory subunit A alpha isoform 
 UniRef90_P30154 66.0 98.1 10 2 Serine/threonine-protein phosphatase 2A 65 kDa 
regulatory subunit A beta isoform 
 UniRef90_P31040 71.7 98.8 11 4 Succinate dehydrogenase [ubiquinone] 
flavoprotein subunit, mitochondrial 
 UniRef90_Q14697 107.0 99.1 11 5 Neutral alpha-glucosidase AB 
 UniRef90_Q15365 37.5 98.9 21 5 Poly(rC)-binding protein 1 
 UniRef90_Q3V3R1 105.4 90.4 4 2 Monofunctional C1-tetrahydrofolate synthase, 
mitochondrial 
 UniRef90_Q9CXW2 41.2 98.3 8 3 28S ribosomal protein S22, mitochondrial 
 
Row B Cluster ID 
MW 
(kDa)* 
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% 
Sequence 
Coverage 
(%) 
# of 
Unique 
Peptides 
Protein Name 
B01 UniRef90_G3HEZ0 65.8 99.0 12 5 Stress-70 protein, mitochondrial 
 UniRef90_G3I6E6 32.0 98.4 21 3 Actin, cytoplasmic 2 
 UniRef90_H0X554 30.1 98.9 28 5 NADH dehydrogenase [ubiquinone] iron-sulfur 
protein 3, mitochondrial 
 UniRef90_P08670 53.7 99.1 30 6 Vimentin 
 UniRef90_P11021 72.4 99.1 17 10 78 kDa glucose-regulated protein 
 UniRef90_P14625 92.6 99.2 24 17 Endoplasmin 
 UniRef90_P60709 41.7 98.4 16 3 Actin, cytoplasmic 1 
 UniRef90_Q99798 85.5 99.1 23 11 Aconitate hydratase, mitochondrial 
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B02 UniRef90_F1MDN4 29.9 99.0 26 5 60S acidic ribosomal protein P0 
 UniRef90_G3HC01 35.4 98.7 16 3 Tropomyosin alpha-3 chain 
 UniRef90_G3HEZ0 65.8 96.5 6 2 Stress-70 protein, mitochondrial 
 UniRef90_G3IBF1 31.1 96.0 16 2 Nucleophosmin 
 UniRef90_P11021 72.4 99.1 16 6 78 kDa glucose-regulated protein 
 UniRef90_P31040 71.7 99.1 12 6 Succinate dehydrogenase [ubiquinone] 
flavoprotein subunit, mitochondrial 
 UniRef90_Q99798 85.5 98.5 10 3 Aconitate hydratase, mitochondrial 
B03 UniRef90_G3GTF9 18.9 98.8 32 6 ATP synthase subunit d, mitochondrial 
 UniRef90_G3HHK0 35.4 98.7 16 4 28S ribosomal protein S31, mitochondrial 
 UniRef90_G3HNG2 49.8 98.8 10 4 Acyl-coenzyme A thioesterase 2, mitochondrial 
 UniRef90_G3HNG5 50.4 98.7 9 4 Acyl-coenzyme A thioesterase 1 
 UniRef90_G3I6E6 32.0 98.2 13 3 Actin, cytoplasmic 2 
 UniRef90_H0X554 30.1 98.3 21 3 NADH dehydrogenase [ubiquinone] iron-sulfur 
protein 3, mitochondrial 
 UniRef90_P21981 77.2 98.8 12 4 Protein-glutamine gamma-glutamyltransferase 2 
 UniRef90_P46061 63.1 99.1 22 9 Ran GTPase-activating protein 1 
 UniRef90_P50213 39.7 98.5 15 4 Isocitrate dehydrogenase [NAD] subunit alpha, 
mitochondrial 
 UniRef90_P60709 41.7 98.2 10 3 Actin, cytoplasmic 1 
 UniRef90_Q99N15 27.2 99.1 43 9 17beta-hydroxysteroid dehydrogenase type 
10/short chain L-3-hydroxyacyl-CoA 
dehydrogenase 
B04 UniRef90_G3HB04 28.4 98.9 32 5 Protein disulfide-isomerase A6 
 UniRef90_G3HE28 40.1 99.1 26 9 Mitochondrial-processing peptidase subunit beta 
 UniRef90_G3HEZ0 65.8 99.1 33 13 Stress-70 protein, mitochondrial 
 UniRef90_G3HJA9 19.9 98.1 18 3 Eukaryotic translation initiation factor 3 subunit 
K (Fragment) 
 UniRef90_G3I2M0 25.5 98.8 24 5 Sulfatase-modifying factor 2 
 UniRef90_H0X554 30.1 99.0 33 6 NADH dehydrogenase [ubiquinone] iron-sulfur 
protein 3, mitochondrial 
 UniRef90_P08670 53.7 99.1 21 5 Vimentin 
 UniRef90_P11021 72.4 99.0 13 5 78 kDa glucose-regulated protein 
 UniRef90_P21981 77.2 99.1 19 6 Protein-glutamine gamma-glutamyltransferase 2 
 UniRef90_P46061 63.1 99.1 18 10 Ran GTPase-activating protein 1 
 UniRef90_Q16576 47.0 98.4 11 4 Histone-binding protein RBBP7 
 UniRef90_Q99653 22.5 99.1 49 6 Calcineurin B homologous protein 1 
B05 UniRef90_G3H0L9 37.5 99.0 29 5 Cathepsin B 
 UniRef90_G3I6E6 32.0 98.9 22 5 Actin, cytoplasmic 2 
 UniRef90_G3IBF1 31.1 98.3 16 3 Nucleophosmin 
 UniRef90_G3ILN5 34.4 98.9 18 5 Reticulocalbin-3 
 UniRef90_H0X554 30.1 99.1 38 6 NADH dehydrogenase [ubiquinone] iron-sulfur 
protein 3, mitochondrial 
 UniRef90_P02545-2 64.0 99.1 24 9 Isoform C of Prelamin-A/C 
 UniRef90_P02794 21.5 98.7 26 4 Ferritin heavy chain 
 UniRef90_P08670 53.7 99.1 27 6 Vimentin 
 UniRef90_P50213 39.7 98.8 17 4 Isocitrate dehydrogenase [NAD] subunit alpha, 
mitochondrial 
 UniRef90_P60709 41.7 98.9 17 5 Actin, cytoplasmic 1 
B06 UniRef90_G3HNG2 49.8 99.1 30 8 Acyl-coenzyme A thioesterase 2, mitochondrial 
 UniRef90_G3HPK0 56.3 98.7 10 3 Hydroxysteroid dehydrogenase-like protein 2 
 UniRef90_G3I6E6 32.0 99.1 42 5 Actin, cytoplasmic 2 
 UniRef90_G3ILN5 34.4 98.9 19 5 Reticulocalbin-3 
 UniRef90_P02545-2 64.0 99.1 28 12 Isoform C of Prelamin-A/C 
 UniRef90_P07910 33.7 99.0 25 2 Heterogeneous nuclear ribonucleoproteins C1/C2 
 UniRef90_P08670 53.7 99.1 24 6 Vimentin 
 UniRef90_P11021 72.4 99.2 43 20 78 kDa glucose-regulated protein 
 UniRef90_P31040 71.7 99.2 34 16 Succinate dehydrogenase [ubiquinone] 
flavoprotein subunit, mitochondrial 
 UniRef90_P60709 41.7 99.1 35 6 Actin, cytoplasmic 1 
 UniRef90_Q14697 107.0 99.2 23 17 Neutral alpha-glucosidase AB 
 UniRef90_Q16822 70.8 99.0 15 5 Phosphoenolpyruvate carboxykinase [GTP], 
mitochondrial 
 UniRef90_Q9CWG8 48.8 98.6 11 3 NADH dehydrogenase [ubiquinone] complex I, 
 111 
 
assembly factor 7 
 UniRef90_Q9Z0X1 66.8 98.9 12 4 Apoptosis-inducing factor 1, mitochondrial 
B07 UniRef90_G3HC79 102.8 99.0 9 5 Putative alanyl-tRNA synthetase, mitochondrial 
 UniRef90_G3HEZ0 65.8 99.2 36 11 Stress-70 protein, mitochondrial 
 UniRef90_G3HQI8 229.3 98.7 4 4 Myosin-Vb 
 UniRef90_P02545-2 64.0 99.2 47 22 Isoform C of Prelamin-A/C 
 UniRef90_P02794 21.5 99.1 43 7 Ferritin heavy chain 
 UniRef90_P08670 53.7 98.0 11 2 Vimentin 
 UniRef90_P11021 72.4 99.2 36 19 78 kDa glucose-regulated protein 
 UniRef90_P14625 92.6 99.2 14 9 Endoplasmin 
 UniRef90_P35232 29.8 99.1 44 6 Prohibitin 
 UniRef90_P55302 41.2 98.1 15 3 Alpha-2-macroglobulin receptor-associated 
protein 
 UniRef90_P60709 41.7 99.0 20 5 Actin, cytoplasmic 1 
 UniRef90_Q14697 107.0 99.2 28 22 Neutral alpha-glucosidase AB 
 UniRef90_Q3V3R1 105.4 99.1 14 7 Monofunctional C1-tetrahydrofolate synthase, 
mitochondrial 
 UniRef90_Q8CGK3 95.0 99.1 17 9 Lon protease homolog, mitochondrial 
 UniRef90_Q9CQN1 80.3 99.1 19 5 Heat shock protein 75 kDa, mitochondrial 
 UniRef90_Q9DB77 48.3 99.0 20 5 Cytochrome b-c1 complex subunit 2, 
mitochondrial 
B08 UniRef90_G3HEZ0 65.8 99.1 28 11 Stress-70 protein, mitochondrial 
 UniRef90_G3HZ25 25.5 99.0 29 5 NADH dehydrogenase [ubiquinone] flavoprotein 
2, mitochondrial 
 UniRef90_G3I6E6 32.0 97.1 17 2 Actin, cytoplasmic 2 
 UniRef90_P02545-2 64.0 99.2 37 15 Isoform C of Prelamin-A/C 
 UniRef90_P11021 72.4 99.2 34 13 78 kDa glucose-regulated protein 
 UniRef90_P14625 92.6 99.1 14 9 Endoplasmin 
 UniRef90_P17987 60.3 99.1 25 11 T-complex protein 1 subunit alpha 
 UniRef90_P60709 41.7 97.1 13 2 Actin, cytoplasmic 1 
 UniRef90_Q99653 22.5 99.1 36 6 Calcineurin B homologous protein 1 
B09 UniRef90_A4FUY3 73.1 98.3 7 3 Prolyl 3-hydroxylase 1 
 UniRef90_G3GWC4 30.2 97.3 15 2 GrpE protein-like 1, mitochondrial 
 UniRef90_G3HHK0 35.4 98.8 20 4 28S ribosomal protein S31, mitochondrial 
 UniRef90_G3HN14 237.6 98.8 4 3 Transitional endoplasmic reticulum ATPase 
 UniRef90_G3HZ25 25.5 98.4 33 3 NADH dehydrogenase [ubiquinone] flavoprotein 
2, mitochondrial 
 UniRef90_G3IAS8 185.7 98.9 5 4 Kinesin-like protein KIF27 
 UniRef90_G3ILN5 34.4 99.0 18 5 Reticulocalbin-3 
 UniRef90_I3MCK6 29.3 98.3 25 3 Reticulocalbin-1 
 UniRef90_P08670 53.7 99.0 18 4 Vimentin 
 UniRef90_P09382 14.8 98.0 28 2 Galectin-1 
 UniRef90_P50213 39.7 98.3 10 3 Isocitrate dehydrogenase [NAD] subunit alpha, 
mitochondrial 
 UniRef90_Q9UJZ1 38.2 98.8 20 4 Stomatin-like protein 2 
B10 UniRef90_F1MDN4 29.9 98.9 24 5 60S acidic ribosomal protein P0 
 UniRef90_G3H1B3 55.0 97.9 8 2 Lamin-L(I) 
 UniRef90_G3HB04 28.4 99.0 36 5 Protein disulfide-isomerase A6 
 UniRef90_G3HC01 35.4 99.1 23 6 Tropomyosin alpha-3 chain 
 UniRef90_G3HE28 40.1 99.1 21 8 Mitochondrial-processing peptidase subunit beta 
 UniRef90_G3I6E6 32.0 98.2 11 3 Actin, cytoplasmic 2 
 UniRef90_G3ILG6 14.5 98.3 37 3 Inorganic pyrophosphatase 2, mitochondrial 
(Fragment) 
 UniRef90_G3ILN5 34.4 98.7 18 4 Reticulocalbin-3 
 UniRef90_P07910 33.7 99.1 26 4 Heterogeneous nuclear ribonucleoproteins C1/C2 
 UniRef90_P17987 60.3 99.2 43 17 T-complex protein 1 subunit alpha 
 UniRef90_P35232 29.8 99.1 38 7 Prohibitin 
 UniRef90_P50213 39.7 98.8 18 4 Isocitrate dehydrogenase [NAD] subunit alpha, 
mitochondrial 
 UniRef90_P60709 41.7 98.2 8 3 Actin, cytoplasmic 1 
 UniRef90_Q02218 104.5 90.0 4 2 2-oxoglutarate dehydrogenase, mitochondrial 
 UniRef90_Q3V3R1 105.4 99.1 15 8 Monofunctional C1-tetrahydrofolate synthase, 
mitochondrial 
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B11 UniRef90_A4FUY3 73.1 99.0 12 6 Prolyl 3-hydroxylase 1 
 UniRef90_G3HB04 28.4 99.1 31 6 Protein disulfide-isomerase A6 
 UniRef90_G3HEZ0 65.8 99.1 29 12 Stress-70 protein, mitochondrial 
 UniRef90_G3HRE2 313.8 94.1 4 2 Apoptotic chromatin condensation inducer in the 
nucleus 
 UniRef90_P08670 53.7 97.8 20 2 Vimentin 
 UniRef90_P11021 72.4 99.1 20 5 78 kDa glucose-regulated protein 
 UniRef90_P14625 92.6 99.1 16 9 Endoplasmin 
 UniRef90_P50454 46.6 94.9 9 2 Serpin H1 
 UniRef90_Q14568 38.1 97.7 13 2 Putative heat shock protein HSP 90-alpha A2 
 UniRef90_Q16576 47.0 98.8 9 4 Histone-binding protein RBBP7 
 UniRef90_Q99798 85.5 99.1 12 6 Aconitate hydratase, mitochondrial 
 UniRef90_Q99N15 27.2 99.1 41 6 17beta-hydroxysteroid dehydrogenase type 
10/short chain L-3-hydroxyacyl-CoA 
dehydrogenase 
 UniRef90_Q9CQN1 80.3 99.0 12 4 Heat shock protein 75 kDa, mitochondrial 
B12 UniRef90_F1MDN4 29.9 98.2 12 3 60S acidic ribosomal protein P0 
 UniRef90_G3GTF9 18.9 98.8 31 5 ATP synthase subunit d, mitochondrial 
 UniRef90_G3HDY7 29.9 98.2 12 3 60S acidic ribosomal protein P0 
 UniRef90_G3HQI8 229.3 99.0 4 5 Myosin-Vb 
 UniRef90_G3HW62 35.5 98.7 17 4 Elongation factor Ts, mitochondrial 
 UniRef90_G3HZ25 25.5 99.0 31 5 NADH dehydrogenase [ubiquinone] flavoprotein 
2, mitochondrial 
 UniRef90_G3I2M0 25.5 98.7 19 3 Sulfatase-modifying factor 2 
 UniRef90_G3I6E6 32.0 99.1 31 5 Actin, cytoplasmic 2 
 UniRef90_P14625 92.6 99.1 20 11 Endoplasmin 
 UniRef90_P55735 35.5 98.7 18 4 Protein SEC13 homolog 
 UniRef90_P60709 41.7 99.1 27 5 Actin, cytoplasmic 1 
 UniRef90_Q3V3R1 105.4 99.1 19 12 Monofunctional C1-tetrahydrofolate synthase, 
mitochondrial 
 UniRef90_Q9DB77 48.3 98.3 11 3 Cytochrome b-c1 complex subunit 2, 
mitochondrial 
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C01 UniRef90_G3H0U6 50.1 99.2 27 10 Protein disulfide-isomerase A3 
 UniRef90_G3H697 62.4 90.3 5 2 Glucosidase 2 subunit beta 
 UniRef90_G3HC84 47.8 99.1 20 8 Heat shock protein HSP 90-beta 
 UniRef90_G3HE28 40.1 98.3 11 2 Mitochondrial-processing peptidase subunit beta 
 UniRef90_G3HEQ3 25.2 98.3 17 3 Ran-specific GTPase-activating protein 
 UniRef90_G3HQX0 19.7 98.9 33 5 40S ribosomal protein SA 
 UniRef90_O43681 38.8 98.3 11 3 ATPase ASNA1 
 UniRef90_P07910 33.7 99.0 22 3 Heterogeneous nuclear ribonucleoproteins C1/C2 
 UniRef90_P08670 53.7 99.1 32 8 Vimentin 
 UniRef90_P14625 92.6 99.2 28 20 Endoplasmin 
 UniRef90_P20108 28.1 98.8 19 4 Thioredoxin-dependent peroxide reductase, 
mitochondrial 
 UniRef90_Q14568 38.1 98.9 16 5 Putative heat shock protein HSP 90-alpha A2 
C02 UniRef90_F1MDN4 29.9 98.3 16 3 60S acidic ribosomal protein P0 
 UniRef90_G3HEZ0 65.8 99.1 25 10 Stress-70 protein, mitochondrial 
 UniRef90_G3HFL6 69.6 98.9 13 4 ATP-binding cassette sub-family G member 3 
 UniRef90_G3HQX0 19.7 98.6 36 3 40S ribosomal protein SA 
 UniRef90_G3I6E6 32.0 98.7 19 4 Actin, cytoplasmic 2 
 UniRef90_G3ILN5 34.4 98.7 16 4 Reticulocalbin-3 
 UniRef90_O43681 38.8 99.1 28 6 ATPase ASNA1 
 UniRef90_P07910 33.7 98.8 22 2 Heterogeneous nuclear ribonucleoproteins C1/C2 
 UniRef90_P08670 53.7 99.2 39 13 Vimentin 
 UniRef90_P08758 36.1 98.9 18 5 Annexin A5 
 UniRef90_P35232 29.8 98.8 15 4 Prohibitin 
 UniRef90_P56537 26.6 98.8 34 4 Eukaryotic translation initiation factor 6 
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 UniRef90_P60709 41.7 98.8 17 4 Actin, cytoplasmic 1 
C03 UniRef90_G3H0L9 37.5 98.0 14 3 Cathepsin B 
 UniRef90_G3HBY4 24.5 99.0 29 2 Heterogeneous nuclear ribonucleoproteins C1/C2 
 UniRef90_G3I6E6 32.0 98.2 17 3 Actin, cytoplasmic 2 
 UniRef90_P07910 33.7 99.2 42 7 Heterogeneous nuclear ribonucleoproteins C1/C2 
 UniRef90_P08758 36.1 99.0 23 6 Annexin A5 
 UniRef90_P14625 92.6 99.1 18 12 Endoplasmin 
 UniRef90_P35232 29.8 98.8 19 4 Prohibitin 
 UniRef90_P60709 41.7 98.2 16 3 Actin, cytoplasmic 1 
C04 UniRef90_G3GT05 22.2 98.3 21 3 T-complex protein 1 subunit theta 
 UniRef90_G3H0U6 50.1 99.1 40 16 Protein disulfide-isomerase A3 
 UniRef90_G3HB04 28.4 99.0 38 5 Protein disulfide-isomerase A6 
 UniRef90_G3HBZ7 12.2 98.2 32 3 HCLS1-associated protein X-1 
 UniRef90_G3HKP3 40.6 96.1 10 3 Cytochrome b-c1 complex subunit 1, 
mitochondrial 
 UniRef90_G3HNV4 16.4 98.9 39 3 Triosephosphate isomerase 
 UniRef90_G3HQX0 19.7 98.8 41 2 40S ribosomal protein SA 
 UniRef90_G3I216 20.4 99.1 32 4 Triosephosphate isomerase 
 UniRef90_G3IAS8 185.7 98.6 5 3 Kinesin-like protein KIF27 
 UniRef90_G3ILN5 34.4 99.0 19 6 Reticulocalbin-3 
 UniRef90_O43681 38.8 99.1 24 6 ATPase ASNA1 
 UniRef90_P06733 46.7 98.3 14 3 Alpha-enolase 
 UniRef90_P07910 33.7 99.1 31 5 Heterogeneous nuclear ribonucleoproteins C1/C2 
 UniRef90_P08670 53.7 99.1 22 5 Vimentin 
 UniRef90_P27797 48.2 96.0 9 2 Calreticulin 
 UniRef90_P30153 59.0 99.2 40 13 Serine/threonine-protein phosphatase 2A 65 kDa 
regulatory subunit A alpha isoform 
 UniRef90_P30154 66.0 99.0 14 5 Serine/threonine-protein phosphatase 2A 65 kDa 
regulatory subunit A beta isoform 
C05 UniRef90_F8VPV9 56.9 97.9 6 3 ATP synthase subunit beta 
 UniRef90_G3H0U6 50.1 98.0 10 3 Protein disulfide-isomerase A3 
 UniRef90_G3H697 62.4 97.9 5 3 Glucosidase 2 subunit beta 
 UniRef90_G3HE28 40.1 99.1 20 6 Mitochondrial-processing peptidase subunit beta 
 UniRef90_G3HKP3 40.6 98.9 22 3 Cytochrome b-c1 complex subunit 1, 
mitochondrial 
 UniRef90_O00571 73.2 95.9 7 2 ATP-dependent RNA helicase DDX3X 
 UniRef90_P02545-2 64.0 99.2 43 21 Isoform C of Prelamin-A/C 
 UniRef90_P07910 33.7 98.0 13 3 Heterogeneous nuclear ribonucleoproteins C1/C2 
 UniRef90_P08670 53.7 99.1 44 18 Vimentin 
 UniRef90_P08758 36.1 98.9 23 5 Annexin A5 
 UniRef90_P10809 56.5 98.8 11 4 60 kDa heat shock protein, mitochondrial 
 UniRef90_P20108 28.1 98.9 19 5 Thioredoxin-dependent peroxide reductase, 
mitochondrial 
 UniRef90_P28331 79.8 99.1 9 7 NADH-ubiquinone oxidoreductase 75 kDa 
subunit, mitochondrial 
 UniRef90_Q96I25 45.3 94.0 8 2 Splicing factor 45 
 UniRef90_Q99798 85.5 98.4 6 3 Aconitate hydratase, mitochondrial 
 UniRef90_Q9CQN1 80.3 99.0 11 5 Heat shock protein 75 kDa, mitochondrial 
C06 UniRef90_F8VPV9 56.9 99.2 25 10 ATP synthase subunit beta 
 UniRef90_G3HC01 35.4 98.3 12 3 Tropomyosin alpha-3 chain 
 UniRef90_G3I1Y9 27.4 98.5 20 3 Sulfated glycoprotein 1 
 UniRef90_G3I220 36.4 91.5 12 2 Cytoskeleton-associated protein 4 
 UniRef90_P07910 33.7 92.1 12 2 Heterogeneous nuclear ribonucleoproteins C1/C2 
 UniRef90_P08670 53.7 99.2 49 13 Vimentin 
 UniRef90_P10809 56.5 99.0 14 5 60 kDa heat shock protein, mitochondrial 
 UniRef90_P14625 92.6 99.2 21 16 Endoplasmin 
 UniRef90_P27797 48.2 97.6 9 2 Calreticulin 
 UniRef90_P30153 59.0 99.1 17 6 Serine/threonine-protein phosphatase 2A 65 kDa 
regulatory subunit A alpha isoform 
 UniRef90_P30154 66.0 98.5 14 3 Serine/threonine-protein phosphatase 2A 65 kDa 
regulatory subunit A beta isoform 
 UniRef90_P31946 27.9 98.0 14 3 14-3-3 protein beta/alpha 
 UniRef90_P31947 27.7 98.0 10 3 14-3-3 protein sigma 
 UniRef90_P63101 27.7 98.0 10 3 14-3-3 protein zeta/delta 
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 UniRef90_P68254 27.7 98.0 10 3 14-3-3 protein theta 
 UniRef90_Q3V3R1 105.4 98.3 8 3 Monofunctional C1-tetrahydrofolate synthase, 
mitochondrial 
 UniRef90_Q9R0A0 35.2 99.0 22 4 Peroxisomal membrane protein PEX14 
 UniRef90_Q9Y224 12.3 98.3 37 3 UPF0568 protein C14orf166 
C07 UniRef90_A4FUY3 73.1 99.0 15 5 Prolyl 3-hydroxylase 1 
 UniRef90_G3HNV4 16.4 98.6 30 3 Triosephosphate isomerase 
 UniRef90_G3HPV6 28.5 97.3 13 2 Histone H2A type 1 
 UniRef90_G3HRE2 138.8 98.7 4 4 Apoptotic chromatin condensation inducer in the 
nucleus 
 UniRef90_G3I216 20.4 98.4 21 3 Triosephosphate isomerase 
 UniRef90_P07910 33.7 99.1 31 4 Heterogeneous nuclear ribonucleoproteins C1/C2 
 UniRef90_P08670 53.7 99.2 48 15 Vimentin 
 UniRef90_P14625 92.6 99.2 28 17 Endoplasmin 
 UniRef90_P31937 31.7 94.6 12 2 3-hydroxyisobutyrate dehydrogenase, 
mitochondrial 
 UniRef90_Q8CGK3 95.0 97.3 4 2 Lon protease homolog, mitochondrial 
C08 UniRef90_B9A067 79.3 97.8 8 3 Mitochondrial inner membrane protein 
 UniRef90_F1MDN4 29.9 99.1 36 8 60S acidic ribosomal protein P0 
 UniRef90_F6T365 7.9 98.2 56 3 14-3-3 protein epsilon 
 UniRef90_F8VPV9 56.9 98.3 11 3 ATP synthase subunit beta 
 UniRef90_G3H697 62.4 99.0 12 6 Glucosidase 2 subunit beta 
 UniRef90_G3HC01 35.4 98.3 10 3 Tropomyosin alpha-3 chain 
 UniRef90_G3HC84 47.8 97.9 14 2 Heat shock protein HSP 90-beta 
 UniRef90_G3HEZ0 65.8 99.1 23 10 Stress-70 protein, mitochondrial 
 UniRef90_G3HFL6 69.6 98.9 10 5 ATP-binding cassette sub-family G member 3 
 UniRef90_G3I6E6 32.0 98.1 11 3 Actin, cytoplasmic 2 
 UniRef90_G3IIE7 76.0 98.3 6 3 Procollagen-lysine,2-oxoglutarate 5-dioxygenase 
1 
 UniRef90_G3ILN5 34.4 98.8 14 4 Reticulocalbin-3 
 UniRef90_O43681 38.8 99.0 21 5 ATPase ASNA1 
 UniRef90_P02545-2 64.0 99.0 17 4 Isoform C of Prelamin-A/C 
 UniRef90_P07910 33.7 99.2 44 8 Heterogeneous nuclear ribonucleoproteins C1/C2 
 UniRef90_P08670 53.7 99.1 26 7 Vimentin 
 UniRef90_P11021 72.4 99.2 29 12 78 kDa glucose-regulated protein 
 UniRef90_P31946 27.9 98.2 10 2 14-3-3 protein beta/alpha 
 UniRef90_P31947 27.7 98.2 10 2 14-3-3 protein sigma 
 UniRef90_P60709 41.7 98.1 8 3 Actin, cytoplasmic 1 
 UniRef90_P63101 27.7 98.2 10 2 14-3-3 protein zeta/delta 
 UniRef90_P68254 27.7 98.2 10 2 14-3-3 protein theta 
 UniRef90_P99027 11.7 98.4 46 4 60S acidic ribosomal protein P2 
 UniRef90_Q07955 27.7 98.1 13 3 Serine/arginine-rich splicing factor 1 
 UniRef90_Q8K0D5 83.3 97.9 6 3 Elongation factor G, mitochondrial 
 UniRef90_Q99798 85.5 99.2 23 13 Aconitate hydratase, mitochondrial 
 UniRef90_Q9CQN1 80.3 98.8 10 3 Heat shock protein 75 kDa, mitochondrial 
C09 UniRef90_F8VPV9 56.9 99.2 26 11 ATP synthase subunit beta 
 UniRef90_G3HB04 28.4 98.8 22 4 Protein disulfide-isomerase A6 
 UniRef90_G3HEQ3 25.2 98.3 20 3 Ran-specific GTPase-activating protein 
 UniRef90_G3HFL6 69.6 98.3 10 3 ATP-binding cassette sub-family G member 3 
 UniRef90_P02545-2 64.0 98.6 9 3 Isoform C of Prelamin-A/C 
 UniRef90_P07910 33.7 99.2 41 7 Heterogeneous nuclear ribonucleoproteins C1/C2 
 UniRef90_P08670 53.7 99.2 59 15 Vimentin 
 UniRef90_P10809 56.5 98.2 6 3 60 kDa heat shock protein, mitochondrial 
 UniRef90_P14625 92.6 99.1 18 6 Endoplasmin 
 UniRef90_P27797 48.2 97.7 13 2 Calreticulin 
 UniRef90_P28331 79.8 99.1 17 8 NADH-ubiquinone oxidoreductase 75 kDa 
subunit, mitochondrial 
 UniRef90_P62879 30.5 98.7 14 4 Guanine nucleotide-binding protein 
G(I)/G(S)/G(T) subunit beta-2 
 UniRef90_Q16576 47.0 98.7 9 4 Histone-binding protein RBBP7 
 UniRef90_Q61576 64.7 98.8 15 4 Peptidyl-prolyl cis-trans isomerase FKBP10 
 UniRef90_Q71U36 50.1 99.1 23 3 Tubulin alpha-1A chain 
 UniRef90_Q96I25 45.3 98.8 15 3 Splicing factor 45 
C10 UniRef90_F1MDN4 29.9 98.8 18 4 60S acidic ribosomal protein P0 
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 UniRef90_F8VPV9 56.9 98.4 7 3 ATP synthase subunit beta 
 UniRef90_G3H0U6 50.1 99.1 20 8 Protein disulfide-isomerase A3 
 UniRef90_G3HC84 47.8 98.8 13 5 Heat shock protein HSP 90-beta 
 UniRef90_P07910 33.7 99.2 23 4 Heterogeneous nuclear ribonucleoproteins C1/C2 
 UniRef90_P08670 53.7 98.9 15 4 Vimentin 
 UniRef90_P11021 72.4 99.0 12 5 78 kDa glucose-regulated protein 
 UniRef90_P14625 92.6 99.1 16 11 Endoplasmin 
 UniRef90_P28331 79.8 99.0 12 6 NADH-ubiquinone oxidoreductase 75 kDa 
subunit, mitochondrial 
 UniRef90_P56537 26.6 98.3 18 3 Eukaryotic translation initiation factor 6 
 UniRef90_Q14568 38.1 98.9 18 5 Putative heat shock protein HSP 90-alpha A2 
 UniRef90_Q14697 107.0 98.8 9 5 Neutral alpha-glucosidase AB 
 UniRef90_Q16576 47.0 98.7 11 4 Histone-binding protein RBBP7 
 UniRef90_Q8CGK3 95.0 91.1 5 2 Lon protease homolog, mitochondrial 
C11 UniRef90_B9A067 79.3 99.1 18 10 Mitochondrial inner membrane protein 
 UniRef90_G1SLD5 111.5 99.1 14 7 Hypoxia up-regulated protein 1 
 UniRef90_G3H0U6 50.1 99.2 39 16 Protein disulfide-isomerase A3 
 UniRef90_G3HB04 28.4 98.8 23 4 Protein disulfide-isomerase A6 
 UniRef90_G3HE28 40.1 98.6 14 3 Mitochondrial-processing peptidase subunit beta 
 UniRef90_G3HEZ0 65.8 99.2 39 16 Stress-70 protein, mitochondrial 
 UniRef90_G3HKP3 40.6 99.0 24 6 Cytochrome b-c1 complex subunit 1, 
mitochondrial 
 UniRef90_P02545-2 64.0 99.1 19 5 Isoform C of Prelamin-A/C 
 UniRef90_P08670 53.7 99.1 50 17 Vimentin 
 UniRef90_P10809 56.5 99.1 18 6 60 kDa heat shock protein, mitochondrial 
 UniRef90_P28331 79.8 99.1 19 9 NADH-ubiquinone oxidoreductase 75 kDa 
subunit, mitochondrial 
 UniRef90_P31946 27.9 94.6 10 2 14-3-3 protein beta/alpha 
 UniRef90_P31947 27.7 94.6 10 2 14-3-3 protein sigma 
 UniRef90_P63101 27.7 94.6 10 2 14-3-3 protein zeta/delta 
 UniRef90_P68254 27.7 94.6 10 2 14-3-3 protein theta 
 UniRef90_Q16576 47.0 98.3 8 4 Histone-binding protein RBBP7 
 UniRef90_Q99798 85.5 99.1 23 14 Aconitate hydratase, mitochondrial 
 UniRef90_Q9CQN1 80.3 98.3 9 3 Heat shock protein 75 kDa, mitochondrial 
 UniRef90_Q9R0A0 35.2 98.9 22 4 Peroxisomal membrane protein PEX14 
C12 UniRef90_F8VPV9 56.9 97.9 6 3 ATP synthase subunit beta 
 UniRef90_G3H0U6 50.1 98.0 10 3 Protein disulfide-isomerase A3 
 UniRef90_G3H697 62.4 97.9 5 3 Glucosidase 2 subunit beta 
 UniRef90_G3HE28 40.1 99.1 20 6 Mitochondrial-processing peptidase subunit beta 
 UniRef90_G3HKP3 40.6 98.9 22 3 Cytochrome b-c1 complex subunit 1, 
mitochondrial 
 UniRef90_O00571 73.2 95.9 7 2 ATP-dependent RNA helicase DDX3X 
 UniRef90_P02545-2 64.0 99.2 43 19 Isoform C of Prelamin-A/C 
 UniRef90_P07910 33.7 98.0 13 3 Heterogeneous nuclear ribonucleoproteins C1/C2 
 UniRef90_P08670 53.7 99.1 44 18 Vimentin 
 UniRef90_P08758 36.1 98.9 23 5 Annexin A5 
 UniRef90_P10809 56.5 98.8 11 4 60 kDa heat shock protein, mitochondrial 
 UniRef90_P20108 28.1 98.9 19 5 Thioredoxin-dependent peroxide reductase, 
mitochondrial 
 UniRef90_P28331 79.8 99.1 9 7 NADH-ubiquinone oxidoreductase 75 kDa 
subunit, mitochondrial 
 UniRef90_Q96I25 45.3 94.0 8 2 Splicing factor 45 
 UniRef90_Q99798 85.5 98.4 6 3 Aconitate hydratase, mitochondrial 
 UniRef90_Q9CQN1 80.3 99.0 11 5 Heat shock protein 75 kDa, mitochondrial 
 
Row D Cluster ID 
MW 
(kDa)* 
Score 
% 
Sequence 
Coverage 
(%) 
# of 
Unique 
Peptides 
Protein Name 
D01 UniRef90_A4FUY3 73.1 98.9 11 4 Prolyl 3-hydroxylase 1 
 UniRef90_G3GT05 22.2 96.1 14 2 T-complex protein 1 subunit theta 
 UniRef90_G3GYD5 23.7 98.3 22 4 Complement component 1 Q subcomponent-
binding protein, mitochondrial 
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 UniRef90_G3H0U6 50.1 96.9 14 2 Protein disulfide-isomerase A3 
 UniRef90_G3H584 28.2 99.0 27 5 SPARC 
 UniRef90_G3HRE2 138.8 98.2 5 3 Apoptotic chromatin condensation inducer in the 
nucleus 
 UniRef90_G3IAS8 185.7 99.1 6 6 Kinesin-like protein KIF27 
 UniRef90_G3ILN5 34.4 98.9 19 5 Reticulocalbin-3 
 UniRef90_P02545-2 64.0 99.1 28 7 Isoform C of Prelamin-A/C 
 UniRef90_P08670 53.7 99.2 38 13 Vimentin 
 UniRef90_P10809 56.5 98.5 10 3 60 kDa heat shock protein, mitochondrial 
 UniRef90_P28331 79.8 99.1 24 10 NADH-ubiquinone oxidoreductase 75 kDa 
subunit, mitochondrial 
 UniRef90_P62873 37.4 99.0 17 5 Guanine nucleotide-binding protein 
G(I)/G(S)/G(T) subunit beta-1 
 UniRef90_Q02790 46.6 98.1 13 3 Peptidyl-prolyl cis-trans isomerase FKBP4 
 UniRef90_Q14568 38.1 98.9 23 5 Putative heat shock protein HSP 90-alpha A2 
 UniRef90_Q8BMF4 68.0 99.1 24 11 Dihydrolipoyllysine-residue acetyltransferase 
component of pyruvate dehydrogenase complex, 
mitochondrial 
D02 UniRef90_A4FUY3 73.1 99.0 13 6 Prolyl 3-hydroxylase 1 
 UniRef90_G3HC01 35.4 99.1 28 4 Tropomyosin alpha-3 chain 
 UniRef90_G3HC84 47.8 90.9 14 2 Heat shock protein HSP 90-beta 
 UniRef90_G3HEZ0 65.8 99.1 21 6 Stress-70 protein, mitochondrial 
 UniRef90_G3HN14 237.6 98.4 3 3 Transitional endoplasmic reticulum ATPase 
 UniRef90_G3HR08 50.3 98.9 20 5 Cytosol aminopeptidase 
 UniRef90_G3HRE2 138.8 98.6 5 4 Apoptotic chromatin condensation inducer in the 
nucleus 
 UniRef90_G3HSM8 67.7 99.1 18 5 Lamin-B2 
 UniRef90_G3ILN5 34.4 98.7 14 4 Reticulocalbin-3 
 UniRef90_I3MCK6 29.3 98.3 28 3 Reticulocalbin-1 
 UniRef90_P05091 45.9 99.1 35 8 Aldehyde dehydrogenase, mitochondrial 
 UniRef90_P08003 72.6 98.9 17 4 Protein disulfide-isomerase A4 
 UniRef90_P08670 53.7 99.2 50 22 Vimentin 
 UniRef90_P09622 54.1 99.1 27 8 Dihydrolipoyl dehydrogenase, mitochondrial 
 UniRef90_P11021 72.4 99.1 20 9 78 kDa glucose-regulated protein 
 UniRef90_P14625 92.6 90.1 7 2 Endoplasmin 
 UniRef90_P28331 79.8 99.1 18 7 NADH-ubiquinone oxidoreductase 75 kDa 
subunit, mitochondrial 
 UniRef90_P34897 55.9 98.5 16 3 Serine hydroxymethyltransferase, mitochondrial 
 UniRef90_Q14568 38.1 99.1 34 9 Putative heat shock protein HSP 90-alpha A2 
D03 UniRef90_G3H0U6 50.1 99.0 16 6 Protein disulfide-isomerase A3 
 UniRef90_G3HEZ0 65.8 99.2 28 12 Stress-70 protein, mitochondrial 
 UniRef90_G3HFL6 69.6 99.1 12 5 ATP-binding cassette sub-family G member 3 
 UniRef90_G3HSM8 67.7 99.1 20 8 Lamin-B2 
 UniRef90_G3IE04 53.4 99.0 14 6 Pre-mRNA-processing factor 19 
 UniRef90_G3ILN5 34.4 99.0 19 5 Reticulocalbin-3 
 UniRef90_O95302 63.0 98.2 10 3 Peptidyl-prolyl cis-trans isomerase FKBP9 
 UniRef90_P02545-2 64.0 99.1 39 16 Isoform C of Prelamin-A/C 
 UniRef90_P08670 53.7 98.7 17 4 Vimentin 
 UniRef90_P11021 72.4 99.2 23 8 78 kDa glucose-regulated protein 
 UniRef90_P14625 92.6 99.2 23 15 Endoplasmin 
 UniRef90_P28331 79.8 99.2 18 10 NADH-ubiquinone oxidoreductase 75 kDa 
subunit, mitochondrial 
 UniRef90_P56537 26.6 98.8 22 4 Eukaryotic translation initiation factor 6 
 UniRef90_P60709 41.7 98.7 11 4 Actin, cytoplasmic 1 
 UniRef90_P78371 57.5 99.1 21 6 T-complex protein 1 subunit beta 
 UniRef90_Q8BMF4 68.0 99.2 28 12 Dihydrolipoyllysine-residue acetyltransferase 
component of pyruvate dehydrogenase complex, 
mitochondrial 
 UniRef90_Q91W90 46.4 99.2 37 12 Thioredoxin domain-containing protein 5 
 UniRef90_Q9CQN1 80.3 98.9 14 5 Heat shock protein 75 kDa, mitochondrial 
D04 UniRef90_A4FUY3 73.1 98.8 11 4 Prolyl 3-hydroxylase 1 
 UniRef90_G1SLD5 111.5 98.7 7 4 Hypoxia up-regulated protein 1 
 UniRef90_G3H0U6 50.1 99.1 26 9 Protein disulfide-isomerase A3 
 UniRef90_G3HNJ3 51.8 98.8 11 4 Clusterin 
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 UniRef90_G3HRE2 138.8 97.7 3 3 Apoptotic chromatin condensation inducer in the 
nucleus 
 UniRef90_G3ILN5 34.4 98.8 15 4 Reticulocalbin-3 
 UniRef90_P02545-2 64.0 99.0 16 6 Isoform C of Prelamin-A/C 
 UniRef90_P07910 33.7 99.1 22 5 Heterogeneous nuclear ribonucleoproteins C1/C2 
 UniRef90_P08670 53.7 99.1 20 7 Vimentin 
 UniRef90_P14625 92.6 99.2 15 11 Endoplasmin 
 UniRef90_Q14568 38.1 99.0 18 5 Putative heat shock protein HSP 90-alpha A2 
D05 UniRef90_G3HEZ0 65.8 99.2 44 21 Stress-70 protein, mitochondrial 
 UniRef90_G3HFL6 69.6 98.9 10 4 ATP-binding cassette sub-family G member 3 
 UniRef90_G3HHK0 35.4 99.1 33 8 28S ribosomal protein S31, mitochondrial 
 UniRef90_G3HSM8 67.7 98.9 18 4 Lamin-B2 
 UniRef90_O95302 63.0 98.9 15 5 Peptidyl-prolyl cis-trans isomerase FKBP9 
 UniRef90_O96019 47.5 98.3 10 3 Actin-like protein 6A 
 UniRef90_P08003 72.6 99.2 24 13 Protein disulfide-isomerase A4 
 UniRef90_P27797 48.2 99.0 18 6 Calreticulin 
 UniRef90_P49821 50.6 93.7 8 2 NADH dehydrogenase [ubiquinone] flavoprotein 
1, mitochondrial 
 UniRef90_P50213 39.7 98.5 14 4 Isocitrate dehydrogenase [NAD] subunit alpha, 
mitochondrial 
 UniRef90_P62873 37.4 99.0 21 6 Guanine nucleotide-binding protein 
G(I)/G(S)/G(T) subunit beta-1 
 UniRef90_Q07955 27.7 98.2 12 3 Serine/arginine-rich splicing factor 1 
 UniRef90_Q16576 47.0 99.1 13 7 Histone-binding protein RBBP7 
 UniRef90_Q91W90 46.4 99.1 27 8 Thioredoxin domain-containing protein 5 
 UniRef90_Q9Y265 50.2 98.6 16 4 RuvB-like 1 
D06 UniRef90_G3H0U6 50.1 99.2 32 11 Protein disulfide-isomerase A3 
 UniRef90_G3H2T7 29.6 98.6 17 2 Histone H3 
 UniRef90_G3H584 28.2 98.4 24 3 SPARC 
 UniRef90_G3HAE2 7.0 98.2 58 3 ATP synthase subunit alpha, mitochondrial 
 UniRef90_G3HDS3 26.7 98.6 19 2 Histone H2A 
 UniRef90_G3HE28 40.1 98.9 14 4 Mitochondrial-processing peptidase subunit beta 
 UniRef90_G3HKP3 40.6 99.2 33 11 Cytochrome b-c1 complex subunit 1, 
mitochondrial 
 UniRef90_G3IE04 53.4 99.1 23 5 Pre-mRNA-processing factor 19 
 UniRef90_G3ILN5 34.4 99.0 32 8 Reticulocalbin-3 
 UniRef90_H0X554 30.1 99.2 44 10 NADH dehydrogenase [ubiquinone] iron-sulfur 
protein 3, mitochondrial 
 UniRef90_I3MCK6 29.3 98.9 32 4 Reticulocalbin-1 
 UniRef90_P07910 33.7 99.0 25 3 Heterogeneous nuclear ribonucleoproteins C1/C2 
 UniRef90_P08670 53.7 99.2 31 9 Vimentin 
 UniRef90_P10809 56.5 99.2 28 10 60 kDa heat shock protein, mitochondrial 
 UniRef90_P14625 92.6 99.2 16 10 Endoplasmin 
 UniRef90_Q9GZL7 47.6 98.1 11 3 Ribosome biogenesis protein WDR12 
D07 UniRef90_A6QR15 30.7 98.9 28 6 Tropomyosin beta chain 
 UniRef90_G3H0U6 50.1 99.2 32 11 Protein disulfide-isomerase A3 
 UniRef90_G3HB04 28.4 98.2 17 3 Protein disulfide-isomerase A6 
 UniRef90_G3HFY6 19.0 98.7 31 4 Stromal cell-derived factor 2-like protein 1 
 UniRef90_G3HNG2 49.8 99.1 21 9 Acyl-coenzyme A thioesterase 2, mitochondrial 
 UniRef90_G3HR08 50.3 98.7 11 4 Cytosol aminopeptidase 
 UniRef90_G3IAS8 185.7 99.2 6 8 Kinesin-like protein KIF27 
 UniRef90_H0X554 30.1 99.1 27 7 NADH dehydrogenase [ubiquinone] iron-sulfur 
protein 3, mitochondrial 
 UniRef90_O88696 29.8 99.1 40 8 Putative ATP-dependent Clp protease proteolytic 
subunit, mitochondrial 
 UniRef90_O96019 47.5 98.3 10 3 Actin-like protein 6A 
 UniRef90_P02545-2 64.0 99.1 19 8 Isoform C of Prelamin-A/C 
 UniRef90_P05091 45.9 98.2 11 3 Aldehyde dehydrogenase, mitochondrial 
 UniRef90_P08670 53.7 99.1 22 6 Vimentin 
 UniRef90_P10809 56.5 98.3 9 3 60 kDa heat shock protein, mitochondrial 
 UniRef90_P14625 92.6 99.2 27 22 Endoplasmin 
 UniRef90_P60709 41.7 99.1 31 7 Actin, cytoplasmic 1 
 UniRef90_Q02790 46.6 99.0 18 6 Peptidyl-prolyl cis-trans isomerase FKBP4 
 UniRef90_Q14697 107.0 99.1 11 9 Neutral alpha-glucosidase AB 
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 UniRef90_Q3V3R1 105.4 99.1 18 11 Monofunctional C1-tetrahydrofolate synthase, 
mitochondrial 
 UniRef90_Q8CGK3 95.0 99.1 16 6 Lon protease homolog, mitochondrial 
 UniRef90_Q91W90 46.4 99.0 6 3 Thioredoxin domain-containing protein 5 
D08 UniRef90_B9A067 79.3 99.1 12 6 Mitochondrial inner membrane protein 
 UniRef90_F8VPV9 56.9 98.3 8 3 ATP synthase subunit beta 
 UniRef90_G3HEZ0 65.8 99.2 32 17 Stress-70 protein, mitochondrial 
 UniRef90_G3HSM8 67.7 99.1 19 7 Lamin-B2 
 UniRef90_H0X554 30.1 99.1 32 8 NADH dehydrogenase [ubiquinone] iron-sulfur 
protein 3, mitochondrial 
 UniRef90_P02545-2 64.0 99.1 36 16 Isoform C of Prelamin-A/C 
 UniRef90_P08003 72.6 99.1 18 11 Protein disulfide-isomerase A4 
 UniRef90_P08670 53.7 99.2 40 17 Vimentin 
 UniRef90_P11021 72.4 98.3 9 3 78 kDa glucose-regulated protein 
 UniRef90_P14625 92.6 99.2 21 16 Endoplasmin 
 UniRef90_P27797 48.2 99.1 29 12 Calreticulin 
 UniRef90_P28331 79.8 99.1 18 10 NADH-ubiquinone oxidoreductase 75 kDa 
subunit, mitochondrial 
 UniRef90_P49411 49.6 98.4 12 3 Elongation factor Tu, mitochondrial 
 UniRef90_P50454 46.6 97.4 9 3 Serpin H1 
 UniRef90_Q16576 47.0 98.8 13 5 Histone-binding protein RBBP7 
 UniRef90_Q8CGK3 95.0 99.1 12 5 Lon protease homolog, mitochondrial 
 UniRef90_Q8K0D5 83.3 99.1 14 6 Elongation factor G, mitochondrial 
 UniRef90_Q91W90 46.4 98.9 18 5 Thioredoxin domain-containing protein 5 
 UniRef90_Q99798 85.5 99.2 17 9 Aconitate hydratase, mitochondrial 
 UniRef90_Q9CQN1 80.3 99.1 21 9 Heat shock protein 75 kDa, mitochondrial 
 UniRef90_Q9Y3B8 26.8 96.7 16 3 Oligoribonuclease, mitochondrial 
D09 UniRef90_A6QR15 30.7 99.0 28 6 Tropomyosin beta chain 
 UniRef90_B4DJ75 58.7 98.2 5 3 Serine/threonine-protein phosphatase 
 UniRef90_B6UV57 49.4 98.9 11 5 Cysteine desulfurase, mitochondrial 
 UniRef90_F8VPV9 56.9 98.4 13 4 ATP synthase subunit beta 
 UniRef90_G2HG05 17.1 98.3 32 3 Interleukin enhancer-binding factor 2 
 UniRef90_G3GXA9 21.1 98.9 39 4 Protein disulfide-isomerase 
 UniRef90_G3H0U6 50.1 99.1 27 9 Protein disulfide-isomerase A3 
 UniRef90_G3H298 34.1 98.2 9 3 Serine/threonine-protein phosphatase 
 UniRef90_G3HNJ3 51.8 99.0 17 5 Clusterin 
 UniRef90_G3HSM8 67.7 97.6 7 3 Lamin-B2 
 UniRef90_G3I5H3 36.6 99.0 26 5 Elongation factor 1-delta 
 UniRef90_P07910 33.7 99.2 37 7 Heterogeneous nuclear ribonucleoproteins C1/C2 
 UniRef90_P08670 53.7 99.0 19 4 Vimentin 
 UniRef90_P10809 56.5 99.1 23 11 60 kDa heat shock protein, mitochondrial 
 UniRef90_P27797 48.2 98.2 9 3 Calreticulin 
 UniRef90_P38159 42.1 98.8 20 4 Heterogeneous nuclear ribonucleoprotein G 
 UniRef90_P50213 39.7 99.2 23 9 Isocitrate dehydrogenase [NAD] subunit alpha, 
mitochondrial 
 UniRef90_P60709 41.7 99.1 28 6 Actin, cytoplasmic 1 
 UniRef90_Q16576 47.0 99.1 13 3 Histone-binding protein RBBP7 
 UniRef90_Q7TP98 12.8 98.7 37 4 Interleukin enhancer-binding factor 2 
 UniRef90_Q91W90 46.4 99.2 36 12 Thioredoxin domain-containing protein 5 
D10 UniRef90_F8VPV9 56.9 98.9 10 4 ATP synthase subunit beta 
 UniRef90_G3H1B3 55.0 98.0 6 2 Lamin-L(I) 
 UniRef90_G3HC84 47.8 99.1 21 4 Heat shock protein HSP 90-beta 
 UniRef90_G3HEZ0 65.8 97.6 11 2 Stress-70 protein, mitochondrial 
 UniRef90_G3HNG2 49.8 99.1 17 6 Acyl-coenzyme A thioesterase 2, mitochondrial 
 UniRef90_G3HNG5 50.4 99.1 16 6 Acyl-coenzyme A thioesterase 1 
 UniRef90_P02545-2 64.0 99.1 31 13 Isoform C of Prelamin-A/C 
 UniRef90_P08670 53.7 99.2 50 22 Vimentin 
 UniRef90_P10809 56.5 99.0 12 5 60 kDa heat shock protein, mitochondrial 
 UniRef90_P11021 72.4 99.1 23 9 78 kDa glucose-regulated protein 
 UniRef90_P14625 92.6 99.1 17 10 Endoplasmin 
 UniRef90_P27797 48.2 99.1 20 7 Calreticulin 
 UniRef90_P50213 39.7 99.1 28 10 Isocitrate dehydrogenase [NAD] subunit alpha, 
mitochondrial 
 UniRef90_Q14568 38.1 99.0 23 6 Putative heat shock protein HSP 90-alpha A2 
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 UniRef90_Q16576 47.0 98.8 11 4 Histone-binding protein RBBP7 
D11 UniRef90_A4FUY3 73.1 98.4 10 3 Prolyl 3-hydroxylase 1 
 UniRef90_F8VPV9 56.9 98.7 11 4 ATP synthase subunit beta 
 UniRef90_G3H584 28.2 99.0 27 5 SPARC 
 UniRef90_G3H937 58.8 92.1 5 2 Histone-binding protein RBBP4 
 UniRef90_G3HC84 47.8 98.9 15 5 Heat shock protein HSP 90-beta 
 UniRef90_G3HFL6 69.6 98.8 10 4 ATP-binding cassette sub-family G member 3 
 UniRef90_G3HRE2 138.8 98.6 5 4 Apoptotic chromatin condensation inducer in the 
nucleus 
 UniRef90_G3I7A8 131.3 98.3 5 3 Sortilin (Fragment) 
 UniRef90_G3ILN5 34.4 98.9 19 6 Reticulocalbin-3 
 UniRef90_I3MCK6 29.3 98.4 35 3 Reticulocalbin-1 
 UniRef90_P08670 53.7 99.2 64 25 Vimentin 
 UniRef90_P14625 92.6 99.1 17 12 Endoplasmin 
 UniRef90_P27797 48.2 98.2 14 3 Calreticulin 
 UniRef90_P56537 26.6 99.0 31 5 Eukaryotic translation initiation factor 6 
 UniRef90_P62873 37.4 97.8 10 3 Guanine nucleotide-binding protein 
G(I)/G(S)/G(T) subunit beta-1 
 UniRef90_Q14568 38.1 99.1 26 6 Putative heat shock protein HSP 90-alpha A2 
 UniRef90_Q16576 47.0 98.4 8 3 Histone-binding protein RBBP7 
D12 UniRef90_A6QR15 30.7 99.1 29 8 Tropomyosin beta chain 
 UniRef90_G3HE28 40.1 98.7 14 3 Mitochondrial-processing peptidase subunit beta 
 UniRef90_G3HEZ0 65.8 99.1 21 6 Stress-70 protein, mitochondrial 
 UniRef90_G3HGS2 96.2 98.9 8 4 Propionyl-CoA carboxylase alpha chain, 
mitochondrial 
 UniRef90_G3HKP3 40.6 99.1 24 6 Cytochrome b-c1 complex subunit 1, 
mitochondrial 
 UniRef90_G3HNJ3 51.8 98.4 9 3 Clusterin 
 UniRef90_G3HR08 50.3 98.8 13 4 Cytosol aminopeptidase 
 UniRef90_P02545-2 64.0 99.1 28 9 Isoform C of Prelamin-A/C 
 UniRef90_P08670 53.7 99.1 37 8 Vimentin 
 UniRef90_P09622 54.1 99.2 26 9 Dihydrolipoyl dehydrogenase, mitochondrial 
 UniRef90_P14625 92.6 99.2 23 18 Endoplasmin 
 UniRef90_P54652 69.7 98.8 10 4 Heat shock-related 70 kDa protein 2 
 UniRef90_Q3V3R1 105.4 98.8 11 4 Monofunctional C1-tetrahydrofolate synthase, 
mitochondrial 
 UniRef90_Q9CQN1 80.3 99.2 27 15 Heat shock protein 75 kDa, mitochondrial 
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E01 UniRef90_G3HEZ0 65.8 98.0 7 3 Stress-70 protein, mitochondrial 
 UniRef90_O88696 29.8 99.1 27 6 Putative ATP-dependent Clp protease proteolytic 
subunit, mitochondrial 
 UniRef90_P02545-2 64.0 98.4 11 3 Isoform C of Prelamin-A/C 
 UniRef90_P14625 92.6 99.1 18 9 Endoplasmin 
 UniRef90_P27797 48.2 99.0 19 6 Calreticulin 
 UniRef90_P31040 71.7 99.0 11 5 Succinate dehydrogenase [ubiquinone] 
flavoprotein subunit, mitochondrial 
 UniRef90_P54652 69.7 98.2 5 3 Heat shock-related 70 kDa protein 2 
 UniRef90_P60709 41.7 98.9 15 5 Actin, cytoplasmic 1 
 UniRef90_Q02218 104.5 95.6 4 2 2-oxoglutarate dehydrogenase, mitochondrial 
 UniRef90_Q3V3R1 105.4 98.3 9 3 Monofunctional C1-tetrahydrofolate synthase, 
mitochondrial 
 UniRef90_Q7TP98 12.8 98.0 27 3 Interleukin enhancer-binding factor 2 
 UniRef90_Q8BMF4 68.0 99.2 28 10 Dihydrolipoyllysine-residue acetyltransferase 
component of pyruvate dehydrogenase complex, 
mitochondrial 
 UniRef90_Q8CGK3 95.0 99.1 11 6 Lon protease homolog, mitochondrial 
 UniRef90_Q91W90 46.4 99.1 22 7 Thioredoxin domain-containing protein 5 
 UniRef90_Q9CQN1 80.3 99.1 29 15 Heat shock protein 75 kDa, mitochondrial 
E02 UniRef90_B9W7J9 11.4 98.3 27 3 Histone H4 
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 UniRef90_F8VPV9 56.9 99.2 27 9 ATP synthase subunit beta 
 UniRef90_G2HG05 17.1 98.4 32 3 Interleukin enhancer-binding factor 2 
 UniRef90_G3HC84 47.8 99.1 23 6 Heat shock protein HSP 90-beta 
 UniRef90_G3HDS1 14.9 98.3 21 3 Histone H4 
 UniRef90_G3HKP3 40.6 99.0 20 7 Cytochrome b-c1 complex subunit 1, 
mitochondrial 
 UniRef90_G3HPV6 28.5 98.3 11 3 Histone H2A type 1 
 UniRef90_G3HPV7 21.8 98.3 14 3 Histone H4 
 UniRef90_G3HQI8 229.3 98.7 2 4 Myosin-Vb 
 UniRef90_H0X554 30.1 99.2 51 11 NADH dehydrogenase [ubiquinone] iron-sulfur 
protein 3, mitochondrial 
 UniRef90_P00505 47.4 98.8 17 5 Aspartate aminotransferase, mitochondrial 
 UniRef90_P05091 45.9 99.1 21 6 Aldehyde dehydrogenase, mitochondrial 
 UniRef90_P08670 53.7 99.1 30 8 Vimentin 
 UniRef90_P27797 48.2 99.1 24 7 Calreticulin 
 UniRef90_P34897 55.9 98.3 12 3 Serine hydroxymethyltransferase, mitochondrial 
 UniRef90_P55302 41.2 99.1 28 8 Alpha-2-macroglobulin receptor-associated 
protein 
 UniRef90_P60709 41.7 99.2 36 10 Actin, cytoplasmic 1 
 UniRef90_P62805 10.8 98.3 29 3 Histone H4 
 UniRef90_Q14568 38.1 99.1 29 6 Putative heat shock protein HSP 90-alpha A2 
 UniRef90_Q91W90 46.4 99.1 37 10 Thioredoxin domain-containing protein 5 
 UniRef90_Q9DB77 48.3 98.8 16 4 Cytochrome b-c1 complex subunit 2, 
mitochondrial 
E03 UniRef90_B9A067 79.3 99.2 28 16 Mitochondrial inner membrane protein 
 UniRef90_F8VPV9 56.9 98.2 7 3 ATP synthase subunit beta 
 UniRef90_G3HEZ0 65.8 99.2 51 28 Stress-70 protein, mitochondrial 
 UniRef90_G3IDL7 22.7 99.2 45 4 Heat shock cognate 71 kDa protein 
 UniRef90_G3IE04 53.4 98.8 12 4 Pre-mRNA-processing factor 19 
 UniRef90_G3IGQ3 23.1 99.0 33 2 Heat shock cognate 71 kDa protein 
 UniRef90_O88696 29.8 99.0 31 5 Putative ATP-dependent Clp protease proteolytic 
subunit, mitochondrial 
 UniRef90_P07910 33.7 99.1 30 6 Heterogeneous nuclear ribonucleoproteins C1/C2 
 UniRef90_P08670 53.7 99.2 55 20 Vimentin 
 UniRef90_P27797 48.2 99.2 24 10 Calreticulin 
 UniRef90_P55302 41.2 99.0 19 6 Alpha-2-macroglobulin receptor-associated 
protein 
 UniRef90_P78371 57.5 99.0 17 5 T-complex protein 1 subunit beta 
 UniRef90_Q8BMF4 68.0 98.6 9 4 Dihydrolipoyllysine-residue acetyltransferase 
component of pyruvate dehydrogenase complex, 
mitochondrial 
 UniRef90_Q99798 85.5 98.7 12 4 Aconitate hydratase, mitochondrial 
E04 UniRef90_B9W7J9 11.4 98.4 39 3 Histone H4 
 UniRef90_G3HDS1 14.9 98.4 30 3 Histone H4 
 UniRef90_G3HEZ0 65.8 99.1 21 8 Stress-70 protein, mitochondrial 
 UniRef90_G3HFQ4 33.2 98.2 16 3 Dihydrolipoyllysine-residue succinyltransferase 
component of 2-oxoglutarate dehydrogenase 
complex, mitochondrial 
 UniRef90_G3HGS2 96.2 98.9 11 4 Propionyl-CoA carboxylase alpha chain, 
mitochondrial 
 UniRef90_G3HPV6 28.5 98.4 15 3 Histone H2A type 1 
 UniRef90_G3HPV7 21.8 98.4 20 3 Histone H4 
 UniRef90_G3HR08 50.3 99.1 23 7 Cytosol aminopeptidase 
 UniRef90_G3IE04 53.4 99.0 12 5 Pre-mRNA-processing factor 19 
 UniRef90_H0X554 30.1 99.1 34 8 NADH dehydrogenase [ubiquinone] iron-sulfur 
protein 3, mitochondrial 
 UniRef90_P02545-2 64.0 99.1 29 8 Isoform C of Prelamin-A/C 
 UniRef90_P07910 33.7 99.2 37 6 Heterogeneous nuclear ribonucleoproteins C1/C2 
 UniRef90_P20108 28.1 99.1 36 7 Thioredoxin-dependent peroxide reductase, 
mitochondrial 
 UniRef90_P28331 79.8 99.2 27 16 NADH-ubiquinone oxidoreductase 75 kDa 
subunit, mitochondrial 
 UniRef90_P43304 80.7 98.7 16 3 Glycerol-3-phosphate dehydrogenase, 
mitochondrial 
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 UniRef90_P49411 49.6 99.2 44 16 Elongation factor Tu, mitochondrial 
 UniRef90_P51855 52.2 97.1 12 2 Glutathione synthetase 
 UniRef90_P62805 10.8 98.4 41 3 Histone H4 
 UniRef90_Q61576 64.7 96.8 12 2 Peptidyl-prolyl cis-trans isomerase FKBP10 
 UniRef90_Q757K0 11.3 98.3 29 3 Histone H4.1 
 UniRef90_Q8K3J1 23.1 98.7 23 5 NADH dehydrogenase [ubiquinone] iron-sulfur 
protein 8, mitochondrial 
 UniRef90_Q9CQN1 80.3 99.2 30 20 Heat shock protein 75 kDa, mitochondrial 
 UniRef90_Q9GZL7 47.6 95.6 9 2 Ribosome biogenesis protein WDR12 
 UniRef90_Q9UQ80 43.7 96.1 13 2 Proliferation-associated protein 2G4 
 UniRef90_Q9Y265 50.2 98.6 20 3 RuvB-like 1 
E05 UniRef90_F8VPV9 56.9 99.2 28 11 ATP synthase subunit beta 
 UniRef90_G3H0U6 50.1 99.1 25 7 Protein disulfide-isomerase A3 
 UniRef90_G3HC79 102.8 97.6 6 2 Putative alanyl-tRNA synthetase, mitochondrial 
 UniRef90_G3HZY1 57.2 98.9 12 5 RuvB-like 2 
 UniRef90_G3I5W2 22.6 98.8 24 4 TAR DNA-binding protein 43 
 UniRef90_G3I6E6 32.0 99.0 25 3 Actin, cytoplasmic 2 
 UniRef90_G3IAS8 185.7 94.4 2 2 Kinesin-like protein KIF27 
 UniRef90_P05091 45.9 99.2 26 8 Aldehyde dehydrogenase, mitochondrial 
 UniRef90_P08670 53.7 99.2 50 20 Vimentin 
 UniRef90_P09622 54.1 98.3 11 3 Dihydrolipoyl dehydrogenase, mitochondrial 
 UniRef90_P10809 56.5 99.2 27 10 60 kDa heat shock protein, mitochondrial 
 UniRef90_P14625 92.6 99.2 18 9 Endoplasmin 
 UniRef90_P27797 48.2 98.9 18 4 Calreticulin 
 UniRef90_P34897 55.9 97.9 18 2 Serine hydroxymethyltransferase, mitochondrial 
 UniRef90_P35232 29.8 99.2 54 12 Prohibitin 
 UniRef90_P60709 41.7 99.1 22 3 Actin, cytoplasmic 1 
 UniRef90_Q13148 21.8 99.0 31 4 TAR DNA-binding protein 43 
 UniRef90_Q14697 107.0 99.1 18 10 Neutral alpha-glucosidase AB 
 UniRef90_Q71U36 50.1 98.5 25 7 Tubulin alpha-1A chain 
 UniRef90_Q8CGK3 95.0 99.1 18 10 Lon protease homolog, mitochondrial 
 UniRef90_Q9CWG8 48.8 94.1 9 2 Protein midA-like, mitochondrial 
 UniRef90_Q9Y265 50.2 99.2 30 10 RuvB-like 1 
 UniRef90_Q9Z1N5 48.7 94.4 11 2 Spliceosome RNA helicase Ddx39b 
E06 UniRef90_F8VPV9 56.9 99.2 21 9 ATP synthase subunit beta 
 UniRef90_G3HEZ0 65.8 99.2 43 21 Stress-70 protein, mitochondrial 
 UniRef90_H0X554 30.1 99.2 36 9 NADH dehydrogenase [ubiquinone] iron-sulfur 
protein 3, mitochondrial 
 UniRef90_P02545-2 64.0 99.1 20 6 Isoform C of Prelamin-A/C 
 UniRef90_P08670 53.7 99.2 58 26 Vimentin 
 UniRef90_P14625 92.6 99.1 17 11 Endoplasmin 
 UniRef90_P28331 79.8 99.2 24 14 NADH-ubiquinone oxidoreductase 75 kDa 
subunit, mitochondrial 
 UniRef90_P31040 71.7 99.2 21 12 Succinate dehydrogenase [ubiquinone] 
flavoprotein subunit, mitochondrial 
 UniRef90_P35232 29.8 98.3 13 3 Prohibitin 
 UniRef90_P49368 60.6 97.8 11 3 T-complex protein 1 subunit gamma 
 UniRef90_P60709 41.7 99.1 24 7 Actin, cytoplasmic 1 
 UniRef90_Q13509 49.7 99.0 28 8 Tubulin beta-3 chain 
 UniRef90_Q16822 70.8 99.1 18 8 Phosphoenolpyruvate carboxykinase [GTP], 
mitochondrial 
 UniRef90_Q8CGK3 95.0 98.7 8 4 Lon protease homolog, mitochondrial 
E07 UniRef90_F8VPV9 56.9 99.1 21 6 ATP synthase subunit beta 
 UniRef90_G3H584 28.2 99.0 24 5 SPARC 
 UniRef90_G3HAE2 7.0 98.2 58 3 ATP synthase subunit alpha, mitochondrial 
 UniRef90_G3HC84 47.8 99.1 19 6 Heat shock protein HSP 90-beta 
 UniRef90_G3HEZ0 65.8 98.7 11 4 Stress-70 protein, mitochondrial 
 UniRef90_G3HJB6 71.8 97.6 6 3 Ras and Rab interactor-like protein 
 UniRef90_G3HR08 50.3 99.1 29 8 Cytosol aminopeptidase 
 UniRef90_G3I129 48.7 98.9 11 4 Ubiquitin 
 UniRef90_G3I834 8.6 94.6 32 3 Cytochrome c oxidase subunit 5A, mitochondrial 
 UniRef90_G3IE04 53.4 99.1 19 8 Pre-mRNA-processing factor 19 
 UniRef90_G3ILN5 34.4 99.0 19 6 Reticulocalbin-3 
 UniRef90_O43175 56.6 98.2 9 3 D-3-phosphoglycerate dehydrogenase 
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 UniRef90_P02545-2 64.0 99.2 50 23 Isoform C of Prelamin-A/C 
 UniRef90_P08670 53.7 99.2 58 24 Vimentin 
 UniRef90_P09622 54.1 98.2 9 3 Dihydrolipoyl dehydrogenase, mitochondrial 
 UniRef90_P0CG83 17.3 98.9 32 4 Polyubiquitin (Fragment) 
 UniRef90_P14625 92.6 99.1 17 14 Endoplasmin 
 UniRef90_P27797 48.2 99.0 20 5 Calreticulin 
 UniRef90_P31040 71.7 99.2 21 10 Succinate dehydrogenase [ubiquinone] 
flavoprotein subunit, mitochondrial 
 UniRef90_P49368 60.6 98.4 11 3 T-complex protein 1 subunit gamma 
 UniRef90_P52825 74.5 93.9 6 2 Carnitine O-palmitoyltransferase 2, mitochondrial 
 UniRef90_Q13217 57.6 98.8 13 4 DnaJ homolog subfamily C member 3 
 UniRef90_Q13509 49.7 98.6 17 3 Tubulin beta-3 chain 
 UniRef90_Q14568 38.1 99.0 19 5 Putative heat shock protein HSP 90-alpha A2 
 UniRef90_Q16822 70.8 98.3 11 3 Phosphoenolpyruvate carboxykinase [GTP], 
mitochondrial 
 UniRef90_Q8BMF4 68.0 99.2 26 14 Dihydrolipoyllysine-residue acetyltransferase 
component of pyruvate dehydrogenase complex, 
mitochondrial 
 UniRef90_Q9Z0X1 66.8 99.2 23 7 Apoptosis-inducing factor 1, mitochondrial 
E08 UniRef90_F8VPV9 56.9 99.2 26 10 ATP synthase subunit beta 
 UniRef90_G3GXA9 21.1 98.6 36 4 Protein disulfide-isomerase 
 UniRef90_G3H0U6 50.1 99.1 36 13 Protein disulfide-isomerase A3 
 UniRef90_G3H697 62.4 98.2 7 3 Glucosidase 2 subunit beta 
 UniRef90_G3HC84 47.8 99.0 18 6 Heat shock protein HSP 90-beta 
 UniRef90_G3HFQ4 33.2 99.1 26 6 Dihydrolipoyllysine-residue succinyltransferase 
component of 2-oxoglutarate dehydrogenase 
complex, mitochondrial 
 UniRef90_G3HKP3 40.6 99.1 32 9 Cytochrome b-c1 complex subunit 1, 
mitochondrial 
 UniRef90_G3HNJ3 51.8 98.8 13 4 Clusterin 
 UniRef90_G3HR08 50.3 99.2 42 14 Cytosol aminopeptidase 
 UniRef90_G3IAS8 185.7 98.3 4 3 Kinesin-like protein KIF27 
 UniRef90_G3IE04 53.4 98.2 7 3 Pre-mRNA-processing factor 19 
 UniRef90_H0X554 30.1 99.1 38 9 NADH dehydrogenase [ubiquinone] iron-sulfur 
protein 3, mitochondrial 
 UniRef90_O43175 56.6 98.9 11 5 D-3-phosphoglycerate dehydrogenase 
 UniRef90_P02545-2 64.0 99.2 29 11 Isoform C of Prelamin-A/C 
 UniRef90_P05091 45.9 99.1 18 6 Aldehyde dehydrogenase, mitochondrial 
 UniRef90_P08670 53.7 99.1 36 11 Vimentin 
 UniRef90_P10809 56.5 99.2 25 11 60 kDa heat shock protein, mitochondrial 
 UniRef90_P27797 48.2 99.0 18 6 Calreticulin 
 UniRef90_P78371 57.5 99.2 31 13 T-complex protein 1 subunit beta 
 UniRef90_Q14568 38.1 99.0 25 5 Putative heat shock protein HSP 90-alpha A2 
 UniRef90_Q71U36 50.1 97.3 10 2 Tubulin alpha-1A chain 
E09 UniRef90_F8VPV9 56.9 99.0 15 5 ATP synthase subunit beta 
 UniRef90_G3GVX1 216.7 96.4 2 2 Ribosome-binding protein 1 
 UniRef90_G3HC84 47.8 99.1 21 5 Heat shock protein HSP 90-beta 
 UniRef90_G3HEZ0 65.8 99.1 20 8 Stress-70 protein, mitochondrial 
 UniRef90_G3HFQ4 33.2 98.4 13 3 Dihydrolipoyllysine-residue succinyltransferase 
component of 2-oxoglutarate dehydrogenase 
complex, mitochondrial 
 UniRef90_G3HN14 237.6 98.9 3 5 Transitional endoplasmic reticulum ATPase 
 UniRef90_G3HQI8 229.3 98.3 2 4 Myosin-Vb 
 UniRef90_G3HZH3 32.5 98.9 21 2 Spliceosome RNA helicase BAT1 
 UniRef90_G3HZY1 57.2 99.2 25 14 RuvB-like 2 
 UniRef90_G3I6E6 32.0 98.7 17 4 Actin, cytoplasmic 2 
 UniRef90_P00505 47.4 95.9 6 2 Aspartate aminotransferase, mitochondrial 
 UniRef90_P08670 53.7 99.2 38 12 Vimentin 
 UniRef90_P10809 56.5 98.3 10 3 60 kDa heat shock protein, mitochondrial 
 UniRef90_P14625 92.6 99.1 20 16 Endoplasmin 
 UniRef90_P51855 52.2 97.5 8 2 Glutathione synthetase 
 UniRef90_P60709 41.7 98.9 16 5 Actin, cytoplasmic 1 
 UniRef90_Q14568 38.1 99.1 29 8 Putative heat shock protein HSP 90-alpha A2 
 UniRef90_Q14697 107.0 99.1 14 9 Neutral alpha-glucosidase AB 
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 UniRef90_Q3V3R1 105.4 99.1 12 7 Monofunctional C1-tetrahydrofolate synthase, 
mitochondrial 
 UniRef90_Q8CGK3 95.0 99.1 19 11 Lon protease homolog, mitochondrial 
 UniRef90_Q8VDL4 53.9 99.0 13 5 ADP-dependent glucokinase 
 UniRef90_Q9DB77 48.3 98.7 11 4 Cytochrome b-c1 complex subunit 2, 
mitochondrial 
 UniRef90_Q9GZL7 47.6 97.6 8 3 Ribosome biogenesis protein WDR12 
 UniRef90_Q9Y5S9 19.5 98.2 15 3 RNA-binding protein 8A 
 UniRef90_Q9Z1N5 32.5 98.9 21 2 Spliceosome RNA helicase Ddx39b 
E10 UniRef90_B9A067 79.3 99.0 10 6 Mitochondrial inner membrane protein 
 UniRef90_G3H584 28.2 98.8 16 4 SPARC 
 UniRef90_G3HEZ0 65.8 99.1 26 14 Stress-70 protein, mitochondrial 
 UniRef90_G3HNJ3 51.8 98.4 12 4 Clusterin 
 UniRef90_G3I6E6 32.0 98.7 17 4 Actin, cytoplasmic 2 
 UniRef90_G3ILN5 34.4 98.2 14 3 Reticulocalbin-3 
 UniRef90_P02545-2 64.0 99.1 24 12 Isoform C of Prelamin-A/C 
 UniRef90_P08670 53.7 99.2 51 23 Vimentin 
 UniRef90_P14625 92.6 99.2 17 13 Endoplasmin 
 UniRef90_P17987 60.3 99.1 23 8 T-complex protein 1 subunit alpha 
 UniRef90_P49411 49.6 99.2 35 12 Elongation factor Tu, mitochondrial 
 UniRef90_P60709 41.7 98.7 19 4 Actin, cytoplasmic 1 
 UniRef90_Q14697 107.0 98.7 9 4 Neutral alpha-glucosidase AB 
 UniRef90_Q61112 41.2 97.6 8 3 45 kDa calcium-binding protein 
 UniRef90_Q91W90 46.4 99.1 34 12 Thioredoxin domain-containing protein 5 
E11 UniRef90_F8VPV9 56.9 98.9 10 5 ATP synthase subunit beta 
 UniRef90_G3GVX1 216.7 98.8 6 4 Ribosome-binding protein 1 
 UniRef90_G3H0U6 50.1 98.7 13 4 Protein disulfide-isomerase A3 
 UniRef90_G3HC84 47.8 98.4 10 3 Heat shock protein HSP 90-beta 
 UniRef90_G3HN14 237.6 98.9 4 4 Transitional endoplasmic reticulum ATPase 
 UniRef90_G3HR08 50.3 99.1 29 10 Cytosol aminopeptidase 
 UniRef90_G3IG44 41.9 96.7 13 3 Tubulin beta-2C chain 
 UniRef90_O43175 56.6 98.1 8 3 D-3-phosphoglycerate dehydrogenase 
 UniRef90_P02545-2 64.0 99.2 29 10 Isoform C of Prelamin-A/C 
 UniRef90_P04350 49.6 96.7 11 3 Tubulin beta-4A chain 
 UniRef90_P08670 53.7 99.2 51 22 Vimentin 
 UniRef90_P10809 56.5 99.0 12 5 60 kDa heat shock protein, mitochondrial 
 UniRef90_P20108 28.1 96.9 15 2 Thioredoxin-dependent peroxide reductase, 
mitochondrial 
 UniRef90_P27797 48.2 97.9 9 3 Calreticulin 
 UniRef90_P78371 57.5 99.2 25 10 T-complex protein 1 subunit beta 
 UniRef90_Q13509 49.7 96.7 14 3 Tubulin beta-3 chain 
 UniRef90_Q14568 38.1 97.3 22 3 Putative heat shock protein HSP 90-alpha A2 
 UniRef90_Q8K3J1 23.1 92.8 14 2 NADH dehydrogenase [ubiquinone] iron-sulfur 
protein 8, mitochondrial 
E12 UniRef90_F8VPV9 56.9 98.9 15 4 ATP synthase subunit beta 
 UniRef90_G3H0U6 50.1 99.1 21 8 Protein disulfide-isomerase A3 
 UniRef90_G3HC84 47.8 99.1 21 7 Heat shock protein HSP 90-beta 
 UniRef90_G3HFQ4 33.2 99.0 19 5 Dihydrolipoyllysine-residue succinyltransferase 
component of 2-oxoglutarate dehydrogenase 
complex, mitochondrial 
 UniRef90_G3HPK0 56.3 98.2 8 3 Hydroxysteroid dehydrogenase-like protein 2 
 UniRef90_G3I6E6 32.0 98.3 13 3 Actin, cytoplasmic 2 
 UniRef90_P02545-2 64.0 98.4 8 3 Isoform C of Prelamin-A/C 
 UniRef90_P08670 53.7 99.2 46 15 Vimentin 
 UniRef90_P10809 56.5 99.0 15 5 60 kDa heat shock protein, mitochondrial 
 UniRef90_P31040 71.7 99.1 13 6 Succinate dehydrogenase [ubiquinone] 
flavoprotein subunit, mitochondrial 
 UniRef90_P35232 29.8 99.0 23 6 Prohibitin 
 UniRef90_P49411 49.6 98.8 15 5 Elongation factor Tu, mitochondrial 
 UniRef90_P55302 41.2 99.1 27 10 Alpha-2-macroglobulin receptor-associated 
protein 
 UniRef90_P60709 41.7 98.2 8 3 Actin, cytoplasmic 1 
 UniRef90_Q14568 38.1 99.0 18 5 Putative heat shock protein HSP 90-alpha A2 
 UniRef90_Q7TP98 12.8 96.2 37 3 Interleukin enhancer-binding factor 2 
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 UniRef90_Q9UQ80 43.7 98.5 10 4 Proliferation-associated protein 2G4 
 UniRef90_Q9Z0X1 66.8 99.0 12 5 Apoptosis-inducing factor 1, mitochondrial 
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F01 UniRef90_G3HEZ0 65.8 99.1 18 9 Stress-70 protein, mitochondrial 
 UniRef90_G3HNG2 49.8 93.9 9 3 Acyl-coenzyme A thioesterase 2, mitochondrial 
 UniRef90_G3HNG5 50.4 93.9 9 3 Acyl-coenzyme A thioesterase 1 
 UniRef90_G3I1P6 33.3 98.5 20 4 Nucleosome-binding protein 1 
 UniRef90_G3I6E6 32.0 98.8 23 4 Actin, cytoplasmic 2 
 UniRef90_G3ILN5 34.4 99.0 19 6 Reticulocalbin-3 
 UniRef90_P02545-2 64.0 99.0 18 7 Isoform C of Prelamin-A/C 
 UniRef90_P05091 45.9 99.2 27 11 Aldehyde dehydrogenase, mitochondrial 
 UniRef90_P08670 53.7 99.2 42 13 Vimentin 
 UniRef90_P28331 79.8 99.2 27 16 NADH-ubiquinone oxidoreductase 75 kDa 
subunit, mitochondrial 
 UniRef90_P31040 71.7 99.1 18 10 Succinate dehydrogenase [ubiquinone] 
flavoprotein subunit, mitochondrial 
 UniRef90_P34897 55.9 98.7 10 4 Serine hydroxymethyltransferase, mitochondrial 
 UniRef90_P49411 50.0 99.1 18 7 Elongation factor Tu, mitochondrial 
 UniRef90_P60709 41.7 98.8 18 4 Actin, cytoplasmic 1 
 UniRef90_Q16576 47.0 99.0 14 7 Histone-binding protein RBBP7 
 UniRef90_Q61576 64.7 99.1 19 7 Peptidyl-prolyl cis-trans isomerase FKBP10 
 UniRef90_Q9Z0X1 66.8 98.7 12 4 Apoptosis-inducing factor 1, mitochondrial 
F02 UniRef90_B9A067 79.3 99.2 28 15 Mitochondrial inner membrane protein 
 UniRef90_G3H0U6 50.1 99.2 41 16 Protein disulfide-isomerase A3 
 UniRef90_G3I129 48.7 98.3 9 3 Ubiquitin 
 UniRef90_P02545-2 64.0 99.2 43 19 Isoform C of Prelamin-A/C 
 UniRef90_P05091 45.9 99.2 41 14 Aldehyde dehydrogenase, mitochondrial 
 UniRef90_P08670 53.7 99.2 53 19 Vimentin 
 UniRef90_P0CG83 17.3 98.3 25 3 Polyubiquitin (Fragment) 
 UniRef90_P10809 56.5 99.1 19 7 60 kDa heat shock protein, mitochondrial 
 UniRef90_P14625 92.6 99.2 14 9 Endoplasmin 
 UniRef90_P28331 79.8 98.7 7 4 NADH-ubiquinone oxidoreductase 75 kDa 
subunit, mitochondrial 
 UniRef90_P31040 71.7 99.2 28 12 Succinate dehydrogenase [ubiquinone] 
flavoprotein subunit, mitochondrial 
 UniRef90_P34897 55.9 98.9 18 4 Serine hydroxymethyltransferase, mitochondrial 
 UniRef90_P55302 41.2 99.1 29 8 Alpha-2-macroglobulin receptor-associated 
protein 
 UniRef90_Q13148 21.8 98.2 20 3 TAR DNA-binding protein 43 
 UniRef90_Q16822 70.8 98.9 14 5 Phosphoenolpyruvate carboxykinase [GTP], 
mitochondrial 
 UniRef90_Q9Z0X1 66.8 96.1 13 2 Apoptosis-inducing factor 1, mitochondrial 
F03 UniRef90_F8VPV9 56.9 99.2 22 10 ATP synthase subunit beta 
 UniRef90_G3GT05 22.2 98.1 21 3 T-complex protein 1 subunit theta 
 UniRef90_G3HNG2 49.8 98.9 14 3 Acyl-coenzyme A thioesterase 2, mitochondrial 
 UniRef90_G3HNG5 50.4 98.9 14 3 Acyl-coenzyme A thioesterase 1 
 UniRef90_G3HNJ3 51.8 94.0 8 2 Clusterin 
 UniRef90_G3HR08 50.3 99.1 17 7 Cytosol aminopeptidase 
 UniRef90_G3HZY1 57.2 98.7 8 4 RuvB-like 2 
 UniRef90_G3I129 48.7 98.3 8 3 Ubiquitin 
 UniRef90_G3IAS8 185.7 98.9 4 5 Kinesin-like protein KIF27 
 UniRef90_G3IE04 53.4 99.0 12 5 Pre-mRNA-processing factor 19 
 UniRef90_O43402 23.5 98.2 13 3 ER membrane protein complex subunit 8 
 UniRef90_P08670 53.7 99.2 41 16 Vimentin 
 UniRef90_P0CG83 17.3 98.3 22 3 Polyubiquitin (Fragment) 
 UniRef90_P10809 56.5 99.1 21 9 60 kDa heat shock protein, mitochondrial 
 UniRef90_P20108 28.1 98.9 19 5 Thioredoxin-dependent peroxide reductase, 
mitochondrial 
 UniRef90_P62873 37.4 99.0 23 6 Guanine nucleotide-binding protein 
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G(I)/G(S)/G(T) subunit beta-1 
F04 UniRef90_F8VPV9 56.9 99.2 38 14 ATP synthase subunit beta 
 UniRef90_G3H0U6 50.1 99.1 48 15 Protein disulfide-isomerase A3 
 UniRef90_G3HB04 28.4 98.7 23 4 Protein disulfide-isomerase A6 
 UniRef90_G3HNJ3 51.8 98.0 10 3 Clusterin 
 UniRef90_P02545-2 64.0 99.2 51 21 Isoform C of Prelamin-A/C 
 UniRef90_P07910 33.7 99.2 40 9 Heterogeneous nuclear ribonucleoproteins C1/C2 
 UniRef90_P08670 53.7 99.2 61 22 Vimentin 
 UniRef90_P14625 92.6 99.2 28 19 Endoplasmin 
 UniRef90_P27797 48.2 99.2 32 12 Calreticulin 
 UniRef90_P34897 55.9 98.6 8 3 Serine hydroxymethyltransferase, mitochondrial 
 UniRef90_Q16576 47.0 99.1 13 6 Histone-binding protein RBBP7 
 UniRef90_Q71U36 50.1 99.0 20 2 Tubulin alpha-1A chain 
F05 UniRef90_B9A067 79.3 99.1 16 10 Mitochondrial inner membrane protein 
 UniRef90_F8VPV9 56.9 99.1 20 6 ATP synthase subunit beta 
 UniRef90_G3GTF9 18.9 99.1 59 9 ATP synthase subunit d, mitochondrial 
 UniRef90_G3H0U6 50.1 98.9 16 4 Protein disulfide-isomerase A3 
 UniRef90_G3HEZ0 65.8 99.1 22 7 Stress-70 protein, mitochondrial 
 UniRef90_G3IAS8 185.7 99.1 7 6 Kinesin-like protein KIF27 
 UniRef90_P00505 47.4 96.1 11 2 Aspartate aminotransferase, mitochondrial 
 UniRef90_P02545-2 64.0 98.8 4 4 Isoform C of Prelamin-A/C 
 UniRef90_P08670 53.7 99.2 58 22 Vimentin 
 UniRef90_P10809 56.5 99.1 24 8 60 kDa heat shock protein, mitochondrial 
 UniRef90_P14625 92.6 99.2 23 15 Endoplasmin 
 UniRef90_P27797 48.2 98.5 19 3 Calreticulin 
 UniRef90_P28331 79.8 99.2 39 21 NADH-ubiquinone oxidoreductase 75 kDa 
subunit, mitochondrial 
 UniRef90_P32119 21.8 98.2 17 3 Peroxiredoxin-2 
 UniRef90_P55302 41.2 99.1 36 11 Alpha-2-macroglobulin receptor-associated 
protein 
 UniRef90_Q14697 107.0 98.9 9 4 Neutral alpha-glucosidase AB 
 UniRef90_Q16576 47.0 98.2 6 3 Histone-binding protein RBBP7 
 UniRef90_Q3V3R1 105.4 99.1 15 10 Monofunctional C1-tetrahydrofolate synthase, 
mitochondrial 
 UniRef90_Q61576 64.7 98.8 18 4 Peptidyl-prolyl cis-trans isomerase FKBP10 
 UniRef90_Q99798 85.5 99.1 12 7 Aconitate hydratase, mitochondrial 
F06 UniRef90_F8VPV9 56.9 99.2 29 12 ATP synthase subunit beta 
 UniRef90_G1SLD5 111.5 99.2 35 24 Hypoxia up-regulated protein 1 
 UniRef90_G3HHK0 35.4 99.0 23 5 28S ribosomal protein S31, mitochondrial 
 UniRef90_G3HR08 50.3 99.1 26 7 Cytosol aminopeptidase 
 UniRef90_G3I6E6 32.0 99.0 34 5 Actin, cytoplasmic 2 
 UniRef90_G3IE04 53.4 99.1 25 7 Pre-mRNA-processing factor 19 
 UniRef90_P02545-2 64.0 99.2 43 15 Isoform C of Prelamin-A/C 
 UniRef90_P07910 33.7 99.1 47 9 Heterogeneous nuclear ribonucleoproteins C1/C2 
 UniRef90_P08670 53.7 99.2 54 23 Vimentin 
 UniRef90_P14625 92.6 99.1 23 12 Endoplasmin 
 UniRef90_P31040 71.7 99.2 25 11 Succinate dehydrogenase [ubiquinone] 
flavoprotein subunit, mitochondrial 
 UniRef90_P50213 39.7 99.0 15 5 Isocitrate dehydrogenase [NAD] subunit alpha, 
mitochondrial 
 UniRef90_P60709 41.7 99.0 30 5 Actin, cytoplasmic 1 
 UniRef90_Q13509 49.7 99.0 24 6 Tubulin beta-3 chain 
 UniRef90_Q14697 107.0 99.1 18 11 Neutral alpha-glucosidase AB 
 UniRef90_Q16822 70.8 99.0 13 4 Phosphoenolpyruvate carboxykinase [GTP], 
mitochondrial 
 UniRef90_Q3V3R1 105.4 99.2 18 12 Monofunctional C1-tetrahydrofolate synthase, 
mitochondrial 
F07 UniRef90_B9A067 79.3 99.2 41 25 Mitochondrial inner membrane protein 
 UniRef90_F8VPV9 56.9 99.2 26 11 ATP synthase subunit beta 
 UniRef90_G3ILN5 34.4 99.0 19 6 Reticulocalbin-3 
 UniRef90_H0X554 30.1 99.1 30 6 NADH dehydrogenase [ubiquinone] iron-sulfur 
protein 3, mitochondrial 
 UniRef90_P02545-2 64.0 99.2 40 15 Isoform C of Prelamin-A/C 
 UniRef90_P05091 46.0 99.2 38 13 Aldehyde dehydrogenase, mitochondrial 
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 UniRef90_P08670 53.7 98.8 14 3 Vimentin 
 UniRef90_P09622 54.1 97.4 8 2 Dihydrolipoyl dehydrogenase, mitochondrial 
 UniRef90_P14625 92.6 99.2 24 17 Endoplasmin 
 UniRef90_P34897 55.9 99.0 16 5 Serine hydroxymethyltransferase, mitochondrial 
 UniRef90_Q14697 107.0 99.1 15 10 Neutral alpha-glucosidase AB 
 UniRef90_Q3V3R1 105.4 99.2 20 13 Monofunctional C1-tetrahydrofolate synthase, 
mitochondrial 
 UniRef90_Q71U36 50.1 99.0 14 3 Tubulin alpha-1A chain 
 UniRef90_Q8BKZ9 54.2 99.0 12 5 Pyruvate dehydrogenase protein X component, 
mitochondrial 
 UniRef90_Q8CGK3 95.0 98.7 7 3 Lon protease homolog, mitochondrial 
 UniRef90_Q8K0D5 83.3 99.2 17 8 Elongation factor G, mitochondrial 
 UniRef90_Q99798 85.5 99.2 19 13 Aconitate hydratase, mitochondrial 
 UniRef90_Q9CQN1 80.3 98.7 9 3 Heat shock protein 75 kDa, mitochondrial 
 UniRef90_Q9Y265 50.2 99.0 19 6 RuvB-like 1 
F08 UniRef90_B9A067 79.3 99.2 33 18 Mitochondrial inner membrane protein 
 UniRef90_G3HEZ0 65.8 99.1 29 8 Stress-70 protein, mitochondrial 
 UniRef90_G3HF59 25.4 98.3 17 3 DNA-directed RNA polymerases I, II, and III 
subunit RPABC1 
 UniRef90_G3HHK0 35.4 99.1 31 6 28S ribosomal protein S31, mitochondrial 
 UniRef90_G3HW13 45.7 95.9 9 2 Torsin-3A 
 UniRef90_G3ILN5 34.4 99.0 25 6 Reticulocalbin-3 
 UniRef90_P02545-2 64.0 99.1 26 8 Isoform C of Prelamin-A/C 
 UniRef90_P05091 45.9 99.2 34 11 Aldehyde dehydrogenase, mitochondrial 
 UniRef90_P08670 53.7 99.2 41 13 Vimentin 
 UniRef90_P14625 92.6 99.1 24 12 Endoplasmin 
 UniRef90_P28331 79.8 99.2 42 22 NADH-ubiquinone oxidoreductase 75 kDa 
subunit, mitochondrial 
 UniRef90_P50213 39.7 98.9 13 4 Isocitrate dehydrogenase [NAD] subunit alpha, 
mitochondrial 
 UniRef90_P55302 41.2 99.1 32 8 Alpha-2-macroglobulin receptor-associated 
protein 
 UniRef90_Q61576 64.7 99.1 23 8 Peptidyl-prolyl cis-trans isomerase FKBP10 
 UniRef90_Q99798 85.5 99.2 25 12 Aconitate hydratase, mitochondrial 
F09 UniRef90_F7G3R3 45.2 98.0 11 3 Heterogeneous nuclear ribonucleoprotein H 
(Fragment) 
 UniRef90_F8VPV9 56.9 99.2 28 11 ATP synthase subunit beta 
 UniRef90_G3H0U6 50.1 99.1 23 6 Protein disulfide-isomerase A3 
 UniRef90_G3HFQ4 33.2 99.0 22 5 Dihydrolipoyllysine-residue succinyltransferase 
component of 2-oxoglutarate dehydrogenase 
complex, mitochondrial 
 UniRef90_G3HZY1 57.2 99.2 28 11 RuvB-like 2 
 UniRef90_G3ILN5 34.4 98.0 9 3 Reticulocalbin-3 
 UniRef90_O43681 38.8 99.0 25 5 ATPase ASNA1 
 UniRef90_P02545-2 64.0 99.2 50 23 Isoform C of Prelamin-A/C 
 UniRef90_P05091 45.9 99.2 45 14 Aldehyde dehydrogenase, mitochondrial 
 UniRef90_P07910 33.7 99.1 40 7 Heterogeneous nuclear ribonucleoproteins C1/C2 
 UniRef90_P08670 53.7 99.2 47 18 Vimentin 
 UniRef90_P10809 56.5 99.0 16 6 60 kDa heat shock protein, mitochondrial 
 UniRef90_P14625 92.6 99.2 33 25 Endoplasmin 
 UniRef90_P28331 79.8 98.4 9 3 NADH-ubiquinone oxidoreductase 75 kDa 
subunit, mitochondrial 
 UniRef90_P34897 55.9 99.1 24 8 Serine hydroxymethyltransferase, mitochondrial 
 UniRef90_P50213 39.7 99.1 29 10 Isocitrate dehydrogenase [NAD] subunit alpha, 
mitochondrial 
 UniRef90_Q16576 47.0 99.2 26 10 Histone-binding protein RBBP7 
 UniRef90_Q8BKZ9 54.2 98.4 9 3 Pyruvate dehydrogenase protein X component, 
mitochondrial 
F10 UniRef90_F8VPV9 56.9 98.3 7 3 ATP synthase subunit beta 
 UniRef90_G3GTF9 18.9 99.1 40 8 ATP synthase subunit d, mitochondrial 
 UniRef90_G3H5Z5 59.0 98.8 13 4 Cleavage stimulation factor 64 kDa subunit 
 UniRef90_G3HQI8 229.3 99.0 5 6 Myosin-Vb 
 UniRef90_G3IE04 53.4 99.1 15 7 Pre-mRNA-processing factor 19 
 UniRef90_H0X554 30.1 99.2 56 11 NADH dehydrogenase [ubiquinone] iron-sulfur 
 127 
 
protein 3, mitochondrial 
 UniRef90_O43175 56.6 99.1 16 8 D-3-phosphoglycerate dehydrogenase 
 UniRef90_P00505 47.4 98.5 9 3 Aspartate aminotransferase, mitochondrial 
 UniRef90_P02545-2 64.0 99.2 52 26 Isoform C of Prelamin-A/C 
 UniRef90_P11021 72.4 98.3 7 3 78 kDa glucose-regulated protein 
 UniRef90_P20108 28.1 99.1 24 6 Thioredoxin-dependent peroxide reductase, 
mitochondrial 
 UniRef90_P28331 79.8 99.2 38 18 NADH-ubiquinone oxidoreductase 75 kDa 
subunit, mitochondrial 
 UniRef90_P31040 71.7 98.7 12 4 Succinate dehydrogenase [ubiquinone] 
flavoprotein subunit, mitochondrial 
 UniRef90_P55302 41.2 99.1 28 8 Alpha-2-macroglobulin receptor-associated 
protein 
 UniRef90_P60709 41.7 99.0 21 5 Actin, cytoplasmic 1 
 UniRef90_Q61576 64.7 98.5 15 3 Peptidyl-prolyl cis-trans isomerase FKBP10 
 UniRef90_Q91W90 46.4 99.1 34 8 Thioredoxin domain-containing protein 5 
 UniRef90_Q9DB77 48.3 98.4 16 3 Cytochrome b-c1 complex subunit 2, 
mitochondrial 
F11 UniRef90_B9A067 79.3 99.2 23 10 Mitochondrial inner membrane protein 
 UniRef90_G3GTF9 18.9 98.9 48 6 ATP synthase subunit d, mitochondrial 
 UniRef90_P02545-2 64.0 99.1 16 7 Isoform C of Prelamin-A/C 
 UniRef90_P05091 45.9 99.2 43 14 Aldehyde dehydrogenase, mitochondrial 
 UniRef90_P08670 53.7 99.2 31 8 Vimentin 
 UniRef90_P32119 21.8 98.1 18 3 Peroxiredoxin-2 
 UniRef90_P49411 49.6 99.1 31 7 Elongation factor Tu, mitochondrial 
 UniRef90_P50213 39.7 99.2 29 10 Isocitrate dehydrogenase [NAD] subunit alpha, 
mitochondrial 
 UniRef90_P62873 37.4 99.1 33 6 Guanine nucleotide-binding protein 
G(I)/G(S)/G(T) subunit beta-1 
 UniRef90_Q8K0D5 83.3 98.3 7 3 Elongation factor G, mitochondrial 
 UniRef90_Q99798 85.5 99.1 22 13 Aconitate hydratase, mitochondrial 
F12 UniRef90_G3GRH9 39.4 98.1 9 3 Tropomodulin-3 
 UniRef90_G3HNG2 49.8 99.2 27 8 Acyl-coenzyme A thioesterase 2, mitochondrial 
 UniRef90_G3ILN5 34.4 99.0 19 6 Reticulocalbin-3 
 UniRef90_P02545-2 64.0 99.2 46 22 Isoform C of Prelamin-A/C 
 UniRef90_P07910 33.7 99.2 36 6 Heterogeneous nuclear ribonucleoproteins C1/C2 
 UniRef90_P08670 53.7 99.2 36 14 Vimentin 
 UniRef90_P14625 92.6 99.2 22 12 Endoplasmin 
 UniRef90_P31040 71.7 99.1 18 7 Succinate dehydrogenase [ubiquinone] 
flavoprotein subunit, mitochondrial 
 UniRef90_P55302 41.2 99.1 21 6 Alpha-2-macroglobulin receptor-associated 
protein 
 UniRef90_P60709 41.7 99.0 32 5 Actin, cytoplasmic 1 
 UniRef90_Q16576 47.0 98.6 9 3 Histone-binding protein RBBP7 
 UniRef90_Q91W90 46.4 99.1 32 6 Thioredoxin domain-containing protein 5 
 UniRef90_Q9Z0X1 66.8 99.0 13 5 Apoptosis-inducing factor 1, mitochondrial 
 
Row G Cluster ID 
MW 
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G01 UniRef90_A6QR15 30.7 99.1 34 7 Tropomyosin beta chain 
 UniRef90_G3HB04 28.4 99.0 35 5 Protein disulfide-isomerase A6 
 UniRef90_G3HKP3 40.6 99.1 31 10 Cytochrome b-c1 complex subunit 1, 
mitochondrial 
 UniRef90_P02545-2 64.0 99.2 51 24 Isoform C of Prelamin-A/C 
 UniRef90_P06733 46.7 99.1 35 10 Alpha-enolase 
 UniRef90_P07910 33.7 99.2 46 8 Heterogeneous nuclear ribonucleoproteins C1/C2 
 UniRef90_P55302 41.2 99.0 29 5 Alpha-2-macroglobulin receptor-associated 
protein 
 UniRef90_P60709 41.7 99.2 51 9 Actin, cytoplasmic 1 
 UniRef90_P81117 50.3 98.3 11 3 Nucleobindin-2 
G02 UniRef90_F8VPV9 56.9 98.4 10 3 ATP synthase subunit beta 
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 UniRef90_G3H0U6 50.1 99.2 52 19 Protein disulfide-isomerase A3 
 UniRef90_G3H1B3 55.0 99.2 46 14 Lamin-L(I) 
 UniRef90_G3HB04 28.4 99.1 33 6 Protein disulfide-isomerase A6 
 UniRef90_G3HFQ4 33.2 99.1 26 7 Dihydrolipoyllysine-residue succinyltransferase 
component of 2-oxoglutarate dehydrogenase 
complex, mitochondrial 
 UniRef90_G3HKP3 40.6 99.1 20 5 Cytochrome b-c1 complex subunit 1, 
mitochondrial 
 UniRef90_G3HNG2 49.8 98.3 10 3 Acyl-coenzyme A thioesterase 2, mitochondrial 
 UniRef90_P02545-2 64.0 99.2 53 21 Isoform C of Prelamin-A/C 
 UniRef90_P08670 53.7 99.2 67 26 Vimentin 
 UniRef90_P11021 72.4 94.5 7 2 78 kDa glucose-regulated protein 
 UniRef90_P49411 49.6 99.1 28 9 Elongation factor Tu, mitochondrial 
 UniRef90_P81117 50.3 94.9 10 2 Nucleobindin-2 
 UniRef90_Q16576 47.0 98.9 12 5 Histone-binding protein RBBP7 
 UniRef90_Q9Z1N5 48.7 97.8 8 3 Spliceosome RNA helicase Ddx39b 
G03 UniRef90_A6QR15 30.7 99.1 43 8 Tropomyosin beta chain 
 UniRef90_F8VPV9 56.9 98.8 13 4 ATP synthase subunit beta 
 UniRef90_G3H4E2 32.0 98.2 14 3 tRNA modification GTPase GTPBP3, 
mitochondrial 
 UniRef90_G3HE28 40.1 98.2 8 3 Mitochondrial-processing peptidase subunit beta 
 UniRef90_G3HFQ4 33.2 98.3 13 3 Dihydrolipoyllysine-residue succinyltransferase 
component of 2-oxoglutarate dehydrogenase 
complex, mitochondrial 
 UniRef90_P02545-2 64.0 99.2 60 30 Isoform C of Prelamin-A/C 
 UniRef90_P05091 45.9 99.1 30 8 Aldehyde dehydrogenase, mitochondrial 
 UniRef90_P08670 53.7 99.2 58 21 Vimentin 
 UniRef90_P14625 92.6 99.1 20 11 Endoplasmin 
 UniRef90_P50213 39.7 99.2 23 9 Isocitrate dehydrogenase [NAD] subunit alpha, 
mitochondrial 
 UniRef90_P60709 41.7 99.1 34 3 Actin, cytoplasmic 1 
 UniRef90_P62873 37.4 99.1 27 7 Guanine nucleotide-binding protein 
G(I)/G(S)/G(T) subunit beta-1 
G04 UniRef90_G3H0U6 50.1 99.2 42 16 Protein disulfide-isomerase A3 
 UniRef90_G3H1B3 55.0 98.8 10 3 Lamin-L(I) 
 UniRef90_G3HEZ0 65.8 99.2 55 26 Stress-70 protein, mitochondrial 
 UniRef90_G3HFQ4 33.2 99.1 26 7 Dihydrolipoyllysine-residue succinyltransferase 
component of 2-oxoglutarate dehydrogenase 
complex, mitochondrial 
 UniRef90_G3HKP3 40.6 99.2 31 12 Cytochrome b-c1 complex subunit 1, 
mitochondrial 
 UniRef90_G3HR08 50.3 96.6 9 2 Cytosol aminopeptidase 
 UniRef90_G3HSM8 67.7 99.2 52 25 Lamin-B2 
 UniRef90_G3HZY1 57.2 98.3 11 3 RuvB-like 2 
 UniRef90_G3IDL7 22.7 99.0 33 2 Heat shock cognate 71 kDa protein 
 UniRef90_O95302 63.0 99.1 20 9 Peptidyl-prolyl cis-trans isomerase FKBP9 
 UniRef90_P02545-2 64.0 99.2 60 28 Isoform C of Prelamin-A/C 
 UniRef90_P02794 21.5 99.1 39 6 Ferritin heavy chain 
 UniRef90_P05091 45.9 99.2 41 13 Aldehyde dehydrogenase, mitochondrial 
 UniRef90_P06733 46.7 99.2 41 10 Alpha-enolase 
 UniRef90_P07910 33.7 99.2 46 14 Heterogeneous nuclear ribonucleoproteins C1/C2 
 UniRef90_P08003 72.6 99.2 37 14 Protein disulfide-isomerase A4 
 UniRef90_P09622 54.1 98.2 9 3 Dihydrolipoyl dehydrogenase, mitochondrial 
 UniRef90_P11021 72.4 99.2 43 21 78 kDa glucose-regulated protein 
 UniRef90_P28331 79.8 99.1 14 7 NADH-ubiquinone oxidoreductase 75 kDa 
subunit, mitochondrial 
 UniRef90_P34897 55.9 99.0 11 6 Serine hydroxymethyltransferase, mitochondrial 
 UniRef90_P50213 39.7 99.2 30 10 Isocitrate dehydrogenase [NAD] subunit alpha, 
mitochondrial 
 UniRef90_P78371 57.5 98.4 18 3 T-complex protein 1 subunit beta 
 UniRef90_Q9CQN1 80.3 99.2 28 14 Heat shock protein 75 kDa, mitochondrial 
G05 UniRef90_G3GS40 38.8 99.0 28 5 Succinyl-CoA ligase [GDP-forming] subunit 
beta, mitochondrial 
 UniRef90_G3H1B3 55.0 99.2 43 17 Lamin-L(I) 
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 UniRef90_G3H5Z5 59.0 91.5 8 2 Cleavage stimulation factor 64 kDa subunit 
 UniRef90_G3HEZ0 65.8 99.2 38 18 Stress-70 protein, mitochondrial 
 UniRef90_G3HSM8 67.7 99.2 46 20 Lamin-B2 
 UniRef90_G3I1Y9 27.4 98.8 27 4 Sulfated glycoprotein 1 
 UniRef90_O75531 10.1 98.1 43 3 Barrier-to-autointegration factor 
 UniRef90_O95302 63.0 99.1 17 7 Peptidyl-prolyl cis-trans isomerase FKBP9 
 UniRef90_P02545-2 64.0 99.2 48 19 Isoform C of Prelamin-A/C 
 UniRef90_P07910 33.7 92.4 16 2 Heterogeneous nuclear ribonucleoproteins C1/C2 
 UniRef90_P08003 72.6 99.2 30 11 Protein disulfide-isomerase A4 
 UniRef90_P08670 53.7 99.2 64 26 Vimentin 
 UniRef90_P10809 56.5 99.0 15 5 60 kDa heat shock protein, mitochondrial 
 UniRef90_P11021 72.4 99.2 24 8 78 kDa glucose-regulated protein 
 UniRef90_P14625 92.6 99.2 31 25 Endoplasmin 
 UniRef90_P28331 79.8 98.3 8 3 NADH-ubiquinone oxidoreductase 75 kDa 
subunit, mitochondrial 
 UniRef90_P54652 69.7 99.0 12 3 Heat shock-related 70 kDa protein 2 
 UniRef90_Q12874 58.8 98.8 13 4 Splicing factor 3A subunit 3 
 UniRef90_Q71U36 50.1 98.1 15 3 Tubulin alpha-1A chain 
G06 UniRef90_A6QR15 30.7 99.1 30 7 Tropomyosin beta chain 
 UniRef90_G3GS40 38.8 99.2 53 15 Succinyl-CoA ligase [GDP-forming] subunit 
beta, mitochondrial 
 UniRef90_G3HEZ0 65.8 99.2 38 18 Stress-70 protein, mitochondrial 
 UniRef90_G3HKP3 40.6 99.2 44 14 Cytochrome b-c1 complex subunit 1, 
mitochondrial 
 UniRef90_G3HSM8 67.7 99.1 20 5 Lamin-B2 
 UniRef90_G3ILN5 34.4 99.1 25 7 Reticulocalbin-3 
 UniRef90_P02545-2 64.0 99.2 70 36 Isoform C of Prelamin-A/C 
 UniRef90_P05091 45.9 99.1 39 9 Aldehyde dehydrogenase, mitochondrial 
 UniRef90_P08670 53.7 99.0 20 3 Vimentin 
 UniRef90_P09622 54.1 98.7 13 4 Dihydrolipoyl dehydrogenase, mitochondrial 
 UniRef90_P11021 72.4 99.2 26 8 78 kDa glucose-regulated protein 
 UniRef90_P14625 92.6 99.2 28 22 Endoplasmin 
 UniRef90_P34897 55.9 99.0 18 5 Serine hydroxymethyltransferase, mitochondrial 
 UniRef90_Q91W90 46.4 99.1 51 16 Thioredoxin domain-containing protein 5 
 UniRef90_Q9Y265 50.2 98.4 10 3 RuvB-like 1 
G07 UniRef90_F8VPV9 56.9 99.2 38 13 ATP synthase subunit beta 
 UniRef90_G3HEZ0 65.8 99.2 36 15 Stress-70 protein, mitochondrial 
 UniRef90_G3HGS2 96.2 92.7 5 2 Propionyl-CoA carboxylase alpha chain, 
mitochondrial 
 UniRef90_G3HZY1 57.2 98.6 8 4 RuvB-like 2 
 UniRef90_G3ILN5 34.4 98.9 21 6 Reticulocalbin-3 
 UniRef90_P02545-2 64.0 99.0 13 5 Isoform C of Prelamin-A/C 
 UniRef90_P05091 45.9 99.2 32 8 Aldehyde dehydrogenase, mitochondrial 
 UniRef90_P07910 33.7 99.2 41 13 Heterogeneous nuclear ribonucleoproteins C1/C2 
 UniRef90_P08670 53.7 99.2 42 12 Vimentin 
 UniRef90_P09382 14.8 99.0 47 6 Galectin-1 
 UniRef90_P14625 92.6 99.2 35 27 Endoplasmin 
 UniRef90_P20108 28.1 99.1 31 7 Thioredoxin-dependent peroxide reductase, 
mitochondrial 
 UniRef90_P55302 41.2 99.1 30 7 Alpha-2-macroglobulin receptor-associated 
protein 
 UniRef90_P60709 41.7 99.2 35 3 Actin, cytoplasmic 1 
 UniRef90_Q13509 49.7 98.2 8 3 Tubulin beta-3 chain 
 UniRef90_Q16576 47.0 99.2 32 11 Histone-binding protein RBBP7 
 UniRef90_Q9CQN1 80.3 99.2 32 15 Heat shock protein 75 kDa, mitochondrial 
G08 UniRef90_F8VPV9 56.9 99.0 12 5 ATP synthase subunit beta 
 UniRef90_G3HFQ4 33.2 99.1 26 7 Dihydrolipoyllysine-residue succinyltransferase 
component of 2-oxoglutarate dehydrogenase 
complex, mitochondrial 
 UniRef90_G3HKP3 40.6 99.1 22 8 Cytochrome b-c1 complex subunit 1, 
mitochondrial 
 UniRef90_G3HZY1 57.2 99.2 29 11 RuvB-like 2 
 UniRef90_G3IBF1 31.1 98.8 33 4 Nucleophosmin 
 UniRef90_P00505 47.4 98.6 12 3 Aspartate aminotransferase, mitochondrial 
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 UniRef90_P02794 21.5 99.1 43 7 Ferritin heavy chain 
 UniRef90_P07910 33.7 99.2 46 9 Heterogeneous nuclear ribonucleoproteins C1/C2 
 UniRef90_P08670 53.7 99.2 62 24 Vimentin 
 UniRef90_P14625 92.6 99.2 37 29 Endoplasmin 
 UniRef90_P55302 41.2 99.1 46 14 Alpha-2-macroglobulin receptor-associated 
protein 
 UniRef90_Q3V3R1 105.4 98.1 9 3 Monofunctional C1-tetrahydrofolate synthase, 
mitochondrial 
G09 UniRef90_F8VPV9 56.9 99.2 43 16 ATP synthase subunit beta 
 UniRef90_G1SLD5 111.5 99.1 15 8 Hypoxia up-regulated protein 1 
 UniRef90_G3H1B3 55.0 98.2 9 2 Lamin-L(I) 
 UniRef90_G3HNV4 16.4 98.3 30 3 Triosephosphate isomerase 
 UniRef90_G3HZY1 57.2 98.9 11 5 RuvB-like 2 
 UniRef90_G3I6E6 32.0 98.8 19 4 Actin, cytoplasmic 2 
 UniRef90_P02545-2 64.0 98.2 7 2 Isoform C of Prelamin-A/C 
 UniRef90_P05091 45.9 99.1 26 8 Aldehyde dehydrogenase, mitochondrial 
 UniRef90_P08670 53.7 98.5 13 2 Vimentin 
 UniRef90_P14625 92.6 99.1 16 8 Endoplasmin 
 UniRef90_P20108 28.1 99.1 36 7 Thioredoxin-dependent peroxide reductase, 
mitochondrial 
 UniRef90_P50213 39.7 99.1 39 11 Isocitrate dehydrogenase [NAD] subunit alpha, 
mitochondrial 
 UniRef90_P55302 41.2 99.1 33 8 Alpha-2-macroglobulin receptor-associated 
protein 
 UniRef90_P60709 41.7 98.8 14 4 Actin, cytoplasmic 1 
 UniRef90_Q71U36 50.1 99.0 17 2 Tubulin alpha-1A chain 
 UniRef90_Q91W90 46.4 99.2 38 14 Thioredoxin domain-containing protein 5 
G10 UniRef90_F8VPV9 56.9 99.1 20 9 ATP synthase subunit beta 
 UniRef90_G3H1B3 55.0 99.0 12 4 Lamin-L(I) 
 UniRef90_G3HB04 28.4 98.8 21 4 Protein disulfide-isomerase A6 
 UniRef90_G3HE28 40.1 98.1 8 2 Mitochondrial-processing peptidase subunit beta 
 UniRef90_G3HEZ0 65.8 99.1 21 6 Stress-70 protein, mitochondrial 
 UniRef90_G3HFQ4 33.2 98.2 13 3 Dihydrolipoyllysine-residue succinyltransferase 
component of 2-oxoglutarate dehydrogenase 
complex, mitochondrial 
 UniRef90_G3HKP3 40.6 99.1 29 8 Cytochrome b-c1 complex subunit 1, 
mitochondrial 
 UniRef90_G3HRG8 29.7 98.1 19 3 Endoplasmic reticulum resident protein ERp44 
(Fragment) 
 UniRef90_G3HSM8 67.7 99.2 46 21 Lamin-B2 
 UniRef90_G3I6E6 32.0 98.7 17 4 Actin, cytoplasmic 2 
 UniRef90_O95302 63.0 99.0 12 6 Peptidyl-prolyl cis-trans isomerase FKBP9 
 UniRef90_P00505 47.4 98.9 16 4 Aspartate aminotransferase, mitochondrial 
 UniRef90_P02545-2 64.0 99.2 54 23 Isoform C of Prelamin-A/C 
 UniRef90_P06733 46.7 99.2 25 9 Alpha-enolase 
 UniRef90_P07910 33.7 99.2 49 9 Heterogeneous nuclear ribonucleoproteins C1/C2 
 UniRef90_P08003 72.6 98.5 12 4 Protein disulfide-isomerase A4 
 UniRef90_P08670 53.7 99.2 36 10 Vimentin 
 UniRef90_P11021 72.4 99.2 24 12 78 kDa glucose-regulated protein 
 UniRef90_P50213 39.7 97.2 9 3 Isocitrate dehydrogenase [NAD] subunit alpha, 
mitochondrial 
 UniRef90_P55302 41.2 99.1 39 11 Alpha-2-macroglobulin receptor-associated 
protein 
 UniRef90_P60709 41.7 98.7 13 4 Actin, cytoplasmic 1 
 UniRef90_Q16576 47.0 99.1 9 9 Histone-binding protein RBBP7 
 UniRef90_Q8VDL4 53.9 91.1 8 2 ADP-dependent glucokinase 
 UniRef90_Q91W90 46.4 98.1 8 3 Thioredoxin domain-containing protein 5 
 UniRef90_Q9Z1N5 48.7 96.6 8 2 Spliceosome RNA helicase Ddx39b 
G11 UniRef90_B9A067 79.3 99.1 11 8 Mitochondrial inner membrane protein 
 UniRef90_G3H1B3 55.0 98.3 10 2 Lamin-L(I) 
 UniRef90_G3HB04 28.4 99.0 29 5 Protein disulfide-isomerase A6 
 UniRef90_G3HE28 40.1 98.7 15 3 Mitochondrial-processing peptidase subunit beta 
 UniRef90_G3HEZ0 65.8 99.2 32 14 Stress-70 protein, mitochondrial 
 UniRef90_G3HFQ4 33.2 98.8 19 4 Dihydrolipoyllysine-residue succinyltransferase 
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component of 2-oxoglutarate dehydrogenase 
complex, mitochondrial 
 UniRef90_G3HKP3 40.6 99.1 29 10 Cytochrome b-c1 complex subunit 1, 
mitochondrial 
 UniRef90_G3HZY1 57.2 99.1 19 8 RuvB-like 2 
 UniRef90_P02545-2 64.0 99.2 52 29 Isoform C of Prelamin-A/C 
 UniRef90_P06733 46.7 98.7 14 4 Alpha-enolase 
 UniRef90_P07910 33.7 99.1 48 9 Heterogeneous nuclear ribonucleoproteins C1/C2 
 UniRef90_P08670 53.7 99.2 59 22 Vimentin 
 UniRef90_P11021 72.4 99.2 23 11 78 kDa glucose-regulated protein 
 UniRef90_P20108 28.1 99.0 24 6 Thioredoxin-dependent peroxide reductase, 
mitochondrial 
 UniRef90_Q71U36 50.1 99.0 16 2 Tubulin alpha-1A chain 
 UniRef90_Q9CQN1 80.3 98.8 9 4 Heat shock protein 75 kDa, mitochondrial 
G12 UniRef90_B9A067 79.3 99.2 22 14 Mitochondrial inner membrane protein 
 UniRef90_F8VPV9 56.9 99.2 42 15 ATP synthase subunit beta 
 UniRef90_G3HB04 28.4 98.3 16 3 Protein disulfide-isomerase A6 
 UniRef90_G3HKP3 40.6 99.1 31 11 Cytochrome b-c1 complex subunit 1, 
mitochondrial 
 UniRef90_G3HPK0 56.3 98.2 10 3 Hydroxysteroid dehydrogenase-like protein 2 
 UniRef90_G3HSM8 67.7 98.8 13 3 Lamin-B2 
 UniRef90_P02545-2 64.0 99.1 26 9 Isoform C of Prelamin-A/C 
 UniRef90_P06733 46.7 98.6 21 3 Alpha-enolase 
 UniRef90_P08670 53.7 99.2 27 10 Vimentin 
 UniRef90_P09382 14.8 99.1 59 6 Galectin-1 
 UniRef90_P11021 72.4 99.2 21 10 78 kDa glucose-regulated protein 
 UniRef90_P31040 71.7 99.1 21 7 Succinate dehydrogenase [ubiquinone] 
flavoprotein subunit, mitochondrial 
 UniRef90_P49411 49.6 99.2 29 9 Elongation factor Tu, mitochondrial 
 UniRef90_P62873 37.4 99.1 26 4 Guanine nucleotide-binding protein 
G(I)/G(S)/G(T) subunit beta-1 
 UniRef90_Q16576 47.0 99.2 22 8 Histone-binding protein RBBP7 
 UniRef90_Q16822 70.8 98.7 10 4 Phosphoenolpyruvate carboxykinase [GTP], 
mitochondrial 
 UniRef90_Q99798 85.5 98.4 9 4 Aconitate hydratase, mitochondrial 
 
Row H Cluster ID 
MW 
(kDa)* 
Score 
% 
Sequence 
Coverage 
(%) 
# of 
Unique 
Peptides 
Protein Name 
H01 UniRef90_F8VPV9 56.9 99.2 39 16 ATP synthase subunit beta 
 UniRef90_G3GXA9 21.1 99.1 49 10 Protein disulfide-isomerase 
 UniRef90_G3H0U6 50.1 99.2 44 14 Protein disulfide-isomerase A3 
 UniRef90_G3HB04 28.4 99.1 35 5 Protein disulfide-isomerase A6 
 UniRef90_G3HEZ0 65.8 99.2 38 15 Stress-70 protein, mitochondrial 
 UniRef90_G3HSM8 67.7 98.5 17 3 Lamin-B2 
 UniRef90_G3IDL7 22.7 99.1 41 2 Heat shock cognate 71 kDa protein 
 UniRef90_P08670 53.7 99.0 15 5 Vimentin 
 UniRef90_P11021 72.4 99.2 51 24 78 kDa glucose-regulated protein 
 UniRef90_P14625 92.6 99.2 29 22 Endoplasmin 
 UniRef90_P43304 80.7 98.6 8 4 Glycerol-3-phosphate dehydrogenase, 
mitochondrial 
 UniRef90_P60709 41.7 99.2 38 9 Actin, cytoplasmic 1 
 UniRef90_P81117 50.3 93.4 8 2 Nucleobindin-2 
 UniRef90_Q9CQN1 80.3 98.4 7 3 Heat shock protein 75 kDa, mitochondrial 
H02 UniRef90_F8VPV9 56.9 99.2 34 13 ATP synthase subunit beta 
 UniRef90_G3GXA9 21.1 99.1 42 7 Protein disulfide-isomerase 
 UniRef90_G3H0U6 50.1 99.1 34 14 Protein disulfide-isomerase A3 
 UniRef90_G3HB04 28.4 98.2 18 3 Protein disulfide-isomerase A6 
 UniRef90_G3HEZ0 65.8 99.2 54 29 Stress-70 protein, mitochondrial 
 UniRef90_G3HKP3 40.6 99.1 22 8 Cytochrome b-c1 complex subunit 1, 
mitochondrial 
 UniRef90_G3IDL7 22.7 99.0 34 3 Heat shock cognate 71 kDa protein 
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 UniRef90_P02545-2 64.0 99.2 66 37 Isoform C of Prelamin-A/C 
 UniRef90_P06733 46.7 98.9 17 4 Alpha-enolase 
 UniRef90_P08670 53.7 99.2 62 27 Vimentin 
 UniRef90_P10809 56.5 99.1 30 13 60 kDa heat shock protein, mitochondrial 
 UniRef90_P50213 39.7 99.2 28 10 Isocitrate dehydrogenase [NAD] subunit alpha, 
mitochondrial 
 UniRef90_P54652 69.7 99.0 13 2 Heat shock-related 70 kDa protein 2 
 UniRef90_P60709 41.7 99.2 58 6 Actin, cytoplasmic 1 
 UniRef90_Q16576 47.0 99.0 17 6 Histone-binding protein RBBP7 
 UniRef90_Q9CQN1 80.3 99.1 17 6 Heat shock protein 75 kDa, mitochondrial 
H03 UniRef90_F8VPV9 56.9 99.2 46 16 ATP synthase subunit beta 
 UniRef90_G3H0U6 50.1 99.1 37 15 Protein disulfide-isomerase A3 
 UniRef90_G3H1B3 55.0 98.8 16 4 Lamin-L(I) 
 UniRef90_G3H697 62.4 98.8 13 4 Glucosidase 2 subunit beta 
 UniRef90_G3HB04 28.4 99.2 46 8 Protein disulfide-isomerase A6 
 UniRef90_G3HEZ0 65.8 99.2 60 34 Stress-70 protein, mitochondrial 
 UniRef90_G3IDL7 22.7 99.2 50 4 Heat shock cognate 71 kDa protein 
 UniRef90_G3IGQ3 23.1 98.8 27 2 Heat shock cognate 71 kDa protein 
 UniRef90_P08670 53.7 99.2 38 15 Vimentin 
 UniRef90_P10809 56.5 99.2 49 21 60 kDa heat shock protein, mitochondrial 
 UniRef90_P60709 41.7 99.1 29 8 Actin, cytoplasmic 1 
 UniRef90_Q12874 58.8 98.4 14 3 Splicing factor 3A subunit 3 
 UniRef90_Q13509 49.7 99.1 24 6 Tubulin beta-3 chain 
 UniRef90_Q16576 47.0 99.1 22 9 Histone-binding protein RBBP7 
 UniRef90_Q71U36 50.1 98.8 14 2 Tubulin alpha-1A chain 
H04 UniRef90_F8VPV9 56.9 99.2 44 16 ATP synthase subunit beta 
 UniRef90_G3GS40 38.8 96.4 12 2 Succinyl-CoA ligase [GDP-forming] subunit 
beta, mitochondrial 
 UniRef90_G3H697 62.4 99.1 16 8 Glucosidase 2 subunit beta 
 UniRef90_G3HB04 28.4 99.1 35 7 Protein disulfide-isomerase A6 
 UniRef90_G3HEZ0 65.8 99.2 61 32 Stress-70 protein, mitochondrial 
 UniRef90_G3I2N0 42.5 98.2 15 3 Inhibitor of nuclear factor kappa-B kinase-
interacting protein 
 UniRef90_O95302 63.0 95.5 7 2 Peptidyl-prolyl cis-trans isomerase FKBP9 
 UniRef90_P07910 33.7 98.4 17 3 Heterogeneous nuclear ribonucleoproteins C1/C2 
 UniRef90_P08670 53.7 99.2 68 29 Vimentin 
 UniRef90_P11021 72.4 99.2 56 28 78 kDa glucose-regulated protein 
 UniRef90_P35232 29.8 99.2 59 15 Prohibitin 
 UniRef90_P50213 39.7 99.2 32 10 Isocitrate dehydrogenase [NAD] subunit alpha, 
mitochondrial 
 UniRef90_P54652 69.7 99.1 14 2 Heat shock-related 70 kDa protein 2 
 UniRef90_P60709 41.7 99.0 25 5 Actin, cytoplasmic 1 
 UniRef90_Q13509 49.7 98.2 10 3 Tubulin beta-3 chain 
H05 UniRef90_F8VPV9 56.9 98.8 13 4 ATP synthase subunit beta 
 UniRef90_G3H1B3 55.0 99.2 30 9 Lamin-L(I) 
 UniRef90_G3HB04 28.4 99.1 33 5 Protein disulfide-isomerase A6 
 UniRef90_G3HEZ0 65.8 99.2 54 28 Stress-70 protein, mitochondrial 
 UniRef90_G3HRG8 29.7 98.6 33 3 Endoplasmic reticulum resident protein ERp44 
(Fragment) 
 UniRef90_O95302 63.0 99.1 25 10 Peptidyl-prolyl cis-trans isomerase FKBP9 
 UniRef90_P02545-2 64.0 99.2 58 26 Isoform C of Prelamin-A/C 
 UniRef90_P05091 45.9 99.1 23 7 Aldehyde dehydrogenase, mitochondrial 
 UniRef90_P08670 53.7 99.2 64 27 Vimentin 
 UniRef90_P09622 54.1 99.0 14 5 Dihydrolipoyl dehydrogenase, mitochondrial 
 UniRef90_P10809 56.5 99.2 42 17 60 kDa heat shock protein, mitochondrial 
 UniRef90_P11021 72.4 99.2 54 30 78 kDa glucose-regulated protein 
 UniRef90_P14625 92.6 99.2 37 30 Endoplasmin 
 UniRef90_Q12874 58.8 98.5 8 3 Splicing factor 3A subunit 3 
 UniRef90_Q71U36 50.1 98.3 16 3 Tubulin alpha-1A chain 
H06 UniRef90_B9W7J9 11.4 98.3 39 3 Histone H4 
 UniRef90_G3HB04 28.4 99.1 35 7 Protein disulfide-isomerase A6 
 UniRef90_G3HDS1 14.9 98.3 30 3 Histone H4 
 UniRef90_G3HPV6 28.5 98.3 15 3 Histone H2A type 1 
 UniRef90_G3HPV7 21.8 98.3 20 3 Histone H4 
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 UniRef90_G3I1Y9 27.4 99.2 49 8 Sulfated glycoprotein 1 
 UniRef90_G3IBF1 31.1 99.0 30 4 Nucleophosmin 
 UniRef90_P02545-2 64.0 99.2 67 37 Isoform C of Prelamin-A/C 
 UniRef90_P05091 46.0 99.2 43 11 Aldehyde dehydrogenase, mitochondrial 
 UniRef90_P08670 53.7 99.0 20 4 Vimentin 
 UniRef90_P09382 14.8 99.0 36 5 Galectin-1 
 UniRef90_P09622 54.1 99.1 22 7 Dihydrolipoyl dehydrogenase, mitochondrial 
 UniRef90_P10809 56.5 99.2 31 12 60 kDa heat shock protein, mitochondrial 
 UniRef90_P14625 92.6 99.2 38 28 Endoplasmin 
 UniRef90_P27797 48.2 99.2 48 16 Calreticulin 
 UniRef90_P35232 29.8 99.2 59 14 Prohibitin 
 UniRef90_P48643 59.5 98.2 9 3 T-complex protein 1 subunit epsilon 
 UniRef90_P60709 41.7 99.2 55 5 Actin, cytoplasmic 1 
 UniRef90_P62736 49.5 99.1 31 2 Actin, aortic smooth muscle 
 UniRef90_P62805 10.8 98.3 41 3 Histone H4 
 UniRef90_P63267 81.6 99.1 17 2 Actin, gamma-enteric smooth muscle 
 UniRef90_P68032 42.0 99.2 39 2 Actin, alpha cardiac muscle 1 
 UniRef90_Q9CQN1 80.3 99.0 15 5 Heat shock protein 75 kDa, mitochondrial 
H07 UniRef90_F8VPV9 56.9 99.2 37 13 ATP synthase subunit beta 
 UniRef90_G3GS40 38.8 99.1 26 7 Succinyl-CoA ligase [GDP-forming] subunit 
beta, mitochondrial 
 UniRef90_G3GXA9 21.1 99.1 53 11 Protein disulfide-isomerase 
 UniRef90_G3H1B3 55.0 99.2 38 16 Lamin-L(I) 
 UniRef90_G3HB04 28.4 99.2 40 7 Protein disulfide-isomerase A6 
 UniRef90_G3HEZ0 65.8 98.9 9 5 Stress-70 protein, mitochondrial 
 UniRef90_G3I1Y9 27.4 98.8 28 4 Sulfated glycoprotein 1 
 UniRef90_G3I2Q7 58.0 96.7 4 2 Transcription intermediary factor 1-beta 
 UniRef90_P08670 53.7 99.1 40 8 Vimentin 
 UniRef90_P10809 56.5 99.2 31 13 60 kDa heat shock protein, mitochondrial 
 UniRef90_P14625 53.7 99.1 40 8 Endoplasmin 
 UniRef90_P17980 29.5 98.3 14 3 26S protease regulatory subunit 6A 
 UniRef90_P48643 59.5 99.1 16 8 T-complex protein 1 subunit epsilon 
 UniRef90_P54652 69.7 98.8 8 4 Heat shock-related 70 kDa protein 2 
 UniRef90_P60709 41.7 99.2 52 9 Actin, cytoplasmic 1 
H08 UniRef90_F8VPV9 56.9 99.2 44 17 ATP synthase subunit beta 
 UniRef90_G3H0U6 50.1 99.1 40 17 Protein disulfide-isomerase A3 
 UniRef90_G3H1B3 55.0 99.2 42 16 Lamin-L(I) 
 UniRef90_G3HB04 28.4 99.0 33 5 Protein disulfide-isomerase A6 
 UniRef90_G3HEZ0 65.8 99.2 53 25 Stress-70 protein, mitochondrial 
 UniRef90_G3I1Y9 27.4 94.9 23 3 Sulfated glycoprotein 1 
 UniRef90_G3IDL7 22.7 99.1 45 3 Heat shock cognate 71 kDa protein 
 UniRef90_G3IGQ3 23.1 98.8 31 2 Heat shock cognate 71 kDa protein 
 UniRef90_O95302 63.0 98.8 9 5 Peptidyl-prolyl cis-trans isomerase FKBP9 
 UniRef90_P08003 72.6 98.7 7 4 Protein disulfide-isomerase A4 
 UniRef90_P08670 53.7 99.2 67 30 Vimentin 
 UniRef90_P09382 14.8 98.9 36 6 Galectin-1 
 UniRef90_P10809 56.5 99.2 51 22 60 kDa heat shock protein, mitochondrial 
 UniRef90_P14625 92.6 99.2 30 22 Endoplasmin 
 UniRef90_Q13509 49.7 98.1 13 3 Tubulin beta-3 chain 
 UniRef90_Q71U36 50.1 98.2 9 3 Tubulin alpha-1A chain 
H09 UniRef90_F5H6R6 29.3 98.2 15 3 Heterogeneous nuclear ribonucleoprotein D0 
 UniRef90_F8VPV9 56.9 99.2 35 13 ATP synthase subunit beta 
 UniRef90_G3GXA9 21.1 99.1 48 9 Protein disulfide-isomerase 
 UniRef90_G3HB04 28.4 99.2 33 6 Protein disulfide-isomerase A6 
 UniRef90_G3HEZ0 65.8 99.2 55 21 Stress-70 protein, mitochondrial 
 UniRef90_G3IDC2 26.1 97.2 20 2 Heat shock cognate 71 kDa protein 
 UniRef90_G3IDL7 22.7 99.1 50 4 Heat shock cognate 71 kDa protein 
 UniRef90_P02545-2 64.0 99.2 57 29 Isoform C of Prelamin-A/C 
 UniRef90_P08670 53.7 99.2 62 24 Vimentin 
 UniRef90_P10809 56.5 99.2 51 22 60 kDa heat shock protein, mitochondrial 
 UniRef90_P11021 72.4 99.2 25 11 78 kDa glucose-regulated protein 
 UniRef90_P14625 92.6 99.2 17 11 Endoplasmin 
 UniRef90_P27797 48.2 96.9 9 2 Calreticulin 
 UniRef90_P60709 41.7 99.2 44 12 Actin, cytoplasmic 1 
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 UniRef90_P81117 50.3 96.7 6 2 Nucleobindin-2 
 UniRef90_Q71U36 50.1 96.8 9 2 Tubulin alpha-1A chain 
 UniRef90_Q8BMF4 68.0 99.1 19 7 Dihydrolipoyllysine-residue acetyltransferase 
component of pyruvate dehydrogenase complex, 
mitochondrial 
 UniRef90_Q9CQN1 80.3 99.1 11 5 Heat shock protein 75 kDa, mitochondrial 
H10 UniRef90_F8VPV9 56.9 99.2 45 15 ATP synthase subunit beta 
 UniRef90_G3H0U6 50.1 99.2 35 14 Protein disulfide-isomerase A3 
 UniRef90_G3HB04 28.4 99.1 37 6 Protein disulfide-isomerase A6 
 UniRef90_G3HEZ0 65.8 99.2 28 10 Stress-70 protein, mitochondrial 
 UniRef90_G3I2N0 42.5 98.6 18 3 Inhibitor of nuclear factor kappa-B kinase-
interacting protein 
 UniRef90_G3IBF1 31.1 98.7 23 3 Nucleophosmin 
 UniRef90_P08670 53.7 99.2 62 26 Vimentin 
 UniRef90_P10809 56.5 99.2 54 19 60 kDa heat shock protein, mitochondrial 
 UniRef90_P14625 92.6 99.1 22 13 Endoplasmin 
 UniRef90_P35232 29.8 99.1 35 10 Prohibitin 
 UniRef90_P60709 41.7 99.2 34 11 Actin, cytoplasmic 1 
 UniRef90_Q13509 49.7 98.4 16 3 Tubulin beta-3 chain 
 UniRef90_Q16576 47.0 98.3 12 3 Histone-binding protein RBBP7 
 UniRef90_Q8BMF4 68.0 99.2 25 10 Dihydrolipoyllysine-residue acetyltransferase 
component of pyruvate dehydrogenase complex, 
mitochondrial 
H11 UniRef90_F8VPV9 56.9 99.1 14 5 ATP synthase subunit beta 
 UniRef90_G3GXA9 21.1 99.1 41 7 Protein disulfide-isomerase 
 UniRef90_G3H1B3 55.0 99.1 23 9 Lamin-L(I) 
 UniRef90_G3HEZ0 65.8 99.2 58 29 Stress-70 protein, mitochondrial 
 UniRef90_G3IDL7 22.7 99.1 45 4 Heat shock cognate 71 kDa protein 
 UniRef90_O95302 63.0 99.0 17 6 Peptidyl-prolyl cis-trans isomerase FKBP9 
 UniRef90_P02545-2 64.0 99.2 57 22 Isoform C of Prelamin-A/C 
 UniRef90_P08003 72.6 96.0 8 2 Protein disulfide-isomerase A4 
 UniRef90_P08670 53.7 99.2 26 9 Vimentin 
 UniRef90_P10809 56.5 99.2 42 17 60 kDa heat shock protein, mitochondrial 
 UniRef90_P11021 72.4 98.7 9 2 78 kDa glucose-regulated protein 
 UniRef90_P14625 92.6 99.2 42 32 Endoplasmin 
 UniRef90_P35232 29.8 99.2 51 11 Prohibitin 
 UniRef90_P60709 41.7 99.2 38 7 Actin, cytoplasmic 1 
 UniRef90_Q12874 58.8 92.8 10 2 Splicing factor 3A subunit 3 
 UniRef90_Q9CQN1 80.3 99.0 12 4 Heat shock protein 75 kDa, mitochondrial 
H12 UniRef90_F8VPV9 56.9 99.2 45 16 ATP synthase subunit beta 
 UniRef90_G3GXA9 21.1 99.1 49 8 Protein disulfide-isomerase 
 UniRef90_G3H0U6 50.1 99.1 37 15 Protein disulfide-isomerase A3 
 UniRef90_G3HB04 28.4 98.3 20 3 Protein disulfide-isomerase A6 
 UniRef90_G3HEZ0 65.8 99.2 52 19 Stress-70 protein, mitochondrial 
 UniRef90_G3HSM8 67.7 99.0 19 4 Lamin-B2 
 UniRef90_G3IDL7 22.7 98.9 28 2 Heat shock cognate 71 kDa protein 
 UniRef90_O95302 63.0 96.1 9 2 Peptidyl-prolyl cis-trans isomerase FKBP9 
 UniRef90_P08670 53.7 99.2 22 7 Vimentin 
 UniRef90_P10809 56.5 99.0 12 4 60 kDa heat shock protein, mitochondrial 
 UniRef90_P11021 72.4 99.2 33 14 78 kDa glucose-regulated protein 
 UniRef90_P14625 92.6 99.2 31 22 Endoplasmin 
 UniRef90_P27797 48.2 99.1 26 12 Calreticulin 
 UniRef90_P60709 41.7 99.2 55 12 Actin, cytoplasmic 1 
 UniRef90_Q8BMF4 68.0 99.1 16 7 Dihydrolipoyllysine-residue acetyltransferase 
component of pyruvate dehydrogenase complex, 
mitochondrial 
*MW values were calculated from their amino acid sequence, derived from the accession no., using 
the ExPASy Compute pI/MW tool [103]. 
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Table B 3. Identified MG1655 Proteins (Multiplex). Each table denotes a specific row of a 96-well 
plate with identifications shown in each well. 
Row A Cluster ID 
MW 
(kDa)* 
Score 
% 
Sequence 
Coverage 
(%) 
# of 
Unique 
Peptides 
Protein Name 
A01 UniRef90_A7MQX5 41.4 99.0 16 6 Succinyl-CoA ligase [ADP-forming] subunit beta 
 UniRef90_A7ZPW1  15.5 82.8 18 2 Nucleoside diphosphate kinase 
 UniRef90_A7ZJD2  41.4 82.8 5 2 Galactokinase 
 UniRef90_P00946 42.8 82.9 14 2 Mannose-6-phosphate isomerase 
 UniRef90_B5F6U1 49.9 98.0 7 3 Argininosuccinate synthase 
 UniRef90_A1AFA2  24.3 78.7 7 2 Ribose-5-phosphate isomerase A 
 UniRef90_A7ZR34 41.4 73.0 5 2 Phosphoglycerate kinase 
A02 UniRef90_A7ZHR7 90.6 99.1 13 11 Outer membrane protein assembly factor BamA 
 UniRef90_A8ACN8  55.2 99.1 16 8 ATP synthase subunit alpha 
 UniRef90_A8ALC4  29.9 98.7 19 4 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-
succinyltransferase 
 UniRef90_P23847 60.3 98.7 8 4 Periplasmic dipeptide transport protein 
 UniRef90_A8AIH6  39.9 98.2 9 3 Phosphoserine aminotransferase 
 UniRef90_A8ACZ6  50.2 82.8 5 2 Xaa-Pro dipeptidase 
 UniRef90_P09832 52.0 82.7 5 2 Glutamate synthase [NADPH] small chain 
 UniRef90_B7NUD2 23.3 82.2 18 2 Peptide methionine sulfoxide reductase MsrA 
 UniRef90_P08200 45.8 82.8 6 2 Isocitrate dehydrogenase [NADP] 
 UniRef90_A7ZPU1  22.5 59.2 4 2 Uracil phosphoribosyltransferase 
A03 UniRef90_P0A797 34.8 99.0 16 6 6-phosphofructokinase isozyme 1 
 UniRef90_P75960 26.7 98.7 21 4 NAD-dependent protein deacylase 
 UniRef90_C4K4F8  43.3 98.2 8 3 Elongation factor Tu 
 UniRef90_P22731 26.3 83.0 8 2 High-affinity branched-chain amino acid 
transport ATP-binding protein LivF 
 UniRef90_A7MQE1 97.3 85.7 4 2 Translation initiation factor IF-2 
 UniRef90_P75792 30.4 72.3 6 2 Sugar phosphatase YbiV 
A04 UniRef90_A8ACN8  55.2 99.0 12 6 ATP synthase subunit alpha 
 UniRef90_P33363 83.5 99.0 7 6 Periplasmic beta-glucosidase 
 UniRef90_A7MQX5 41.4 99.0 19 7 Succinyl-CoA ligase [ADP-forming] subunit beta 
 UniRef90_P66794 36.7 98.7 11 4 Selenide, water dikinase 
 UniRef90_P23847 60.3 98.6 8 3 Periplasmic dipeptide transport protein 
 UniRef90_P0A797 34.8 99.0 16 5 6-phosphofructokinase isozyme 1 
 UniRef90_A8AIH6  39.9 98.2 9 3 Phosphoserine aminotransferase 
 UniRef90_P58603 35.6 98.2 8 3 Protease 7 
 UniRef90_P00509 43.6 98.2 8 3 Aspartate aminotransferase 
 UniRef90_P04693 43.5 82.9 6 2 Aromatic-amino-acid aminotransferase 
 UniRef90_P0A6G4  17.6 82.9 15 2 Protein YgaD 
 UniRef90_P37344 37.0 86.3 8 2 Psp operon transcriptional activator 
A05 UniRef90_A7ZPV7  47.0 99.1 23 9 Histidine--tRNA ligase 
 UniRef90_P04425 35.4 98.9 23 5 Glutathione synthetase 
 UniRef90_P0AEN3 26.2 98.7 21 4 NAD(P)H-flavin reductase 
 UniRef90_P00888 38.8 98.2 8 3 Phospho-2-dehydro-3-deoxyheptonate aldolase, 
Tyr-sensitive 
 UniRef90_P12281 44.1 83.0 11 2 Molybdopterin molybdenumtransferase 
 UniRef90_P75736 28.4 98.2 15 3 Esterase ybfF 
 UniRef90_Q3Z606 35.2 98.2 9 3 Transaldolase 1 
 UniRef90_A7ZN88 31.2 83.0 8 2 Molecular chaperone Hsp31 and glyoxalase 3 
 UniRef90_Q8X7W8  25.5 83.0 11 2 PKHD-type hydroxylase ybiX 
 UniRef90_B7UMJ8 31.6 83.0 7 2 ATP synthase gamma chain 
 UniRef90_P38489 23.9 59.6 5 2 Oxygen-insensitive NAD(P)H nitroreductase 
A06 UniRef90_B5FTC5  27.8 98.9 22 5 Deoxyribose-phosphate aldolase 
 UniRef90_P0A9L8  28.1 98.7 18 4 Pyrroline-5-carboxylate reductase 
 UniRef90_B7LNW7  37.2 98.9 18 5 Outer membrane protein A 
 UniRef90_P39099 47.2 98.9 12 5 Periplasmic pH-dependent serine endoprotease 
DegQ 
 UniRef90_P33363 83.5 98.2 4 3 Periplasmic beta-glucosidase 
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 UniRef90_P0AFU8  23.4 98.7 18 4 Riboflavin synthase alpha chain 
 UniRef90_P12282 26.7 85.5 13 2 Molybdopterin-synthase adenylyltransferase 
 UniRef90_P0AE20 29.3 82.9 16 2 Methionine aminopeptidase 
 UniRef90_P22731 26.3 82.9 14 2 High-affinity branched-chain amino acid 
transport ATP-binding protein LivF 
 UniRef90_A7ZPW1  15.4 82.8 18 2 Nucleoside diphosphate kinase 
 UniRef90_P38489 23.9 59.5 5 2 Oxygen-insensitive NAD(P)H nitroreductase 
A07 UniRef90_B5FTC5  27.8 98.3 18 3 Deoxyribose-phosphate aldolase 
 UniRef90_A8AIH6  39.9 98.2 9 3 Phosphoserine aminotransferase 
 UniRef90_P0C8J9 47.0 98.2 9 3 D-tagatose-1,6-bisphosphate aldolase subunit 
gatZ 
 UniRef90_Q8XDJ8 33.6 98.0 12 3 Murein tetrapeptide carboxypeptidase 
 UniRef90_P07003 62.0 84.1 5 2 Pyruvate dehydrogenase [ubiquinone] 
A08 NA NA NA   NA 
A09 UniRef90_A7ZPV7  47.0 99.1 23 9 Histidine--tRNA ligase 
 UniRef90_P00509 43.6 99.0 17 6 Aspartate aminotransferase 
 UniRef90_A7ZHR7 90.6 99.0 9 7 Outer membrane protein assembly factor BamA 
 UniRef90_Q8FBC3 56.2 98.3 9 3 Glycerol kinase 
 UniRef90_A7MQX5 41.4 99.0 16 5 Succinyl-CoA ligase [ADP-forming] subunit beta 
 UniRef90_Q0T204 40.7 98.7 11 4 4-hydroxy-3-methylbut-2-en-1-yl diphosphate 
synthase 
 UniRef90_P0A6G4  17.6 82.7 16 2 Protein YgaD 
 UniRef90_A8AIH6  39.9 82.8 10 2 Phosphoserine aminotransferase 
A10 UniRef90_P27833 41.9 98.9 15 5 Lipopolysaccharide biosynthesis protein RffA 
 UniRef90_P00509 43.6 99.0 19 8 Aspartate aminotransferase 
 UniRef90_A8AJD6  63.5 98.9 10 5 Glutamine--tRNA ligase 
 UniRef90_P16703 32.7 82.7 7 2 Cysteine synthase B 
 UniRef90_B7UMJ8 31.6 82.6 8 2 ATP synthase gamma chain 
 UniRef90_A7ZPU1  22.5 82.4 12 2 Uracil phosphoribosyltransferase 
A11 UniRef90_A7ZLK8  21.6 98.2 18 3 FMN-dependent NADH-azoreductase 
 UniRef90_P15047 26.2 83.0 11 2 2,3-dihydro-2,3-dihydroxybenzoate 
dehydrogenase 
 UniRef90_P0A9L8  28.1 83.0 8 2 Pyrroline-5-carboxylate reductase 
 UniRef90_P0AEN3 26.2 83.0 10 2 NAD(P)H-flavin reductase 
 UniRef90_A7ZPS1  27.0 82.9 7 2 Phosphoribosylaminoimidazole-
succinocarboxamide synthase 
 UniRef90_B5F6U1 50.0 63.3 6 2 Argininosuccinate synthase 
A12 UniRef90_P18815 43.4 82.7 5 2 Maltose-binding periplasmic protein 
 
Row B Cluster ID 
MW 
(kDa)* 
Score 
% 
Sequence 
Coverage 
(%) 
# of 
Unique 
Peptides 
Protein Name 
B01 UniRef90_B7LNW7  37.2 99.0 19 6 Outer membrane protein A 
 UniRef90_P02930 53.7 99.0 14 6 Outer membrane protein tolC 
 UniRef90_P33030 36.1 98.7 15 4 Uncharacterized protein YeiR 
 UniRef90_P0ABK6  34.5 98.7 17 4 Cysteine synthase A 
 UniRef90_Q8X4S6 43.8 98.2 7 3 Acetylornithine/succinyldiaminopimelate 
aminotransferase 
 UniRef90_A7ZHR7 90.6 98.7 5 4 Outer membrane protein assembly factor BamA 
 UniRef90_P75682 32.5 82.9 8 2 Probable 2-keto-3-deoxy-galactonate aldolase 
YagE 
 UniRef90_P0AEY7 21.9 82.8 10 2 Modulator of drug activity B 
 UniRef90_A7ZIN4  23.6 98.1 16 3 Adenylate kinase 
B02 UniRef90_A7ZHR7 90.6 99.1 9 8 Outer membrane protein assembly factor BamA 
 UniRef90_A7ZKW9  63.7 98.7 10 4 Periplasmic trehalase 
 UniRef90_P06971 82.2 98.2 4 3 Ferrichrome-iron receptor 
 UniRef90_P09029 39.5 98.7 10 4 N5-carboxyaminoimidazole ribonucleotide 
synthase 
 UniRef90_P76270 18.1 95.1 15 2 Free methionine-R-sulfoxide reductase 
 UniRef90_B7UJV9 29.5 82.9 7 2 Transcriptional regulator NanR 
 UniRef90_A7ZH92 33.6 82.7 7 2 Homoserine kinase 
B03 UniRef90_P02930 53.7 98.7 8 4 Outer membrane protein tolC 
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 UniRef90_A8AHY1  33.5 86.6 19 2 3-oxoacyl-[acyl-carrier-protein] synthase 3 
 UniRef90_P37985 61.2 96.4 5 2 30S ribosomal protein S1 
 UniRef90_A7ZHM3 31.6 98.0 9 3 Pantothenate synthetase 
B04 UniRef90_A7ZSD0  32.3 99.1 39 9 Malate dehydrogenase 
 UniRef90_P0A9W9 20.2 98.9 27 5 Protein YrdA 
B05 UniRef90_P0ADG8  52.0 98.3 9 3 Inosine-5'-monophosphate dehydrogenase 
 UniRef90_P23917 32.5 98.9 19 5 Fructokinase 
 UniRef90_P0A9P5 34.6 98.6 13 3 Thioredoxin reductase 
 UniRef90_Q32EF3 26.0 98.2 11 3 1-(5-phosphoribosyl)-5-[(5-
phosphoribosylamino)methylideneamino] 
imidazole-4-carboxamide isomerase 
B06 UniRef90_A8ACN6  50.3 99.0 15 6 ATP synthase subunit beta 
 UniRef90_Q32EF3 26.0 99.0 24 5 1-(5-phosphoribosyl)-5-[(5-
phosphoribosylamino)methylideneamino] 
imidazole-4-carboxamide isomerase 
 UniRef90_A7ZPS4  31.3 98.7 15 4 Dihydrodipicolinate synthase 
 UniRef90_P33030 36.1 98.2 11 3 Uncharacterized protein YeiR 
 UniRef90_A8AIH6  39.9 98.2 9 3 Phosphoserine aminotransferase 
 UniRef90_B5F769 31.3 98.2 9 3 Bis(5'-nucleosyl)-tetraphosphatase, symmetrical 
B07 UniRef90_P06971 82.2 99.1 12 9 Ferrichrome-iron receptor 
 UniRef90_P0ABZ8 47.3 98.7 11 4 Chaperone SurA 
 UniRef90_Q57TE8 49.9 98.2 9 3 3-isopropylmalate dehydratase large subunit 1 
 UniRef90_Q8X621 42.9 98.2 8 3 Uncharacterized protein ydhQ 
 UniRef90_P00370 48.6 82.8 6 2 NADP-specific glutamate dehydrogenase 
 UniRef90_A7ZNJ3  39.4 99.0 15 6 Histidinol-phosphate aminotransferase 
 UniRef90_P33363 83.5 98.2 4 3 Periplasmic beta-glucosidase 
 UniRef90_A1AIG4  23.0 82.8 11 2 Thiamine-phosphate synthase 
 UniRef90_P0A9W9 20.2 97.9 16 3 Protein YrdA 
 UniRef90_A8AFI0  22.1 82.8 10 2 Holliday junction ATP-dependent DNA helicase 
RuvA 
 UniRef90_B5F769 31.3 82.8 6 2 Bis(5'-nucleosyl)-tetraphosphatase, symmetrical 
B08 UniRef90_P07003 62.0 99.0 12 5 Pyruvate dehydrogenase [ubiquinone] 
 UniRef90_B5Y275 44.4 98.2 8 3 Phosphopentomutase 
 UniRef90_P08200 45.8 99.0 12 5 Isocitrate dehydrogenase [NADP] 
 UniRef90_P59735 27.2 98.2 14 3 3'(2'),5'-bisphosphate nucleotidase CysQ 
 UniRef90_P0AFG9  99.7 82.7 2 2 Pyruvate dehydrogenase E1 component 
 UniRef90_P0AF09  39.9 82.7 5 2 Protein mrp 
B09 UniRef90_Q8XBL0  30.8 99.0 17 5 Pyridoxine kinase 
 UniRef90_P30138 27.0 82.7 14 2 Sulfur carrier protein ThiS adenylyltransferase 
 UniRef90_P58603 35.6 98.2 8 3 Protease 7 
 UniRef90_P69784 18.3 82.7 15 2 Glucose-specific phosphotransferase enzyme IIA 
component 
B10 UniRef90_P58603 35.6 99.1 31 2 Protease 7 
 UniRef90_P23917 32.5 98.7 19 4 Fructokinase 
 UniRef90_P12758 27.2 98.2 13 3 Uridine phosphorylase 
 UniRef90_P23905 35.7 82.7 9 2 D-galactose-binding periplasmic protein 
 UniRef90_Q8X4S6 43.8 98.2 7 3 Acetylornithine/succinyldiaminopimelate 
aminotransferase 
 UniRef90_P66794 36.7 82.5 5 2 Selenide, water dikinase 
B11 UniRef90_P08331 70.8 89.0 5 2 2',3'-cyclic-nucleotide 2'-phosphodiesterase/3'-
nucleotidase 
 UniRef90_P0A2K8  32.8 83.3 7 2 UTP--glucose-1-phosphate uridylyltransferase 
B12 UniRef90_P77804 54.7 83.1 4 2 Protein ydgA 
 UniRef90_A7ZH92 33.6 78.5 7 2 Homoserine kinase 
 
Row B Cluster ID 
MW 
(kDa)* 
Score 
% 
Protein Name 
B01 UniRef90_B7LNW7  37.2 99.0 Outer membrane protein A 
 
UniRef90_P02930 53.7 99.0 Outer membrane protein tolC 
 
UniRef90_P33030 36.1 98.7 Uncharacterized protein YeiR 
 
UniRef90_P0ABK6  34.5 98.7 Cysteine synthase A 
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UniRef90_Q8X4S6 43.8 98.2 Acetylornithine/succinyldiaminopimelate aminotransferase 
 
UniRef90_A7ZHR7 90.6 98.7 Outer membrane protein assembly factor BamA 
 
UniRef90_P75682 32.5 82.9 Probable 2-keto-3-deoxy-galactonate aldolase YagE 
 
UniRef90_P0AEY7 21.9 82.8 Modulator of drug activity B 
  UniRef90_A7ZIN4  23.6 98.1 Adenylate kinase 
B02 UniRef90_A7ZHR7 90.6 99.1 Outer membrane protein assembly factor BamA 
 
UniRef90_A7ZKW9  63.7 98.7 Periplasmic trehalase 
 
UniRef90_P06971 82.2 98.2 Ferrichrome-iron receptor 
 
UniRef90_P09029 39.5 98.7 N5-carboxyaminoimidazole ribonucleotide synthase 
 
UniRef90_P76270 18.1 95.1 Free methionine-R-sulfoxide reductase 
 
UniRef90_B7UJV9 29.5 82.9 Transcriptional regulator NanR 
  UniRef90_A7ZH92 33.6 82.7 Homoserine kinase 
B03 UniRef90_P02930 53.7 98.7 Outer membrane protein tolC 
 
UniRef90_A8AHY1  33.5 86.6 3-oxoacyl-[acyl-carrier-protein] synthase 3 
 
UniRef90_P37985 61.2 96.4 30S ribosomal protein S1 
  UniRef90_A7ZHM3 31.6 98.0 Pantothenate synthetase 
B04 UniRef90_A7ZSD0  32.3 99.1 Malate dehydrogenase 
  UniRef90_P0A9W9 20.2 98.9 Protein YrdA 
B05 UniRef90_P0ADG8  52.0 98.3 Inosine-5'-monophosphate dehydrogenase 
 
UniRef90_P23917 32.5 98.9 Fructokinase 
 
UniRef90_P0A9P5 34.6 98.6 Thioredoxin reductase 
  
UniRef90_Q32EF3 26.0 98.2 1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino)methylideneamino] 
imidazole-4-carboxamide isomerase 
B06 UniRef90_A8ACN6  50.3 99.0 ATP synthase subunit beta 
 
UniRef90_Q32EF3 26.0 99.0 1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino)methylideneamino] 
imidazole-4-carboxamide isomerase 
 
UniRef90_A7ZPS4  31.3 98.7 Dihydrodipicolinate synthase 
 
UniRef90_P33030 36.1 98.2 Uncharacterized protein YeiR 
 
UniRef90_A8AIH6  39.9 98.2 Phosphoserine aminotransferase 
  UniRef90_B5F769 31.3 98.2 Bis(5'-nucleosyl)-tetraphosphatase, symmetrical 
B07 UniRef90_P06971 82.2 99.1 Ferrichrome-iron receptor 
 
UniRef90_P0ABZ8 47.3 98.7 Chaperone SurA 
 
UniRef90_Q57TE8 49.9 98.2 3-isopropylmalate dehydratase large subunit 1 
 
UniRef90_Q8X621 42.9 98.2 Uncharacterized protein ydhQ 
 
UniRef90_P00370 48.6 82.8 NADP-specific glutamate dehydrogenase 
 
UniRef90_A7ZNJ3  39.4 99.0 Histidinol-phosphate aminotransferase 
 
UniRef90_P33363 83.5 98.2 Periplasmic beta-glucosidase 
 
UniRef90_A1AIG4  23.0 82.8 Thiamine-phosphate synthase 
 
UniRef90_P0A9W9 20.2 97.9 Protein YrdA 
 
UniRef90_A8AFI0  22.1 82.8 Holliday junction ATP-dependent DNA helicase RuvA 
  UniRef90_B5F769 31.3 82.8 Bis(5'-nucleosyl)-tetraphosphatase, symmetrical 
B08 UniRef90_P07003 62.0 99.0 Pyruvate dehydrogenase [ubiquinone] 
 
UniRef90_B5Y275 44.4 98.2 Phosphopentomutase 
 
UniRef90_P08200 45.8 99.0 Isocitrate dehydrogenase [NADP] 
 
UniRef90_P59735 27.2 98.2 3'(2'),5'-bisphosphate nucleotidase CysQ 
 
UniRef90_P0AFG9  99.7 82.7 Pyruvate dehydrogenase E1 component 
  UniRef90_P0AF09  39.9 82.7 Protein mrp 
B09 UniRef90_Q8XBL0  30.8 99.0 Pyridoxine kinase 
 
UniRef90_P30138 27.0 82.7 Sulfur carrier protein ThiS adenylyltransferase 
 
UniRef90_P58603 35.6 98.2 Protease 7 
  UniRef90_P69784 18.3 82.7 Glucose-specific phosphotransferase enzyme IIA component 
B10 UniRef90_P58603 35.6 99.1 Protease 7 
 
UniRef90_P23917 32.5 98.7 Fructokinase 
 
UniRef90_P12758 27.2 98.2 Uridine phosphorylase 
 
UniRef90_P23905 35.7 82.7 D-galactose-binding periplasmic protein 
 
UniRef90_Q8X4S6 43.8 98.2 Acetylornithine/succinyldiaminopimelate aminotransferase 
  UniRef90_P66794 36.7 82.5 Selenide, water dikinase 
B11 UniRef90_P08331 70.8 89.0 2',3'-cyclic-nucleotide 2'-phosphodiesterase/3'-nucleotidase 
  UniRef90_P0A2K8  32.8 83.3 UTP--glucose-1-phosphate uridylyltransferase 
B12 UniRef90_P77804 54.7 83.1 Protein ydgA 
  UniRef90_A7ZH92 33.6 78.5 Homoserine kinase 
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Row C Cluster ID 
MW 
(kDa)* 
Score 
% 
Sequence 
Coverage 
(%) 
# of 
Unique 
Peptides 
Protein Name 
C01 UniRef90_P04425 35.4 98.9 22 5 Glutathione synthetase 
 UniRef90_Q3Z606 35.2 98.5 13 3 Transaldolase 1 
 UniRef90_P0AFK9  38.9 98.9 14 4 Spermidine/putrescine-binding periplasmic 
protein 
 UniRef90_P0AF94  13.6 83.2 17 2 Enamine/imine deaminase 
C02 UniRef90_A8ALC4  29.9 99.1 35 9 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-
succinyltransferase 
 UniRef90_P00509 43.6 99.1 28 11 Aspartate aminotransferase 
 UniRef90_A8ALS4  28.7 99.0 31 5 Dihydrodipicolinate reductase 
 UniRef90_P02930 53.7 99.1 19 8 Outer membrane protein tolC 
 UniRef90_B5FTC5  27.7 98.7 19 4 Deoxyribose-phosphate aldolase 
 UniRef90_P0ADS7 26.6 98.7 19 5 Uncharacterized protein yggE 
 UniRef90_Q0T204 40.7 98.7 15 4 4-hydroxy-3-methylbut-2-en-1-yl diphosphate 
synthase 
 UniRef90_A8AKV5  42.0 82.8 6 2 tRNA (uracil(54)-C(5))-methyltransferase 
 UniRef90_P07023 42.0 82.8 6 2 T-protein 
 UniRef90_P67097 20.1 82.8 14 2 Phosphodiesterase yfcE 
C03 UniRef90_A7MQX5 41.4 98.7 13 4 Succinyl-CoA ligase [ADP-forming] subunit beta 
 UniRef90_A7ZSR4 38.9 98.7 13 4 3-dehydroquinate synthase 
 UniRef90_A8ANW8  28.0 98.2 13 3 Phosphoadenosine phosphosulfate reductase 
 UniRef90_A8AIH6  40.0 82.7 6 2 Phosphoserine aminotransferase 
 UniRef90_P0AGD5  21.3 98.7 20 4 Superoxide dismutase [Fe] 
 UniRef90_A7ZL78  28.8 82.7 7 2 Tryptophan synthase alpha chain 
 UniRef90_A7ZHR7 90.6 82.3 2 2 Outer membrane protein assembly factor BamA 
C04 UniRef90_Q3Z606 35.2 99.1 26 8 Transaldolase 1 
 UniRef90_A7ZTD9  50.6 99.0 14 6 L-seryl-tRNA(Sec) selenium transferase 
 UniRef90_P0ADS7 26.6 98.7 17 5 Uncharacterized protein yggE 
 UniRef90_A8AIH6  39.9 98.7 13 4 Phosphoserine aminotransferase 
 UniRef90_P0AF94  13.6 98.2 24 3 Enamine/imine deaminase 
 UniRef90_P0ACL0  28.0 98.2 13 3 Glycerol-3-phosphate regulon repressor 
 UniRef90_P0A928 33.6 82.7 8 2 Nucleoside-specific channel-forming protein tsx 
 UniRef90_B7MI93 42.3 85.8 12 2 Acetylornithine deacetylase 
C05 UniRef90_A7ZTD9  50.6 99.1 19 8 L-seryl-tRNA(Sec) selenium transferase 
 UniRef90_P02930 53.7 99.0 16 7 Outer membrane protein tolC 
 UniRef90_A8AIH6  39.9 99.0 17 5 Phosphoserine aminotransferase 
 UniRef90_A7ZKW9  63.7 98.9 10 4 Periplasmic trehalase 
 UniRef90_Q8X732 35.9 98.7 15 4 N-acetyl-gamma-glutamyl-phosphate reductase 
 UniRef90_Q57TE8 49.9 82.8 5 2 3-isopropylmalate dehydratase large subunit 1 
 UniRef90_A7ZHY1  20.8 82.7 10 2 Phosphoheptose isomerase 
 UniRef90_A8AJD6  63.5 97.5 5 2 Glutamine--tRNA ligase 
C06 UniRef90_Q8XDS0 52.4 99.1 15 6 Aspartate ammonia-lyase 
 UniRef90_P25906 30.7 98.2 13 3 Putative oxidoreductase YdbC 
 UniRef90_P75736 28.4 83.2 10 2 Esterase ybfF 
 UniRef90_P24232 43.8 76.1 5 2 Flavohemoprotein 
C07 UniRef90_A8ACN8  55.2 99.1 14 7 ATP synthase subunit alpha 
 UniRef90_P06999 32.5 98.9 19 5 6-phosphofructokinase isozyme 2 
 UniRef90_Q3Z3B7 20.8 98.8 25 4 Flavoprotein WrbA 
 UniRef90_Q9S5G3  22.8 83.2 14 2 Histidine biosynthesis bifunctional protein HisIE 
 UniRef90_P0AGD5  21.3 98.2 16 3 Superoxide dismutase [Fe] 
C08 UniRef90_P16657 27.9 98.7 15 4 Enoyl-[acyl-carrier-protein] reductase [NADH] 
FabI 
 UniRef90_A7ZR71 20.7 98.1 20 3 UPF0301 protein yqgE 
 UniRef90_A7ZSR4 38.9 98.3 11 3 3-dehydroquinate synthase 
 UniRef90_P25906 30.7 98.1 12 3 Putative oxidoreductase YdbC 
 UniRef90_Q57TE8 49.9 82.6 6 2 3-isopropylmalate dehydratase large subunit 1 
 UniRef90_A7MH28 43.3 82.6 6 2 Acetate kinase 
 UniRef90_B7UN33 19.0 98.1 16 3 3-hydroxydecanoyl-[acyl-carrier-protein] 
dehydratase 
 UniRef90_A7ZTD9  50.6 82.6 5 2 L-seryl-tRNA(Sec) selenium transferase 
 UniRef90_P0A252 20.8 82.6 17 2 Alkyl hydroperoxide reductase subunit C 
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C09 UniRef90_B5Y275 44.4 99.0 20 8 Phosphopentomutase 
 UniRef90_Q3Z606 35.2 99.0 35 13 Transaldolase 1 
 UniRef90_A8ALS4  28.7 99.0 27 6 Dihydrodipicolinate reductase 
 UniRef90_Q8XDS0 52.4 99.0 16 8 Aspartate ammonia-lyase 
 UniRef90_P0AF94  13.6 98.1 24 3 Enamine/imine deaminase 
 UniRef90_P08331 70.8 98.1 5 3 2',3'-cyclic-nucleotide 2'-phosphodiesterase/3'-
nucleotidase 
 UniRef90_P38489 23.9 82.4 10 3 Oxygen-insensitive NAD(P)H nitroreductase 
 UniRef90_P0AEB8 12.5 82.4 22 2 RutC family protein yoaB 
C10 UniRef90_P46837 85.1 99.1 18 12 Protein yhgF 
 UniRef90_A8ACN8  55.2 99.1 18 8 ATP synthase subunit alpha 
 UniRef90_P58603 35.6 99.1 28 2 Protease 7 
 UniRef90_P36938 58.4 99.0 12 6 Phosphoglucomutase 
 UniRef90_P0AEB8 12.5 98.2 33 3 RutC family protein yoaB 
 UniRef90_P0A928 33.6 82.8 8 2 Nucleoside-specific channel-forming protein tsx 
 UniRef90_P0AEJ3 42.9 98.2 8 3 Isochorismate synthase entC 
 UniRef90_Q8X732 35.9 98.2 8 3 N-acetyl-gamma-glutamyl-phosphate reductase 
 UniRef90_P0ABQ3 30.4 82.8 8 2 2-hydroxy-3-oxopropionate reductase 
 UniRef90_A7ZTA0  35.4 82.8 8 2 Glyoxylate/hydroxypyruvate reductase B 
 UniRef90_P12994 17.1 82.7 11 2 UPF0098 protein ybhB 
C11 UniRef90_A8ALC4  29.9 99.1 41 10 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-
succinyltransferase 
 UniRef90_Q8XDS0 52.4 99.0 13 6 Aspartate ammonia-lyase 
 UniRef90_Q57TE8 49.9 98.2 9 3 3-isopropylmalate dehydratase large subunit 1 
 UniRef90_P75736 28.4 98.2 15 3 Esterase ybfF 
 UniRef90_P76034 27.6 98.7 14 4 Uncharacterized HTH-type transcriptional 
regulator YciT 
 UniRef90_P08331 70.8 82.7 3 2 2',3'-cyclic-nucleotide 2'-phosphodiesterase/3'-
nucleotidase 
 UniRef90_B7UN33 19.0 98.2 16 3 3-hydroxydecanoyl-[acyl-carrier-protein] 
dehydratase 
 UniRef90_B7MI93 42.4 82.7 6 2 Acetylornithine deacetylase 
 UniRef90_P12994 17.1 78.6 11 2 UPF0098 protein ybhB 
 UniRef90_P09126 27.8 82.6 7 2 Uroporphyrinogen-III synthase 
C12 UniRef90_P00509 43.6 99.1 26 10 Aspartate aminotransferase 
 UniRef90_A8ALC4  29.9 98.9 22 5 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-
succinyltransferase 
 UniRef90_A8AKV5  42.0 98.2 12 3 tRNA (uracil(54)-C(5))-methyltransferase 
 UniRef90_P76034 27.6 98.7 16 4 Uncharacterized HTH-type transcriptional 
regulator YciT 
 UniRef90_Q3Z3B7 20.8 98.2 16 3 Flavoprotein WrbA 
 UniRef90_Q0T204 40.7 98.7 11 4 4-hydroxy-3-methylbut-2-en-1-yl diphosphate 
synthase 
 UniRef90_P58603 35.6 98.3 15 3 Protease 7 
 UniRef90_P0AGD5  21.3 98.7 20 4 Superoxide dismutase [Fe] 
 UniRef90_P09126 27.8 89.6 9 2 Uroporphyrinogen-III synthase 
 UniRef90_P0AF94  13.6 82.9 14 2 Enamine/imine deaminase 
 UniRef90_P0AAY0  33.3 82.8 6 2 Probable L,D-transpeptidase YbiS 
 
Row D Cluster ID 
MW 
(kDa)* 
Score 
% 
Sequence 
Coverage 
(%) 
# of 
Unique 
Peptides 
Protein Name 
D01 UniRef90_P46837 85.1 99.1 16 13 Protein yhgF 
 UniRef90_P0AFK9  38.9 99.0 28 9 Spermidine/putrescine-binding periplasmic 
protein 
 UniRef90_P34209 29.7 98.9 24 5 Protein ydcF 
 UniRef90_A8ALC4  29.9 98.9 23 5 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-
succinyltransferase 
 UniRef90_P33570 35.7 99.0 22 6 Transketolase 2 
 UniRef90_P66794 36.7 98.9 15 5 Selenide, water dikinase 
 UniRef90_P00888 38.8 98.2 12 4 Phospho-2-dehydro-3-deoxyheptonate aldolase, 
Tyr-sensitive 
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 UniRef90_A8AEK3  39.4 99.0 17 6 Histidinol-phosphate aminotransferase 
 UniRef90_A7ZN88 31.2 82.8 8 2 Molecular chaperone Hsp31 and glyoxalase 3 
 UniRef90_A8ANW8  28.0 82.8 9 2 Phosphoadenosine phosphosulfate reductase 
 UniRef90_Q3Z606 35.2 83.8 9 2 Transaldolase 1 
 UniRef90_P0A4L6  23.1 97.8 13 3 Thiol:disulfide interchange protein DsbA 
D02 UniRef90_A7ZSD0  32.3 99.1 29 9 Malate dehydrogenase 
 UniRef90_A7ZPV7  47.0 99.0 17 6 Histidine--tRNA ligase 
 UniRef90_P19926 45.7 98.9 14 5 Glucose-1-phosphatase 
 UniRef90_B5FTC5  27.7 98.7 19 4 Deoxyribose-phosphate aldolase 
 UniRef90_A8ANW8  28.0 98.9 22 5 Phosphoadenosine phosphosulfate reductase 
 UniRef90_P31550 36.2 98.2 15 3 Thiamine-binding periplasmic protein 
 UniRef90_B7US97 36.8 98.2 12 3 Phenylalanine--tRNA ligase alpha subunit 
 UniRef90_P00370 48.6 83.0 6 2 NADP-specific glutamate dehydrogenase 
 UniRef90_Q57M35 20.5 98.2 16 3 NADH-quinone oxidoreductase subunit I 
 UniRef90_Q3Z3B7 20.8 83.0 12 2 Flavoprotein WrbA 
D03 UniRef90_A7ZVS5  47.2 99.1 33 11 Thymidine phosphorylase 
 UniRef90_P02930 53.7 99.0 20 8 Outer membrane protein tolC 
 UniRef90_Q3Z606 35.2 99.0 19 6 Transaldolase 1 
 UniRef90_A1AIG4  23.0 98.1 21 3 Thiamine-phosphate synthase 
 UniRef90_P0A9K5  39.0 98.1 10 3 PhoH-like protein 
 UniRef90_B7MG93 39.2 82.5 8 2 Chorismate synthase 
D04 UniRef90_A7ZPV7  47.0 99.1 28 9 Histidine--tRNA ligase 
 UniRef90_P22715 37.3 98.9 21 6 UDP-glucose 4-epimerase 
 UniRef90_A8ANW8  28.0 99.1 34 8 Phosphoadenosine phosphosulfate reductase 
 UniRef90_B7US97 36.8 99.0 21 6 Phenylalanine--tRNA ligase alpha subunit 
 UniRef90_Q3Z606 35.2 99.0 23 7 Transaldolase 1 
 UniRef90_Q3Z3B7 20.8 98.7 25 4 Flavoprotein WrbA 
 UniRef90_P0ABZ8 47.3 82.8 5 2 Chaperone SurA 
 UniRef90_P0AGD5  21.3 98.7 20 4 Superoxide dismutase [Fe] 
 UniRef90_P0A9D3 22.9 98.2 15 3 Glutathione S-transferase GstA 
 UniRef90_A7ZIN4  23.6 82.8 11 2 Adenylate kinase 
 UniRef90_P76014 22.6 82.7 9 2 PTS-dependent dihydroxyacetone kinase, ADP-
binding subunit dhaL 
 UniRef90_A7ZL78  28.7 82.8 7 2 Tryptophan synthase alpha chain 
D05 UniRef90_P0AEJ3 42.9 99.0 15 6 Isochorismate synthase entC 
 UniRef90_Q8X9Z2 53.4 98.2 7 3 UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--
2,6-diaminopimelate ligase 
 UniRef90_A8ALA3  35.3 98.2 11 3 Acetyl-coenzyme A carboxylase carboxyl 
transferase subunit alpha 
 UniRef90_Q8X4S5 34.0 98.7 13 4 Arabinose 5-phosphate isomerase GutQ 
 UniRef90_P0A9R0 40.0 82.8 9 2 Aspartate-semialdehyde dehydrogenase 
 UniRef90_Q57M35 20.5 98.2 16 3 NADH-quinone oxidoreductase subunit I 
 UniRef90_Q0TIY7  21.7 82.8 11 2 Maf-like protein yceF 1 
 UniRef90_P58409 38.9 82.8 9 2 Uncharacterized oxidoreductase ybiC 
 UniRef90_P0ADS7 26.6 82.7 7 2 Uncharacterized protein yggE 
D06 UniRef90_P02930 53.7 99.1 19 8 Outer membrane protein tolC 
 UniRef90_B5Y275 44.4 98.9 16 5 Phosphopentomutase 
 UniRef90_P00888 38.8 98.7 12 4 Phospho-2-dehydro-3-deoxyheptonate aldolase, 
Tyr-sensitive 
 UniRef90_P0A9R0 40.0 82.9 9 2 Aspartate-semialdehyde dehydrogenase 
 UniRef90_A8AIH6  39.9 82.9 6 2 Phosphoserine aminotransferase 
 UniRef90_B7N5L4  44.2 82.9 6 2 CinA-like protein 
 UniRef90_P22715 37.3 82.8 6 2 UDP-glucose 4-epimerase 
D07 UniRef90_P09551 28.0 99.0 26 6 Lysine-arginine-ornithine-binding periplasmic 
protein 
 UniRef90_B5FTC5  27.7 99.0 22 5 Deoxyribose-phosphate aldolase 
 UniRef90_A7ZNJ3  39.4 99.0 15 6 Histidinol-phosphate aminotransferase 
 UniRef90_B7US97 36.8 82.8 8 2 Phenylalanine--tRNA ligase alpha subunit 
 UniRef90_A7FGQ6  25.1 82.8 10 2 NADH-quinone oxidoreductase subunit B 
 UniRef90_B7MG93 39.2 82.8 7 2 Chorismate synthase 
 UniRef90_P22715 37.3 96.5 9 2 UDP-glucose 4-epimerase 
 UniRef90_A8AJD6  63.5 82.6 3 2 Glutamine--tRNA ligase 
D08 UniRef90_Q9S5G5  40.3 99.0 15 6 Histidine biosynthesis bifunctional protein HisB 
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 UniRef90_P06971 82.2 98.7 6 4 Ferrichrome-iron receptor 
 UniRef90_Q8X4S5 34.0 98.9 18 6 Arabinose 5-phosphate isomerase GutQ 
 UniRef90_B2U2C1 36.4 99.0 12 4 Adenosine deaminase 
 UniRef90_P0ADS7 26.6 98.1 16 4 Uncharacterized protein yggE 
 UniRef90_P0A9K5  39.0 98.1 10 3 PhoH-like protein 
 UniRef90_A7FGQ6  25.1 82.3 10 2 NADH-quinone oxidoreductase subunit B 
D09 UniRef90_A8ALC4  29.9 98.9 24 5 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-
succinyltransferase 
 UniRef90_A7MH28 43.3 98.7 14 4 Acetate kinase 
 UniRef90_P31550 36.2 98.7 15 4 Thiamine-binding periplasmic protein 
 UniRef90_A8ANW0  16.9 82.6 19 2 2-C-methyl-D-erythritol 2,4-cyclodiphosphate 
synthase 
 UniRef90_B5Y275 44.4 98.1 8 3 Phosphopentomutase 
 UniRef90_A7ZN88 31.2 82.5 8 2 Molecular chaperone Hsp31 and glyoxalase 3 
 UniRef90_B2VCV8 15.8 82.6 17 2 50S ribosomal protein L9 
 UniRef90_P0AEX1 33.8 82.4 5 2 1-phosphofructokinase 
 UniRef90_P0C0L2  15.1 82.5 14 2 Peroxiredoxin osmC 
 UniRef90_P0A9D3 22.9 82.4 10 2 Glutathione S-transferase GstA 
D10 UniRef90_Q0T204 40.7 99.1 23 9 4-hydroxy-3-methylbut-2-en-1-yl diphosphate 
synthase 
 UniRef90_A7ZVS5  47.2 99.1 23 8 Thymidine phosphorylase 
 UniRef90_P06971 82.2 99.0 10 6 Ferrichrome-iron receptor 
 UniRef90_Q8X769 50.5 99.0 13 6 Fumarate hydratase class II 
 UniRef90_P09551 28.0 99.0 26 6 Lysine-arginine-ornithine-binding periplasmic 
protein 
 UniRef90_P19926 45.7 98.7 11 4 Glucose-1-phosphatase 
 UniRef90_Q8X9Z2 53.4 98.7 9 4 UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--
2,6-diaminopimelate ligase 
 UniRef90_P0AFK9  38.9 99.0 19 7 Spermidine/putrescine-binding periplasmic 
protein 
 UniRef90_A7ZPV7  47.0 83.2 8 2 Histidine--tRNA ligase 
 UniRef90_Q3Z606 35.2 82.7 7 2 Transaldolase 1 
D11 UniRef90_P19926 45.7 98.7 13 4 Glucose-1-phosphatase 
 UniRef90_P77804 54.7 98.9 11 5 Protein ydgA 
 UniRef90_Q9S5G5  40.3 98.1 10 3 Histidine biosynthesis bifunctional protein HisB 
 UniRef90_A8ACN6  50.3 82.5 5 2 ATP synthase subunit beta 
 UniRef90_P66794 36.7 82.5 6 2 Selenide, water dikinase 
 UniRef90_B7N5L4  44.2 82.5 6 2 CinA-like protein 
D12 UniRef90_A8ACN6  50.3 98.9 16 5 ATP synthase subunit beta 
 UniRef90_A8ANW8  28.0 98.7 18 4 Phosphoadenosine phosphosulfate reductase 
 UniRef90_P0AEJ3 42.9 98.7 11 4 Isochorismate synthase entC 
 UniRef90_A1AC10 42.4 98.7 11 4 Phosphoribosylglycinamide formyltransferase 2 
 UniRef90_Q0T204 40.7 82.8 6 2 4-hydroxy-3-methylbut-2-en-1-yl diphosphate 
synthase 
 
Row E Cluster ID 
MW 
(kDa)* 
Score 
% 
Sequence 
Coverage 
(%) 
# of 
Unique 
Peptides 
Protein Name 
E01 NA NA NA   NA 
E02 UniRef90_B7US97 36.8 99.1 32 10 Phenylalanine--tRNA ligase alpha subunit 
 UniRef90_P06971 82.2 99.0 11 8 Ferrichrome-iron receptor 
 UniRef90_A7ZNJ1  33.4 98.9 18 5 ATP phosphoribosyltransferase 
 UniRef90_A7ZHM4 28.2 98.2 13 3 3-methyl-2-oxobutanoate 
hydroxymethyltransferase 
 UniRef90_A9MHF3  12.3 98.2 26 3 50S ribosomal protein L7/L12 
 UniRef90_P0AD98 39.1 82.6 6 2 Leu/Ile/Val-binding protein 
 UniRef90_A8AIH6  39.8 82.6 6 2 Phosphoserine aminotransferase 
 UniRef90_P21367 23.1 82.6 9 2 Uncharacterized protein ycaC 
 UniRef90_Q8FF18  26.4 82.3 9 2 Pyridoxine 5'-phosphate synthase 
E03 UniRef90_B5F446 34.4 99.0 30 8 Aspartate carbamoyltransferase 
 UniRef90_A1AC10 42.4 99.1 26 9 Phosphoribosylglycinamide formyltransferase 2 
 UniRef90_A7FGQ6  25.1 98.9 26 5 NADH-quinone oxidoreductase subunit B 
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 UniRef90_P0ABK6  34.5 98.7 15 4 Cysteine synthase A 
 UniRef90_P06971 82.2 98.7 6 4 Ferrichrome-iron receptor 
 UniRef90_P0AD98 39.1 98.5 13 3 Leu/Ile/Val-binding protein 
 UniRef90_A4WC74 28.4 98.7 20 4 Imidazole glycerol phosphate synthase subunit 
HisF 
 UniRef90_P76576 22.2 98.1 18 3 UPF0070 protein yfgM 
 UniRef90_A8AIH6  39.8 82.6 6 2 Phosphoserine aminotransferase 
 UniRef90_P66794 36.7 82.5 5 2 Selenide, water dikinase 
 UniRef90_P0AAY0  33.3 98.1 12 3 Probable L,D-transpeptidase YbiS 
E04 UniRef90_P0AEZ1  33.1 99.0 22 6 5,10-methylenetetrahydrofolate reductase 
 UniRef90_A7ZSR4 38.9 98.7 14 4 3-dehydroquinate synthase 
 UniRef90_P76576 22.2 98.2 18 3 UPF0070 protein yfgM 
 UniRef90_B5F6U1 49.9 98.7 15 4 Argininosuccinate synthase 
 UniRef90_B7UN33 19.0 98.2 22 3 3-hydroxydecanoyl-[acyl-carrier-protein] 
dehydratase 
 UniRef90_P0AD98 39.1 82.6 6 2 Leu/Ile/Val-binding protein 
 UniRef90_P12758 27.2 82.6 8 2 Uridine phosphorylase 
 UniRef90_A8AIH6  39.8 82.6 6 2 Phosphoserine aminotransferase 
 UniRef90_Q83IW8  26.7 98.1 10 3 Uncharacterized protein yigA 
E05 UniRef90_P16703 32.7 99.1 33 8 Cysteine synthase B 
 UniRef90_P26646 34.7 98.2 12 3 Putative quinone oxidoreductase YhdH 
 UniRef90_A4WC74 28.4 98.2 14 3 Imidazole glycerol phosphate synthase subunit 
HisF 
 UniRef90_A7ZHM4 28.2 98.2 13 3 3-methyl-2-oxobutanoate 
hydroxymethyltransferase 
 UniRef90_A8ALS4  28.7 82.8 9 2 Dihydrodipicolinate reductase 
 UniRef90_P23905 35.7 82.8 9 2 D-galactose-binding periplasmic protein 
 UniRef90_A7ZNJ1  33.4 82.7 7 2 ATP phosphoribosyltransferase 
 UniRef90_A7ZKL2  21.2 98.1 12 3 UPF0227 protein ycfP 
 UniRef90_Q46856 42.1 82.8 5 2 Alcohol dehydrogenase YqhD 
 UniRef90_Q46868 11.3 82.7 17 2 Uncharacterized protein yqiC 
E06 UniRef90_A7FGQ6  25.1 82.7 10 2 NADH-quinone oxidoreductase subunit B 
 UniRef90_P33362 32.6 98.8 15 4 Putative osmoprotectant uptake system substrate-
binding protein osmF 
 UniRef90_Q46856 42.1 98.7 11 4 Alcohol dehydrogenase YqhD 
 UniRef90_A9MHF3  12.3 82.7 19 2 50S ribosomal protein L7/L12 
 UniRef90_A7ZHY1  20.8 73.5 10 2 Phosphoheptose isomerase 
E07 UniRef90_A8ANW8  28.0 99.1 35 9 Phosphoadenosine phosphosulfate reductase 
 UniRef90_A8AIH6  39.8 98.9 17 5 Phosphoserine aminotransferase 
 UniRef90_P0AEZ1  33.1 98.9 18 5 5,10-methylenetetrahydrofolate reductase 
 UniRef90_P22731 26.3 98.9 23 5 High-affinity branched-chain amino acid 
transport ATP-binding protein LivF 
 UniRef90_A7ZPX4  45.1 98.7 12 4 Cysteine desulfurase 
 UniRef90_P0AD98 39.1 98.1 8 3 Leu/Ile/Val-binding protein 
 UniRef90_Q8X732 35.9 98.2 8 3 N-acetyl-gamma-glutamyl-phosphate reductase 
 UniRef90_P09551 28.0 82.7 9 2 Lysine-arginine-ornithine-binding periplasmic 
protein 
 UniRef90_P0ADU3 11.5 82.7 17 2 Probable quinol monooxygenase ygiN 
 UniRef90_A7ZIJ5  23.2 82.4 7 2 ATP-dependent Clp protease proteolytic subunit 
E08 UniRef90_B5F446 34.4 99.1 32 9 Aspartate carbamoyltransferase 
 UniRef90_P0AEN0 29.0 99.0 28 7 Cystine-binding periplasmic protein 
 UniRef90_P16703 32.7 98.9 22 5 Cysteine synthase B 
 UniRef90_P25526 51.7 99.0 13 6 Succinate-semialdehyde dehydrogenase 
[NADP(+)] GabD 
 UniRef90_P08200 45.8 98.9 12 5 Isocitrate dehydrogenase [NADP] 
 UniRef90_P0A9L3  22.2 98.2 18 3 FKBP-type 22 kDa peptidyl-prolyl cis-trans 
isomerase 
 UniRef90_P11880 47.4 98.2 9 3 UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-
alanine ligase 
 UniRef90_B7UN33 19.0 98.7 22 4 3-hydroxydecanoyl-[acyl-carrier-protein] 
dehydratase 
 UniRef90_Q8X732 35.9 98.2 8 3 N-acetyl-gamma-glutamyl-phosphate reductase 
 UniRef90_P09029 39.5 82.4 5 2 N5-carboxyaminoimidazole ribonucleotide 
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synthase 
E09 UniRef90_B7UPI6  61.5 99.1 17 8 Glucose-6-phosphate isomerase 
 UniRef90_P33362 32.6 98.9 19 5 Putative osmoprotectant uptake system substrate-
binding protein osmF 
 UniRef90_A1AFA2  22.9 98.9 27 5 Ribose-5-phosphate isomerase A 
 UniRef90_P67271 26.9 98.7 26 4 UPF0135 protein ybgI 
 UniRef90_A8ALC4  29.9 98.9 23 5 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-
succinyltransferase 
 UniRef90_A8ANW8  28.0 98.9 22 5 Phosphoadenosine phosphosulfate reductase 
 UniRef90_A7ZI01  39.1 98.9 14 5 Glutamate 5-kinase 
 UniRef90_P23847 60.3 98.2 6 3 Periplasmic dipeptide transport protein 
 UniRef90_P34209 29.7 82.7 9 2 Protein ydcF 
 UniRef90_P21367 23.1 98.2 18 3 Uncharacterized protein ycaC 
 UniRef90_P23905 35.7 82.7 7 2 D-galactose-binding periplasmic protein 
E10 UniRef90_Q8FBC3 56.2 99.0 12 6 Glycerol kinase 
 UniRef90_P77804 54.7 99.0 13 6 Protein ydgA 
 UniRef90_A8ADK6  34.7 98.7 15 4 Glucokinase 
 UniRef90_B7MI93 42.3 98.7 18 4 Acetylornithine deacetylase 
 UniRef90_P0AD98 39.1 98.6 13 3 Leu/Ile/Val-binding protein 
 UniRef90_P12758 27.2 98.2 12 3 Uridine phosphorylase 
 UniRef90_Q32EF3 26.0 98.2 14 3 1-(5-phosphoribosyl)-5-[(5-
phosphoribosylamino)methylideneamino] 
imidazole-4-carboxamide isomerase 
 UniRef90_P60596 21.6 82.7 11 2 Imidazole glycerol phosphate synthase subunit 
HisH 
 UniRef90_A7ZKL2  21.2 73.8 8 2 UPF0227 protein ycfP 
E11 UniRef90_P26646 34.7 99.1 33 8 Putative quinone oxidoreductase YhdH 
 UniRef90_P77804 54.7 99.1 19 7 Protein ydgA 
 UniRef90_A8ALC4  29.9 98.7 17 4 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-
succinyltransferase 
 UniRef90_P25526 51.7 98.7 10 4 Succinate-semialdehyde dehydrogenase 
[NADP(+)] GabD 
 UniRef90_P0AFG9  99.7 99.0 6 6 Pyruvate dehydrogenase E1 component 
 UniRef90_P23847 60.3 98.7 9 4 Periplasmic dipeptide transport protein 
 UniRef90_A7ZPS1  27.0 82.8 7 2 Phosphoribosylaminoimidazole-
succinocarboxamide synthase 
 UniRef90_P37648 55.5 83.0 5 2 Protein yhjJ 
 UniRef90_A7ZNJ1  33.4 82.9 7 2 ATP phosphoribosyltransferase 
 UniRef90_P0AAY0  33.3 87.6 9 2 Probable L,D-transpeptidase YbiS 
E12 UniRef90_A1AC10 42.3 99.1 27 8 Phosphoribosylglycinamide formyltransferase 2 
 UniRef90_P0A9S4 37.4 99.1 24 8 Galactitol-1-phosphate 5-dehydrogenase 
 UniRef90_P67271 26.9 98.9 30 5 UPF0135 protein ybgI 
 UniRef90_A7ZNJ1  33.4 99.0 20 6 ATP phosphoribosyltransferase 
 UniRef90_Q32EF3 26.0 99.0 33 5 1-(5-phosphoribosyl)-5-[(5-
phosphoribosylamino)methylideneamino] 
imidazole-4-carboxamide isomerase 
 UniRef90_P0ABU1 31.6 98.4 15 3 1,4-Dihydroxy-2-naphthoyl-CoA synthase 
 UniRef90_A8AHY1  33.5 83.0 7 2 3-oxoacyl-[acyl-carrier-protein] synthase 3 
 UniRef90_A7ZSR4 38.9 83.0 6 2 3-dehydroquinate synthase 
 UniRef90_Q8XBL0  30.8 98.0 9 3 Pyridoxine kinase 
 UniRef90_A8AIH6  39.8 76.5 6 2 Phosphoserine aminotransferase 
 
Row F Cluster ID 
MW 
(kDa)* 
Score 
% 
Sequence 
Coverage 
(%) 
# of 
Unique 
Peptides 
Protein Name 
F01 UniRef90_Q0T204 40.7 99.1 40 14 4-hydroxy-3-methylbut-2-en-1-yl diphosphate 
synthase 
 UniRef90_B7MIX6  26.9 99.1 41 9 Thiazole synthase 
 UniRef90_P07023 42.0 42.0 28 11 T-protein 
 UniRef90_P33570 35.7 99.1 31 8 Transketolase 2 
 UniRef90_Q57T38 30.4 99.1 33 9 Elongation factor Ts 
 UniRef90_P0ADG8  52.0 98.7 11 4 Inosine-5'-monophosphate dehydrogenase 
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 UniRef90_A8ALC9  24.4 98.5 26 3 5'-methylthioadenosine/S-adenosylhomocysteine 
nucleosidase 
 UniRef90_P0AB92 38.0 98.9 18 5 Phospho-2-dehydro-3-deoxyheptonate aldolase, 
Phe-sensitive 
 UniRef90_P0AET9  26.8 98.9 22 5 7-alpha-hydroxysteroid dehydrogenase 
 UniRef90_P00509 43.6 99.1 17 7 Aspartate aminotransferase 
 UniRef90_P0AFU8  23.4 98.9 24 5 Riboflavin synthase alpha chain 
 UniRef90_P0C8J9 47.1 98.9 13 5 D-tagatose-1,6-bisphosphate aldolase subunit 
gatZ 
 UniRef90_P0AGD5  21.3 98.7 20 4 Superoxide dismutase [Fe] 
 UniRef90_Q7N590 34.2 83.1 8 2 Ribose-phosphate pyrophosphokinase 
 UniRef90_Q3Z3B7 20.8 83.1 12 2 Flavoprotein WrbA 
F02 UniRef90_A8AIH5  46.1 99.1 27 11 3-phosphoshikimate 1-carboxyvinyltransferase 
 UniRef90_P0A9P5 34.6 99.1 27 7 Thioredoxin reductase 
 UniRef90_P0A252 20.8 98.9 38 5 Alkyl hydroperoxide reductase subunit C 
 UniRef90_P0ADG8  52.0 98.4 9 3 Inosine-5'-monophosphate dehydrogenase 
 UniRef90_Q57T38 30.4 99.1 26 8 Elongation factor Ts 
 UniRef90_P19480 56.2 99.1 16 7 Alkyl hydroperoxide reductase subunit F 
 UniRef90_B7N6B0 46.2 98.9 12 5 Peptidase B 
 UniRef90_P0AGD5  21.3 98.9 40 5 Superoxide dismutase [Fe] 
 UniRef90_P00904 56.9 98.2 7 3 Anthranilate synthase component II 
 UniRef90_A7ZUD3  27.0 98.7 16 4 Triosephosphate isomerase 
 UniRef90_P0A7B0 19.7 98.7 22 4 Inorganic pyrophosphatase 
 UniRef90_P23847 60.3 83.0 4 2 Periplasmic dipeptide transport protein 
 UniRef90_A8API1  11.0 98.2 27 3 Probable Fe(2+)-trafficking protein 
 UniRef90_P0A9T9 24.5 83.0 9 2 Uncharacterized ABC transporter ATP-binding 
protein YbbA 
 UniRef90_A7ZLL8  62.8 83.0 3 2 Glucans biosynthesis protein D 
F03 UniRef90_B7N6B0 46.2 99.1 33 13 Peptidase B 
 UniRef90_A7FDW9  44.8 99.1 27 10 UDP-N-acetylglucosamine 1-
carboxyvinyltransferase 
 UniRef90_P77804 54.7 99.1 20 8 Protein ydgA 
 UniRef90_A8AHY1  33.5 99.1 29 7 3-oxoacyl-[acyl-carrier-protein] synthase 3 
 UniRef90_P0AFU8  23.4 99.0 38 6 Riboflavin synthase alpha chain 
 UniRef90_Q57RI5  28.6 98.9 22 5 2,3-bisphosphoglycerate-dependent 
phosphoglycerate mutase 
 UniRef90_P76422 28.6 98.7 23 4 Hydroxymethylpyrimidine/phosphomethylpyrimi
dine kinase 
 UniRef90_P0AGD5  21.3 99.0 37 6 Superoxide dismutase [Fe] 
 UniRef90_A7ZIN4  23.6 98.7 21 4 Adenylate kinase 
 UniRef90_P10346 26.7 83.0 9 2 Glutamine transport ATP-binding protein GlnQ 
 UniRef90_A7ZNJ3  39.4 98.7 10 4 Histidinol-phosphate aminotransferase 
 UniRef90_P67082 25.8 97.8 15 3 UPF0001 protein yggS 
 UniRef90_P0ACS1 20.6 81.5 12 2 Transcriptional repressor mprA 
F04 UniRef90_B7LNW7  37.2 99.1 31 11 Outer membrane protein A 
 UniRef90_P77804 54.7 99.1 30 11 Protein ydgA 
 UniRef90_P0AFK9  38.9 99.1 38 13 Spermidine/putrescine-binding periplasmic 
protein 
 UniRef90_Q7N590 34.2 99.0 26 6 Ribose-phosphate pyrophosphokinase 
 UniRef90_B7MIX6  26.9 99.1 34 8 Thiazole synthase 
 UniRef90_P0A9P5 34.6 99.0 25 7 Thioredoxin reductase 
 UniRef90_Q57T38 30.0 99.1 33 10 Elongation factor Ts 
 UniRef90_P0ADG8  52.0 98.9 13 5 Inosine-5'-monophosphate dehydrogenase 
 UniRef90_P0AET9  26.8 98.9 22 5 7-alpha-hydroxysteroid dehydrogenase 
 UniRef90_P0AE20 29.3 98.7 16 4 Methionine aminopeptidase 
 UniRef90_Q3Z606 35.2 98.7 12 4 Transaldolase 1 
 UniRef90_B7UPI6  61.5 98.9 11 5 Glucose-6-phosphate isomerase 
 UniRef90_P16657 27.9 98.2 10 3 Enoyl-[acyl-carrier-protein] reductase [NADH] 
FabI 
 UniRef90_P0ADS7 26.6 98.2 10 3 Uncharacterized protein yggE 
 UniRef90_A7ZNJ1  33.4 82.8 5 2 ATP phosphoribosyltransferase 
 UniRef90_P0ADN4 13.1 82.3 12 2 UPF0438 protein yifE 
F05 UniRef90_B7US97 36.8 99.1 41 14 Phenylalanine--tRNA ligase alpha subunit 
 UniRef90_P0ADG8  52.0 99.0 17 7 Inosine-5'-monophosphate dehydrogenase 
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 UniRef90_A7ZTA0  35.4 99.1 27 8 Glyoxylate/hydroxypyruvate reductase B 
 UniRef90_Q9S5G5  40.3 99.0 23 7 Histidine biosynthesis bifunctional protein HisB 
 UniRef90_P39099 47.2 99.0 15 7 Periplasmic pH-dependent serine endoprotease 
DegQ 
 UniRef90_P16657 27.9 98.9 19 5 Enoyl-[acyl-carrier-protein] reductase [NADH] 
FabI 
 UniRef90_A7ZUD3  27.0 98.9 20 4 Triosephosphate isomerase 
 UniRef90_P0AD98 39.1 98.2 10 3 Leu/Ile/Val-binding protein 
 UniRef90_Q3Z3B7 20.8 98.2 16 3 Flavoprotein WrbA 
 UniRef90_P0AE20 29.3 98.2 12 3 Methionine aminopeptidase 
 UniRef90_P0A797 34.8 98.9 13 5 6-phosphofructokinase isozyme 1 
 UniRef90_P00509 43.6 98.7 10 4 Aspartate aminotransferase 
 UniRef90_A7ZIN4  23.6 98.2 16 3 Adenylate kinase 
 UniRef90_Q57RI5  28.6 98.2 13 3 2,3-bisphosphoglycerate-dependent 
phosphoglycerate mutase 
 UniRef90_P0AEG7  25.6 82.8 9 2 Thiol:disulfide interchange protein DsbC 
 UniRef90_P0ADS7 26.6 82.8 7 2 Uncharacterized protein yggE 
 UniRef90_P38489 23.9 59.5 5 2 Oxygen-insensitive NAD(P)H nitroreductase 
F06 UniRef90_B7LNW7  37.2 99.0 24 8 Outer membrane protein A 
 UniRef90_A7FDW9  44.8 99.1 20 8 UDP-N-acetylglucosamine 1-
carboxyvinyltransferase 
 UniRef90_P07003 62.0 99.1 19 9 Pyruvate dehydrogenase [ubiquinone] 
 UniRef90_P0AEZ1  33.1 99.0 27 6 5,10-methylenetetrahydrofolate reductase 
 UniRef90_A8AEK3  39.4 99.1 20 8 Histidinol-phosphate aminotransferase 
 UniRef90_A8ALC9  24.4 82.9 10 2 5'-methylthioadenosine/S-adenosylhomocysteine 
nucleosidase 
 UniRef90_A8API1  11.0 98.2 27 3 Probable Fe(2+)-trafficking protein 
 UniRef90_P0AAY0  33.3 89.5 8 2 Probable L,D-transpeptidase YbiS 
 UniRef90_A7ZNJ1  33.4 62.6 6 2 ATP phosphoribosyltransferase 
F07 UniRef90_P18815 43.4 99.1 38 15 Maltose-binding periplasmic protein 
 UniRef90_Q8FG52  46.1 99.1 23 9 Histidinol dehydrogenase 
 UniRef90_A8AIH5  46.1 99.1 26 10 3-phosphoshikimate 1-carboxyvinyltransferase 
 UniRef90_Q8XEG2 66.9 99.1 16 8 Glucosamine--fructose-6-phosphate 
aminotransferase [isomerizing] 
 UniRef90_A7ZII0  18.3 99.0 47 6 UPF0234 protein yajQ 
 UniRef90_A7ZPX4  45.1 99.0 18 6 Cysteine desulfurase 
 UniRef90_A8AEK3  46.1 99.1 26 9 Histidinol-phosphate aminotransferase 
 UniRef90_B7US97 36.8 98.7 15 4 Phenylalanine--tRNA ligase alpha subunit 
 UniRef90_A8ACN6  50.3 98.9 12 5 ATP synthase subunit beta 
 UniRef90_P0AGD5  21.3 99.0 35 6 Superoxide dismutase [Fe] 
 UniRef90_A7MH28 43.3 83.0 6 2 Acetate kinase 
 UniRef90_P07023 42.0 82.8 5 2 T-protein 
 UniRef90_P0ADN4 13.1 75.0 12 2 UPF0438 protein yifE 
F08 UniRef90_Q8XEG2 66.9 99.1 24 13 Glucosamine--fructose-6-phosphate 
aminotransferase [isomerizing] 
 UniRef90_P0AFK9  38.9 99.1 33 11 Spermidine/putrescine-binding periplasmic 
protein 
 UniRef90_P25526 51.7 99.1 19 9 Succinate-semialdehyde dehydrogenase 
[NADP(+)] GabD 
 UniRef90_B7N6B0 46.2 99.0 18 7 Peptidase B 
 UniRef90_P0AB92 38.0 98.9 18 5 Phospho-2-dehydro-3-deoxyheptonate aldolase, 
Phe-sensitive 
 UniRef90_P07023 42.0 99.1 27 10 T-protein 
 UniRef90_P33570 35.7 99.0 20 6 Transketolase 2 
 UniRef90_P0ADG8  52.0 98.7 9 4 Inosine-5'-monophosphate dehydrogenase 
 UniRef90_P00904 56.9 98.9 11 5 Anthranilate synthase component II 
 UniRef90_A8AEK3  39.4 99.1 22 8 Histidinol-phosphate aminotransferase 
 UniRef90_P0ACE1 62.5 98.7 7 4 Hydrogenase-2 large chain 
 UniRef90_P00893 63.0 98.9 8 5 Acetolactate synthase isozyme 3 large subunit 
 UniRef90_A8AKV5  42.0 82.9 6 2 tRNA (uracil(54)-C(5))-methyltransferase 
 UniRef90_B7UPI6  61.5 98.2 5 3 Glucose-6-phosphate isomerase 
 UniRef90_P0ACS1 20.6 78.3 9 2 Transcriptional repressor mprA 
F09 UniRef90_B7N6B0 46.2 99.1 26 9 Peptidase B 
 UniRef90_P0A9L8  28.1 99.0 26 6 Pyrroline-5-carboxylate reductase 
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 UniRef90_Q7N590 34.2 98.9 22 5 Ribose-phosphate pyrophosphokinase 
 UniRef90_P0AEZ1  33.1 99.0 21 6 5,10-methylenetetrahydrofolate reductase 
 UniRef90_P07003 62.0 99.0 13 6 Pyruvate dehydrogenase [ubiquinone] 
 UniRef90_Q8XEG2 66.9 99.0 10 6 Glucosamine--fructose-6-phosphate 
aminotransferase [isomerizing] 
 UniRef90_P10346 26.7 98.2 15 3 Glutamine transport ATP-binding protein GlnQ 
 UniRef90_P38489 23.9 83.0 10 3 Oxygen-insensitive NAD(P)H nitroreductase 
 UniRef90_P33362 32.6 98.9 15 5 Putative osmoprotectant uptake system substrate-
binding protein osmF 
 UniRef90_P76004 23.7 83.0 11 2 Uncharacterized protein ycgM 
 UniRef90_Q57T38 30.4 98.9 20 5 Elongation factor Ts 
 UniRef90_Q8X4S6 43.8 83.0 5 2 Acetylornithine/succinyldiaminopimelate 
aminotransferase 
 UniRef90_P0AFH9  21.1 83.0 10 2 Osmotically-inducible protein Y 
 UniRef90_P09030 31.0 83.0 9 2 Exodeoxyribonuclease III 
 UniRef90_P67082 25.8 83.0 9 2 UPF0001 protein yggS 
F10 UniRef90_P07023 42.0 99.1 39 17 T-protein 
 UniRef90_B7N6B0 46.2 99.1 28 10 Peptidase B 
 UniRef90_P39099 47.2 99.1 26 11 Periplasmic pH-dependent serine endoprotease 
DegQ 
 UniRef90_B7LNW7  37.2 99.1 26 9 Outer membrane protein A 
 UniRef90_P25526 51.7 99.1 19 10 Succinate-semialdehyde dehydrogenase 
[NADP(+)] GabD 
 UniRef90_Q8FG52  46.1 99.0 19 6 Histidinol dehydrogenase 
 UniRef90_Q0T204 40.7 99.0 17 7 4-hydroxy-3-methylbut-2-en-1-yl diphosphate 
synthase 
 UniRef90_A8ALG8  32.3 98.7 19 4 Spermidine synthase 
 UniRef90_P09030 31.0 98.9 18 5 Exodeoxyribonuclease III 
 UniRef90_P0A9K5  39.0 98.7 12 5 PhoH-like protein 
 UniRef90_P00509 43.6 98.9 12 5 Aspartate aminotransferase 
 UniRef90_P33362 32.6 98.7 15 4 Putative osmoprotectant uptake system substrate-
binding protein osmF 
 UniRef90_B5F769 31.3 98.2 9 3 Bis(5'-nucleosyl)-tetraphosphatase, symmetrical 
 UniRef90_P0AF09  39.9 83.0 5 2 Protein mrp 
 UniRef90_A8ACN6  55.2 79.4 5 2 ATP synthase subunit beta 
F11 UniRef90_Q0T204 40.7 99.1 45 15 4-hydroxy-3-methylbut-2-en-1-yl diphosphate 
synthase 
 UniRef90_P0AFK9  38.9 99.1 33 11 Spermidine/putrescine-binding periplasmic 
protein 
 UniRef90_B7US97 36.8 98.9 18 5 Phenylalanine--tRNA ligase alpha subunit 
 UniRef90_P33570 35.7 99.1 21 7 Transketolase 2 
 UniRef90_P0A797 34.8 99.1 22 7 6-phosphofructokinase isozyme 1 
 UniRef90_P0A9K5  39.0 98.9 16 6 PhoH-like protein 
 UniRef90_P0A9L8  28.1 98.2 14 3 Pyrroline-5-carboxylate reductase 
 UniRef90_A8AEK3  39.4 99.1 20 8 Histidinol-phosphate aminotransferase 
 UniRef90_P19480 56.2 99.0 14 6 Alkyl hydroperoxide reductase subunit F 
 UniRef90_P0AEZ1  33.1 98.7 12 4 5,10-methylenetetrahydrofolate reductase 
 UniRef90_Q3Z606 35.2 62.6 9 2 Transaldolase 1 
 UniRef90_P76569 11.3 59.7 11 2 Uncharacterized protein YfgD 
F12 NA NA NA NA NA NA 
 
Row G Cluster ID 
MW 
(kDa)* 
Score 
% 
Sequence 
Coverage 
(%) 
# of 
Unique 
Peptides 
Protein Name 
G01 UniRef90_P19480 56.2 99.1 26 12 Alkyl hydroperoxide reductase subunit F 
 UniRef90_Q57T38 30.4 99.1 33 10 Elongation factor Ts 
 UniRef90_A1AFA2  22.9 98.9 27 5 Ribose-5-phosphate isomerase A 
 UniRef90_P0AEU2 28.5 98.7 18 5 Histidine-binding periplasmic protein 
 UniRef90_P0A9J9 43.1 98.9 12 6 P-protein 
 UniRef90_A8ACN8  55.2 99.0 12 6 ATP synthase subunit alpha 
 UniRef90_P0ADG8  52.0 83.0 5 2 Inosine-5'-monophosphate dehydrogenase 
 UniRef90_P0A957 22.2 98.2 15 3 KHG/KDPG aldolase 
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 UniRef90_P0A9D3 22.9 98.2 16 3 Glutathione S-transferase GstA 
 UniRef90_P21367 23.1 98.2 14 3 Uncharacterized protein ycaC 
 UniRef90_Q8FK07  15.9 98.2 26 3 Universal stress protein G 
 UniRef90_B5FI12  15.2 98.1 21 3 Ribosome-binding factor A 
G02 UniRef90_A8ACN6  50.3 99.1 40 14 ATP synthase subunit beta 
 UniRef90_A7ZHG6  57.3 99.1 24 12 2-isopropylmalate synthase 
 UniRef90_B7US97 36.8 99.1 29 9 Phenylalanine--tRNA ligase alpha subunit 
 UniRef90_A7FDW9  44.8 99.1 24 10 UDP-N-acetylglucosamine 1-
carboxyvinyltransferase 
 UniRef90_Q8XEG2 66.9 99.1 19 10 Glucosamine--fructose-6-phosphate 
aminotransferase [isomerizing] 
 UniRef90_P00370 48.6 83.1 6 2 NADP-specific glutamate dehydrogenase 
 UniRef90_A7ZIN4  23.6 98.9 25 5 Adenylate kinase 
 UniRef90_Q57RI5  28.6 98.2 13 3 2,3-bisphosphoglycerate-dependent 
phosphoglycerate mutase 
 UniRef90_P0ADG8  52.0 83.1 5 2 Inosine-5'-monophosphate dehydrogenase 
 UniRef90_P21367 23.1 98.2 14 3 Uncharacterized protein ycaC 
 UniRef90_A7ZHM4 28.2 83.1 9 2 3-methyl-2-oxobutanoate 
hydroxymethyltransferase 
 UniRef90_P0A4L6  23.1 98.2 13 3 Thiol:disulfide interchange protein DsbA 
 UniRef90_P19480 56.2 98.2 5 3 Alkyl hydroperoxide reductase subunit F 
 UniRef90_P0ACE1 62.5 98.2 5 3 Hydrogenase-2 large chain 
 UniRef90_P00893 63.0 98.9 8 5 Acetolactate synthase isozyme 3 large subunit 
 UniRef90_A7ZML6  43.7 82.7 4 2 Succinylornithine transaminase 
 UniRef90_P36938 58.4 82.7 3 2 Phosphoglucomutase 
G03 UniRef90_Q57T38 30.4 99.1 41 11 Elongation factor Ts 
 UniRef90_P0A6C9 27.0 99.1 37 8 Acetylglutamate kinase 
 UniRef90_A7MH28 43.3 99.0 20 6 Acetate kinase 
 UniRef90_P00370 48.6 99.0 19 6 NADP-specific glutamate dehydrogenase 
 UniRef90_P0AEU2 28.5 98.7 18 5 Histidine-binding periplasmic protein 
 UniRef90_A7ZPZ4  45.3 99.1 17 7 Serine hydroxymethyltransferase 
 UniRef90_Q8XBT6 31.1 99.1 29 8 2,5-diketo-D-gluconic acid reductase A 
 UniRef90_P0C8J9 47.1 99.0 13 6 D-tagatose-1,6-bisphosphate aldolase subunit 
gatZ 
 UniRef90_A7ZPS4  31.3 98.7 15 4 Dihydrodipicolinate synthase 
 UniRef90_B7UN33 19.0 98.7 27 4 3-hydroxydecanoyl-[acyl-carrier-protein] 
dehydratase 
 UniRef90_P0A9D6 29.3 98.7 14 4 Serine acetyltransferase 
 UniRef90_A7ZHM4 28.2 83.1 9 2 3-methyl-2-oxobutanoate 
hydroxymethyltransferase 
 UniRef90_Q9S5G5  28.5 98.7 5 2 Histidine biosynthesis bifunctional protein HisB 
 UniRef90_P0A9T2 44.2 83.0 5 2 D-3-phosphoglycerate dehydrogenase 
G04 UniRef90_P00370 48.6 99.1 36 15 NADP-specific glutamate dehydrogenase 
 UniRef90_P33570 35.7 99.1 42 12 Transaldolase A 
 UniRef90_P02925 31.0 99.0 26 7 D-ribose-binding periplasmic protein 
 UniRef90_P0A252 20.8 99.0 44 6 Alkyl hydroperoxide reductase subunit C 
 UniRef90_A7FDW9  44.8 99.1 19 8 UDP-N-acetylglucosamine 1-
carboxyvinyltransferase 
 UniRef90_P78067 48.2 99.0 17 5 Thiosulfate sulfurtransferase YnjE 
 UniRef90_Q57RI5  28.6 98.9 22 4 2,3-bisphosphoglycerate-dependent 
phosphoglycerate mutase 
 UniRef90_Q8XBT6 31.1 99.1 25 7 2,5-diketo-D-gluconic acid reductase A 
 UniRef90_P0A919 18.6 98.2 22 3 Outer membrane protein X 
 UniRef90_P0AGD5  21.3 99.0 45 6 Superoxide dismutase [Fe] 
 UniRef90_A8AK39  16.2 98.7 39 4 6,7-dimethyl-8-ribityllumazine synthase 
 UniRef90_P0A9T2 44.2 98.9 11 5 D-3-phosphoglycerate dehydrogenase 
 UniRef90_P0ABC8 45.5 98.2 10 3 Protein HflK 
 UniRef90_A7ZPZ4  45.3 98.6 8 4 Serine hydroxymethyltransferase 
 UniRef90_P0AB92 38.0 82.9 6 2 Phospho-2-dehydro-3-deoxyheptonate aldolase, 
Phe-sensitive 
 UniRef90_B7US97 36.8 83.1 6 2 Phenylalanine--tRNA ligase alpha subunit 
 UniRef90_P0AEN0 29.0 98.6 13 3 Cystine-binding periplasmic protein 
 UniRef90_A7ZIN4  23.6 83.0 10 2 Adenylate kinase 
 UniRef90_P37769 27.1 83.0 9 2 2-dehydro-3-deoxy-D-gluconate 5-dehydrogenase 
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G05 UniRef90_P0A6C9 27.0 99.1 44 9 Acetylglutamate kinase 
 UniRef90_P0C8J9 47.1 99.1 25 10 D-tagatose-1,6-bisphosphate aldolase subunit 
gatZ 
 UniRef90_B7UH18 14.3 99.1 55 8 Autonomous glycyl radical cofactor 
 UniRef90_P0A252 20.8 98.7 27 4 Alkyl hydroperoxide reductase subunit C 
 UniRef90_P04816 39.4 99.0 18 6 Leucine-specific-binding protein 
 UniRef90_P0A797 34.8 99.1 22 8 6-phosphofructokinase isozyme 1 
 UniRef90_Q3Z3B7 20.8 98.9 31 4 Flavoprotein WrbA 
 UniRef90_A7ZPU1  22.5 98.7 20 5 Uracil phosphoribosyltransferase 
 UniRef90_P0ADK2  25.7 98.2 14 3 Uncharacterized protein yiaF 
 UniRef90_Q8XEG2 66.9 98.2 5 3 Glucosamine--fructose-6-phosphate 
aminotransferase [isomerizing] 
 UniRef90_P0AG09  24.6 82.9 8 2 Ribulose-phosphate 3-epimerase 
G06 UniRef90_A8ACN6  50.3 99.1 34 13 ATP synthase subunit beta 
 UniRef90_A8ACN8  55.2 99.1 28 12 ATP synthase subunit alpha 
 UniRef90_P19480 56.2 99.1 31 14 Alkyl hydroperoxide reductase subunit F 
 UniRef90_A7ZPZ4  45.3 99.1 17 7 Serine hydroxymethyltransferase 
 UniRef90_P0ADS7 26.6 99.0 25 7 Uncharacterized protein yggE 
 UniRef90_P0ACA5  24.3 98.9 25 5 Stringent starvation protein A 
 UniRef90_P02925 31.0 98.9 21 5 D-ribose-binding periplasmic protein 
 UniRef90_P21367 23.1 98.7 23 4 Uncharacterized protein ycaC 
 UniRef90_B7UH18 14.3 99.0 42 7 Autonomous glycyl radical cofactor 
 UniRef90_P00370 48.6 98.2 7 3 NADP-specific glutamate dehydrogenase 
 UniRef90_A7ZN88 31.2 94.4 12 2 Molecular chaperone Hsp31 and glyoxalase 3 
 UniRef90_P0A9T2 44.2 98.3 9 3 D-3-phosphoglycerate dehydrogenase 
 UniRef90_P23847 60.3 83.1 4 2 Periplasmic dipeptide transport protein 
 UniRef90_P0AFM7  25.5 97.3 11 2 Phage shock protein A 
 UniRef90_P0A6C9 27.0 83.1 7 2 Acetylglutamate kinase 
 UniRef90_Q8FG52  46.2 98.2 6 3 Histidinol dehydrogenase 
 UniRef90_A7ZHG6  57.3 83.1 4 2 2-isopropylmalate synthase 
 UniRef90_P09832 52.0 83.0 8 2 Glutamate synthase [NADPH] small chain 
 UniRef90_P30859 26.9 83.3 14 2 Putative ABC transporter arginine-binding 
protein 2 
G07 UniRef90_P00370 48.6 99.1 33 14 NADP-specific glutamate dehydrogenase 
 UniRef90_A8ACN6  50.3 99.1 28 11 ATP synthase subunit beta 
 UniRef90_A7ZSD0  32.3 99.1 29 9 Malate dehydrogenase 
 UniRef90_A7ZPS4  31.3 99.0 26 6 Dihydrodipicolinate synthase 
 UniRef90_P19480 56.2 99.1 21 10 Alkyl hydroperoxide reductase subunit F 
 UniRef90_P04816 39.4 99.1 23 7 Leucine-specific-binding protein 
 UniRef90_P58603 35.6 99.1 34 10 Protease 7 
 UniRef90_P0AFK9  38.9 99.1 28 10 Spermidine/putrescine-binding periplasmic 
protein 
 UniRef90_P0A9K5  39.0 99.0 22 7 PhoH-like protein 
 UniRef90_A7ZHG6  57.3 99.0 14 6 2-isopropylmalate synthase 
 UniRef90_P0AEU2 28.5 98.7 17 4 Histidine-binding periplasmic protein 
 UniRef90_P78067 48.2 96.8 6 2 Thiosulfate sulfurtransferase YnjE 
 UniRef90_A7ZPZ4  45.3 98.2 6 3 Serine hydroxymethyltransferase 
 UniRef90_P16657 27.9 83.0 7 2 Enoyl-[acyl-carrier-protein] reductase [NADH] 
FabI 
G08 UniRef90_B7US97 36.8 99.1 48 16 Phenylalanine--tRNA ligase alpha subunit 
 UniRef90_P0AET9  26.8 99.1 36 8 7-alpha-hydroxysteroid dehydrogenase 
 UniRef90_A8ACN8  55.2 99.1 25 11 ATP synthase subunit alpha 
 UniRef90_P0A9K5  39.0 99.1 25 8 PhoH-like protein 
 UniRef90_A8AIH5  46.1 99.1 21 9 3-phosphoshikimate 1-carboxyvinyltransferase 
 UniRef90_A1AFA2  22.9 98.9 27 5 Ribose-5-phosphate isomerase A 
 UniRef90_P0C8J9 47.1 99.1 24 9 D-tagatose-1,6-bisphosphate aldolase subunit 
gatZ 
 UniRef90_A7ZHY1  20.8 99.0 28 6 Phosphoheptose isomerase 
 UniRef90_P0ADK2  25.7 98.2 14 3 Uncharacterized protein yiaF 
 UniRef90_P23847 60.3 98.7 8 4 Periplasmic dipeptide transport protein 
 UniRef90_P30859 26.9 98.2 12 3 Putative ABC transporter arginine-binding 
protein 2 
 UniRef90_P0AG09  24.6 98.2 27 5 Ribulose-phosphate 3-epimerase 
 UniRef90_P09832 52.0 81.0 3 2 Glutamate synthase [NADPH] small chain 
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G09 UniRef90_P58603 35.6 99.1 40 2 Protease 7 
 UniRef90_P0ACA5  24.3 99.0 32 6 Stringent starvation protein A 
 UniRef90_A7ZPU1  22.5 99.0 36 7 Uracil phosphoribosyltransferase 
 UniRef90_P0A919 18.6 98.7 32 4 Outer membrane protein X 
 UniRef90_B5XNU6 19.6 99.1 49 8 UPF0304 protein KPK_1463 
 UniRef90_A8AIH5  46.1 99.1 21 8 3-phosphoshikimate 1-carboxyvinyltransferase 
 UniRef90_P04816 39.4 98.9 14 5 Leucine-specific-binding protein 
 UniRef90_B7UN33 19.0 98.9 27 5 3-hydroxydecanoyl-[acyl-carrier-protein] 
dehydratase 
 UniRef90_P0A957 22.3 98.7 20 4 KHG/KDPG aldolase 
 UniRef90_P0AEU2 28.5 98.7 21 4 Histidine-binding periplasmic protein 
 UniRef90_P0AE54 17.6 98.2 24 3 Putative peroxiredoxin bcp 
 UniRef90_P0A4L6  23.1 98.2 13 3 Thiol:disulfide interchange protein DsbA 
 UniRef90_P0A6C9 27.0 83.1 7 2 Acetylglutamate kinase 
 UniRef90_P0ADI8  20.5 83.1 11 2 Uncharacterized isochorismatase family protein 
yecD 
 UniRef90_P30859 26.9 83.0 7 2 Putative ABC transporter arginine-binding 
protein 2 
 UniRef90_P0AEN0 29.0 82.9 6 2 Cystine-binding periplasmic protein 
 UniRef90_P0A9D3 22.9 83.1 10 2 Glutathione S-transferase GstA 
G10 UniRef90_Q57T38 30.4 99.1 53 14 Elongation factor Ts 
 UniRef90_A7ZSD0  32.3 99.1 35 9 Malate dehydrogenase 
 UniRef90_P0A797 34.8 99.1 27 9 6-phosphofructokinase isozyme 1 
 UniRef90_B7MUC3 26.4 99.1 37 8 Orotidine 5'-phosphate decarboxylase 
 UniRef90_B7UH18 14.3 99.1 61 8 Autonomous glycyl radical cofactor 
 UniRef90_A7ZIN4  23.6 99.1 44 8 Adenylate kinase 
 UniRef90_A7ZTA0  35.4 98.2 10 3 Glyoxylate/hydroxypyruvate reductase B 
G11 UniRef90_A8ACN6  50.3 99.1 38 14 ATP synthase subunit beta 
 UniRef90_P0AFK9  38.9 99.1 29 11 Spermidine/putrescine-binding periplasmic 
protein 
 UniRef90_P04816 39.4 99.0 21 6 Leucine-specific-binding protein 
 UniRef90_P0AET9  26.8 99.0 26 6 7-alpha-hydroxysteroid dehydrogenase 
 UniRef90_Q3Z3B7 20.8 98.9 31 5 Flavoprotein WrbA 
 UniRef90_B7MUC3 26.4 99.1 31 7 Orotidine 5'-phosphate decarboxylase 
 UniRef90_P0AGD5  21.3 99.0 37 6 Superoxide dismutase [Fe] 
 UniRef90_Q57RI5  28.6 98.7 19 4 2,3-bisphosphoglycerate-dependent 
phosphoglycerate mutase 
 UniRef90_Q8FK07  15.9 83.2 16 3 Universal stress protein G 
 UniRef90_B5FI12  15.2 98.7 28 4 Ribosome-binding factor A 
 UniRef90_Q9S5G3  40.3 83.0 5 2 Histidine biosynthesis bifunctional protein HisIE 
 UniRef90_A7MH28 43.3 83.2 6 2 Acetate kinase 
 UniRef90_B5FTC5  27.7 97.9 12 3 Deoxyribose-phosphate aldolase 
 UniRef90_Q9S5G5  40.3 83.0 5 2 Histidine biosynthesis bifunctional protein HisB 
 UniRef90_P0AFU8  23.4 80.7 9 2 Riboflavin synthase alpha chain 
G12 UniRef90_P33570 35.7 99.1 22 7 Transketolase 2 
 UniRef90_A7ZHG6  57.3 99.1 15 7 2-isopropylmalate synthase 
 UniRef90_B5XNU6 19.6 99.1 42 8 UPF0304 protein KPK_1463 
 UniRef90_B7UH18 14.3 99.0 45 6 Autonomous glycyl radical cofactor 
 UniRef90_A7ZHY1  20.8 99.0 30 6 Phosphoheptose isomerase 
 UniRef90_Q57T38 30.4 99.1 27 9 Elongation factor Ts 
 UniRef90_A7ZN88 31.2 98.7 16 4 Molecular chaperone Hsp31 and glyoxalase 3 
 UniRef90_Q9S5G3  22.8 98.1 17 3 Histidine biosynthesis bifunctional protein HisIE 
 UniRef90_A7ZSD0  32.3 98.2 12 3 Malate dehydrogenase 
 
Row H Cluster ID 
MW 
(kDa)* 
Score 
% 
Sequence 
Coverage 
(%) 
# of 
Unique 
Peptides 
Protein Name 
H01 UniRef90_P0AEN0 29.0 99.1 49 11 Cystine-binding periplasmic protein 
 UniRef90_Q57RI5  28.6 99.1 34 8 2,3-bisphosphoglycerate-dependent 
phosphoglycerate mutase 
 UniRef90_A7MQX5 41.4 99.1 31 11 Succinyl-CoA ligase [ADP-forming] subunit beta 
 UniRef90_P0A797 34.8 99.1 27 9 6-phosphofructokinase isozyme 1 
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 UniRef90_P18815 43.4 99.1 25 10 Maltose-binding periplasmic protein 
 UniRef90_P04693 43.5 99.1 21 7 Aromatic-amino-acid aminotransferase 
 UniRef90_P0AD98 39.1 99.0 19 6 Leu/Ile/Val-binding protein 
 UniRef90_P23847 60.3 99.0 15 6 Periplasmic dipeptide transport protein 
 UniRef90_P12758 27.2 98.9 19 5 Uridine phosphorylase 
 UniRef90_P0A252 20.8 98.7 29 4 Alkyl hydroperoxide reductase subunit C 
 UniRef90_P30860 26.8 98.2 12 3 ABC transporter arginine-binding protein 1 
 UniRef90_Q3Z606 35.2 83.1 6 2 Transaldolase 1 
 UniRef90_P0A4L6  23.1 93.4 21 2 Thiol:disulfide interchange protein DsbA 
H02 UniRef90_Q3Z606 35.2 99.1 49 17 Transaldolase 1 
 UniRef90_A8ALC4  29.9 99.1 46 12 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-
succinyltransferase 
 UniRef90_B7LNW7  37.2 99.1 31 11 Outer membrane protein A 
 UniRef90_P0AD98 39.1 99.0 19 7 Leu/Ile/Val-binding protein 
 UniRef90_P0AFM7  25.5 99.0 27 6 Phage shock protein A 
 UniRef90_P0A797 34.8 99.1 22 8 6-phosphofructokinase isozyme 1 
 UniRef90_Q8X505 27.3 98.7 17 4 NADP-dependent L-serine/L-allo-threonine 
dehydrogenase ydfG 
 UniRef90_A7MQX5 41.4 99.0 19 6 Succinyl-CoA ligase [ADP-forming] subunit beta 
 UniRef90_B5QX24 46.0 98.7 8 4 Protein TolB 
 UniRef90_P0AFH9  21.1 98.2 17 3 Osmotically-inducible protein Y 
 UniRef90_P0ACA5  24.3 98.2 17 3 Stringent starvation protein A 
 UniRef90_Q9S5G5  40.3 98.9 13 5 Histidine biosynthesis bifunctional protein HisB 
 UniRef90_P23847 60.3 98.7 8 4 Periplasmic dipeptide transport protein 
 UniRef90_P0AD60 16.9 83.1 10 2 Inhibitor of vertebrate lysozyme 
H03 UniRef90_B7LNW7  37.2 99.1 33 12 Outer membrane protein A 
 UniRef90_P0AEN0 29.0 99.1 41 10 Cystine-binding periplasmic protein 
 UniRef90_A7ZSD0  32.3 99.1 35 10 Malate dehydrogenase 
 UniRef90_P00805 36.9 99.1 25 8 L-asparaginase 2 
 UniRef90_A7ZII0  18.3 99.1 55 8 UPF0234 protein yajQ 
 UniRef90_B5QX24 46.0 99.1 21 7 Protein TolB 
 UniRef90_A7MH28 43.3 99.0 22 6 Acetate kinase 
 UniRef90_P0A957 22.3 99.0 34 6 KHG/KDPG aldolase 
 UniRef90_P0AE20 29.3 99.0 27 6 Methionine aminopeptidase 
 UniRef90_Q9S5G5  40.3 99.0 15 6 Histidine biosynthesis bifunctional protein HisB 
 UniRef90_A7ZUD3  27.0 98.7 17 4 Triosephosphate isomerase 
 UniRef90_A7ZN88 31.2 98.2 12 3 Molecular chaperone Hsp31 and glyoxalase 3 
 UniRef90_P0A6F2  41.4 98.2 9 3 Carbamoyl-phosphate synthase small chain 
 UniRef90_P0A2K8  32.8 83.2 7 2 UTP--glucose-1-phosphate uridylyltransferase 
 UniRef90_A8ALA3  35.2 83.2 6 2 Acetyl-coenzyme A carboxylase carboxyl 
transferase subunit alpha 
 UniRef90_P16657 27.9 83.2 7 2 Enoyl-[acyl-carrier-protein] reductase [NADH] 
FabI 
 UniRef90_P0A4L6  23.1 83.0 10 2 Thiol:disulfide interchange protein DsbA 
 UniRef90_P00509 43.6 68.0 5 2 Aspartate aminotransferase 
H04 UniRef90_Q3Z606 35.2 99.1 55 17 Transaldolase 1 
 UniRef90_P00370 48.6 99.1 33 13 NADP-specific glutamate dehydrogenase 
 UniRef90_P0AEN0 29.0 99.1 41 10 Cystine-binding periplasmic protein 
 UniRef90_A7ZII0  18.3 99.0 45 7 UPF0234 protein yajQ 
 UniRef90_P0AGD5  21.3 99.0 35 6 Superoxide dismutase [Fe] 
 UniRef90_Q8FG52  46.2 99.0 14 6 Histidinol dehydrogenase 
 UniRef90_P0ADE7 16.1 99.0 40 6 Uncharacterized protein ygaU 
 UniRef90_P0AD98 39.1 99.0 19 6 Leu/Ile/Val-binding protein 
 UniRef90_P0C0L2  15.1 98.7 27 4 Peroxiredoxin osmC 
 UniRef90_P00509 43.6 99.0 15 6 Aspartate aminotransferase 
 UniRef90_P04693 43.5 98.7 10 4 Aromatic-amino-acid aminotransferase 
 UniRef90_A8AFH1  27.8 98.0 19 3 tRNA (cmo5U34)-methyltransferase 
 UniRef90_P0ACG0  15.5 98.7 30 4 DNA-binding protein H-NS 
 UniRef90_A7FDW9  44.8 98.2 5 3 UDP-N-acetylglucosamine 1-
carboxyvinyltransferase 
H05 UniRef90_A7MQX5 41.4 99.1 51 19 Succinyl-CoA ligase [ADP-forming] subunit beta 
 UniRef90_A8ACN8  55.2 99.1 33 15 ATP synthase subunit alpha 
 UniRef90_Q57T38 30.4 99.1 46 13 Elongation factor Ts 
 UniRef90_A8ALC4  29.9 99.1 41 11 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-
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succinyltransferase 
 UniRef90_Q8FG52  46.1 99.1 21 8 Histidinol dehydrogenase 
 UniRef90_P09551 28.0 99.1 35 8 Lysine-arginine-ornithine-binding periplasmic 
protein 
 UniRef90_P0A957 22.3 99.0 34 6 KHG/KDPG aldolase 
 UniRef90_A7ZPS1  27.0 99.1 38 8 Phosphoribosylaminoimidazole-
succinocarboxamide synthase 
 UniRef90_P0A9R0 40.0 99.0 19 5 Aspartate-semialdehyde dehydrogenase 
 UniRef90_P04693 43.5 99.0 16 6 Aromatic-amino-acid aminotransferase 
 UniRef90_A8ACN6  50.3 99.0 15 6 ATP synthase subunit beta 
 UniRef90_Q3Z3B7 20.8 98.2 16 3 Flavoprotein WrbA 
 UniRef90_P0AD98 39.1 83.0 5 2 Leu/Ile/Val-binding protein 
H06 NA NA NA   NA 
H07 UniRef90_P00370 48.6 99.1 31 12 NADP-specific glutamate dehydrogenase 
 UniRef90_Q57RI5  28.6 99.1 34 8 2,3-bisphosphoglycerate-dependent 
phosphoglycerate mutase 
 UniRef90_P18815 43.4 99.1 33 12 Maltose-binding periplasmic protein 
 UniRef90_A8ALS4  28.7 99.1 33 7 Dihydrodipicolinate reductase 
 UniRef90_P0AD98 39.1 99.0 21 6 Leu/Ile/Val-binding protein 
 UniRef90_P09551 28.0 99.1 35 8 Lysine-arginine-ornithine-binding periplasmic 
protein 
 UniRef90_P0A6F2  41.4 99.0 19 6 Carbamoyl-phosphate synthase small chain 
 UniRef90_A7ZPU1  22.5 99.0 39 7 Uracil phosphoribosyltransferase 
 UniRef90_P0AFM7  25.5 99.1 34 8 Phage shock protein A 
 UniRef90_A7MH28 43.3 98.9 16 5 Acetate kinase 
 UniRef90_B5QX24 46.0 99.1 18 7 Protein TolB 
 UniRef90_A7ZPS1  27.0 99.0 25 5 Phosphoribosylaminoimidazole-
succinocarboxamide synthase 
 UniRef90_P0A7B0 19.7 99.0 34 6 Inorganic pyrophosphatase 
 UniRef90_A7ZIM8  19.9 98.7 25 4 Adenine phosphoribosyltransferase 
 UniRef90_Q3Z3B7 20.8 98.2 16 3 Flavoprotein WrbA 
 UniRef90_P0A957 22.3 98.7 19 4 KHG/KDPG aldolase 
 UniRef90_A7FDW9  44.8 99.0 13 6 UDP-N-acetylglucosamine 1-
carboxyvinyltransferase 
 UniRef90_P0A9T2 44.2 98.2 7 3 D-3-phosphoglycerate dehydrogenase 
H08 UniRef90_P0ADG8  52.0 99.1 35 11 Inosine-5'-monophosphate dehydrogenase 
 UniRef90_Q3Z606 35.2 99.1 40 13 Transaldolase 1 
 UniRef90_Q7N590 34.2 99.1 34 8 Ribose-phosphate pyrophosphokinase 
 UniRef90_A8ALS4  28.7 99.1 34 7 Dihydrodipicolinate reductase 
 UniRef90_P23847 60.3 99.1 19 10 Periplasmic dipeptide transport protein 
 UniRef90_P00509 43.6 99.1 32 12 Aspartate aminotransferase 
 UniRef90_Q3Z3B7 20.8 98.9 31 6 Flavoprotein WrbA 
 UniRef90_P0AD98 39.1 99.0 19 6 Leu/Ile/Val-binding protein 
 UniRef90_A8ACN8  55.2 99.1 15 7 ATP synthase subunit alpha 
 UniRef90_A7ZUD3  27.0 98.9 21 6 Triosephosphate isomerase 
 UniRef90_P0AFH9  21.1 98.7 22 4 Osmotically-inducible protein Y 
 UniRef90_A7ZH92 33.6 99.1 22 7 Homoserine kinase 
 UniRef90_P0A9R0 40.0 98.7 15 4 Aspartate-semialdehyde dehydrogenase 
 UniRef90_P04693 43.5 98.7 11 4 Aromatic-amino-acid aminotransferase 
 UniRef90_P60596 21.6 98.1 15 3 Imidazole glycerol phosphate synthase subunit 
HisH 
H09 UniRef90_A8ALC4  29.9 99.1 46 12 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-
succinyltransferase 
 UniRef90_A7ZSD0  32.3 99.1 42 10 Malate dehydrogenase 
 UniRef90_P0AD98 39.1 99.0 19 6 Leu/Ile/Val-binding protein 
 UniRef90_P0A252 20.8 98.9 38 5 Alkyl hydroperoxide reductase subunit C 
 UniRef90_B7UH18 14.3 99.0 46 5 Autonomous glycyl radical cofactor 
 UniRef90_A7ZH92 33.6 99.0 20 6 Homoserine kinase 
 UniRef90_P0AGD5  21.3 99.0 37 6 Superoxide dismutase [Fe] 
 UniRef90_A7ZPS1  27.0 98.8 23 4 Phosphoribosylaminoimidazole-
succinocarboxamide synthase 
 UniRef90_P0A9R0 40.0 98.7 14 4 Aspartate-semialdehyde dehydrogenase 
 UniRef90_P0A7B0 19.7 99.0 34 6 Inorganic pyrophosphatase 
 UniRef90_P0AEU2 28.5 98.2 14 3 Histidine-binding periplasmic protein 
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 UniRef90_A7MQX5 41.4 87.3 8 2 Succinyl-CoA ligase [ADP-forming] subunit beta 
 UniRef90_P00805 36.9 83.2 6 2 L-asparaginase 2 
H10 UniRef90_Q3Z606 35.2 99.1 49 16 Transaldolase 1 
 UniRef90_B7LNW7  37.2 99.1 35 12 Outer membrane protein A 
 UniRef90_P33570 35.7 99.1 29 12 Transketolase 2 
 UniRef90_Q7N590 34.2 99.1 32 7 Ribose-phosphate pyrophosphokinase 
 UniRef90_P12758 27.2 99.0 26 6 Uridine phosphorylase 
 UniRef90_P0AEU2 28.5 98.9 28 5 Histidine-binding periplasmic protein 
 UniRef90_P21599 51.4 98.9 10 5 Pyruvate kinase II 
 UniRef90_P23847 60.3 98.7 8 4 Periplasmic dipeptide transport protein 
 UniRef90_P0AF94  13.6 98.2 24 3 Enamine/imine deaminase 
 UniRef90_P0A7B0 19.7 98.8 27 4 Inorganic pyrophosphatase 
 UniRef90_A8ACN8  55.2 82.8 6 2 ATP synthase subunit alpha 
 UniRef90_A7ZUD3  27.0 70.7 7 2 Triosephosphate isomerase 
H11 UniRef90_P0AEN0 29.0 99.1 41 10 Cystine-binding periplasmic protein 
 UniRef90_P33570 35.7 99.1 34 13 Transketolase 2 
 UniRef90_B7LNW7  37.2 99.1 21 8 Outer membrane protein A 
 UniRef90_Q57T38 30.4 99.1 33 9 Elongation factor Ts 
 UniRef90_P0ABZ8 47.3 99.1 22 8 Chaperone SurA 
 UniRef90_A7ZPU1  22.5 99.0 36 7 Uracil phosphoribosyltransferase 
 UniRef90_A7ZPS1  27.0 99.0 30 6 Phosphoribosylaminoimidazole-
succinocarboxamide synthase 
 UniRef90_B7UH18 14.3 99.1 65 6 Autonomous glycyl radical cofactor 
 UniRef90_Q3Z3B7 20.8 98.9 31 4 Flavoprotein WrbA 
 UniRef90_P0C0L2  15.1 98.2 20 3 Peroxiredoxin osmC 
 UniRef90_A7ZPZ4  45.3 98.1 6 3 Serine hydroxymethyltransferase 
 UniRef90_P0A957 22.3 82.7 8 2 KHG/KDPG aldolase 
H12 NA NA NA NA NA NA 
*MW values were calculated from their amino acid sequence, derived from the accession no., using 
the ExPASy Compute pI/MW tool [103] 
 
Table B 4. Identified MG1655 Proteins (Singlet). A 96-well plate with 1 gel piece per well. The 
table displays the identifications in each well as analyzed using PEAKS. Highlighted in green are 
protein IDs that were also confirmed in the multiplex plate, refer to Table 3-4. Samples where 
identification was unsuccessful are denoted as NA. 
 
Spot 
Id 
Cluster ID 
MW 
(kDa)* 
pI* 
Score 
% 
Sequence 
Coverage 
(%) 
# of 
Unique 
Peptides 
Protein Name 
A01 4212 NA NA NA NA NA NA NA 
A02 2506 UniRef90_P18815 38.9 5.3 99.0 22 7 Maltose-binding periplasmic 
protein 
A03 1512 UniRef90_P66794 35.0 5.2 99.0 19 6 Selenide, water dikinase 
  UniRef90_P58603 35.0 5.2 99.0 21 6 Protease 7 
A04 3506 UniRef90_P00888 37.9 5.5 98.2 8 3 Phospho-2-dehydro-3-
deoxyheptonate aldolase, Tyr-
sensitive  
  UniRef90_A8AIH6  37.9 5.5 83.0 6 2 Phosphoserine aminotransferase 
A05 2705 NA NA NA NA NA NA NA 
A06 2516 UniRef90_A7ZHR7 35.1 5.3 99.0 12 10 Outer membrane protein assembly 
factor BamA 
  UniRef90_P0A797 35.1 5.3 99.0 16 6 6-phosphofructokinase 
  UniRef90_A8AIH6  35.1 5.3 82.4 6 2 Phosphoserine aminotransferase 
A07 3511 UniRef90_P27833 39.7 5.7 98.2 9 3 Lipopolysaccharide biosynthesis 
protein RffA 
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  UniRef90_Q0T204 39.7 5.7 98.2 8 3 4-hydroxy-3-methylbut-2-en-1-yl 
diphosphate synthase 
  UniRef90_P0A9K5  39.7 5.7 82.6 5 2 PhoH-like protein 
A08 3209 UniRef90_P22731 26.3 5.6 83.2 14 2 High-affinity branched-chain amino 
acid transport ATP-binding protein 
LivF 
A09 2519 UniRef90_P04693 41.3 5.3 98.2 8 3 Aromatic-amino-acid 
aminotransferase 
A10 2220 UniRef90_A7ZPU1  22.5 5.3 98.2 12 4 Uracil phosphoribosyltransferase 
A11 4211 UniRef90_P75736 26.7 6.0 98.7 18 4 Esterase ybfF 
A12 4720 NA NA NA NA NA NA NA 
B01 1024 UniRef90_A8AK39  15.3 5.2 83.3 18 2 6,7-dimethyl-8-ribityllumazine 
synthase 
B02 1602 UniRef90_B5Y275 44.6 5.2 83.0 5 2 Phosphopentomutase 
B03 1109 UniRef90_P0A9W9  20.7 5.2 99.0 38 6 Protein YrdA 
B04 1116 NA NA NA NA NA NA NA 
B05 3211 UniRef90_P59735 27.1 5.7 98.9 22 5 3'(2'),5'-bisphosphate nucleotidase 
CysQ 
  UniRef90_A7ZUD3  27.1 5.7 83.0 12 2 Triosephosphate isomerase 
B06 4602 NA NA NA NA NA NA NA 
B07 4704 UniRef90_P0ADG8  59.1 6.0 99.0 15 6 Inosine-5'-monophosphate 
dehydrogenase 
  UniRef90_P23847 59.1 6.0 98.3 7 3 Periplasmic dipeptide transport 
protein 
B08 3202 UniRef90_P12758 27.2 5.4 98.1 11 3 Uridine phosphorylase 
  UniRef90_P30843 27.2 5.4 87.3 17 2 Transcriptional regulatory protein 
BasR 
B09 706 UniRef90_P77804 54.6 5.1 98.2 6 3 Protein ydgA 
B10 2012 NA NA NA NA NA NA NA 
B11 3512 UniRef90_A7MH28 43.6 5.7 82.9 6 2 Acetate kinase 
  UniRef90_Q8X4S6  43.6 5.7 82.9 5 2 Acetylornithine/succinyldiaminopi
melate aminotransferase 
B12 3806 NA NA NA NA NA NA NA 
C01 4808 NA NA NA NA NA NA NA 
C02 3011 UniRef90_P0AF94  10.9 5.6 98.2 24 3 Enamine/imine deaminase 
C03 2314 UniRef90_P0AEJ3 31.0 5.3 98.7 11 4 Isochorismate synthase entC 
  UniRef90_P58603 31.0 5.3 99.0 27 8 Protease 7 
C04 2311 UniRef90_A8ALC4  34.5 5.3 99.0 33 9 2,3,4,5-tetrahydropyridine-2,6-
dicarboxylate N-succinyltransferase 
  UniRef90_P0ADS7 34.5 5.3 98.9 19 5 Uncharacterized protein yggE 
C05 4714 NA NA NA NA NA NA NA 
C06 4206 UniRef90_P76034 27.8 6.0 99.0 32 7 Uncharacterized HTH-type 
transcriptional regulator YciT 
  UniRef90_P09126 27.8 6.0 99.0 30 7 Uroporphyrinogen-III synthase 
  UniRef90_Q57RI5  27.8 6.0 98.1 13 3 2,3-bisphosphoglycerate-dependent 
phosphoglycerate mutase 
  UniRef90_A7ZIN4  27.8 6.0 82.5 19 2 Adenylate kinase 
C07 4804 UniRef90_P46837 85.1 6.0 98.7 5 4 Protein yhgF 
C08 2518 UniRef90_P0AEJ3 43.0 5.3 98.9 13 5 Isochorismate synthase entC 
C09 4313 NA NA NA NA NA NA NA 
C10 3102 UniRef90_P67097 21.3 5.4 98.2 23 3 Phosphodiesterase yfcE 
C11 3505 UniRef90_P00509 39.4 5.5 99.1 33 13 Aspartate aminotransferase 
  UniRef90_Q0T204 39.4 5.5 99.1 25 9 4-hydroxy-3-methylbut-2-en-1-yl 
diphosphate synthase 
  UniRef90_A8AKV5  39.4 5.5 98.9 15 5 tRNA (uracil(54)-C(5))-
methyltransferase 
  UniRef90_P07023 39.4 5.5 98.7 10 4 T-protein 
  UniRef90_P76223 39.4 5.5 98.4 10 3 Protein ynjB 
  UniRef90_P27830 39.4 5.5 82.6 6 2 dTDP-glucose 4,6-dehydratase 2 
C12 1120 UniRef90_P0AGD5  21.6 5.2 98.1 14 3 Superoxide dismutase [Fe] 
D01 4415 UniRef90_P22715 35.0 6.1 98.0 9 3 UDP-glucose 4-epimerase 
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D02 4505 UniRef90_A7ZVR0 35.1 6.0 98.7 12 4 Ribosomal RNA small subunit 
methyltransferase C 
  UniRef90_B7US97 35.1 6.0 82.5 8 2 Phenylalanine--tRNA ligase alpha 
subunit 
D03 2612 UniRef90_A1AC10  43.9 5.3 99.0 19 7 Phosphoribosylglycinamide 
formyltransferase 2 
  UniRef90_A8AIH5  43.9 5.3 82.7 5 2 3-phosphoshikimate 1-
carboxyvinyltransferase 
D04 3801 UniRef90_Q8XEG2 66.8 5.4 80.7 3 2 Glucosamine--fructose-6-phosphate 
aminotransferase [isomerizing] 
D05 2217 UniRef90_A1AIG4  22.5 5.3 83.1 11 2 Thiamine-phosphate synthase 
D06 505 UniRef90_B5Y275 43.7 5.1 98.7 11 4 Phosphopentomutase 
D07 3510 UniRef90_A7MH28 43.0 5.6 83.0 6 2 Acetate kinase 
  UniRef90_B5QX24 43.0 5.6 83.0 4 2 Protein TolB 
  UniRef90_Q9S5G5  43.0 5.6 82.9 5 2 Histidine biosynthesis bifunctional 
protein HisB 
D08 3220 UniRef90_A7FGQ6  27.0 5.9 99.0 34 7 NADH-quinone oxidoreductase 
subunit B 
  UniRef90_P0AEN0 27.0 5.9 97.1 9 2 Cystine-binding periplasmic protein 
D09 2507 UniRef90_A7MQX
5 
41.6 5.3 99.1 32 11 Succinyl-CoA ligase [ADP-
forming] subunit beta 
  UniRef90_P0AEJ3 41.6 5.3 99.1 25 9 Isochorismate synthase entC 
D10 3518 UniRef90_P0AF09  38.3 5.8 99.0 19 6 Protein mrp 
  UniRef90_B7MG93 38.3 5.8 82.6 6 2 Chorismate synthase 
D11 1412 UniRef90_P0AEX1 34.8 5.2 98.2 8 3 1-phosphofructokinase 
D12 1706 NA NA NA NA NA NA NA 
E01 705 NA NA NA NA NA NA NA 
E02 4511 UniRef90_A7ZI01  37.6 6.0 99.0 16 6 Glutamate 5-kinase 
  UniRef90_P0A9S4  37.6 6.0 81.9 6 2 Galactitol-1-phosphate 5-
dehydrogenase 
E03 3709 UniRef90_P0ADG8  59.5 5.8 98.7 11 4 Inosine-5'-monophosphate 
dehydrogenase 
E04 4315 UniRef90_A8ADK6  34.5 6.0 99.0 21 6 Glucokinase 
E05 2707 NA NA NA NA NA NA NA 
E06 217 UniRef90_P67271 24.4 5.1 83.1 13 2 UPF0135 protein ybgI 
E07 3018 UniRef90_Q46868 12.5 5.7 98.2 25 3 Uncharacterized protein yqiC 
E08 210 UniRef90_Q32EF3 23.2 5.1 98.7 18 4 1-(5-phosphoribosyl)-5-[(5-
phosphoribosylamino)methylidenea
mino] imidazole-4-carboxamide 
isomerase 
E09 2510 UniRef90_P00509 42.4 5.3 98.9 12 5 Aspartate aminotransferase 
  UniRef90_P0AD98  42.4 5.3 98.5 13 3 Leu/Ile/Val-binding protein 
E10 2316 UniRef90_Q8FF18  30.5 5.3 98.2 14 3 Pyridoxine 5'-phosphate synthase 
E11 4309 UniRef90_P0AEZ1  34.3 6.0 98.9 20 5 5,10-methylenetetrahydrofolate 
reductase 
E12 2512 UniRef90_P09029 35.1 5.3 99.0 17 5 N5-carboxyaminoimidazole 
ribonucleotide synthase 
  UniRef90_Q8X732 35.1 5.3 98.2 8 3 N-acetyl-gamma-glutamyl-
phosphate reductase 
  UniRef90_P58603 35.1 5.3 98.2 8 3 Protease 7 
F01 4202 NA NA NA NA NA NA NA 
F02 219 UniRef90_A8ALC9  25.9 5.1 98.2 18 3 5'-methylthioadenosine/S-
adenosylhomocysteine nucleosidase 
F03 3410 NA NA NA NA NA NA NA 
F04 2002 NA NA NA NA NA NA NA 
F05 4705 UniRef90_P07003 62.0 6.0 98.7 7 4 Pyruvate dehydrogenase 
[ubiquinone] 
F06 4701 UniRef90_A8ACN8  57.8 5.9 99.1 18 8 ATP synthase subunit alpha 
  UniRef90_P0ADG8  57.8 5.9 82.8 5 2 Inosine-5'-monophosphate 
dehydrogenase 
  UniRef90_P23847 57.8 5.9 98.7 8 4 Periplasmic dipeptide transport 
protein 
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F07 4713 UniRef90_P0ADG8  59.6 6.0 99.0 15 6 Inosine-5'-monophosphate 
dehydrogenase 
  UniRef90_P0ACE1 59.6 6.0 98.9 10 5 Hydrogenase-2 large chain 
F08 2408 UniRef90_A7ZTA0  35.0 5.3 83.1 8 2 Glyoxylate/hydroxypyruvate 
reductase B 
F09 2808 NA NA NA NA NA NA NA 
F10 2701 UniRef90_P25526 52.9 5.2 98.7 8 4 Succinate-semialdehyde 
dehydrogenase [NADP(+)] GabD 
F11 4307 UniRef90_P0AEZ1  33.1 6.0 98.9 16 5 5,10-methylenetetrahydrofolate 
reductase 
F12 4004 UniRef90_A8API1  11.0 5.9 83.0 20 2 Probable Fe(2+)-trafficking protein 
G01 1407 UniRef90_Q57T38 34.7 5.2 99.0 33 10 Elongation factor Ts 
G02 4303 UniRef90_P02925 29.0 5.9 98.9 21 5 D-ribose-binding periplasmic 
protein 
G03 2611 UniRef90_P0C8J9 50.2 5.3 99.0 17 7 D-tagatose-1,6-bisphosphate 
aldolase subunit gatZ 
G04 1203 UniRef90_A1AFA2  22.4 5.2 98.9 27 5 Ribose-5-phosphate isomerase A 
G05 1011 UniRef90_P0A919 16.4 5.2 98.2 22 3 Outer membrane protein X 
G06 8 NA NA NA NA NA NA NA 
G07 2009 NA NA NA NA NA NA NA 
G08 4111 UniRef90_A7ZHY1  21.8 6.0 99.1 51 9 Phosphoheptose isomerase 
G09 1101 NA NA NA NA NA NA NA 
G10 116 UniRef90_P0A252 21.2 5.1 98.7 29 4 Alkyl hydroperoxide reductase 
subunit C 
G11 1610 UniRef90_A8AIH5  44.0 5.2 99.1 24 10 3-phosphoshikimate 1-
carboxyvinyltransferase 
  UniRef90_B7N6B0 44.0 5.2 82.7 5 2 Peptidase B 
G12 4118 UniRef90_B5XNU6 19.4 6.1 99.0 42 8 UPF0304 protein KPK_1463 
H01 2013 NA NA NA NA NA NA NA 
H02 2509 NA NA NA NA NA NA NA 
H03 3006 NA NA NA NA NA NA NA 
H04 4214 UniRef90_Q57RI5  28.1 6.0 99.0 34 8 2,3-bisphosphoglycerate-dependent 
phosphoglycerate mutase 
H05 2301 UniRef90_A7ZH92  34.4 5.2 99.0 22 7 Homoserine kinase 
  UniRef90_A8ALG8  34.4 5.2 98.2 13 3 Spermidine synthase 
  UniRef90_A8ALC4  34.4 5.2 98.2 12 3 2,3,4,5-tetrahydropyridine-2,6-
dicarboxylate N-succinyltransferase 
H06 3704 NA NA NA NA NA NA NA 
H07 1507 NA NA NA NA NA NA NA 
H08 309 NA NA NA NA NA NA NA 
H09 4506 UniRef90_B5QX24 42.3 6.0 99.1 25 9 Protein TolB 
  UniRef90_Q9S5G5  42.3 6.0 99.0 20 7 Histidine biosynthesis bifunctional 
protein HisB 
  UniRef90_A7MH28 42.3 6.0 98.2 12 3 Acetate kinase 
  UniRef90_P08390 42.3 6.0 82.7 7 2 USG-1 protein 
  UniRef90_P00509 42.3 6.0 82.7 6 2 Aspartate aminotransferase 
H10 5 NA NA NA NA NA NA NA 
H11 2109 UniRef90_Q3Z3B7 22.2 5.3 99.0 40 7 Flavoprotein WrbA 
  UniRef90_P0A957 22.2 5.3 98.7 20 4 KHG/KDPG aldolase 
  UniRef90_P60596 22.2 5.3 98.6 23 4 Imidazole glycerol phosphate 
synthase subunit HisH 
H12 2115 UniRef90_P0A4L6  21.7 5.3 98.2 13 3 Thiol:disulfide interchange protein 
DsbA 
  UniRef90_A7ZIJ5  21.7 5.3 82.6 7 2 ATP-dependent Clp protease 
proteolytic subunit 
*MW and pI of the identified proteins were estimated from their gel locations and compared to 
calculated values using ExPASy Compute pI/MW tool [104].  
 
